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Ultrahigh-Throughput Microfluidic Droplet Screening of
Metagenomic Libraries for Esterases and Kemp Eliminases
Philip Mair
In the search for new enzymes, functional metagenomic libraries are particularly inter-
esting since they give access to the genomes of the 99% of microorganisms which cannot
be cultured in the laboratory. However, using classical biochemical assays to screen such li-
braries is impeded by the fact that enzymes for a given reaction are incredibly rare (1 in 105 on
average). Ultrahigh-throughput dropletmicrofluidics has emerged as an effective technology
to overcome this limitation, with the ability to screen 107 reactions per day. However, fewer
than ten enzyme assays have been implemented in droplets to date and only once has droplet
microfluidics been applied to functional metagenomics. Therefore, for the wider adoption
of this technology, it is critical to develop more enzyme assays in droplets.
To address this need, first I built an ultrahigh-throughput droplet sorting instrument
and then set out to establish two new enzyme assays in droplets: one for the industrially-
important esterase reaction and another for the Kemp elimination, an artificial reaction.
In Chapter 2, I describe the state-of-the-art fluorescence-activated droplet sorter (FADS)
I developed for use with fluorogenic enzyme substrates. I improved this instrument incre-
mentally based on the needs of collaborative projects, which ensured the success of these
projects in screening enzyme libraries.
In Chapter 3, I established an esterase assay and performed the first reported functional
metagenomic screen for esterases in droplets. Over 30million droplets were sorted, amount-
ing to 10× coverage of a metagenomic library consisting of over one million members; mak-
ing this the largest esterase screen performed to date. Twelve clones encoding thirteen novel
esterases were isolated. The majority were members of the α/β-hydrolase super-family of
proteins. Four came from small families taking up less than 1% of the sequence space within
the super-family. Therefore, functional screening at ultrahigh-throughput provided access
to thinly populated sequence-space. It is unlikely that these sequences would have been ex-
plored using prediction-based methods. Eight out of eleven enzymes had detectable thio-
esterase activity, three had β-lactamase activity, one had β-galactosidase activity, and one
had Kemp eliminase activity. This finding corroborates the idea that the ability of enzymes
to catalyse more than one reaction, a property called enzyme promiscuity, is widespread.
In Chapter 4, I established a Kemp eliminase assay in droplets with the aim of exploring
how widespread promiscuous enzymes catalysing this non-natural reaction are. Using the
substrate 5-nitro-1,2-benzisoxazole in combination with absorbance-activated droplet sort-
ing (AADS). I describe the enrichment of a previously reported Kemp eliminase, HG3.17,
viii
over a negative control using droplet microfluidics and use this method to screen substitu-
tion, insertion and deletion libraries ofHG3.17. Active library variants were enriched and the
variants with improved soluble expression isolated. Five locations were identified that toler-
ate insertions and deletions and, in one investigated case, have improved soluble expression.
These variants may serve as starting points to explore previously inaccessible mutational tra-
jectories to improve the catalytic parameters of HG3.17. Due to the limited sensitivity of the
assay, functional metagenomic screening was not possible using this substrate.
In Chapter 5, I report the newly-discovered fluorogenic Kemp substrate 5-azido-1,2-
benzisoxazole, reported and characterised here for the first time. I established this substrate
in droplets and, using the FADS instrument, enriched the Kemp eliminase HG3.17 over a
negative control. This assay was sufficiently sensitive to detect Kemp eliminase activity in a
metagenomic library. The apparent hit rate was comparable to that of the esterases, suggest-
ing that promiscuous enzymes capable of catalysing this reaction are commonplace. A large
number of false positives impeded the straightforward isolation of the responsible library
members. This constraint is likely to be overcome in future by using a bias-free metage-
nomic library. Here, a combination of functional re-screening and sequencing allowed the
identification of one lead: a predicted class IV adenylyl cyclase.
In conclusion, I have built a highly sensitive droplet sorting instrument using which I
isolated thirteen new esterases, established the first Kemp eliminase assay in droplets, used
both for mutant library and metagenomic screening, and additionally enabled the improve-
ment of numerous enzymes through library screenings in collaboration with others. This
work contributes to the success of ultrahigh-throughput droplet microfluidics in furthering




1. Die Welt ist alles, was der Fall ist.
2. Was der Fall ist, die Tatsache, ist das Bestehen von Sachverhalten.
3. Das logische Bild der Tatsachen ist der Gedanke.
4. Der Gedanke ist der sinnvolle Satz.
5. Der Satz ist eine Wahrheitsfunktion der Elementarsätze.
(Der Elementarsatz ist eine Wahrheitsfunktion seiner selbst.)
6. Die allgemeine Form der Wahrheitsfunktion ist: [p,ξ,N(ξ)].
Dies ist die allgemeine Form des Satzes.
7. Wovon man nicht sprechen kann, darüber muss man schweigen.
Tractatus Logico-Philosophicus, Ludwig Wittgenstein
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Enzymes drive the chemistry of life. From the original capture of inorganic compounds fun-
damental to life to their eventual release back into the environment, enzymes are involved
in every step of the way. In this introduction, I will convince the reader that the discovery of
enzymes remains an important enterprise given the sometimes surprising chemical transfor-
mations they are able to catalyse. Even for simpler chemistries, such as the hydrolysis of es-
ters, new enzymes are increasingly sought after to help our industrial processes becomemore
sustainable. I will explain that the screening of metagenomes, i.e. the screening of pooled
genomes rather than a single one, has emerged as a powerful tool to discover new enzymes.
However, the hit rates in functionalmetagenomics are low and the screening throughput lim-
ited. Thus, I will argue that combining functional metagenomics with droplet microfluidics,
a method with ultrahigh-throughput, is attractive to enhance the outcomes of such screening
campaigns. I will therefore describe the development of new assays for two reactions, ester
hydrolysis and the Kemp elimination, to discover enzymes in the metagenome.
1.1 Enzymes
Enzymes are outstanding catalysts which drive all chemical reactions sustaining life on earth.
Beyond their importance in nature, they are attractive for use in chemical synthesis given
their distinct advantages over chemical catalysts: high turnover frequencies (107 s-1), high
degree of selectivity (enantio-, regio- and chemoselectivity), mild reaction conditions, and
environmental friendliness [1]. Despite these advantages, the list of chemical transforma-
tions for which off-the-shelf enzymes are readily available is currently limited. The discov-
ery of enzymes for new reactions has been constrained mostly by the failure to find them
rather than the natural biodiversity: there are more enzymes to be discovered than there
are known [2]. The one gene-one enzyme hypothesis formulated in the 20th century was
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fundamental to the inception of molecular biology [3]. Implicit in this hypothesis was, that
one enzyme is linked to one function. It is now known, that most enzymes are likely to be
promiscuous, i.e. they catalyse several reactions and not just the chief one they evolved for,
which further increases the chance of finding enzymes for a given reaction [4].
Enzyme promiscuity
Enzyme promiscuity allows chemists to use enzymes for their own purpose. In a typical ap-
plication, an enzyme is employed for a reaction close to its natural activity as in the case of
the ω-transaminase used in the production of the antidiabetic drug sitagliptin on an indus-
trial scale [5]. This approach relies on the ability of an enzyme to catalyse the transformation
of several substrates including the one of interest. This so-called substrate promiscuity can
be used as a handle to engineer the enzyme towards enhanced activity on the synthetic sub-
strate if needed. Enzymes also exhibit catalytic promiscuity, i.e. the ability to catalyse differ-
ent chemical reactions, which was first conceptualised in mechanistic terms by O’Brien and
Herschlag [6].
1.1.1 How to find an enzyme
Discovery of new enzyme activities has been limited by the difficulty to access the full range
of natural diversity. To find a biocatalyst for a specific process, for example the making or
breaking of an ester bond, four major approaches are possible: protein engineering, compu-
tational design, database mining, and metagenomics (Figure 1.1).
Engineering. If an enzyme is available for the wanted reaction, but does not meet the set
performance criteria, protein engineering technologies are used to adapt or enhance enzymes
for the reaction under the needed solvent, temperature, and substrate load conditions. Both
rational (re)-design and directed evolution have been used to tailor enzyme properties [7, 8].
In directed evolution, a library of gene variants is created by random mutagenesis, e.g. by
error-prone PCR, followed by selection of phenotypically superior mutants. The selected
gene variants are then subjected to the same process, thus completing several cycles of varia-
ton, selection, and amplification [9]. The evolutionary approach requires functional expres-
sion of the enzyme and a robust screening or selection strategy but not necessarily a high
degree of insight into the enzyme’s mechanism of action. Detailed characterisation of the
enzyme is needed in rational design and re-purposing. Even if often guided by “chemical
intuiton”, the structure and a detailed understanding of the catalytic mechanism are needed
to identify residues for mutation and potential catalytic activites to explore [10].
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Fig. 1.1 There are four major sources for new enzymes: engineering of existing proteins,
design of new catalysts, database mining, and metagenomics.
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Design. If there is no biocatalyst available that can be modified, an enzyme can be created
in rare cases. Enzymes have been generated by arranging amino acids around a calculated
transition state and docking this arrangement into pre-existing protein scaffolds. As was the
case for Kemp eliminases, retro-aldolases, and diels-alderases [11–13]. These are catalysts by
design, a concept once dubbed the “Holy Grail” of chemistry by Wong and Whitesides [14].
While the crystal structure of these enzymes was close to the intended design (within 1Å)
and catalytic activity was detectable, the initial catalytic efficiencies were low (the highest
was 103 M−1s−1 for the Kemp eliminase HG3 [15]). The enzymes needed improvement by
directed evolution to reach activities reminiscent of natural catalysts [16]. As long as this
limitation persists, the screening of the natural biodiversity for functional catalysts remains
an attractive alternative.
Mining. One cost-effective way to screen the natural diversity is tomine databases in silico.
Sequence databases are growing rapidly due to massive next-generation sequencing efforts
[17]. The PFAM database (PFAM 31.0, March 2017) distinguishes 16,712 protein families of
which 3918 are classified as domains of unknown function (DUFs) [18, 19]. This illustrates
just howmuch chemistry may yet be discovered with over 20% of protein families not having
a known function at all. However, functional annotation in databases is based on sequence
homology, which itself is inferred from similarity between the new and previously-assigned
sequences [20], see also Section 1.4. Therefore, the success of database mining depends on
the existence and accuracy of previous assignments. Errors in databases can be misguiding.
Recently, the first enzyme catalysing N-N bond formation was found by sequence analysis of
biosynthetic gene clusters. Its sequence had beenmis-annotated as a transcriptional regulator
with a flavin binding domain in the database. The enzyme, found to use a heme cofactor,
was not a regulator and catalysed this unusual reaction [21, 22]. As in this study by Du et
al., database mining can be guided by natural compounds containing an unusual chemical
moiety and their associated gene clusters. Identifying homologous, uncharacterised genes
that appear in all the clusters and testing them may yield enzymes with truly novel catalytic
properties. However, such an approach requires extensive knowledge of natural compounds
and their respective gene clusters.
Metagenomics. The only way to avoid pre-selective assumptions regarding either the se-
quence, structure, or mechanism of the desired catalyst would be by performing a direct
biochemical test on a library of expressed proteins. Accessing the natural biodiversity in this
way has become possible thanks to functional metagenomics and will be discussed in more
detail in the following section.
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It was long noted in microbiology that only a fraction of the microorganisms from any envi-
ronment could be cultured under laboratory conditions. The effect was known as “the great
plate count anomaly”, referring to the fact that the number of colonies growing on a culture
plate was, in the best of cases, only 1% of the number of cells observed under the microscope
[23]. This led to the development of culture-independent methods to study the diversity of
microorganisms based on the direct sequencing of genetic material isolated from an envi-
ronment.
1.2.1 Early studies and metagenomic sequencing
Inspired by the groundbreakingwork of CarlWoese on ribosomal RNA (rRNA) as a phyloge-
netic marker, early studies on microbial diversity focused on the genes encoding 16S rRNA
[24, 25]. These efforts led to the creation of the first recombinant DNA library containing
genetic material from a mixed population of organisms rather than a single one [26]. In the
latter study, 15 unique rRNA sequences were found in a library from the Sargasso Sea of
which 2 were from previously unknown phyolgenetic groups.
The development of shot-gun next generation sequencing revolutionised the field. In
2004, a single such study (again of the Sargasso Sea) found at least 1800 genomic species
with 148 constituting new phylotypes [27]. Importantly, the power of next generation se-
quencing allowed the shift towards the analysis of existing genes and their frequencies in a
given environment. It also opened the door to the discovery of novel genes. The 2004 Sar-
gasso Sea study alone reported over one million previously unknown genes [27]. To date, al-
most 34,000 projects and near to 800,000 samples associated with metagenomic sequencing
were deposited on the BioProject and Biosamples database of National Center for Biotech-
nology Information (NCBI).1 Most of the projects are very recent: 80% of the 50,000metage-
nomic sequencing projects on the manually-curated genome online database (GOLD) were
deposited while this thesis was carried out, i.e. in the last three years [28].
These sequencing projects yielded some notable discoveries. Beja et al. identified the
proteorhodopsins of marine bacteria [29]. These proteins are homologoues of bacterio-
rhodopsin, a light-driven proton-pump which was previously thought to only exist in ar-
chaea. Similarly, ammonium monooxygenases, which were previously thought to only exist
in bacteria, were discovered in archaea [30]. Both findings had a major impact on their re-
spective fields of research. However, they were also only possible due to the existence of
homologous sequences associated with a known, i.e. experimentally verified, function. To
1As of September 2018. The search term used was “metagenom*”.
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discover genuinely novel enzymes, approaches solely based on sequencing are unsuitable a
priori. By reviewing the literature, Ferrer et al. found that while only 200 new enzymes were
discovered and characterised using sequencing based methods, almost 6,000 had been iso-
lated using a functional metagenomic approach [31].
1.2.2 Functional metagenomic screening
Metagenomic libraries are constructed in analogy to classical genomic libraries. A general
workflow is shown in Figure 1.2. The DNA of interest is extracted and purified from an
environmental sample. It is then physically fragmented or enzymatically digested and ligated
to a vector for transformation into a host organism [32]. The constructed library is then
subjected to a functional assay to detect hits, i.e. clones that exhibit the desired activity. The
most frequent type of assay is a phenotypic screen, for example the formation of a clear zone
around a colony on a skimmed-milk plate for protease activity [33]. Another approach is
heterologous complementation, where the host lacks a functionwhich is essential for survival
or detectable growth which can then complemented by the recombinant DNA [33]. Healy
et al. reported the first functional metagenomic screen [34]. They isolated DNA from an
anaerobic digester, cloned it into the vector pUC19, transformed it into E. coli, and screened
15,000 colonies using a plate assay for cellulase activity. They detected 23 clones, but reported
only one new sequence. This study is still representative of the typical hit rate of a functional
metagenomic screen: 10−5 to 10−4 [31]. Besides the chosen environment and quality of
the extracted DNA, the number of hits obtained from a screening is affected by three major
factors: the library format (i.e. the chosen vector), the efficiency of heterologous expression,
and the throughput of the detection assay.
Vector system. Libraries fall into two principal categories: small insert libraries up to 10
kbp in plasmids and large insert libraries at 40 kbp in fosmids or cosmids (or even larger
inserts in bacterial artificial chromosomes) [35]. Smalller inserts are more likely to be tran-
scribed effectively due to higher copy numbers and possible transcription from the promoter
of the vector. This helps to detect weakly expressed metagenomic genes [35, 36]. Larger in-
sert libraries allow the detection of large genes and gene clusters, a smaller number of clones
is required to screen a set number of genes, and the insert size is more consistent thus re-
ducing cloning biases [37]. However, they rely more on transcription from within the DNA
insert rather than the vector and have lower copy numbers.
Expression host. As implied above, either library format relies on the host organism’s abil-
ity to transcribe foreign DNA. Transcription was shown to be enhanced by randomly in-
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Fig. 1.2 A general workflow for the functional screening of a metagenomic library. Once the
metagenomic DNA is extracted, there are three major decisions to make that influence the
success of a screening campaign: which vector to use to construct the library, which host
organism to express the library in, and which assay to use to detect the desired enyzmatic
activity.
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troducing promoter sequences into the metagenomic DNA [38, 39], by using bidirectional
transcription [40], or by introducing heterologous σ-factors into E. coli [41]. However, tran-
scription is only the first step in the expression of a functional protein. The translation ma-
chinery, the absence of required post-translational factors such as chaperones, and toxicity
to the chosen host may be limiting access to new enzymes [33, 42]. The use of different
hosts such as B. subtilis can lead to the identification of different hits [43], or improved hit
rates if the aim is specific, such as finding thermostable enzymes using T. thermophilus as a
host [44]. An entirely new class of enzymes was discovered using heterologous expression
in cyanobacteria: the enzymes involved in the synthesis of poly-brominated aromatic com-
pounds [45]. However, E. coli remains the host of choice in most studies to date, because of
its high transformation efficiency and ease of use.
Assay throughput. The third factor affecting how many hits are obtained is the through-
put of an assay, which is the main limitation addressed in this thesis. Tallying the numbers
reported by Simon and Daniel, the median number of clones tested in phenotypic screens
for fosmid/cosmid libraries is less than 104 and for plasmid based libraries less than 105 [33].
Usually, less than ten positive clones are found resulting in the typical hit rates of 10−5 to 10−4
[31]. It stands to reason, that if the throughput of the phenotypic screens were increased by
a factor of ten, ten times more hits would be obtained. The technology which allows such a
boost in throughput is droplet microfluidics, the topic of the next section.
1.3 Droplet microfluidics
Droplet microfluidics provides a screening technology which allows us to routinely assay 107
library entities per day, thus providing ultrahigh-throughput [46]. Any enzyme discovery
and enzyme engineering/evolution campaign benefits from such increased screening capa-
bility compared to traditional methods, as shown for example by an improved outcome in
Obexer et al. compared to Giger et al. [47, 48]. Hence, droplet microfluidics is becoming
an increasingly important technology. In the following paragraphs, the central concepts in
library screening using droplets will be laid out.
In droplet microfluidics the biological entities, e.g. E. coli cells, are compartmentalised
into monodisperse water-in-oil droplets. The reaction vessel in which the bioconversion
takes place is the water droplet (typically 2 to 200 pl in volume) which is spatially separated
from all other reaction compartments by the oil phase. There must be no, or very limited,
exchange of contents between the droplets to ensure genotype (DNA sequence) and phe-
notype (enzyme activity) linkage just as in living cells (Figure 1.3) [49, 50]. Thanks to the
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miniaturisation to picolitre volumes, only small amounts of valuable chemicals are required
to perform a large number of reactions.
Fig. 1.3 Left: Shown is droplet generation in a microfluidic flow-focusing device. In a typical
application, cells and assay reagents are mixed on chip, before the aqueous phase is sheared
off in oil containing a surfactant. The droplet boundary ensures that the identifier (gene) of
the function (enzyme activity) and its readout (e.g. fluorescence) remain linked. Adapted
from [50]. Right: In polydisperse emulsions the cytosol of cells is diluted to different degrees,
i.e. therefore the same genotype yields different levels of signals. Inmonodisperse emulsions,
the same signal is obtained for the same genotype.
One factor limiting the throughput of library screening in droplets is the probabilistic
nature of cell encapsulation (and of other library entities such as plasmids). The distribution
of cells in solution and therefore their arrival at the encapsulation site is random [51]. At high
cell concentrations the number of cells per droplet follows a normal distribution. However,
in library screening it is desired to have only one cell present in one droplet and thus lower
concentrations need to be used. The number of cells contained in a given droplet is then
governed by the Poisson distribution [51]:
𝑃 (𝜆, 𝑘) = 𝜆
𝑘𝑒−𝜆




With λ being the average number of cells per droplet (occupancy), 𝑘 the number of cells per
droplet, [Cells] the concentration of cells, and Vdroplet the mean droplet volume. The highest
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achievable proportion of droplets containing one cell only is 37% at a λ of 1. However, as
shown in Figure 1.4B, the proportion of droplets with 2 or more cells would be 8%. Co-
encapsulation of several cells can severely limit the ability to enrich improved library variants.
Therefore, many reported studies use a λ of 0.1 to limit co-encapsulation, which means that
90% of droplets are empty. However, the ability to generate andmanipulate tens ofmillions of
dropletsmeans that the throughput of dropletmicrofluidics still exceeds traditional screening
methods by several orders of magnitude.
Fig. 1.4 Likelihood that a droplet contains 0, 1, or more than 1 cells depending on the average
occupancy λ of the Poisson distribution.
In its earliest form, the generation of picolitre droplets for a library selectionwas achieved
by simplymixing oil, surfactant, and an aqueous solution using amagnetic stirrer bar. Thus it
was possible to enrich theHaeIIImethyltransferase gene out of an excess of 107 dihydrofolate
reductase genes [52]. Although technically simple to generate, the droplet size distribution
in such emulsions is very sensitive to themixing conditions limiting the reproducibility of ex-
periments [53]. Furthermore, the size distribution of such droplets is generally wide with the
standard deviation often larger than the mean diameter, i.e. they are polydisperse. This in-
troduces bias limiting quantitative comparison between the droplets in screening campaigns
(Figure 1.3) [53, 54]. Monodisperse droplet populations with only a few percent variation
around the mean diameter overcome these limitations and are generated and manipulated
using microfluidic devices.
The fabrication of microfluidic devices has become widely accessible thanks to the devel-
opment of soft lithography [55]. The general steps are outlined in Figure 1.5. In soft lithog-
raphy, replica molding is used to create a micropatterned elastomer. The liquid prepolymer
of the elastomer is poured over a master with a relief structure on its surface, allowed to
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polymerise, and then peeled off. The most commonly used elastomer is poly(dimethyl silox-
ane) (PDMS). The master is obtained by photolithography. In photolithography, a pattern is
transferred from a photomask to a light-sensitive chemical, the photoresist, on a substrate.
The substrate usually is a single-crystal silicon wafer and themost widely used photoresist for
soft lithography is SU-8 [56]. SU-8 is a negative photoresist, i.e. where exposed to UV light
it polymerises. Unpolymerised SU-8 is removed by washing with a solvent, revealing the in-
tended microfluidic channels as a relief structure [56]. Several dozen of PDMS replicas can
be created from a single silicon/SU-8 master. A replica is bonded to a glass or second PDMS
surface after treatment with an oxygen plasma to seal the imprinted microfluidic channels.
The plasma-activated channel surfaces can be modified with a trichloro-silane derivative to
obtain the required surface properties [55].
In 2001, the first monodisperse droplets using a PDMS microfludic device were gen-
erated [57]. Since then, a plethora of geometries and devices have been designed that can
be used as individual modules to re-create macroscale laboratory procedures on the mi-
croscale [58, 50]. It is now possible to generate highly monodisperse droplets at frequen-
cies of several kilohertz, to incubate them, to inject solutions into them, as well as to per-
form quantitative measurements like the selection of droplets according to their fluorescence
(fluorescence-activated droplet sorting, FADS) or absorbance (absorbance-activated droplet
sorting, AADS) [59–61]. Moreover, the transformation of microfluidic emulsions to double
emulsions (water-in-oil-in-water compartments) or hydrogel beads equipped with polyelec-
trolyte shells are compatible with fluorescence-activated cell sorting (FACS) [62, 63]. So far,
droplet-based microfluidics have been successfully used for directed evolution, strain selec-
tion, bioprospecting, and in one case the screening of a metagenomic library which will be
discussed below [64–67].
1.3.1 Screening enzyme libraries using droplet microfluidics
The basic workflow to screen enzyme libraries in microfluidic droplets is illustrated in Fig-
ure 1.6. A gene library is first transformed and expressed by a host organism (1). Single cells
are encapsulated together with a chosen substrate and a lysis agent into water-in-oil droplets
(2). Each cell lyses inside its droplet causing the release of the expressed enzymes (3). Cru-
cially, the droplet boundary ensures retention of both genotype and phenotype. Depending
on the activity of a given enzyme variant, a substrate is turned into product. Droplets above
a set amount of product are collected using droplet sorting (4). After sorting, the genetic
material can be recovered and the phenotypically superior mutants expressed for further
characterization or for further enrichment (5).
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Fig. 1.5 The steps in the fabrication of a microfluidic PDMS device. First, a silicon substrate
is patterned with the photoresist SU-8 to generate a master. Using the master, many PDMS
devices can be generated via replica molding. The patterned PDMS is plasma-bonded to
another PDMS surface or a glass substrate to seal the microlfuidic channels. The activated
PDMS/glass surface is usually modified using trichloro-silane derivatives, e.g. to create a flu-
orophilic layer to allow the use of fluorous oils. Adapted from [55].
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Fig. 1.6 A typical workflow for the screening of an enzyme library usingmicrofluidic droplets.
1: A gene library is first transformed and expressed by a host organism. 2: Individual cells
are encapsulated into picoliter water-in-oil droplets together with a chosen substrate and ly-
sis reagents. 3: After cell lysis, the expressed enzymes are released and, if active, convert the
substrate into product. 4: If the fluorescence of a droplet exceeds a set threshold it is physi-
cally sorted using a bespoke microfluidic device. 5: After sorting, the genetic material can be
recovered and the phenotypically superior mutants expressed for further characterization.
Adapted from [46].
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After a decade dominated by proof-of-principle experiments in droplets, the utility of
this new technology was shown in several library screening campaigns [61, 66–69]. The first
directed evolution campaign in microfluidic droplets was targeting horseradish peroxidase,
using a coupled assay and lead to over 10-fold improved catalysts [64]. In addition to such
highly active enzymes, even slow reactions can be screened, as exemplified for a sulfatase: the
thermodynamicallymost challenging biochemical reaction is amenable to the droplet format
[67, 69]. These experiments demonstrate the range of possible timescales with incubations
between 5 minutes and 48 hours, suggesting that fast and slow reactions can be monitored.
1.3.2 Enzyme substrates in droplet experiments
For droplet sorting to be successful, the used substrates and their products play a critical
role. The availability of suitable substrates is what currently limits the range of enzymatic
assays amenable to droplet microfluidic methods. The chief requirement is that the reaction
product and any long-lived intermediates do not exchange between the droplets otherwise
the geno- to phenotype linkage is lost [49].
A number of established fluorescent or absorbing leaving groups used in enzyme assays
do readily exchange between droplets, for example rhodamine, coumarin derivatives, and 4-
nitrophenol [70]. This observed leakage of product molecules may be due to direct transfer
through the carrier oil or by micellar transport [71, 72]. Exchange can be reduced by using
fluorinated carrier oils and by using additives such as bovine serum albumin (BSA) [73].
An effective way to prevent leakage is the chemical modification of the leaving group.
Most studies aimed at installing charged groups on the substrate to reduce solubility in the
oil phase. Several authors succeeded in eliminating substrate/product leakage by introduc-
ing a sulfonic acid, which due to its low pKa introduces an effectively permanent negative
charge. Najah et al. introduced a sulfonic acid group into a coumarin derivative; no ex-
change between droplets was detected over 24 h at 30 °C. The resulting substrate was used
to screen for cellobiohydrolase activity on model bacterial strains [74]. Similarly, Fenneteau
et al. generated a sulfonylated rhodamine-based enzymatic substrate and used it to assay
amino-peptidases [75]. A permanent positive charge was used to improve a previously opti-
mized artificial retro-aldolase in droplets by introducing a charged ammonium group into a
methodol derivative [47]. Ma et al. followed a smiliar approach for phosphotriesterase sub-
strates with coumarin derivatives as leaving groups [76]. This study specifically exploited the
differential solubility of substrate and product, so as to trap only the product inside droplets,
but allow the substrate to diffuse in and out of droplets. This enabled the quick addition and
removal of substrate to all droplets at defined times, increasing the control over the reaction
time.
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1.3.3 Enzyme assays available in microfluidic droplets
Thanks to the development of substrates and droplet workflows the range of enzymatic assays
available in droplet format is increasing. An overview of the assays currently available are
reviewed below and the corresponding workflows are shown schematically in Table 1.1.
Hydrolases. Hydrolytic reactions in which water displaces a fluorescent leaving group are
perhaps the reactions that can be assayed most simply, as the reaction product itself is de-
tectable. Directed evolution of triesterases, phosphonate hydrolases, and enrichment ex-
periments for glycosidases as well as sulfatases were successful [62, 63, 69, 77]. Screening
of natural gene repertoires for glycosidases, amylases, and triesterases were demonstrated
[66, 67, 78] .
Aldolases. Obexer et al. accomplished the directed evolution of a computationally-designed
aldolase which had previously been evolved in a microtiter-plate screening assay [48, 79].
Notably, in this study the enzyme evolved a strong preference for the (S)-enantiomer of the
substrate. In a similar study, the same authors achieved (R)-selectivity by choosing an evo-
lutionary trajectory which had not been accessible in the classic screening format [47].
Polymerases. The above studies monitored formation of a fluorescent product directly. In
a different approach, Larsen et al. used a molecular beacon to evolve a non-natural thre-
ose nucleic acid (TNA) polymerase [80]. This assay was performed in a double emulsion,
which is compatible with commercial FACS devices circumventing the need for a custom-
built fluorescence-activated droplet sorting (FADS) setup [62]. Using a molecular beacon
and the multistep format, Ryckelynck et al. achieved the implementation of a full SELEX
workflow in order to evolve a ribozyme [81].
Proteases. Although no library screening was achieved, protease activity has been success-
fully detected in droplets. A single-cell secretion assay in droplets employing multiple pro-
tease substrates andmulti-colour analysis was implemented based on fluorescence quenchers
[82]. Price and Paegel developed a droplet assay to detect inhibition of HIV-1 protease ac-
tivity by UV-induced release of defined amounts pepstatin A from beads [83].
Amino-acid dehydrogenases. A coupled reaction was implemented to select improved L-
phenylalanine dehydrogenases. This study established the first AADS module. The coupling
of cofactor reduction with production of a tetrazolium dye enabled a 25-fold signal ampli-
fication for product detection compared to direct detection of NADH. Similar assays are
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available for dehydrogenases and reductases and should make these reactions amenable to
screening in droplets [61].






















































































































































































































1.4 Ultrahigh-throughput metagenomics in droplets
As laid out in the previous sections, functional metagenomics is a powerful method to find
new enzymes, albeit with low success rates and limited throughput. Droplet microfluidics
is a technology that allows the screening of biological entities at ultrahigh-throughput. Us-
ing droplet microfluidics to enhance the outcomes of functional metagenomics is thus an
attractive entreprise. There has been one previous study which achieved this.
Colin et al. screened a plasmid-based library, the SCV library, consisting of more than
one million members for sulfatase and phosphotrieseterae activity, see Appendix Table B.1
[67, 84]. Remarkably, it was possible to detect enzymatic activity using a single-cell lysate
assay as outlined in Figure 1.6. Six unique DNA inserts encoding new sulfatases and eight
inserts encoding newphosphotriesteraseswere isolated using FADS.Thephosphotriesterases
would have been particularly difficult to isolate using traditional methods: there is no agar
plate assay available, only much more time- and resource-intensive well plate assays. The
average catalytic efficiency (kcat/Km) on the substrate used for selection was 103 M−1 sec−1.
Such low activities would have further limited the ability to reliably identify them from a
library of millions in a classical approach. Only one of the open reading frames (ORFs)
showed homology with a previously characterised phosphotriesterase. None of the other
hits would have been identifiable using a sequence-based approach. Extending and applying
the microfluidic screening platform pioneered by Colin et al. to more reactions is likely to
yield more catalysts, but may also yield fundamental insights not otherwise possible. The
conditions for the success of the ideas outlined below are that the assays are sensitive, that hit
confirmation is simple, and that sequence analysis and ORF assignment are reasonably fast.
Enzyme annotation. Currently, the annotation of new sequences is based on sequence
similarity searches against databases. If the similarity is higher than would be expected for
two random sequences, this implies homology, i.e. that the two sequences are related by
common ancestry. Evidence for homology is then further extrapolated to the gene products
having a similar function [20]. This line of thinking has several limitations:
• With the increase in database sizes the chance of randomly detected homology has
increased, leading to potentially false annotations from the outset [85].
• While such false positives are limited for the most commonly used algorithms, there
is no assessment of their false negative rates [20]. Structure is more conserved than
sequence, implying that while homology may clearly exist in terms of structure, it may
not be detectable at the sequence level [86]. Also, some enzyme classes, such as the
hydroxynitrile lyases, show little homology due to convergent evolution [87].
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• The relationship between homology and function is complex, in particular for enzymes
where very few amino acid substitutions can change or abolish the catalytic activity
[20, 88].
• The vast amount of annotated sequences available on the databases today are from
whole genome ormetagenomic sequencing projects. Therefore, the annotation of large
clusters of sequences may only be underpinned by very limited functional evidence.
The ultrahigh-throughput functional tests possible in droplets provide data that complement
and correct sequence analysis, allowing a better understanding of the existing sequences. As
mentioned above, the activities of the phosphotriesterase hits identified by Colin et al. sug-
gested by sequence similarity could rarely be validated, while the droplet screening estab-
lished a functional assignment [67, 84]. Functional metagenomics in droplets thus provides
a means for more comprehensive annotation based on experiments.
New bridgeheads for functional annotation. Sometimes enzymatic activities are particu-
larly difficult to predict, for example when very few experimentally-characterised examples
exist. Given the difficulty in predicting primary activities, the prediction of promiscuous re-
actions of enzymes is even more challenging. These can be understood as evolutionary start-
ing points: after gene duplication they can be further refined by adaptive evolution and lead
to re-functionalised proteins [6, 89]. There is increasing experimental evidence, that promis-
cuous activities play an important role in the adaptation of metabolic pathways [90, 91] The
more such activities are known, themore can they be understood in biology and be exploited
for industrial applications. The activities identified by Colin et al. were largely such promis-
cuous activities [67, 84].
Simulating early evolution. A scenario in which an expressed metagenomic library is
tested against a non-natural substrate mimics the encounter of environmental microbiota
with compounds introduced bymankind (as e.g. in the case of phosphate triesters). Evidence
suggests that an initial response to novel compounds already exists even in naïve environ-
ments [6, 89]. These starting points based on promiscuous enzymes then further evolve to
create efficient pathways that extract energy and nutrients [91, 92]. A droplet microfluidic
assaymay provide the throughput needed to identify these rare starting points formany reac-
tions. Performing rounds of directed evolution following the identification of a promiscuous
enzyme could lead to improvement of the activity of the target reaction. Together, such an
experiment would constitute a simulation of the early evolution of a new function.
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1.4.1 Goals of this thesis
To investigate the three hypotheses outlined above, three major goals were set in this thesis:
• Building a fluorescence-activated droplet sorter.
At the start of this work no FADS was available. Given that such a set-up was the pre-
condition to setting up many types of assays, a new sorter was built and tested. It was
then used successfully in several collaborative projects as described in Chapter 2.
• Establishing a metagenomic droplet assay for esterases.
Interestingly, no major study in droplets has reported on the directed evolution or
selection of esterases. Yet, they are most frequently screened for in functional metage-
nomics [93]. Esterases are a well-studied class of enzymes, common in nature, and of
industrial interest. A droplet microfluidic assay to screen for such fundamentally im-
portant enzymes was deemed of high interest. Therefore, a functional metagenomic
droplet screen for esterases was developed in Chapter 3
• Establishing a metagenomic droplet assay for Kemp eliminase.
TheKempelimination is the general base catalysed rearrangement of 1,2-benzisoxazole
to cyanophenol [94, 95]. It is a reaction not known to naturally occur in living organ-
isms which has been used extensively to engineer chemical and biological catalysts, as
will be reviewed in Chapter 4. This reaction requires only a general base within a hy-
drophobic environment to achieve high catalytic rates and is therefore a good starting
point to screen a metagenome for promiscuous enzymes.
To establish and perform these assays, the goal was to follow the approach outlined in
Figure 1.7. First, the sorting technology had to be established, i.e. the optics, electronics, and
data analysis had to be set up. Next, the assay conditions needed to be tested using a positive
and negative control. Conditions to distinguish the controls were established in well plate
assays and then tested in droplets. Once suitable conditions were found, they were validated
by enriching the positive over the negative control. This finally allowed the screening of the
metagenomic library (the SCV library by Colin et al. was used). After droplet screening, a
secondary screen was required to retrieve hits. TheKemp eliminase screen is currently at this
step. In the esterase screen, it was possible to retrieve the twelve unique hits and sequence the
DNA inserts. The most likely ORFs to encode for an esterase were cloned and the esterase
activity of thirteen genes was confirmed. After this, the hits were expressed, purified, and
characterised kinetically and in terms of their promiscuity.
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The fluorescence-activated droplet sorter
2.1 Abstract
The aim of this chapter is to present the fluorescence-activated droplet sorter (FADS), which
was built over the course of this project. The sorting principle in FADS is analogous both in
name and principle to FACS. Aqueous droplets pass a laser beam and those droplets which
meet the sorting criteria are deviated from their trajectory by an electric field for collection.
In FACS the droplets are generated in air, while in FADS they are suspended in oil. A FADS
system can be divided into a sorting chip, which acts as a disposable flow cell, and the in-
strumentation to control the sorting process. The focus of the work presented here was to
build and incrementally improve the latter. I will now briefly introduce the key concepts in
droplet sorting and follow with a detailed description of the instrument. I will illustrate how
the system was improved based on the needs of key experimental procedures used in the
laboratory and conclude with possible future improvements to the system.
Contributions: All of the work presented in this chapter is entirely my own. I built the optical
instrument, developed the control electronics and programmed the hardware. I wrote the code
for real-time acquisition and display of the data as well as the post-sorting scripts to analyse the
complete datasets. I additionally contributed to a series of collaborative projects as mentioned in
Table 2.3. In the sulfatase project withDrBert vanLoo I performed all of themicrofluidicwork: I
optimised the reaction conditions in droplets, performed enrichment experiments using controls
and sorted the mutant libraries. In the protease project with Dr Josephin Holstein I performed
all of the droplet sorting and adapted the real-time signal processing on my instrument without
which it would have been impossible to isolate improved enzyme variants from the six mutant
libraries I sorted. I trained and performed initial droplet sorting with David Schnettler and
Stefanie Neun, after which they were able to use the instrument independently.
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2.2 Introduction
The creation of large enzyme libraries is routine in molecular biology. Yet, their comprehen-
sive functional assessment is not. For example, metagenomic libraries with up to 107 mem-
bers have been reported [37]. Similarly, random mutagenesis by error-prone PCR creates
so many variants, that the library size is usually limited by the number of transforming cells
(up to 1010 cfu/μg for E. coli, [96]). This diversity outstrips the screening capability of tradi-
tional assays on culture or in well plates by at least two orders of magnitude. In consequence,
libraries are severely under-sampled. With beneficial mutations for a desired activity being
rare, the throughput becomes a limiting factor for the success of a library screening campaign
[9].
Droplet microfluidics has emerged as one technology providing the ultrahigh-through-
puts needed to address this issue. Conceptually, microfluidic water-in-oil droplets are mini-
tuarised reaction vessels that bring biochemical tests from the microlitre to the picolitre
range. Using a flow-focusing geometry, it is possible to generate picolitre-volume droplets at
frequencies of over 10 kHz with excellent monodispersity [97, 98]. At such frequencies over
107 droplets, i.e. independent biochemical reactions, are created in one hour. As in classi-
cal screening approaches, the reaction of interest can be linked to an optical readout such as
fluorescence. However, as opposed to culture and well plate techniques, the content of each
droplet cannot be accessed freely. It is therefore necessary to isolate droplets with the desired
level of fluorescence via droplet sorting.
A number of active droplet sorting techniques have been developed using pneumatic,
thermal, magnetic, electric, and acoustic forces to actuate the droplets [99]. The highest
throughputs (routinely 2-3 kHz) can be achieved by electric and acoustic droplet sorting [99].
While acoustic sorting has been successfully demonstrated, the required instrumentation
and chip fabrication is complex and library selections remain to be demonstrated [100, 101].
Using an electric force to actuate droplets, the simplest chip design for sorting requires only
a Y-junction to separate positive from negative droplets and a pair of electrodes as shown in
Figure 2.1. The introduction of salt water electrodes simplified the fabrication of chips for
FADS markedly, eliminating the need for re-using sorting chips [102].
The most widely used sorting principle to date is based on dielectrophoresis (DEP). The
possibility to use DEP for droplet sorting was first investigated by Ahn et al. and I will here
follow their analysis of the physical principles in action, which will help to understand the
influence of different sorting parameters, e.g. droplet size and oil viscosity [103]. DEP exerts
a force on a particle in a non-uniform electric field. It does not require the particle to have
a net charge, but is caused by an induced dipole moment which drives the movement of the
particle along or against the electric field gradient [104]. The force acting on a particle in its
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medium, in this case a water droplet in oil, is given by [103, 104]:
⃖⃖⃗𝐹DEP = (⃖⃖⃗𝑚 ⋅ ∇) ⃖⃖⃗𝐸rms (2.1)
Where ⃖⃖⃗𝑚 is the dipolemoment of the droplet and ⃖⃖⃗𝐸rms is the root-mean-square of the applied
electric field. The dipole moment is given by [103, 104]:
⃖⃖⃗𝑚 = 4𝜋𝜀oilRe [CM (𝜔)] 𝑟3 ⃖⃖⃗𝐸rms (2.2)
With 𝜀oil being the relative permittivity of the oil phase, Re [CM (𝜔)] being the real term of
the Clausius-Mosotti factor, and 𝑟 being the radius of the droplet. The sign of the Clausius-
Mosotti factor determines if the droplet is attracted to (positive DEP) or repelled by (negative
DEP) areas with a high electric field gradient. This factor takes into account the conductivity
and permittivity of the oil phase and droplet as well as the frequency of the electric field [104].
In principle, DEP is possible in DC fields (frequency = 0). In practice, AC fields (frequency
> 0) are used to avoid heating and electrolysis at the electrodes [105]. For water droplets
in oil, the real part of the Clausius-Mosotti factor is predicted to be +1 (positive DEP) over
a large range of frequencies, which Ahn et al. confirmed in their experiments [103]. The
Fig. 2.1 Dielectrophoresis is used to sort droplets. A: The schematic shows how a droplet is
laterally displaced by switching on the electrodes (indicated by blue-red filling). In positive
dielectrophoresis the force ⃖⃖⃗𝐹DEP points along the gradient of the electric field ⃖⃖⃗𝐸 (dashed
lines). The dielectrophoretic force is balanced by the Stokes drag ⃖⃖⃗𝐹S. B: Snapshots of a video
showinghowadroplet is deviated from its trajectory by switching on the electrodes. Note that
a high voltage 𝑉 was applied to demonstrate the vertical displacement. For routine sorting,
lower voltages that do not deform the droplets are used.
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dielectrophoretic force is balanced by the Stokes drag, given by:
⃖⃖⃗𝐹S = 6𝜋𝜂oil𝑟⃖⃗𝑣 (2.3)
With 𝜂oil being the viscosity of the oil and ⃖⃗𝑣 the speed of the droplet. Thus, and with the










Where 𝑘 is a geometric factor describing the electrode shape and location and 𝑈 the applied
voltage. Therefore, smaller droplets move at lower speed towards the electrode, making it
more difficult to collect them into the sorting channel. Also, a carrier oil with low viscosity
and high permittivity is beneficial to sorting efficiency, which is one advantage of the now
commonly used perfluorinated oils over hexadecane (𝜀 = 6 and 𝜂 = 1mPa s for HFE7500;
𝜀 = 2 and 𝜂 = 8mPa s for hexadecane [103, 107]).
Combining dielectrophoretic actuation with a fluorescence detection system, yielded the
first fluorescence-activated droplet sorter [60]. Baret et al. demonstrated the enrichment of
cells harbouring a functional β-galactosidase gene over cells harbouring an inactive one. The
enrichment was performed at 300Hz, where the sorter had a minimal error-rate of 10−4.
Droplet sorting was possible up to 2 kHz albeit at higher error-rates. This study was soon
followed up by a directed evolution experiment [64]. The sorting chip was improved, run at
2 kHz, and 107 cells were sorted on a single day. This showed the utility of droplet microflu-
idics to access a much larger proportion of a library’s diversity. The record sorting rate for
FADS is now 30 kHzmatching the rates of commercial FACS systems [108]. The method has
also been extended to sort droplets based on absorbancemeasurements, albeit at only 300Hz
[61].
In the following section, I will describe the FADS which I built following the principles
laid out here and starting from the principal set-ups published in [60, 67]. A FADS can
be separated into two main components: the instrumentation to run the sorting chip and
the sorting chip itself. The goal my work was to establish the instrumentation rather than
optimising the chip design. The primary chip design used was previously published in [67].
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2.3 Description of the FADS set-up
The FADS system I developed measured green fluorescence induced at 488 nm, analysed
the signal, sorted droplets, and monitored the sorting performance using high-speed videos.
What follows is a description of what I achieved as of September 2018. First the optical and
electronic set-up and then the sorting algorithm will be explained.
2.3.1 The optical and electronic set-up
The optical set-up was optimised for the detection of fluorescein (excitation maximum at
492 nm and emission maximum at 512 nm [109]), which was used as the reporter molecule
of choice in several studies performed using this instrument.
Fluorescence was induced at 488 nm and measured at 525/28 nm, while the performance
of sorting was monitored using red light above 593 nm. The arrangement is depicted in Fig-
ure 2.2A1. The microfluidic sorting chip was illuminated by a white halogen lamp (100W,
BF) via a longpass filter F1 (F1, 593 nm) to prevent green illumination light from reach-
ing the detector. The laser beam (488 nm, 30mW, attenuated to 3mW with 1.0 ND filter)
was focused onto the chip through an objective (LUCPlanFLN 40x/0.6, Olympus). The in-
duced fluorescence and red light were directed past a longpass filter (F2, 488 nm) to a second
dichroic mirror DC2 (550 nm. The red light was captured by a high-speed camera (CAM).
Lower wavelengths were directed to a band pass filter (F3, 525/28 nm) before reaching the
photomultiplier tube (PMT) for detection. Typically, the gain of the PMT was set to 0.7V
(maximum of 1.25V). The PMT output voltage was read by an field-programmable gate
array (FPGA), which I programmed to measure the fluorescence signal of each droplet. If
a droplet fulfilled the operator-set sorting criteria, the FPGA triggered the pulse generator
(PG) and video acquisition by the high-speed camera (CAM).
The sequence of voltage pulses for sorting is shown in Figure 2.2B.The FPGA sent a 50 µs
transistor-transistor logic (TTL)2 trigger to the pulse generator which opened a gate for the
function generator (FG). The function generator then produced a square-wave which was
amplified a hundred times (AMP) and applied to the electrodes embedded in themicrofluidic
chip. The width of the gate could be set by the operator. The standard width was 500 µs for
2 pL droplets and 5ms for 65 to 200 pL droplets. The frequency of the square-wave was set to
10 kHz with an amplitude between 6 and 9V depending on droplet behaviour. This cascade
1The spectra of the filters are given in Figure A.1 and the model specifications in Section 7.1.4.
2In TTL there are two states: low and high. A trigger sets the state to high for a brief period. Standard TTL
circuits operate at 5V. A TTL input signal is defined as low between 0 and 0.8V and high between 2 and 5V.
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Table 2.1 Standard droplet sorting parameters for 2 pLdroplets. Acronyms refer to Figure 2.2.
Paramter Value
Oil flow rate 100 - 150 µLh−1
Droplet flow rate 5 - 15 µLh−1
CAM frame rate 4 kHz
CAM exposure time 20 µs
FPGA sampling rate 200 kHz
FPGA trigger width 50 µs






FG Frequency 10 kHz
of pulses resulted in a selected droplet being dielectrophoretically pulled into the collection
channel.
The process was continually monitored by the high-speed camera which was typically
acquiring at 4,000 frames per second. When the camera was triggered by the FPGA, a video
file was saved from e.g. 10 frames before to 20 frames after the trigger signal. As shown in
Figure 2.2 this enabled the manual inspection of every single sorting event and the adjust-
ment of the sorting parameters to optimise sorting. Video acquisition was also used as a tool
to check for inadvertently collected droplets due to errors, which could lead to false positives
in screening campaigns. In general, droplet sorting worked ad hoc if the indicated parame-
ters were used (summarised in Table 2.1). However, differences in droplet size and content
between experiments sometimes required small adjustments at the start of a run.
2.3.2 The sorting algorithm
In a previous iteration, the fluorescence signal was split into two lines. One was wired to the
input of a microprocessor which made the sorting decisions, the second was used to record,
analyse, and visualise the signal using a custom LabView virtual instrument (VI), which I
designed3. The splitting had been necessary because the microcontroller could not stream
the analysed data to the host (a desktop PC) andmake sorting decisions simultaneously. This
limited the ability to precisely monitor and control the actions of the microcontroller.
3LabView is a systems engineering software used to control hardware by National Instruments.
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Fig. 2.2 The figure shows how the FADS achieves droplet sorting. A: The optical set-up. BF:
bright field, F: filter, OL: objective lens, BE: beam expander, DC: dichroic mirror, CAM:
camera, PMT: photomultiplier tube, FPGA: field-programmable gate arra, PG: pulse gener-
ator, FG: function generator, AMP: amplifier. The inset shows how the chip is connected to
the amplifier. The spectra of the filters are shown in Figure A.1. B: The pulse sequence was
started by the FPGA, which results in the sorting of a droplet. C: Individual frames of a video
recorded by the camera for one sorting event. Droplets entered from the top and exited via
the waste channel on the left. The droplet which triggered the sorting event was pulled to the
collection channel on the right as indicated by the green arrows.
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In the latest implementation of the FADS, the fluorescence signal was processed by an
FPGA. I programmed the FPGA using the LabView FPGA module allowing the smooth in-
terfacing between the FPGAVI and the host VI such that control, execution, andmonitoring
of the sorting process were synchronised. This was due to the chief advantage of an FPGA: it
can execute different processes in parallel. This also allowed the calculation of several droplet
properties at high speed enabling droplet sorting based on more than one criterion.
The four droplet properties that were calculated were the peak amplitude 𝑈𝑚𝑎𝑥, the area
under the peak, the peak WIDTH at the threshold, and the full width at half maximum
(FWHM). The width measurements (in terms of time spent within the laser beam) were in-
troduced to distinguish droplets of the correct size from satellites and larger droplets, which
was necessary for some experiments performed on the set-up (see Section 2.4.2). TheFWHM
was introduced as a better measure for droplet size compared to theWIDTH. It was assumed
that each droplet’s signal could be approximated using a normal distribution:









Where 𝜎 is the standard deviation, 𝑡 is time, and 𝑡𝑐 the center of the distribution. Under this
assumption, the FWHM depends linearly on 𝜎, which was practical to sort droplets based
on their size. The WIDTH at the threshold was dependent both on 𝜎 and on 𝑈𝑚𝑎𝑥 limiting
its use for size selections as will be shown in Section 2.4.2.
Figures 2.3 and 2.4 show how the four properties were calculated. The FPGA VI was
executed every 5 µs resulting in a sampling rate of 200 kHz. At each iteration of the program,
the sorting parameters and one data point 𝑈(𝑡) were read and sent to downstream processes.
Each unprocessed data point was also added to a FIFO buffer4 which was read by the host VI.
At 200 kHz this yielded, for example, 40 datapoints for a droplet that spent 200 µs in the laser
beam. In Figure 2.3 the four critical points at which the FPGA started or stopped a process
are indicated with red circles. A droplet was assumed to be passing through the laser, if the
signal was above an operator-set threshold. When threshold was crossed upwards (rising
edge) the program started calculating the droplet properties. As the rising edge was passed,
the time 𝑡1 was stored and two processes started. The area under the signal was approximated
according to:
𝐴(𝑡) = 𝐴(𝑡 − Δ𝑡) + 𝑈(𝑡) ∗ Δ𝑡 (2.7)
4A FIFO (first in, first out) is a data buffer where the first element added to the buffer is the first element
read and removed. Refer also to Figure 2.5.
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Fig. 2.3 Simulated fluorescence signal using a normal distribution with added normally-
distributed noise. White circles indicate each datapoint 𝑈(𝑡) read by the FPGA. Red circles
indicate moments at which the FPGA starts or stops a process. Dashed line: threshold, 𝑡1:
time of rising edge, 𝑈𝑚𝑎𝑥: maximum signal at 𝑡2, 𝑡FWHM: time of half maximum, 𝑡WIDTH:
time of falling edge, and 𝐴(𝑡): area under the signal.
Where 𝐴(𝑡) is the area at the current iteration, 𝐴(𝑡 − Δ𝑡) the area from the previous itera-
tion, and Δ𝑡 the time between iterations (fixed to 5 µs). The second process checked if the
incoming datapoint 𝑈(𝑡) was smaller than the previous one 𝑈(𝑡 − Δ𝑡):
𝑈(𝑡) < 𝑈(𝑡 − Δ𝑡) (2.8)
If this is was true, the previous datapoint was stored as the amplitude 𝑈𝑚𝑎𝑥. The process
remained active until the falling edge was detected, i.e. it determined the global maximum
between the two edges. A state change of Equation 2.8 from false to true started a third
process. This process determined the FWHM by storing the time 𝑡2 at which the maximum
was reached and starting the comparison:
𝑈(𝑡) ≤ 𝑈𝑚𝑎𝑥2 (2.9)
When this comparison became true, the difference 𝑡2 − 𝑡 yielded the half width at half maxi-
mum, which was multiplied by two to obtain the FWHM. Note that this process would reset
each time 𝑈𝑚𝑎𝑥 was updated, i.e. until the global maximum was reached.











𝑈(𝑡 − Δ𝑡) 𝑈𝑚𝑎𝑥 = 𝑈(𝑡)
𝑡1 = 𝑡
Start 𝑡2 = 𝑡
𝑈(𝑡) ≤ 𝑈𝑚𝑎𝑥2 FWHM = 2(𝑡 − 𝑡2)
Stop
𝐴(𝑡) = 𝐴(𝑡−Δ𝑡)+𝑈(𝑡)∗Δ𝑡













Fig. 2.4 Flowchart of the signal processing implemented on the FPGA. Tasks branching off
at nodes are executed in parallel. The processes in the droplet properties block are started
when a rising edge occurs and stopped when the falling edge follows. The calculated values
are then used to make a sorting decision. Thick lines indicate the passing of data, thin lines
instructions to execute a step.
2.3 Description of the FADS set-up 33
Finally, as the falling edge was passed, the difference 𝑡1 − 𝑡 yielded the WIDTH at the
threshold level. At this point, all analysing processes were stopped, and the obtained val-
ues compared against the sorting parameters, the sorting decision was made, and the values
added to one of two FIFOs, one for the sorted and one for the unsorted droplets.
The data transfer between FPGA and the host was handled by the direct memory access
(DMA) engine provided by LabView as shown in Figure 2.5. For each FIFO on the FPGA
side there was a corresponding one on the host side. Data points were transferred one-by-
one from the FPGA to the host buffer in a synchronised fashion to ensure there was no data
loss.
Before the host VI read the data from its buffers, it updated the sorting parameters as
shown in Figure 2.6. This was achieved by directly updating the hardware registers holding
each value on the FPGA device. The sorting parameters that an operator could adjust were
the threshold for peak detection, the maximum and minimum peak amplitude, and a choice
between either the maximum and minimum FWHM or WIDTH. The program then read,
analysed, and plotted the data from different FIFOs. Three key indicators were the rate of
droplet sorting, the total number of droplets analysed, and the number of droplets collected.
Finally, the signal properties for each sorted droplet were logged in a separate file, before the
program was executed again.
This analysis workflow improved droplet sorting, because the droplet size criteria allowed
the exclusion of droplets of incorrect size (due to merging or splitting). The background
signal can be different in droplet of differing size, therefore both split and merged droplets
can appear as shoulders in the fluorescence (amplitude) histogramandoverlapwith the signal
of real hits. If the frequency of hits in the droplet population is smaller than that of such
events, e.g. 10−5 and 10−4, this can lead to the collection of a large amount of false positives.
Therefore, assays can significantly profit from information on droplet size.
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Fig. 2.5 The DMA Engine transferred data between the buffers on the FPGA and on the host.
While the FPGA wrote one element at a time at a high rate (200 kHz for the raw signal, at
most 8 kHz for droplet data ), the host read data more slowly (10Hz) but in larger batches,
thus ensuring no data were lost.
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Calculate 2D Histograms Add to 2D Histograms
Start Get Parameters Write Parameters
Read 𝑈(𝑡) FIFO Plot Raw Signal Save Plot Data
















Fig. 2.6 Flowchart of the LabView program used to monitor droplet sorting. The data were
read from the FIFO buffers and plotted. The tasks branching off at nodes were executed
individually before the program moved to the next branch point. Sorting criteria could be
defined according to the obtained data and changed at any point. The sorted droplet data
were logged separately.
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2.4 Results and discussion
Experimental results obtained from the FADS are reported in the next chapter. Here, the
aim is to illustrate how the set-up was tested and sequentially improved to reach its final state
described above.
2.4.1 Single-photon counting module versus photomultiplier tube
Two types of detectors were compared, a single-photon counting module (SPCM) and a
PMT. The former is used for ultra-high sensitivity single-molecules studies and the latter
is widely used in plate readers and FACS instruments. While PMTs have previously been
used in FADS, I tested the SPCM to assess whether it was suitable for sensitive fluorophore
detection in droplet sorting applications.
The SPCM required adjustment of the signal processing algorithm. While the output of
the PMT was an analogue voltage signal between 0 and 10V, the output of the SPCM was
digital. It sent one TTL pulse per detected photon to the FPGA. The detection efficiency in
this wavelength range was about 50% and the maximum photon counting rate was 39MHz.
A counter was implemented on the FPGA which monitored the SPCM at 40MHz, which
was then sampled analogously to the voltage signal. The sampling rate for droplet detection
and analysis was set to 50 kHz during this experiment. Thus, the signal range of the SPCM
was from 0 to 800 photons, an overview is given in Table 2.2. Peak analysis was performed
in the same way for both detectors.
Table 2.2 Comparison of some parameters of the SPCM
and PMT as implemented here.
Parameter SPCM PMT
Flexible Gain No Yes
Sensor diameter 0.18mm 22mm
Quantum efficiency† 70% 21%
Band width N/A 0 - 20 kHz
Maximum counting rate 39MHz N/A
Output format digital analogue
Output range 0-800 photons 0 - 10V
Output linear < 40 photons ≤ 10V
† at respective peak wavelength.
N/A - not applicable.
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A single-cell esterase assay in 15 µm droplets was performed using a positive control to
test the detectors under real conditions5. Not all droplets were expected to contain cells due
to the Poisson distribution governing cell encapsulation, i.e. two peaks were expected: one
with low background fluorescence (65% of droplets) and onewith increased fluorescence due
to enzymatic activity (35% of droplets). The sample was injected two hours after generating
the droplets. At this incubation time, the separation between positive and negative droplets
was not expected to be large. The two measurements were performed one after the other by
simply switching the detector.
The results are presented in Figure 2.7. As can be seen in thewidth versus amplitude plots,
the population of droplets was more polydisperse at the beginning of the measurement (top
panel), compared to the end (bottom panel). This was typically observed in droplet experi-
ments, most likely because droplets flowing at the front of the tubing used to connect devices
experienced pressure fluctuations when connecting and disconnecting to microfluidic de-
vices. When selecting droplets in the expected size range (120 to 320 µs) some outliers are
removed, but the shape of the overall amplitude histogram does not change significantly.
Importantly, both detectors were able to discriminate the two expected peaks. The differ-
ence in signal between the peaks was 2 fold for both detectors. The main distinction between
the two detectors is in the right-hand side tail of the distributions: the SPCM histogram ends
abruptly while the PMT histogram tails off. The latter behaviour is typically observed in
single-cell experiments and can be explained by the varying amount of protein expressed by
individual cells.
The difference observed for the SPCM can be explained by a deviation from linearity at
a high rate of incident photons. Above a counting rate of 1 to 2MHz (photon count of 30 to
40), the detector starts to underestimate the real rate. At a readout of 17MHz (photon count
350), the actual rate of incident photons is two-fold higher. Thus, under these conditions
the amount of light emitted by the droplets was too high to ensure the linearity of the mea-
surements. At a higher attenuation of the laser, the signal was too low to observe the empty
droplets.
5The esterase used here was Est30, which was used to establish the esterase assay in droplets. Refer also to
Section 3.3, specifically Table 3.1. Reaction conditions as in Section 7.1.6
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A
B
Fig. 2.7 The two panels show the difference in using two different detectors to measure the
fluorescence distribution of the same droplet sample. A: single-photon counting module
(SPCM). B: photomultiplier tube (PMT). As opposed to the PMT, the dynamic range of the
SPCM did not allow an accurate measurement of droplets with higher fluorescence.
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It was therefore concluded that the PMT was better-suited for this application. This was
practical for two further reasons. First, the sensor diameter of the PMT is larger than for the
SPCM (22mm vs. 180 µm), simplifying the alignment and maintenance of the optical set-up.
Second, while the SPCM had a fixed gain, the gain of the PMT could be adjusted to fine-tune
the sensitivity as required by each type of experiment.
While the PMTwas preferable to the SPCM, there was still a trade-off between sensitivity
and sorting speed due to its limited bandwidth. In this case, it was 0-20 kHz, i.e. a time-
resolution of 50 µs. At a sorting rate of 2 kHz, the centre of droplets may pass the laser every
500 µs, but because of the required spacing between them, each one may only spend 100 µs
within the illumination area, which means at higher sorting rates the measured fluorescence
signal is at risk of becoming attenuated. In future, new detectors with both high speed and
high sensitivity are needed to improve fluorescence detection in droplet sorters.
Next, the linearity and sensitivity of the PMTwasmeasured under realistic sorting condi-
tions, i.e. at droplet rates of several hundred hertz and using 55% of themaximal gain voltage.
Droplets were generated containing fluorescein at 8 nM to 1 µM in 50mM TrisHCl pH 8 and
measured, see Figure 2.8. Using linear regression the concentration at the detection thresh-
old in this experiment was (13 ± 3) nM. Given the droplet volume of 1.8 pL, a concentration
16 nM corresponds to about 104 fluorescein molecules. This would require only 100 enzyme
molecules to perform 100 reaction turnovers. Even weakly expressed, promiscuous enzymes
are expected to surpass these numbers. Therefore, the system should enable highly sensitive
screening of metagenomic libraries.
Fig. 2.8 Linearity of the fluorescence measurement using the PMT and fluorescein in 15 µm
droplets as a standard. Error bars correspond to the FWHM of the droplet population. The
solid line shows a linear regression (𝑅2 = 1).
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2.4.2 Improvements to the FADS were driven by research projects
The FADS was successfully used in a number of projects. These projects that have yielded
improved or new enzymes to date are listed inTable 2.3. I performed the droplet sorting in the
protease project, established the droplet reaction conditions and performed the sorting in the
sulfatase autodisplay project, and supported all other projects. The metagenomic screening
for esterases was a major part of this thesis and is reported in detail in Chapter 3. Here, I will
briefly highlight how the FADS contributed to the success of the first two projects listed in
the table.
Dr Josephin Holstein performed a directed evolution campaign of a protease in droplets.
Proteases are difficult to evolve in E. coli, because they are toxic to the host cell. Other hosts,
such as B. subtilis, are more tolerant, but suffer from low transformation efficiencies limiting
library size. Therefore, these enyzmes are a casewhere cell-free expression systems are of high
interest. Christian Gylstorff established a cell-free expression system in droplets based on in
vitro transcription and translation (IVTT) [110]. Building on his work, Dr JosephinHolstein
then performed a directed evolution campaign. However, the implemented workflow led to
the generation of unwanted satellite droplets that did not contain functional genes and limited
the sorting efficiency for this assay. Because the formation of these satellites could not be
prevented, the sorting of droplets based on both peak amplitude and width was developed.
Figure 2.9 shows how the width measurement helped to improve the outcomes of this
project. As can be seen in the left panel, the expected droplet size was about 1.1ms, while the
satellites were at 120 to 240 µs. Therefore, only droplets with a width between 0.65 and 1.5ms
were selected for sorting. As the two histograms show, this reduced the number of events at
Table 2.3 Overview of the projects succesfully performed on the FADS.
Enzyme Expression Droplet CollaboratorDiameter (μm)
Directed Evolution
Protease IVTT† 50 Dr Josephin Holstein
Sulfatase E. coli Autodisplay 15 Dr Bert van Loo
Phosphotriesterase Single-cell lysate 20 David Fernández Schnettler
Metagenomics
Esterase Single-cell lysate 15 Dr Mariana Rangel Pereira
Glycosidase Single-cell lysate 20 Stefanie Neun
Sulfatase Single-cell lysate 20 Stefanie Neun
† in vitro transcription and translation
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Fig. 2.9 Screening of a protease library screen using a cell-free expression system. The work-
flow creates small droplets, which could be separated visually from the main droplet pop-
ulation using the width measurement. Sorting based on both width and amplitude of the
droplets improved the outcome of screening campaigns like this.
amplitudes above 5V. This is important, because often only a certain number of droplets can
be collected due to the limited throughput of the available methods for downstream charac-
terisation of the selected variants. Before the widthmeasurement was implemented, the sort-
ing threshold was set too high and only few genuinely improved variants would have been
selected. Furthermore, differing droplet sizes prevent regular spacing due to a difference in
flow resistance [111]. Therefore, small droplets caught up with larger droplets and caused
them to be sorted as a false positive. Avoiding any small droplets from triggering a sorting
event therefore reduced the false positive rate. Using this improved sorting, it was possible to
sort six separate libraries and obtain 38 improved enzymes compared to the starting point.
In another project, I supported Dr Bert van Loo in evolving a sulfatase in droplets using
an expression system in which the enzyme was presented to the extracellular space by E. coli
[112]. This system avoided cell lysis, which allowed live cell recovery and thus simplified the
confirmation and characterisation of selected variants.
During the project it became evident that the first implementation of the width measure-
ment was not independent of the droplet amplitude. Figure 2.10 shows a control experiment
illustrating this point. A positive control and a negative control were encapsulated. Although
almost all droplets containing the positive control were saturating the detector, there was a
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spread of signal amplitudes across thewidth-range. Even though the droplets were uniformly
sized according to video analysis, the width versus amplitude plot implied a more than three-
fold difference in size between the least and most fluorescent droplets.
A simple simulation of the widthmeasurement based on the normal distribution showed
that this was indeed an artefact of measuring the width at a fixed threshold (see Appendix
Figure A.3). Therefore, the determination of the FWHM was implemented, which measured
the width relative to the amplitude of the droplet. Thus, an amplitude-independent measure
of droplet size was created, see Figure 2.10B.
Taken together, these two examples illustrate how the performance of the FADS was in-
crementally improved based on experimental needs.
2.5 Conclusions
The set-up which I have developed in this chapter is a state-of-the-art instrument to control
droplet sorting using a microfluidic chip. It has a proven ability to sort droplets for a number
of biochemical procedures using several droplet properties.
In its current state, the FADS can only measure green fluorescence. Yet, it provides a
tested framework for extension to additional fluorescencemeasurements by incorporation of
more lasers and PMTs. Work by Dr Tomasz Kaminksi is currently on the way to achieve this.
The peak analysis algorithm can be used as a module to analyse each fluorescence channel
separately. Beyond access to different fluorescent dyes, plotting the output from two fluores-
cence channels can be used to control for expression variation between cells by co-expressing,
for example, a red fluorescent protein from a plasmid. Also, a strain that constitutively ex-
pressed a red fluorescent protein from its genome could be used to control for the number
of cells if live cells are used instead of lysed cells. Such measurements would improve the
outcome of droplet sorts.
There are improvements that can be made to the peak analysis algorithm. The current
way to determine the amplitude 𝑈max is the simplest. However, the time at which the global
maximum occurs may be different from the true centre of the peak (𝑡2 − 𝑡𝑐 ≠ 0). This can
be caused by inhomogeneous droplet contents due to, for example, a co-encapsulated dust
particle. In such a case, both the width and the FWHM measurement are inaccurate. To
resolve this, all data-points could be stored in an array and, once the falling edge occurs, sev-
eral values around the temporalmidpoint could be averaged to obtain amore robustmeasure
of the amplitude. Similarly, the FWHM could be determined as the difference between the




Fig. 2.10Thedifference between theWIDTH(A) and the FWHM(B)measurement of droplet
size for the same sample. The WIDTH measurement is dependent on the amplitude of the
signal because it is measured where the peak passes the detection threshold, wherease the
FWHM measures the width at half the amplitude of a fluorescence signal. Therefore, gating
according to droplet size is more reliable using FWHM.
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Another, more difficult to resolve, limitation of the algorithm is that if FWHM is below
the threshold level, it cannot be determined. Therefore, it may be necessary to offset the
fluorescence by adding a small amount of fluorescein (e.g. 10 nM) to the buffer.
The sensitivity of the previously reported set-ups was 1 nM for amplex red and 2.5 nM
fluorescein with droplets of 23 and 20 µm respectively [64, 67]. These were determined us-
ing the same concentration of fluorophore in all droplets. In this chapter, smaller, 15 µm,
droplets were used to reduce the dilution of enzyme upon cell lysis. In a mixture of droplets
with different fluorophore concentrations, the lowest concentration which could be distin-
guised from background at medium gain was 16 nM fluorescein. Because the fluorescence
measurements are performed with droplets under flow, smaller droplets will emit fewer pho-
tons in total, because they spend less time in the laser beam, explaining the somewhat reduced
sensitivity.
The sorting and error rates were not discussed in this chapter, because they are mostly
determined by the chip design [108]. False positives in general may be dominated by biolog-
ical factors. This will form part of the discussion in the next chapter. In it, I will present the
application of the discussed set-up in a functional metagenomic screen for esterases.
Chapter 3
Functional metagenomic screening for
esterases in droplets
3.1 Abstract
In this chapter I present a functionalmetagenomic screen for esterases inmicrofluidic droplets.
Esterases and lipases are an important class of enzymes used in industry . They have been ex-
tensively screened for in metagenomic libraries, albeit using cost- and time-intensive culture
plate methods with most studies reporting only one or two new enzymes. Interestingly, no
major study published to date has used droplet sorting to screen for esterase activity either to
improve existing or discover new esterases. Yet, such a screen is highly desirable to increase
throughput and reduce the cost of screening.
Here, I met this challenge by developing an esterase assay in droplets and using the
droplet sorter I built in Chapter 2 to screen the million-member metagenomic library SCV.
The throughput of droplets allowed full coverage of the library on a single day of screening.
Therefore, this is the largest functional metagenomic esterase screen performed to date in
terms of throughput. Thirteen new genes associated with esterase activity were identified.
Most of these belonged to the α/β-hydrolase superfamily of proteins, which contains most
of the known esterases. However, many were raremembers of small families such as N20 and
RR11ORF1, which are members of the recently discovered family DUF3089. The enzymes
were purified and quantitatively characterised in terms of their esterase activity. They were
also tested against a range of other substrates to find promiscuous activities. The hits N1O5
and N7 showed β-galactosidase and Kemp eliminase activity, respectively. This shows that
using one substrate as “bait” can elicit enzymes that are sometimes difficult to screen for be-
The results presented in this chapter were obtained in collaboration with Dr Mariana Rangel Pereira.
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cause of lack of sensitivity or high background. Together, this research enabled the discovery
of new esterases from small protein families at high throughput and low cost.
Contributions: I performed all of the microfluidic work: I tested and optimised the reaction
conditions in droplets, I expressed and prepared the metagenomic library for droplet screen-
ing, screened the droplets, recovered and re-transformed the DNA. I performed the re-screening
and identification of hits on tributyrin plates together with Dr Mariana Rangel Pereira. The
sequence analysis, family assignment, sequence-similarity network, and interpretation of find-
ings presented here is entirelymywork. The protein expression and determination of the esterase
kinetics was performed in equal share with Dr Mariana Rangel Pereira. I designed the promis-
cuous activity screen and the cross-inhibition test, selected the substrates and performed the
assays jointly with Dr Mariana Rangel Pereira. The analysis, interpretation, presentation and
discussion of the results is my own.
3.2 Introduction
The goal of this chapter is to screen for esterases and lipases in a functional metagenomic
screen using droplets. Esterases catalyse the hydrolysis of carboxylic acid esters. Lipases
are esterases acting preferentially on long-chain triacylglycerides which are insoluble in wa-
ter. Amongst other processes, these enzymes are important in the breakdown of biological
macromolecules to make them available for cellular metabolism.
Being involved in catabolic processes, the substrate scope of esterases is broad while ex-
hibiting regio- and enantioselectivity, which renders them interesting for industrial applica-
tions [113, 114]. Indeed, esterases and lipases are one of the most important enzyme classes
in the chemical and biotechnological industries [115]. Lipases find major applications in the
modification of fats. One example is the synthesis of structured triacylglycerols such as Be-
tapol which is used as a milk-fat substitute for infants [116]. One large scale application of
esterases is the release of ferulic acid from plant cell walls, a compound which is used in the
synthesis of vanillin [117]. Esterases are also used to synthesise optically pure compounds
and to hydrolyse protecting groups under mild conditions in multi-step organic syntheses
[117].
The hydrolysis of esters is achieved by a catalytic triad consisting of Ser-His-Asp, as
schematically shown in Figure 3.2 [119]. The aspartate residue favours the tautomeric state
in which the histidine enhances the nucleophilic strength of the serine residue. The serine
oxygen can thus attack the carbonyl carbon forming the first tetrahedral intermediate. The
negative charge of the tetrahedral intermediate is stabilised by two nearby backbone amides,
referred to as the oxyanion-hole. The breakdown of the intermediate is facilitated by histi-
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Fig. 3.1 Two important industrial applications of lipases and esterases: the synthesis of struc-
tured triacylglycerols (A) and the release of ferulic acid (red part) fromplant cell wall polysac-
charides (B). Ferulic acid is used to synthesize the important flavouring compound vanillin.
Adapted from [116, 118].
dine protonating the leaving alkoxy group. The resulting acyl-enzyme is cleaved by the attack
of activated water releasing the acid product via a second tetrahedral intermediate and re-
covering the free enzyme.
In terms of three-dimensional structure, equivalent catalytic triads have evolved in dif-
ferent protein scaffolds. This constitutes one of the best examples of convergent evolution
on the molecular level. The prominent protease trypsin, for instance, belongs to the PA su-
perfamily (25,000 sequences on Pfam1). Most esterases and lipases belong to the extensive
α/β-hydrolase superfamily (270,000 sequences on Pfam).
As enzymes find wider use in industry, there is growing demand for new esterases and
lipases to fit a specific purpose [115]. Some corporations offer collections of enzymes that
can be screened for their suitability in a certain application [117]. To add to these collections,
research has turned to metagenomic screening as a valuable source for new enzymes.
A typical functional metagenomic screen for esterases and lipases consists of transform-
ing the library into a heterologous host organism for expression followed by screening the
library on culture plates or in well plate format. The culture plate screen is most commonly
used: a growth medium is emulsified with 1% of a triacylglyceride, most commonly tribu-
tyrin, which renders the plates opaque. If a colony expresses an active enzyme, it will de-
1Pfam is a curated protein family database maintained by the European Bioinformatics Institue. Sequences
related by homology are grouped into clans (superfamilies) and families. Users can submit protein sequences
to assign them to a Pfam family. In this thesis Pfam 31.0 was used [120].
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Fig. 3.2 The hydrolysis of esters is catalysed by a catalytic triad consisting of Ser-His-Asp
and the so-called oxyanion-hole formed by two backbone amides. The mechanism proceeds
via three intermediates. After binding of the substrate, serine attacks the carbonyl carbon
atom forming the first tetrahedral intermediate Td1, which is stabilised by the oxyanion-
hole. The acyl-enzyme intermediate formed after the release of the alcohol is attacked by an
activatedwatermolecule. The breakdown of the second tetrahedral intermediateTd2 releases
the acid product and recovers the free enzyme. This figure represents the arrangement of
residues only schematically. In fact, one of the backbone amides is usually provided by the
catalytic serine residue. Also, the catalytic triad only forms upon substrate binding due to
the unfavourable dihedral angles the serine residue has to adopt. Figure adapted from [119].
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grade the droplets of fat over time and create a clear halo around the colony (Figure 3.3).
These colonies are then picked for hit analysis [121, 40, 122–129]. Less frequently used is
the well plate format, in which cell lysates are incubated with a chromogenic substrate, for
example p-nitrophenyl octanoate [130]. These screening procedures are limited by the num-
ber of colonies that can be assayed. Most studies report that 5,000 to 20,000 colonies were
tested. Beyond these numbers the plate assays become impractical. Therefore, metagenomic
libraries are often under-sampled, i.e. fewer clones than a library contains are tested. These
practical limits constrain the library size that can be screened, thus the number and diver-
sity of potential hits. Most studies using these screening methods conclude by characterising
only one of their hits in more detail, highlighting a single property such as high activity at
low temperature, but ignore the potential of any other hit sequences [128].
Fig. 3.3 The tributyrin culture plate assay is the most widely used phenotypic screen in func-
tional metagenomics of esterases. Tributyrin is emulsified with the growth medium, render-
ing an opaque plate. A colony expressing an esterase hydrolyses the compound causing the
formation of a halo around it. Less frequently used for screening are well plate assays using
p-nitrophenyl esters. The release of p-nitrophenolate can be detected at 405 nm, i.e. positive
wells turn yellow.
A notable exception is the recently published, largest screening campaign for esterases
and lipases to date [127]. In this extremely resource- and time-consuming study, one million
clones from 17 distinct metagenomic libraries were screened and 80 new esterases identified
by screening over 1,000 tributyrin plates. Four libraries were based on fosmids and screened
in arrays of 384 colonies, which amounts to about 150 screened plates. However, 95% of
the tested clones were members of λ-phage libraries (lambda ZAP, [131]). These libraries
were plated at 1,000 plaques per plate, indicating that at least a further 1,000 plates were
screened. Interestingly, 33 of the 80 reported esterases, i.e. 40% of the hits, were obtained
from the fosmid libraries representing only 5% of the screened clones. Also, almost half of
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the hits were contained in only two libraries representing just 7% of the tested clones. After
screening and sequencing, the authors select only five hits for further characterisation [127].
It is typical that any one study only characterise a small fraction of the presumed hits in
more detail. In two comprehensive reviews Ferrer et. al reported, firstly, that in total about
4,000 esterases and lipases had been detected in primary functional metagenomic screens up
to 2015, but that, secondly, only 288 were actually validated to be esterases and characterised
biochemically, which equates to less than 1 in 10 hits [132, 31]. While they are sometimes
tested for their substrate scope, this is exclusively done with carboxylic esters. Any potential
promiscuous activities towards other classes of substrates are neglected [121, 40, 122–129].
Authors base their decision on which hit to characterise on homology analysis of their
protein sequences. By aligning them against a database such as UniProt the novelty of a
sequence is assessed and it is assigned to a protein family. However, the use of this method is
increasingly limited because of the vast amount of experimentally uncharacterised sequences
available on databases.
However, assigning hits to protein families can be useful to guide further experiments to
test their biochemical properties. An important protein family database is Pfam. Another
useful resource is ESTHER (ESTerases and α/β-Hydrolase Enzymes and Relatives), a curated
database focusing specifically on esterases. This database currently holds 56,000 sequences,
which are grouped into Families, Parent Families and Blocks [133]. Another influential clas-
sification for bacterial esterases and lipases into eight families was published by Arpigny and
Jaeger [134]. Most authors attempt to assign their new enzymes to one of the originally de-
fined families. However, the increasing number of known esterases and lipases has revealed
the limitations of this classification. Different authors have extended the number of families
to currently eighteen [129, 135].
Taken together, esterases and lipases are needed in industry and metagenomics offers
a way of accessing new biocatalysts. The field of functional metagenomic screening for es-
terases has proliferated many new enzymes using traditional plate assay techniques. How-
ever, all previous studies are limited by the number of library members that can be tested.
Hence, the establishment of an ultrahigh-throughput screen for esterases and lipases is timely
and needed, and is the goal of this chapter. The screening workflow is shown Figure 3.4. The
specific aims were:
1. To increase the throughput of esterase discovery by implementing a droplet assay and
to screen the SCV library (1.25 × 106 members). Only fluorescence-based droplet as-
says allow throughputs higher than 106. Fluorescein has been used previously as a
reporter molecule to isolate metagenomic hits [53]. Other fluorophores, e.g. resorufin
and 4-methylumbelliferone, have been shown to readily exchange between droplets,
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preventing the detection of enzyme activity after long incubation times [70]. There-
fore, fluorescein dicarboxylate was chosen for the initial tests, which can be viewed as
a bait substrate for enzyme active sites catalysing hydrolysis.
2. To re-screen the output of the droplet sorting campaign using culture plates containing
tributyrin. The formation of a halo around a colony was used to validated hits but the
assay may have limited the total number of hits detected because of a lower dynamic
range and specific interactions.
3. To sequence the DNA inserts of the isolated plasmids and analyse them. The gene(s)
most likely responsible for the observed phenotype were re-cloned to confirm activity
and for protein production.
4. To kinetically characterise all enzymes, regardless of the novelty of their sequence, by
measuring timecourses with chromogenic p-nitrophenyl carboxylates.
5. To test the concept of fluorescein dicarboxylate acting as a bait by testing the activity
of the identified enzymes against a range of compounds that undergo hydrolysis, e.g.
glycosides and thioesters.
52 Functional metagenomic screening for esterases in droplets
Fig. 3.4 Workflow to isolate esterase gene from a metagenomic library. The approach used
in the literature is shown in the white boxes. This will be extended here in two ways (blue
boxes): the throughput of the screen will be increased by establishing a droplet assay and the
hits will be tested against a range of other substrates.
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Table 3.1 Overview of the positive and negative controls used to set
up assay conditions for the metagenomic screening.
Protein kcat/Km† (Ms)-1 Vector E. coli strain Expression
Est30 3.5 × 105 pHAT2 BL21(DE3) highEst30Δ –
P91 1.0 × 104 pZero2 E. cloni 10G‡ lowP35 –
† catalytic efficiency for paranitrophenol acetate.
‡ commercial cloning strain by Lucigen, derived from E. coli K12.
(–) no activity detected.
3.3 Establishing the esterase assay in droplets
Before working on the microfluidic droplet assay, the esterase assay was briefly tested in well
plates using cell lysates. The chosen positive and negative controls were Est30 with Est30Δ
and P91 with P35, see Table 3.1. Est30 and Est30Δ are a highly active esterase and its inactive
mutant [136]. They were overexpressed from pHAT2, a T7 expression system based vector
[137]. P91 and P35, an esterase and sulfatase respectively, are hits previously found in the
SCV library (Table B.1, [67]). Here, the originally-isolated plasmids with the metagenomic
DNA insert were used as genuine library controls, i.e. the level of expression could not be
controlled but depended on the ability of the E. coli host to recognise the foreign DNA [41].
To obtain results in well plate format that are transferable to droplets, the cell lysates of the
respective controls were diluted to the concentration that is expected in droplets. The cytosol
of a single E. coli cell (ca. 1 nL) is diluted 2,000 times in a 2 pL droplet. The amount of cell
lysate needed to achieve the equivalent dilution in a well plate measurement was calculated
from the optical density OD600nm for a cell culture assuming a conversion factor of 5 × 1018
cells/mL for an OD600nm of 1. For example, of a cell culture with OD600nm 3 which was
pelleted and resuspended in 100 µL lysis agent, 7.7 µL were added to a 200 µL reaction.
Thus, nine assay conditions were tested as shown in Figures 3.5 and 3.6. Three different
fluorescein diester substrates were tested (fluorescein dibutyrate, dihexanoate, and dilaurate)
at three different pH values (7, 8, and 9). The goal was to identify assay conditions which
allowed overnight incubation to enable even a weak metagenomic hit to hydrolyse sufficient
substrate for detection.
Fluorescein dibutyrate is the most similar substrate to the commonly used tributyrin to
screen for esterases. However, the difference between the positive and negativemetagenomic
controls after overnight incubation was smaller than for fluorescein dihexanoate at all pH
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values tested. The difference between the controls for fluorescein dilaurate was even smaller.
Therefore, fluorescein dihexanoate was selected as the substrate for screening.
Theproduct of the reaction, fluorescein, emitsmost strongly in its di-anionic form. Given
the pKa of 6.7 of the mono-anion, fluorescein emssion plateaus at pH 8 and above [138].
Therefore, pH of 8 was expected to enable the most sensitive detection of product. At this
pH, the rate of substrate hydrolysis in the buffer (no cells control) was still low, as seen in
Figure 3.6. Given the ratio of positive to negative signal was better at pH 8 than pH 9, pH 8
was selected for screening.
Fig. 3.5 Selection of substrate and pH using nine different assay conditions with positive and
negative controls (Table 3.1) over 60min. From left to right the pH of the buffer (50mM Tr-
isHCl, 100mM NaCl) is 7, 8, and 9 respectively. From top to bottom the carbon chain length
of the fluorescein diester (20 µM) increases from 4 (dibutyrate), to 6 (dihexanoate), and to
12 (dilaurate). Fluorescein dibutyrate was fully hydrolysed by the positive controls before
the measurement commenced. However, high rates of hydrolysis in the negative controls
were also observed on this timescale. Fluorescence was excited at 480 nm and measured at
520 nm.
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Fig. 3.6 Fluorescence reached after overnight incubation (18h) of the nine reactions shown
in Figure 3.5. Long incubation times are beneficial for functional metagenomic screening to
isolate weak or weakly expressed enzymes. However, this is only possible if the background
hydrolysis of the substrate is sufficiently low. The difference between positive and negative
controls was largest for fluorescein dihexanoate, while pH 8 is offered the best trade-off be-
tween high positive and low negative signal. Fluorescence was excited at 480 nm and mea-
sured at 520 nm.
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Using the chosen conditions, 15 µm droplets were generated containing cells that had
overexpressed Est30 and Est30Δ. The cell cultures were premixed at a positive to negative
ratio of 1:100 and encapsulated at an occupancy λ of 0.1. Therefore, 0.1% of the total droplet
population, or 1 in 1,000 droplets, was expected to develop strong fluorescence above back-
ground. Indeed, fluorescence microscopy 3h after droplet generation showed bright fluo-
rescent droplets at about the expected occupancy. The micrograph in Figure 3.7 contains 8
fluorescent droplets out of about 7,000 (0.11%) in close agreement with the calculated per-
centage.
Fig. 3.7 Fluorescence micrographs of droplets containing cells which expressed Est30 and
Est30Δ at 1:100 and with an occupancy λ of 0.1. The brightly fluorescent droplets (white)
were observed at the expected frequency for the positive control Est30, indicating that the
esterase assay worked in droplets and had a good signal to noise ratio.
The fluorescence distribution of these droplets was determined by FADS (Chapter 2). The
histograms after 3h and 18h incubation are shown in Figure 3.8. The population above 400
a.u., which represents saturation of the detector in this configuration, is 0.12% and 0.16% re-
spectively, and therefore likely to be the signal stemming from Est30 activity. The shoulder at
100 a.u. appearing after overnight incubation could be explained by the background activity
of Est30Δ seeing as it corresponds to about 10% of the total population.
Encouraged by these results, droplets were created containing the P91 and P35 controls.
However, when mixed at a ratio of 1:100, no distinct population of high fluorescence was
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Fig. 3.8 Esterase assay with fluorescein dihexanoate in droplets using Est30 and Est30Δ ex-
pressing cells in a ratio of 1:100 and at occupancy λ of 0.1. A: Timeseries of the fluorescence
signal of analysed droplets. Each peak is caused by a droplet passing through the laser beam.
The droplet histogram in panel B was generated in real-time by recording the amplitude
(blue circles) of all the peaks. The fluorescence of negative droplets was caused by partial
background hydrolysis of the substrate, no additional fluorophore was added. B: Distribu-
tion of droplet fluorescence after 3h and 18h of incubation. The percentage of droplets with
a signal above 400 a.u. is 0.12 amd 0.16% respectively, in good agreement with the expected
0.1% of positive events.
observed (data not shown). Therefore, separate droplet samples were generated for the two
controls. As shown in Figure 3.9, after overnight incubation the frequency of droplets with
fluorescence above 100 a.u. was much higher in the P91 sample than the P35 sample. How-
ever, the fluorescence values were distributed over the whole signal range, indicating strong
variation in the amount of protein produced from cell to cell. This increased variation in the
P91 sample compared to Est30Δ sample is rationalised by the difference in the expression
constructs. As explained above, the expression of the former relied on spurious transcrip-
tion by the E. coli host from the metagenomic DNA, while the expression of the latter was
under tight control of a T7 promoter in the pHAT vector. Interestingly, the background in
the P35 sample did not increase as much as in the Est30Δ case, likely due to the different E.
coli strain used.
Finally, the SCV library was transformed and encapsulated into droplets using the chosen
conditions (Figure 3.9). The fluorescence distribution revealed rare events above 200 a.u.
which were indicative of the detection of esterase activity in the actual metagenomic library.
Given this result, a droplet sorting campaign was performed, to isolate the library members
responsible for the signal, as reported in the next section.
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Fig. 3.9 Distribution of droplet fluorescence in three distinct droplet samples (λ=0.35). Flu-
orescence above 100 a.u. was much more frequent in the P91 sample compared to the P35
sample as expected. However, no defined population separate from the background was dis-
cernible. The sample with cells expressing the metagenomic SCV library showed events with
fluorescence above 200 a.u., indicative of the presence of esterase activity due to a library
member.
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3.4 Screening of the SCV Library
Taking the insights gained in the previous section, the workflow shown in Figure 3.10 was
devised to screen the metagenomic library for esterases. The principle task was to isolate
individual plasmids conferring esterase activity to cells from a pool of over 1 × 106 plasmids
whichwas the SCV library. To achieve this, first, the plasmid library was transformed and the
transformed cells incubated on plates for two days to allow time for the expression of protein.
The cells were then encapsulatedwith substrate and lysed, incubated for the reaction to occur,
and finally sorted. The DNA was recovered from the collected droplets and re-transformed
into cells to amplify it. To distinguish real hits from false positives, the transformed cells were
plated onto tributyrin containing plates, i.e. the plates were opaque. They were checked for
the formation of a clear halo around the colonies, indicating esterase activity. Both colonies
with halos and, as a control, with no halos were picked and grown as separate cultures to
recover the plasmid for sequencing and downstream characterisation.
Fig. 3.10 The figure shows schematically how the metagenomic SCV library was sorted to
recover individual plasmids conferring esterase activity to cells. Section 3.4 describes the
procedure.
3.4.1 Droplet screening and hit recovery
The library was screened in two separate screening campaigns (campaign I and II) each fol-
lowing the workflow above. In both cases the droplets were generated with an occupancy λ
of 0.35. Batches of these droplets were sorted up to three days after their generation. The
histograms of all droplet sorts are shown in Figure 3.11.
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Fig. 3.11 Fluorescence histograms of the droplet sorting of the SCV library using fluorescein
dihexanoate. Two separate screening campaigns were performed. During each campaign
droplets were sorted over several days to assess if prolonged incubation influenced the hit
rate. The difference in the scales of fluorescence between campaign I and campaign II is due
to the use of different fluorescence detectors, refer to Section 2.4.1 for details.
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Table 3.2 Summary of the two SCV library sorting campaigns.
Campaign Day Droplets Colonies Unique
Sorted /106 Collected Hit Rate Total /103 Halos Hits
I
1 10.0 126 3.5 × 10−5 6 17
2 5.7 110 5.5 × 10−5 10 17
Total 15.7 236 4.3 × 10−5 16 34 11
II
1 7.0 65 2.6 × 10−5
2 4.8 104 6.2 × 10−5
3 3.1 77 7.1 × 10−5
Total 15.0 246 4.7 × 10−5 ND ND 6
ND, not determined.
The key numbers of the two campaigns are summarised in the Table 3.2. In campagin I,
15.7 × 106 droplets were sorted over two days, i.e. an estimated 5.5 × 106 single cells, which
equates to about 4.4-fold over-sampling of the libary. The 126 and 110 most fluorescent
droplets were collected on the first and second day, respectively. In campaign II, 15.0 × 106
droplets were sorted over three days with a focus on longer incubation time. A similar num-
ber of droplets was collected for recovery. An apparent hit rate was calculated based on the
number of droplets collected per number of clones screened. It was in the range of 10−5,
typical for functional metagenomics, [31], and increased with longer incubation times, indi-
cating that the reaction continued to accumulate product up to three days.
Next, the DNA of the collected droplets was recovered and re-transformed separately
for each sorting day. Campaign I yielded about 16,000 colonies in total. The plates were
monitored up to two weeks and 34 colonies with clear halos were picked for downstream
analysis, see Figure 3.12 for representative examples. Thus, the hit rate in the culture plates
was in the range of 10−3 suggesting an average enrichment of 102 from droplets to plates.
Upon sequencing it was found that several halo-forming colonies harboured the same library
plasmid. The number of unique hits was 11 in campaign I, i.e. on average every hit was found
three times (a more detailed analysis follows in the next section). A high number of false
positives, i.e. colonies that did not gain a halo with time, was not unexpected as it had been
observed byColin et al. in theirmetagenomic screening campaigns [67, 84]. Thenaïve library
plated at a similar colony density did not yield any colonies with clear zones around them,
confirming that the droplet sorting was essential to recover hits from this library.
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Fig. 3.12 Photos of tributyrin-containing agar plates with E. coli colonies recovered post-
sorting. At the centre, each photo shows a colony surrounded by a clear zone, or halo, indi-
cating the presence of an esterase.
The clones selected during campaign I were re-grown in a 96-well plate in triplicates.
Their diluted lysates were incubated with fluorescein dihexanoate to test their activity (Fig-
ure 3.13). The figure shows the activity after 45min of incubation. All tested clones showed
activity in the range between the negative and positive controls. The highest activity was ob-
served for N18. After having confirmed the activity of the hits on the substrate used in the
droplet screening, their plasmids were isolated for sequencing.
Fig. 3.13 Activity of cell lysates incubated with 20 µM fluorescein dihexanoate was above
background (dashed line) after 45min of incubation. The lysates were diluted to the extent
expected in droplets (2 × 103) in 50mM TrisHCl pH 8.0, 100mM NaCl. Negative controls:
P35 and Est30Δ, positive controls: P91 and Est30. Dashed lines: three standard deviations
above P35 fluorescence (the Est30Δ value was lower). Error bars are the standard deviation
of triplicate measurements.
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Table 3.3 This table lists the selected postive clones, their DNA insert size, and how
often they were found during each screening campaign.
Clone Restriction Site† Insert size (kbp) Campaign I Campaign II Total
N1 EcoRI 4.2 9 1 10
N2 EcoRV 5.3 1 1 2
N4 EcoRV 3.9 3 8 11
N7 EcoRV 4.1 2 2 4
N11 EcoRI 2.4 2 2
N13 EcoRV 3.1 2 2
N16 EcoRI 2.9 3 3
N18 EcoRV 3.4 1 2 3
N20 EcoRI 2.5 2 2
N26 EcoRV 1.2 1 1
N33 EcoRV 3.5 1 1
RR11 EcoRI 2.2 1 1
† The cow rumen sub-library of SCV was constructed using the EcoRI restriction
site, whereas all others where constructed using EcoRV.
3.4.2 Sequence analysis of the selected clones
All clones selected in the two screening campaigns were sequenced using the standard M13
forward and reverse primers flanking theDNA inserts on the library vector pZero2 (for vector
map see Appendix Figure B.1). The initial sequences revealed that some of the halo-forming
clones were identical. In total, 12 unique clones were found, as listed in Table 3.3. Nine hits
were found more than once. The clones N1 and N4 were found most frequently: 10 and 11
times each. The clones N26, N33 and RR11 were only found once. The multiple recovery of
several hits was indicative that both the library coverage and the DNA recovery were efficient
at isolating these hits. The restriction site used to insert environmental DNA into pZero2 was
EcoRV for most of the sub-libraries contained within the SCV library [84]. Only in the case
of the cow rumen library, which contains 10% of the screened clones, was EcoRI used. Five
of the twelve could therefore be assigned to the cow rumen library, indicating that the hit
rate for this library was 6× higher than the average of the other libraries.
The only clone whose forward and reverse sequences could be aligned to obtain the full
DNA insert after the first round of sequencing was N26, which had the smallest insert at
1.2 kbp. The other clones required up to three rounds of sequencing by primer walking,
i.e. sequencing using custom primers designed to bind near the ends of the known insert
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sequence. All DNA inserts could thus be sequenced. The largest insert had a size of 5.3 kbp,
while the average was 3.3 kbp.
Next, the open reading frames (ORFs) responsible for the detected esterase activity needed
to be identified. As a first assessment, the predicted protein sequences of all the ORFs larger
than 300 nucleotides were searched against the NCBI non-redundant protein database using
Basic Local Alignment Search Tool (BLAST). All DNA inserts contained at least one pre-
dicted protein that had detectable sequence similarity with a sequence which was annotated
as an esterase, lipase or α/β-hydrolase in the database. In total, 13 unique protein sequences
were found to be the likely esterase candidates. The location of each of their respective ORFs
is shown in Figure 3.14. The protein sequences identfied in the inserts of clones N18 and
N33 were identical. It was revealed that these two inserts could be aligned to each other, i.e.
they must have derived from the same stretch of environmental DNA used to construct the
library.
When searched for in October 2016, the sequence identities on the DNA level of the
top hit for N1ORF4 and N1ORF5 had been 34% and 32% respectively. Since then, new se-
quences were deposited on the database and the identity with the top hits is now 88% and
90%. With similar effect, the top hit changed for 10 out of the 13 unique protein sequences.
As of September 2018, 7 sequences had identities equal or larger than 90% with a deposited
sequence, refer to Table B.2 for a detailed list.
Nonetheless, all of the sequences consituted new, uncharacterised proteins. The top hits
listed by BLAST for each predicted protein from this study were predicted proteins them-
selves with no prior experimental evidence underlying the annotation on the database. Only
in the case of RR11ORF2 was the top hit an experimentally verified esterase (85% sequence
identity): EstGK1, which was found in a traditional metagenomic screening campaign in
2010 [130]. However, the highest sequence identities with the next characterised protein for
all other hits ranges from not detectable to a maximum of 68% as shown in Table 3.4. That
is, it was of interest and necessary to clone each of the identified ORFs to prove that they
encoded for an esterase or lipase.
Prior to this, the protein sequences were further analysed. All hits were searched for
matching family entries in the Pfam and ESTHER protein family databases. On Pfam, 10 out
of the 13 unique protein sequenceswere predicted to contain a single domain belonging to the
α/β-hydrolaseclan (CL0028), which contains most known esterase sequences (Figure 3.15).
They were assigned to a number of esterase and lipase families within this clan. Interestingly,
4 of the 13 hits were assigned to small protein families together consisting of less than 4,000
sequences, whereas the remaining 7 were part of families with over 170,000 members. That
is, one third of the hits were from families constituting only 2% of the sequence space of inter-
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Fig. 3.14 This figure shows the ORFs related to esterase genes identified in the sequenced
clones. The orientation is 5’ to 3’ end with respect to the vector pZero2, the length of the
DNA inserts and ORFs are to scale. The DNA inserts of clones N18 and N33 contained an
identical ORF and could be aligned to form a continuous sequence.
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Table 3.4 This table lists the most closely related enzyme (by sequence) for
each hit which was biochemically confirmed to have esterolytic activity.
Hit Enzyme† Query Cover Identity Reference
N1ORF4 PNBCE 90% 34% [139]
N1ORF5 PNBCE 94% 32% [139]
N2 EstA 99% 65% [140]
N4 – – – –
N7 N-Acetyl Hydrolase 65% 33% [141]
N11 XynC 96% 41% [142]
N13 Extracellular Lipase 61% 64% [143]
N16 PNBCE 92% 33% [139]
N18 EstA 98% 59% [140]
N20 EstGK1 96% 68% [130]
N26 XylF 87% 29% [144]
RR11ORF1 Arylesterase 76% 32% [145]
RR11ORF2 EstGK1 98% 85% [130]
† Top BLASTp hits against the non-redundant protein or UniProt
databases associated with publications that prove the activity of the en-
zyme, as of September 2018.
– no characterised protein with homology to N4 could be found.
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est. Notable are N20 and RR11ORF2 which were assigned to DUF3089, a family which was
only recently discovered with few characterised members [130, 146, 147]. Hits N2 and N18
were each predicted to contained two domains. One was assigned to the SGNH-hydrolase
clan (CL0264), which contains the lipases of the GDSL family; the second was a transmem-
brane β-barrel domain (CL0193). These two hits appear to be trans-membrane proteins with
an extracellular lipase domain similar to EstA with which they show 65 and 59% sequence
identity respectively [140, 148].
To gain further insight, the sequences of the hits were also submitted to the ESTHER
database, which specialises in the α/β-hydrolase superfamily and is manually curated [133].
The classifications between the two databases differ, with ESTHER containing more func-
tionally characterised entries. As expected, N2, N13, and N18 could not be assigned to a
family in this database since they are not members of the α/β-hydrolase superfamily. Note-
worthy assignments are N11 and N26. The hit N11 was assigned to the family of feruloyl
estereases (within the Antigen85c family) for which there were only 300 known members.
This family of esterases is of commercial importance as mentioned above [117]. The hit
N26 was assigned to the epoxide-hydrolase like family, specifically the C-C bond hydrolases
for which also only 300 sequences were known. These enzymes hydrolyse conjugated 1,5-
diketones [149, 150], they are catalytically promiscuous [151], and they have previously been
found in a metagenomic screening [152]. Therefore, the functional screen isolated hits from
across the spectrum of known esterase families. There was a notably high proportion of hits
from small families, i.e. they were from families of rarely observed enzymes, which have be-
come accessible thanks to metagenomics at ultrahigh-throughput.
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Fig. 3.15 Sequence similarity network of the α/β-hydrolase superfamily (Pfam CL0028) con-
taining 10 of the 13 hits. Sequence similarity networks are an alternative to phylogenetic trees
showing how large numbers of sequences are related [153]. Hits N4, N20 and RR11O2 are lo-
cated in clusters representing less than 1% of the displayed sequence space. N11 was assigned
to the Esterase family, but is located in a small sub-cluster neighbouring the DUF3089 fam-
ily. The network contains 370,000 sequences clustered into 20,000 nodes representing 80%
of CL0028. The node size is proportional to the number of sequences represented (range 1 to
2600, median 4). Connecting lines represent alignments with e-values <10−20, the median
alignment length was 312. Networks for N2, N13 and N18 shown in Appendix Figures B.3
and B.4.
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Most of the hits were assigned to the α/β-hydrolase superfamily of proteins. The α/β-
hydrolase superfamily was first defined by Ollis et al. in 1992 [154]. As shown in Figure
3.16, the canonical fold consists of a β-sheet surrounded by α-helices. The β-sheet consists
of eight strands of which strand 2 is antiparallel to the others. Strands 3 to 8 are connected
by α-helices. The catalytic residues are located on loops between strand 5 and helix C (Ser),
strand 7 and helix E (Asp), and near the C-terminus (His). Adaptation to different substrates
by individual family members is achieved by differing cap domains above the catalytic triad.
The cap domains are formed by peptides that extend from the C-terminal ends of strands
4 and 6-8. Originally defined using five enzymes, the α/β-hydrolase fold has grown into a
large superfamily of proteins catalysing numerous chemical reactions [155]. As said, many
of them are esterases/lipases but also peptidases. Other hydrolytic enzymes found in this
superfamily are epoxide hydrolases, haloalkane dehalogenases, enolactotases, and C-C bond
hydrolases. The functional versatility of this fold goes even beyond that: Rauwerdink and
Kazlauskas counted the catalysis of 17 distinct reaction mechanisms including oxidoreduc-
tive and lyase mechanisms [119]. Taking this together, it was likely that the hits had a similar
tertiary structure and that the hydrolytic activity observed for the identified hits was brought
about by an active site with a catalytic triad. Furthermore, due to the functional diversity of
this fold, promiscuous activities of these enzymes were likely to exist.
Fig. 3.16 This figure shows the canonical secondary and tertiary structures of the α/β-
hydrolase fold A: The secondary structure shows how strands 4 to 8 of the central β-sheet
are connected to each other by five intervening α-helices. The residues forming the catalytic
triad are located on loops as indicated by the blue circles. B:The tertiary structure of dienelac-
tone hydrolase (PDB: 4P93), a near canonical α/β-hydrolase, shows the relative orientation
of the catalytic residues in the top part of the structure. Accommodation of different sub-
strates in family members of this fold is achieved by insertions into the loops connecting the
β-sheets and α-helices. Figure adapted from [155].
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In summary, eachDNA insert contained anORFwhichwas predicted to be linked to ester
hydrolysis. Further analysis of these ORFs showed that they all represented new, previously
uncharacterised sequences. The sequences were assigned to a diverse range of esterolytic
protein families some of which have interesting catalytic properties. Next, it needed to be
experimentally veryified that the identified ORFs were indeed responsible for the esterase
activity of the respective clone.
3.5 Quantitative analysis of the newly identified esterases
ThepredictedORFswere cloned into the vector pHAT for gene expression inE. coliBL21(DE3)
[137]. Using the SpeI andHindIII cloning sites added anN-terminal 6xHis-tag to all proteins,
which enabled purification using immobilized metal ion affinity chromatography (IMAC).
For all hits, the entire gene was cloned, except in the case of N2, where only the lipase domain
was cloned (residues 25-358), andN4, where a signal peptide was removed (first 19 residues),
see Appendix Table B.3 and Figure B.6. For hit N18, no expression construct was found to
yield sufficient amounts of protein for Michaelis-Menten kinetics .
3.5.1 Esterase kinetics with p-nitrophenyl carboxylates
The Michaelis-Menten kinetic parameters of the purified proteins were determined for p-
nitrophenyl carboxylates. The substrate concentration was varied and the initial rates of re-





; vmax = kcat[E0] (3.1)
With vi and vmax being the initial rate and maximal rate, respectively; [S] the substrate con-
centration; Km the Michaelis constant, which is a measure of the enzyme’s affinity to a sub-
strate; kcat the turnover number, which is maximum number of substrate conversions per
second per enzyme active site; and [E0] the enzyme concentration. The catalytic efficiency
kcat/Km is generally used to compare different enzymes. Figure 3.17A shows a typical mea-
surement for hit N7 with substrate p-nitrophenyl acetate.
The chain length of the p-nitrophenyl carboxylate was varied from two to sixteen car-
bon atoms. Again, typical results are shown for N7 in Figure 3.17B. For N7, the highest
catalytic activity was observed for p-nitrophenyl hexanoate, followed by similar activities for
p-nitrophenyl acetate and butyrate. For longer chains there was a drop in activity, typical
for the substrate preference for an esterase. As a general rule, esterases have been defined
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Fig. 3.17Michelis-Menten kinetics for hitN7. A:The initial rates were determined at different
concentrations of p-nitrophenyl acetate by linear regression. [E0] = 250 nM, 50mM TrisHCl
pH 8, 100mM NaCl, 0.3% TritonX100. Reactions were corrected for the background rate
in buffer. Error bars are the standard deviation of a triplicate measurement. B: Initial rates
were plotted against substrate concentration and Equation 3.1 used to determine the catalytic
parameters. The chain length of the p-nitrophenyl carboxylate was varied to determine the
substrate scope of the enzyme.
by their ability to hydrolyse ester substrates of up to 10 carbons. Those which preferentially
hydrolyse substrates with chains beyond 10 carbon atoms are considered lipases [157].
Similar to N7, all hits showed their highest activities between 4 and 8 carbon atoms,
which agrees with the fact that fluorescein dihexanoate was used to isolate these enzymes
in the droplet screening (Figure 3.18). The majority of esterases isolated from metagenomic
libraries using the tributyrin assay, show their highest activity towards p-nitrophenyl acetate
[40, 122, 126, 129]. Therefore, the droplet screen using fluorescein dihexanoate gave access
to enzymes with a substrate preference shifted towards longer ester chains. Hit N2 had de-
tectable activity only on substrates from two to six carbon atoms. All other enzymes were
active up to chain lengths of ten carbon atoms and five of them had detectable activity up to
the longest chain length. For p-nitrophenyl hexanoate, i.e. at the same chain length as in the
droplet substrate, N20 had the highest activity at (2 ± 1) × 105 M−1s−1 and N11 the lowest
activity at (200 ± 20) M−1s−1. Therefore, enzymes with activities spanning three orders of
magnitude were isolated. The average catalytic efficiency was in the range of 104 placing the
hits into the activity realm of the enzymes active in the fatty acid metabolism [158].
In terms of kcat, therewas a general decreasewith increasing chain length (Figure 3.19). In
terms of Km, nearly all enzymes preferred the short chain esters. Notably, N7 preferred longer
to shorter chain esters and had its lowest Km for p-nitrophenyl palmitate at (360 ± 30) µM,
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Fig. 3.18 Catalytic efficiencies of the metagenomic hits depending on the ester chain length.
Error bars are the standard deviation from the Michaelis-Menten fit.
Fig. 3.19 Turnover number kcat and Michalis constant Km of the metagenomic hits for p-
nitrophenyl esters of different chain lengths (colour legend in Figure 3.18). Error bars omitted
for clarity.
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indicating that this enzyme has a large hydrophobic binding pocket. In summary, all the
expressed metagenomic hits were shown to be esterases.
3.5.2 Melting temperatures
The melting temperature Tm of the hits was determined by thermal denaturation in the pres-
ence of the fluorescent dye SYPRO orange. The quantum yield of this dye increases upon
exposure to a hydrophobic environment [159]. Therefore, as a protein unfolds and exposes
its hydrophobic core, an increase in fluorescence is observed. The resulting melting curves
are shown in Figure 3.20. A Boltzmann equation was fitted to the data assuming there were
no intermediates between the folded and unfolded states [160]:
𝐹 (𝑇 ) = 𝐹end − 𝐹start
1 + exp 𝑇 −𝑇mC
+ 𝐹start (3.2)
With 𝐹 (𝑇 ), 𝐹start, and 𝐹end being the signal depending on temperature 𝑇 , at the start, and
the end of the measurement respectively. The constant C characterises the breadth of the
transition.
Fig. 3.20 Left: Shown are the melting curves from differential scanning fluorimetry of the
metagenomic hits (average of three measurements). Right: A fit of equation 3.2 to the data
yielded the melting temperatures Tm shown in the barplot. Errorbars are the standard devi-
ation of the fit.
The obtained melting temperatures ranged from about 40 °C to 60 °C with an average
Tm of (51 ± 5) °C across all the tested enzymes. These values are typical for mesophilic en-
zymes [161]. N1ORF4 andN1ORF5 have the lowest and very similarmelting temperatures at
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(42.63 ± 0.08) °C and (43.33 ± 0.06) °C. Both come from the same plasmid as their common
origin, explaining the similar melting temperatures. The most thermostable enzyme was N4
at (61.1 ± 0.1) °C. Together, these melting temperatures are consistent with the screening
conditions at room temperature.
3.5.3 Screening for promiscuous reactions
The catalytic promiscuity of the enzymes for different hydrolytic reactions was tested using
a range of substrates with para-Nitrophenol as a leaving group. The hits N2 and N18 were
omitted as they could not be obtained in sufficient quantities. Figure 3.21 shows all of the
tested reactions. Column 1 to 8 tested for esterase (1), lipase (2,3), β-lactamase (4), amidase
(5), phosphatase (6,7), and sulfatase (8) activities. Columns 9-14 tested for the hydrolysis of
different glycosides. Column 17 tested for the Kemp elimination, and finally, columns 18 to
20 tested for thioesterase activity. With regards to the observed initial rate vinit during the
first 3min, a reaction was considered positive if it exceeded 0.3 µMmin−1, which under these
conditions corresponds to a change in absorbance of 0.01. Imperfect mixing at the start of
the reaction can affect the value for the lower rates passing this threshold. Therefore, the
concentration of product after 30min was taken into account and the threshold set to 3 µM.
This corresponds to the concentration that should have accumulated after just 3min given
the speed threshold. An enzyme was only considered positive for a reaction if it met both
these conditions.
As can be seen, in the bottom panel of Figure 3.21, all enzymes tested positive for the
short-chain ester, as expected. All of them except for N1ORF5 andN11 also acted on the two
long-chain esters. Furthermore, all hits except for N11 and N13 showed thioesterase activity.
However, the hydrolysis of thioesters by esterases is not a suprising finding: thioesters are
more reactive than the equivalent esters. This can be seen in the lower pKa of thiols (ca. 11)
than alcohols (ca. 16) making them better leaving groups. More interestingly than the above,
the enzymes N16, N26, and RR11ORF2 showed β-lactamase activity (1), N1ORF5 showed
β-galactosidase activity (2), and N7 showed Kemp eliminase activity (3).
In the literature, the ability of esterases to hydrolyse β-lactams is kown but mostly dis-
cussed in the context ofmembers of family VIII ([134]). These enzymes show homologywith
Class C β-lactamases such as AmpC of E. coli and are not members of the α/β-hydrolase fam-
ily [133] but of the β-lactamase clan (PfamCL0013). Some of them are only able to hydrolyse
esters [162, 163], but some show activity towards both esters and β-lactams [164, 165]. How-
ever, neither of the three enzymes here are members of family VIII. N16 is a member of the
carboxylesterase family (family VII), which also contains porcine liver esterase. Porcine liver
esterase, a canonical esterase of great commercial importance, has already been shown to hy-
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Fig. 3.21 Catalytic promiscuity test of the metagenomic hits. Coloured squares are reac-
tions that exceeded the indicated thresholds for the observed initial reaction rate (top), for
the amount of product that accumulated after 30min (middle), and for both these con-
ditions (bottom) . All enzymes were used at the highest concentration possible and each
substrate was at 1 mM. The substrates were: 1: pNP-hexanoate, 2: pNP-dodecanoate,
3: oNP-decanoate, 4: β-Lactam (CENTA™), 5: pNitroacetanilide, 6: pNP-Phosphate,
7: pNP-Phenylphosphonate, 8: pNP-Sulfate, 9: pNP-β-D-Glucopyranoside, 10: pNP-α-
D-Glucopyranoside, 11: pNP-β-D-Galactopyranoside, 12: pNP-α-D-Galactopyranoside,
13: pNP-β-D-Xylopyranoside, 14: pNP-β-D-Fucopuranoside, 15: 2-Chloro-4-phenyl-β-
cellobioside, 16: pNP-β-Xylobiose, 17: 5-Nitro-1,2-benzisoxazole, 18: S-Phenylthioacetate,
19: 2,3-Mercapto-1-propanol, 20: S-Methyl-thiobutanoate.
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drolyse a β-lactam ring selectively over an ester bond within the same molecule [166]. The
families of N26 (C-C bond hydrolase) and RR11ORF2 (DUF3089) have not been reported
to catalyse the hydrolysis of β-lactams.
To our knowledge, the activities of esterases towards β-galactosides and Kemp substrates
have not been reported previously. The Kemp Elimination is a reaction which will be dis-
cussed in detail in Chapter 4. Briefly, it is the general base catalysed abstraction of a proton
from 1,2-benzisoxazole and its derivatives [94]. The reaction is deemed “non natural”, i.e. it
is not known to play a role in the metabolism of any life form. Any protein found to catal-
yse the Kemp elimination is by definition promiscuous towards it. To our knowledge, no
esterases have yet been reported to catalyse this reaction.
The catalytic parameters of β-galactosidase activity of N1O5 and the Kemp eliminase ac-
tivity of N7 were determined. They were found to be (3.0 ± 0.8) M−1s−1 and (5 ± 1) M−1s−1
respectively. This is 100 to 1000 fold lower than their respective esterase activites and typical
for a promiscuous activity.
To investigate if the two reactions were catalysed by the same active site, cross-inhibition
experiments were performed. Van Loo et al. argued that if the kcat differs substantially be-
tween two reactions, the substrate of one acts as an inhibitor of the other [167]. Consider the









kcat2 E + P2
If kcat1 ≫ kcat2, then S2 acts as an inhibitor of the reaction of E with S1. For N1O5 kcat1 >
1000 ⋅ kcat2 and for N7 kcat1 > 100 ⋅ kcat2. A 100 fold difference was sufficient to observe
cross-inhibition in the case of van Loo et al. [167]. If both reactions are catalysed at the same
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With Ki being similar to the Michaelis constant Km2. If S1 and S2 react at different sites,
S2 would bind to both the free enzyme E and to the enzyme-substrate complex E ⋅ S1 and
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Competitive inhibition is a special case of mixed inhibition where K’i ≫ [S2] and there-
fore [S2]K’i ≈ 0. Non-competitive inhibition is another special case where Ki = K’i, i.e. binding
of S1 does not change the affinity of the enzyme towards S2 and would indicate that the es-
terase and promiscuous reactions are independent.
To distinguish between these cases, the Michaelis-Menten kinetics of N1O5 and N7 were
determined for S1 at varying concentrations of their respective promiscuous substrate S2
(Figure 3.22). Equation 3.3 was globally fitted to the data to determine Ki and K’i.
For N1O5, the esterase reactions was measured in the presence of 0 to 10.5mM pNP-β-
D-galactopyranoside (S2) with 0.3 to 6.3mM pNP-hexanoate (S1). The Ki was determined
to be (2.1 ± 0.7)mM and K’i was (18 ± 9)mM indicating mixed inhibition. This could be
explained by the two substrates reacting at two different sub-sites of the active site or by
binding of S2 at a different site and inducing a conformational change in the enzyme. If S1
and S2 interact with different sub-sites in the active site, this could hint at a natural substrate
that contains both a sugar and an ester moiety (e.g. an o-acylated sugar, which are abun-
dant in plants [168]). Which of these two hypotheses is the case could be investigated by
co-crystallisation experiments of N1O5 with β-galactose, para-nitrophenol and an esterase
inhibitor.
In the case of N7, the esterase reaction was measured in the presence of 0 to 1.35mM
5-nitro-1,2-benzisoxazole (S2) with 0.3 to 6.3mM pNP-butyrate (S1). Ki was found to be
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Fig. 3.22 The Michaelis-Menten parameters were determined for the promiscuous activi-
ties of N1O5 and N7 towards pNP-β-D-galactopyranoside and 5-nitro-1,2-benzisoxazole,
respectively. Cross-inhibition experiments were performed in which the esterase reaction
was measured in the presence of the promiscuous substrates and Equation 3.3 was fitted to
the data to obtain the inhibition constants. The large K’i for N7 indicates competitive in-
hibition between the two substrates (i.e. catalysis within the same active site environment),
whereas N1O5 shows mixed inhibition (indicating catalysis at sites).
80 Functional metagenomic screening for esterases in droplets
(0.7 ± 0.2)mM and K’i > 2 × 107 M. Because K’i ≫ [S2], the term
[S2]
K’i
≈ 0. This suggests
that competitive inhibition of the esterase activity by 5-nitro-1,2-benzisoxazole took place (Ki
≈ Km2 = (0.8 ± 0.2)mM), i.e. that the esterase and Kemp elimination reactions were indeed
catalysed by the same enzyme active site.
The Kemp elimination is catalysed by general bases, whose reactivity can be significantly
increased by non-specific and specific medium effects provided by the interior of enzyme ac-
tive sites [169]. It is thus likely that the active site of N7 provides a hydrophobic environment
in which a reactive general base exists. The nucleophile of the catalytic triad in N7 is not
necessarily responsible for the general base catalysis. Ketosteroid isomerase has a compara-
ble promiscuous activity of 2.5M−1s−1 towards 5-nitro-1,2-benzisoxazole [170]. Mutation
to alanine of the general base involved in the native reaction led to an increase of kcat/Km
to 1.7 × 105 M−1s−1. A nearby residue, not involved in the catalysis of the native reaction,
was identified to catalyse the promiscuous reaction. Whether N7 is a similar case could be
tested in future work by mutation of the residues in the catalytic triad. N7 also provides an
interesting starting point for the evolution of a new non-natural function andmay thus prove
to be an interesting enzyme for directed evolution. While man-made catalysts of the Kemp
elimination have been subjected to directed evolution, an environmental enzyme with nat-
ural promiscuity has not. The implications of such an experiment in the study of enzyme
evolution are discussed in more detail in the introduction of the next chapter.
3.6 Conclusion
This chapter reports the first functional metagenomic screening for esterases using droplet
microfluidics. In total, over 30 million droplets were sorted, amounting to 10× coverage of a
metagenomic library consisting of one million members. This throughput makes it the study
with the highest number of clones screened for esterases to date. Furthermore, the droplet
sorting itself consumed only about 100 µL of aqueous reagents, about 15 µg of surfactant,
and less than 5mL of fluorinated oil per sorting campaign. In terms of consumables, sample
preparation at themacroscopic level thus exceeded the cost of droplet screening, making this
technology very resource-efficient.
Thirteen esterase genes were discovered of which a large proportion was from small es-
terase families with few members characterised to date. All the identified genes were shown
to encode for esterolytic enzymes. Their preference was for esters with chain lengths of 4 to
8, in agreement with the screening conditions.
In the field of directed evolution, Frances Arnold famously stated that “you get what you
screen for” [171], which was the case in this screening campaign. Sometimes one also gets
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something in addition to what was screened for. A test for promiscuous activities of the
esterases showed that 3/11 enzymes exhibited β-lactamase activity, 1/11 showed β-galacto-
sidase activity, and 1/11 showed Kemp eliminase activity. This adds to the evidence that
enzymes are able to catalysemore than one reaction. It also shows that a substrate can be used
as “bait”, to enrich for enzymes which have a certain desired catalytic property. Fluorescein
dihexanoate can be seen as a bait for enzymes with a nucleophile, because a nucleophilic
attack is required to release the fluorophore. Fluorescein, with its aromatic xanthene and
benzene moieties, also probes active sites for a hydrophobic environment, e.g. by interacting
with aromatic side chains, whichmay enrich for activities such as theKemp eliminase activity
of hit N7.
Taking this concept further, the accumulation of plastics in the environment has re-
cently attracted the attention of the public. The first organism shown to degrade polyethy-
lene terephtalate (PET) was isolated in 2016, indicating that microorganisms have started
to evolve enzymes for the degradation of even recalcitrant plastics [172]. PET, and other
polyesters such as poly-lactic acid, are difficult to screen directly at high-throughput because
of their insolubility and the requirement to perform high-performance liquid chromatogra-
phy (HPLC) to obtain a readout. However, pre-screening a large library for esterase activity
should enable the enrichment for enzymes with such activities. Indeed, initial tests suggest
that at least one of the identified hits has hydrolytic towards PET, thus providing a starting
point for the directed evolution of improved activity.
The above quote also highlights the fact that in many enzymatic screening campaigns,
the established assay can reduce the diversity of hits because of inadvertently co-selecting for
properties other than the one of interest, for example the level of soluble protein expression.
In this functional screen, the diversity of the obtained hitsmay have been decreased by the
need to perform a secondary screen on culture plates. The culture plate assay was required
because more colonies were recovered than could have been re-screened in well plates. A
high number of false positives was not surprising since it had been observed in the sorting
campaigns for phosphotriesterase previously performed by Colin [84]. After one round of
droplet screening, 4 hits were identified amongst 7,000 clones during the re-screening on
plates, giving a hit rate of 6 × 10−4. Here, the hit rate during re-screening for the esterases
was 2 × 10−3. The variation in hit-rate between experiments is not known, but the difference
still gives an indication that esterases are more abundant in the SCV library as one would for
an enzyme that is essential to every organism.
The absolute hit rate may have been decreased by the culture plate assay, because the
clones needed to hydrolyse macroscopic amounts of tributyrin to be detected as positives.
This makes the assay less sensitive compared to well plate assays where micromolar (ab-
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sorbance) and nanomolar (fluorescence) concentrations of product are routinely detectable
using optical methods. They also only provide a qualitative yes/no readout with a detection
limit difficult to quantify because it depends on the possible incubation times, colony size,
enzyme activity, amount of enzyme expressed, and judgement of the experimentalist. Some
colonies without halos were tested in the cell lysate assay, but none of them were found to be
active, confirming that the majority of colonies were “true” false positives. However, it can
not be ruled out, that some hits were lost because of the lack of sensitivity.
There are several sources of technical and biological bias, which can explain the high rate
of false positives and will be discussed in more detail in final conclusions (Chapter 6), where
observations made in Chapter 4 will be taken into account.
Chapter 4
An absorbance-activated droplet sorting
assay for the Kemp elimination
4.1 Abstract
In this chapter, I present an absorbance-activated droplet sorting assay to screen for Kemp
eliminases in droplets. The Kemp elimination is an important model reaction of proton
transfer at carbon (Figure 4.1). It has been used extensively to build chemical and biolog-
ical systems to mimic and study catalysis by enzymes. It is considered a non-natural reaction
and only a few classes of natural enzymes are known to catalyse this reaction via promiscu-
ous activities. So far, promiscuous enzymes catalysing the Kemp reaction have been found
one-by-one. Finding them may have been due to intelligent searches (e.g. for hydrophobic
binding pockets) or due to the fact that Kemp catalysts are widespread and therefore easy
to find. The latter question can be addressed by employing ultrahigh-throughput functional
metagenomic screening for Kemp catalysts in droplets.
Fig. 4.1 The Kemp elimination is the general base catalysed elimination of a proton from
1,2-benzisoxazole. Number 1a refers to the 1,2-benzisxazole with X = H, 1b refers to the
respective Kemp reaction product.
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The assay I established in this chapter was based on 5-nitro-1,2-benzisoxazole (2a), the
most widely used substrate among substituted 1,2-benzisoxazoles. Its reaction product can
be detected by virtue of its strong absorbance at 380 nm. The concentration of product was
found to equalise inmixtures of droplets with different starting concentrations on a timescale
of hours, i.e. the product leaked from droplets, which limited the incubation time for enzy-
matic assays.
It was possible to enrich a knownKemp eliminase, HG3.17, over a negative control, based
on the activity detected in single-cell lysates. While the absorbance-based assay was not sen-
sitive enough for functional metagenomic screening, it was employed to screen subsitution
and InDel libraries of Kemp eliminase HG3.17 (the functional metagenomic screen was per-
formed using a novel fluorogenic substrate 6a and is presented in the next chapter). The
screening of HG3.17 libraries confirmed the ability of the developed method the enrich ac-
tive enzyme variants. While no catalytically superior mutants were isolated, the substitution
library yielded variants that were likely to have improved soluble expression. The InDel li-
braries revealed five regions tolerant to insertions and deletions in HG3.17, one of which
showed 4.5 fold improved soluble expression. These near-neutral variants may open un-
precedented mutational trajectories in future directed evolution studies.
Contributions: All of the microfluidic work, the assay optimisation, the leakage study, the
enrichment study, the construction of the libraries, screening, re-screening, hit identification,
protein expression, purification and kinetic characterisation, data analysis, interpretation, pre-
sentation as well as structural interpretation of the identified mutations is entirely my own. Dr
Josephin Holstein provided support by synthesising compounds 3a and 4a. Dr Tomasz Kamin-
ski provided support with the final design of the in-line droplet sorter (the idea, initial designs
and all of the experimental characterisation are mine).
4.2 Introduction
In this introduction, I will first argue that identifying natural catalysts of the Kemp elimina-
tion has implications in the study of the evolution of enzymatic activites. I will then review
the state of the research field focused on designing chemical and biological catalysts for the
Kemp elimination and recent advances in finding promiscuous enzymes with high catalytic
activities. I will end the introduction with the goals of this chapter and the anticipated chal-
lenges.
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4.2.1 The Emergence of Phosphotriesterases
How enzymes with a new catalytic function arise is a central question in the study of molec-
ular evolution. The earliest enzymes are thought to have been broad-range catalysts, which
specialised via gene duplication and divergence [89, 173]. Present day enzymes remain able
to catalyse more than one reaction and are thought to evolve new functions via such promis-
cuous activities [4, 6, 174].
The emergence of a new enzyme can be remarkably fast andwas observed when synthetic
chemicals were first introduced into the environment in the 20th century. One example is the
insecticide parathion. It was developed in the 1940s by Schrader and was in widespread use
from the 1950s until recently [175]. Parathion is converted to the phosphotriester paraoxon
in vivo which inactivates acetylcholin-esterase. Both are types of compounds which do not
occur naturally, but were soon observed to be degraded by microorganisms in soil and wa-
ter. In the early 1970s strains of a Flavobacterium sp. and Brevundimonas diminuta were
isolated that had the ability to hydrolyse the insecticide [176, 177]. Both encoded the same
phosphotriesterase (PTE). Astoundingly, the enzyme catalysed the hydrolysis of paraoxon at
the diffusion limit [178]. This perfect enzyme had evolved within the two decades after the
first exposure of microbial communities to parathion. Other examples of enzymes and en-
tire new metabolic pathways degrading anthropogenic compounds are known to have arisen
during the same period [92].
Identifying the ancestral enzymes of these innovations is not trivial even in the case of
such recent divergence [92]. In the case of the PTEs it was indeed a promiscuous lactonase
activity, which led to the discovery of their progenitors: lactonases involved in quorum sens-
ing [179]. The sequence identities between the two groups of enzymes are only at about
30% and it remains a challenge to reconstruct the evolutionary pathway that connects these
lactonases to the PTEs [180].
4.2.2 How To Find Starting Points of Evolution
To better understand such evolutionary events, an interesting experiment would be to chal-
lenge amicrobial environment with a new synthetic compound to detect and isolate enzymes
which are potential starting points for the acquisition of new function. One way of doing this
in the laboratory is to screen a metagenomic library against such a compound. The principle
was shown by Colin et al. in an ultrahigh-throughput droplet screen for PTEs [67]. Eight
clones encoding nine new PTEs were found in the metagenomic library SCV which consists
of more than one million members (see Table B.1 for its composition). Their ability to hy-
drolyse phosphotriesters was likely to be a promiscuous rather than their native activity [67].
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They may serve as starting points for further evolution and improvement of that activity.
However, because organophosphates were and are used globally as insecticides, it cannot be
ruled out that these activities had already evolved in these enzymes before they were isolated.
Applying thisworkflow to a synthetic substrate thatmicroorganismswere not pre-exposed
to would yield ab initio starting points of evolution.
4.2.3 The Kemp Elimination
A well studied model reaction is suitable for this task: the Kemp elimination [94, 95]. This
is the general base catalysed proton elimination from 1,2-benzisoxazole yielding 2-hydroxy-
benzonitrile, see Figure 4.2. The reaction proceeds readily in dilute aqueous solutions of the
compound and several 5- or 6-substituted derivatives. Kemp and co-workers were interested
in 1,2-benzisxoazol-3-ide as a leaving group in linear free energy relationships which pro-
vided access to a large range of reactivity without secondary effects due to structural changes
[94, 95]. The reaction is susceptible to specific catalysis by hydroxide and general base cataly-
sis but not acid catalysis [94]. The general base catalysis by acetate was found to be enhanced
up to 107 fold in polar aprotic solvents compared to water, which can be ascribed to the des-
olvation of the carboxylate ion (Figure 4.2). Kemp et al. also argued that this effect would be
key in the construction of enzyme-like catalysts for this reaction [181].
Indeed, it has been a long desired goal in enzymology to construct enzymes from first
principles to escape the maxim of “What I cannot create, I do not understand.” (as left on
Richard Feynman’s blackboard at the time of his death). The Kemp elimination is one re-
action frequently used in attempts to achieve this goal. It is considered a model reaction
for proton transfer from carbon, an often rate limiting step in enzymatic reactions [156].
Furthermore, there is no natural enzyme known to catalyse this reaction. The derivative 2a
was employed in most studies as it provides a convenient colorimetric readout (ε380nm of
15.8mM−1 cm−1 of the anionic product) and is activated compared to the unsubsituted 1,2-
benzisoxazole (ΔH° of -39 and -35 kcal mol-1 respectively), thus allowing the observation of
even small rate enhancements [94]. The reaction rates given in this introduction refer to 2a
unless otherwise stated.
The systems developed or discovered to catalyse the Kemp elimination can be broadly
grouped into chemical systems, catalytic antibodies, engineered proteins, the de novo de-
signed enzymes, and promiscuous enzymes. As I will discuss in the following, these were
rationally designed and further improved by directed evolution. I will compare them to
promiscuous catalysts, which promote the reaction by chance.
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Fig. 4.2 Factors contributing to the catalysis of theKemp reaction. If carboxylate is the general
base, its reactivity is strongly enhanced in aprotic solvents. This effect can be exploited by
desolvation of a carboxylate side-chain in the apolar environment of a protein binding pocket.
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Fig. 4.3 Catalytic systems shown to promote this reaction fall into the five groups shown:
chemical systems, catalytic antibodies, engineered enzymes, designed (and subsequently
evolved) enzymes, and promiscuous enzymes.
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Chemical Systems
Chemical host-guest systems bring the substrate into proximity with a catalytic group rem-
iniscent of enzyme-substrate binding in the active site. One previously studied host is β-
cyclodextrin (βCD), which was modified to yield amino-βCDs. A rate acceleration of up to
104 was reported if compared to the background reaction in buffer. However, if compared
to the reaction of the free amine in buffer the rate was accelerated by only 102 fold [182]. The
background rate which the observed reaction rate is compared to is inconsistent in the litera-
ture and has been a matter of debate. In the following, I will give rate accelerations compared
to the free base, but this is not always a sufficient comparison as will be seen in the case of
the catalytic antibodies.
The host-guest complex shown in Figure 4.3 was more successful than the βCDs: the rate
acceleration of the host complex was over 103 compared to the free amine indicating that
host binding contributed strongly to the observed catalytic effect [183].
Another example is a coordinate cage which self-assembles in aqueous solution and ac-
celerates the reaction, notably of unsubstituted 1,2-benzisoxazole, 105 fold. It binds the sub-
strate in its cavity and recruits hydroxide ions to the cage surface as shown by the pH inde-
pendence of the catalysed reaction [184].
Thismechanism is similar to an even simpler system inwhich cationic surfactant-micelles
catalyse theKemp elimination [185]. This systemwas recently expanded by adding surfactant
molecules with a phosphate or carboxylate head group which can act as a general base; rate
accelerations of 104 were observed in both cases [186].
Finally, a chemical system based on methylated polyethyleneimine (synzymes) was syn-
thesized by Hollfelder et al. [187, 169]. This enzyme mimic allowed analysis according to
the Michaelis-Menten model and a rate acceleration of 106 was achieved. Notably, the cat-
alytic amine groups were 100 to a 1,000-fold more reactive than in bulk solvent (either water
or acetonitrile). This suggested that specific medium effects in the active site enhanced the
reactivity of catalytic groups without the need for precise positioning relative to the substrate.
Catalytic Antibodies
Catalytic antibodies were the most advanced protein-based enzyme mimics generated until
the 1990s. They are generated by raising an antibody against a transition-state mimic of the
desired reaction [188]. Among the many reactions for which antibodies were raised was also
the Kemp Elimination [189–191]. One of the most successful catalytic antibodies was 34E4
with a kcat/Km of 5.5 × 103 M−1s−1 [189]. Its catalytic residue was a glutamate and the rate
acceleration compared to acetate in buffer was 3.8 × 108 [189, 192]. The authors explained
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Fig. 4.4 Second order rate constants for various catalysts of the Kemp elimination for which
a (pseudo) first order rate constant was reported. Given are the maxima observed for the
respective systems. Antibody: [189–191], Chemical: [169], De Novo: [11, 15], Engineered:
[194–196, 170], Evolved: [197–199, 16, 200], Promiscuous: [4, 170, 201, 196].
the catalysis by three factors: the desolvation of the catalytic carboxylate, the delocalisation
of the negative charge of the transition state, and precise positioning of the carboxylate. The
latter factor was challenged by Hollfelder et al. who argued that the rate acceleration by des-
olvation of the carboxylate alone (107, see above) explained the majority of the observed rate
enhancement [193]. Indeed, the synzymes mentioned above do not have a defined tertiary
structure, thus cannot precisely position their base, but do exhibit a kcat/Km in the same range
(e.g. 1.8 × 103 M−1s−1) [169]. A later study, in which the catalytic glutamate was replaced by
aspartate, suggested that the positioning of the carboxylate was of some importance in 34E4
[192]. In any case, none of the described enzyme mimics so far come even near the catalyic
efficiency of an average enzyme which is about 105 M−1s−1 [158].
Enzyme Engineering
Two notable studies introduced Kemp eliminase activity into an existing protein scaffold us-
ing a rational approach. Merski et al. introduced Kemp eliminase activity into T4 lysozyme
by creating a hydrophobic binding pocket employed with a histidine acting as the general
base [194]. Korendovych et al. created “AlleyCat”, an allosterically regulated Kemp elimi-
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nase, by means of a single point mutation, phenylalanine to glutamate, in calmodulin [195].
The second order rate constants were 1.8 and 5.8M−1s−1 respectively.
De novo Enzymes
The most advanced attempt at creating a catalytic activity from first principles in an exisiting
protein scaffold was the design of the so-called de novo enzymes. In this approach, chosen
catalytic residueswere positioned around the transition state of the reaction and the geometry
optimised to maximise transition state stabilisation [11]. The idealised active sites were then
matched with protein scaffolds that could accommodate them. Röthlisberger et al. chose to
express 59 of the resulting protein sequences, the KE series of Kemp eliminases, of which
8 had detectable activity. The second order rate constants ranged from 6 to 160M−1s−1.
Privett et al. followed a similar design strategy, but iteratively improved on their first design
by incoporating experimental insights from kinetics and x-ray crystallography [15]. After
two rounds of experimental feedback, they obtained HG3 with a second order rate constant
of 430M−1s−1.
The de novo catalysts are superior to the simpler engineering approaches, but they fall
short of both the synzymes, which made no assumptions about the transition state geome-
try, and the catalytic antibodies, which were based on randomised libraries. The authors in
both papers acknowledged this shortcoming and subjected their design outcomes to directed
evolution to improve their enzymes.
The Success of Enzyme Design
Before commenting on directed evolution, it seems appropriate to assess the success of the
four approaches discussed so far. All aimed to bring about catalytic activity based on the
known principles of enzyme catalysis and detailed knowledge of the Kemp elimination. Most
of the Kemp eliminases discussed use a carboxylate as the catalytic base. The success of
these designed enzymes can thus be benchmarked against the second order rate constant
k2 of carboxylate in water and acetonitrile, respectively (10−4 and 103 M−1s−1, respectively)
[193, 202]. As is evident from Figure 4.4, all of the designed enzymes have a second order
rate constant much improved over carboxylate in buffer (104-108 fold). However, indepen-
dent of the detailed factors contributing to these enhancements, none of them exceed what
is achieved by simply desolvating carboxylate.
Directed evolution produced the most powerful, experimentally-derived Kemp elimi-
nases to date [197–200, 16]. Two KE variants and HG3.17 markedly exceed the benchmark
rate of carboxylate in anorganic solvent. HG3.17 holds the current record at 2.3 × 105 M−1s−1
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after an impressive 17 rounds of directed evolution alternately using random mutagenesis
and recombination of improved variants. In the literature, these final enzymes are often re-
ferred to as computationally-designed, but in truth their current second order rate constants
are thanks to the power of directed evolution. The use of directed evolution changes the cen-
tral problem from a protein design challenge to one of choice: the choice of the starting point
and the choice of method for diversification and screening. In fact, the five Kemp eliminases
that have been evolved reach final second order rate constants in strict order of what the
respective starting efficiency was with a typical increase of 2-3 orders of magnitude. There
is no obvious reason of why the starting point needs to be a de novo designed protein. The
starting point could be a natural, promiscuous enzyme.
Promiscuous Enzymes
The serum albumins were the first proteins investigated systematically for their promiscuous
Kemp eliminase activity [193, 203, 204]. The highest reported second order rate constant
for BSA was 6.5 × 103 M−1s−1 at pH 10 and above – which puts it on a par with catalytic
antibody 34E4. Khersonsky et al. performed the first systematic screening for Kemp elimi-
nase activity [205]. Screening the ASKA library1, two promiscuous enzymes were identified:
YdbC, an oxidoreductase (430M−1s−1), and XapA, a phosphorylase (103 M−1s−1). In 2017,
three groups reported promiscuous Kemp enzymes which were chosen to be studied based
on rational arguments. Lamba et al. selected ketosteroid isomerase (KSI) because it is known
to catalyse a proton transfer using a carboxylate of a hydrophobic substrate [170]. Indeed,
KSI was found to have promiscuous activity of 2.5M−1s−1. Remarkably, the authorsmutated
the catalytic aspartate of the ketosteroid reaction to asparagine and found the promiscuous
acitivity was subsequently 1.7 × 104 M−1s−1, i.e. bymere chance they created one of themost
active Kemp eliminases known. Docking simulations suggested that a different aspartate in
the active site is catalysing the Kemp elimination in KSI [170].
Notably, two studies reported promiscuous Kemp elimination in enzymes which employ
heme as a cofactor. In the first study, Oxd was investigated [201]. These enzymes coor-
dinate the substrate using the heme cofactor, see Figure4.5A. The native nitrile product is
obtained via N-O bond cleavage followed by proton abstraction. As the authors highlight,
this is reminiscent of the Kemp elimination. Therefore, they tested three Oxds and all were
active towards 2a with second order rate constants of 102 M−1s−1 with iron(III) and 104
to 105 M−1s−1 with iron(II). Mutation of either the general base or the iron-coordinating
histidine abolished catalytic activity. The authors concluded that both iron in its active, i.e.
1The ASKA library is composed of variants that allow overexpression of every predicted ORF present in the
E. coli genome [206].
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Fig. 4.5 Recently, aldoxime dehydratase (Oxd) and cytochrome P450 monooxygenase were
shown to catalyse the Kemp elimination [201, 196]. A: In the proposed mechanism of Oxd
N-O bond cleavage occurs before abstraction of the proton by histidine. B: The degradation
of the drug leflunomide by P450 monooxygenase is formally equivalent to the Kemp elimi-
nation. C: The suggested mechanism of P450 monooxygenase involves N-O bond cleavage
before elimination of the proton takes place.
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reduced, state and the general base were required for efficient catalysis. However, they did
not further study the mechanism of the promiscuous activity [201]. Li et al. reported an-
other heme-containing enzyme to promiscuously catalyse the Kemp reaction: cytochrome
P450 monooxygenase [196]. This enzyme catalyses the isoxazole ring scission in the drug
leflunomide (Figure4.5B), which is – again – formally equivalent to the Kemp elimination.
Therefore, they tested P450-BM3 and found it catalysed the Kemp elimination with a second
order rate constant of 240M−1s−1. A mutation known to enhance the activity of P450 with
small molecule substrates boosted the second order rate constant to 3 × 104 M−1s−1. The
authors suggest the redox mechanism in Figure 4.5C and provide experimental and compu-
tational evidence. Notably, there is no general base near the iron centre. Also, when iron(II)
was replaced with zinc(II) there was no catalytic activity and addition of CO reduced the
activity 10 fold, indicating that the reaction takes place at the iron centre.
In summary, a number of promiscuous enzymes have been found that rival the activity of
designed and experimentally evolved Kemp eliminases. Most remarkable is the high activity
withoutmutations of the threeOxds. Theuse of heme as a cofactorwas never even considered
in the design approaches. It is conceivable that in a large scale screening for promiscuous
Kemp catalysts innovations could be identified that are not yet within reach of the decisive
chemical intuition that guided the studies of Li and Mao.
4.3 Overview of this Chapter
In light of the importance of the Kemp elimination in the study of enzyme catalysis and de-
sign, it wasmeaningful to develop a droplet-basedKemp assay to enable higher throughput in
library screening campaigns. The recently developed AADS allowed the implementation of
the colorimetric Kemp assay with 2a (see Figure 4.6). [61] This substrate yields the strongest
reported absorbance upon turnover and is thus the most widely used in screening assays (ε
= 15.8mM−1cm−1 at 380 nm).
In the previous chapter fluorescein was used as the optical reporter. While there had been
previous studies showing the retention of fluorescein within microfluidic droplets enabling
library screening [69, 67], it was not known if this would be the case for 5-nitro-2-hydroxy-
benzonitrile. A number of challenges were anticipated and addressed (see also Figure 4.7:
1. The possible incubation time is limited by the spontaneous turnover of the substrate
(kOH-=15M−1s−1, [94]) and general base catalysis of the buffer. For example, assuming
a kbuffer of 10−4 M−1s−1 and a typical concentration of 50mM at pH 7, the half life
of the reaction would be 27 h. This would be reduced to 17 h by using the buffer at
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Fig. 4.6 Principle of AADS, which was based on [61]. A:Optical fibres (purple) were inserted
into the sorting chip to measure absorbance across a 50 µm gap through which the droplets
passed one by one. A light-emitting diode (385 nm) was coupled to one fibre, and a PMT for
signal detection to the other. The sorting process was controlled by amicrocontroller (MCU)
andmonitored using a customLabView program. B:Thepulse sequence used to sort droplets
follows the same principle as in FADS (Figure 2.2). It was started by the (MCU),which caused
the pulse generator (PG) to open a gate for the function generator (FG).The square-wave was
amplified (AMP) and resulted in the sorting of a droplet by DEP. C: Individual frames of a
video recorded by the camera for one sorting event. Droplets entered from the top and exited
via the waste channel on the right. The droplet which triggered the sorting event was pulled
to the collection channel on the left as indicated by the arrows.
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100mM. Therefore, the buffer conditions were optimised to guarantee the success of
a screening campaign.
2. Small molecules have been found to exchange between droplets [70, 72]. This is par-
ticularly detrimental for the product of a reaction (product leakage): if it is lost to sur-
rounding droplet compartments, the signal is reduced and positives may never emerge
from the droplet population. The degree of molecular transport of the reaction prod-
uct was quantified and minimised.
3. The optimisation of assay conditions was not sufficient to enable detection of Kemp
eliminase activity in droplets. Therefore, the substrate was chemically modified in or-
der to prevent leakage of the product. While exploring different substrates, a novel flu-
orogenic Kemp eliminase substrate was discovered, which did not leak and was used
for metagenomic screening using FADS described in the next chapter.
4. TheAADS assay was used to screen substitution and InDel libraries of Kemp eliminase
HG3.17 using the substrate this enzyme had been evolved with before and screening
much larger libraries than previously possible.
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Fig. 4.7 Overview of the results section. First, substrate 2a was investigated for its suitability
to detect enzymatic activity in droplets. Its reaction product was found to transfer between
droplets, i.e. to leak. Therefore, two strategies were followed with the aim to overcome this
limitation: design of an in-line droplet generation and sorting device andmodification of the
substrate. One of the modified substrates, 6a, was found to be fluorogenic and allowed the
establishment of a fluorescence-based assay.
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4.4 The absorbance-based Kemp eliminase assay
4.4.1 Establishment of buffer conditions and enzyme controls
The substrate 2a was synthesised according to published procedures ([94]) and assay condi-
tions were evaluated for an absorbance-based droplet screen. As explained above, the back-
ground reaction needed to be minimised to allow for long incubation times. Therefore, the
general base catalysis of seven buffers was assessed, see Figure 4.8 and Table 4.1. Buffers are
generally used near their pKa. Using the equilibrium HA + H2O −−−⇀↽−− H3O+ + A– the pKa
is usually defined as:
pKa = − log10 (Ka) = − log10 (
[A−][H3O+]
[HA] ) (4.1)
Assuming the concentration of H2O remains constant. With − log10([H3O+]) = 𝑝𝐻 , this




If the pH equals the pKa, half the buffer molecules are protonated and half are not, which
is where its ability to keep the pH constant is maximal. However, the general base of the
buffering agent participates in the hydrolysis of 1,2-benzisoxazoles according to:
𝑣0
[S0]




In a solution of the buffering agent in water, the initial rate of reaction 𝑣0 divided by the
initial substrate concentration [S]0 is determined by the reactions with water, hydroxide and
the general base. For the Kemp reaction it is thus useful to use the buffering agent below
its pKa. This has the advantage that the general base concentration is lowered and that the
buffering capacity against hydroxide is enhanced. In 70 µm droplets, the cytosol of a single E.
coli cell is diluted 20,000 fold and the surfactant used for cell lysis is mildly basic. Thus, the
major downwards influence on pH is acidification caused by substrate turnover (2a has a pKa
of 4.1, [94]). As long as the general base is used in excess of substrate, this strategy should
not be detrimental to the assay. At fixed pH, the first two terms in Equation 4.3 are constant
(𝑘const) and 𝑘A− can be determined by varying the buffer concentration. The variable term
of the observed reaction rate will be 𝑘obs[Atot] = 𝑘A−[A−] + 𝑘HA[HA]. Assuming 𝑘HA is
negligible at the given pH: 𝑘A− = 𝑘obs/([A−]/[Atot]). The ratio [A−]/[Atot] can be obtained
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Fig. 4.8 Reaction rate of the Kemp elimination for 2a in seven different buffers at pH 7. Left:
The rate of reaction was dependent on the buffer concentration. Lines are linear regressions,
error bars are the standard error of the slope of 𝑣0/[𝑆0]. Right: Slopes (corresponding to 𝑘obs)
of the linear regressions. Sodium-phosphate buffer (NaPi) is most often used in studies of
the Kemp reaction. However, of the tested buffers it caused the highest background reaction
rate, even compared to BisTris, which has a lower pKa. Error bars are the standard error of
the slope estimate. [S0] was 1mM and the reaction was followed at 380 nm.







According to this analysis, seven buffers were tested at pH 7 as shown in Figure 4.8. As
expected, the initial rates were linearly dependent on the total buffer concentration. The
mean of the intercepts yielded a 𝑘const of (1 ± 1) × 10−6 M−1s−1, which is the minimum
background rate possible and is in good agreement with the literature 2.1 × 10−6 s−1 for pH
7, calculated from [95]). The observed reaction rate constants were derived by linear regres-
sion and are given in the bar chart. Notably, the rate constant of the widely used NaPi buffer
was 17 times higher than the one of Tris buffer. Table 4.1 shows the calculated 𝑘A− .BisTris
and Tris have the lowest and second lowest rate constant in terms 𝑘A− . Note, however, that
it is the observed reaction rate which determines the background rate in the final assay.
Next, HG3.17 (the Kemp eliminase with the highest reported catalytic efficiency to date
[16], Appendix C.1 and C.3) was obtained as a positive control and cloned into plasmid
pET32 under T7 expression. Human acid phosphatase 1 (ACP) in pET32 served as a negative
control (plasmid and negative control courtesy ofDr Stephane Emond, Appendix Figures C.1
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Table 4.1 Listed are the seven buffers tested for their reaction rate with the Kemp substrate
2a and the measured reaction rate constants.
Buffer pKa A
−/Atot 𝑘obs 𝑘A−
(at 25 °C) (at pH 7) (10−5 M−1s−1) (10−4 M−1s−1)
BisTris 6.46 0.776 21 ± 2 2.6 ± 0.2
NaPi 7.20 0.387 69 ± 7 17.3 ± 0.9
MOPS 7.31 0.329 22 ± 2 6.7 ± 0.2
HEPES 7.66 0.180 29 ± 3 16.1 ± 0.3
Tris 8.06 0.080 4.0 ± 0.4 5.0 ± 0.1
Bicine 8.46 0.034 7.1 ± 0.7 21.0 ± 0.4
CHES 9.41 0.004 3.8 ± 0.4 96 ± 3
and C.2). Both enzymes were expressed in E. coli BL21(DE3), which were lysed, and diluted
to a total of 1.8 × 105 fold to mimic droplet conditions. The results for NaPi and Tris buffer
are shown in Figure 4.9. The ACP lysate did not show Kemp eliminase activity compared
to the lysis buffer and was thus confirmed as a negative control under these conditions. The
lysis agent (BugBuster, Merck-Millipore) did not affect the rate of reaction, as previously de-
termined (Appendix C.4). After 90min of reaction, (53.5 ± 0.4) µM of 1mM 2awere turned
over by the negative control in NaPi, whereas only (4.7 ± 0.8) µM product appeared in the
negative control in Tris buffer. Therefore, the difference in the two buffers remains above
10 fold under realistic reaction conditions. The positive control HG3.17 retained high activ-
ity even at 20,000 fold dilution and the reaction saturated after 60min in Tris buffer.
In summary, reaction conditions were found that allowed clear distinction of a positive
and negative control at dilutions equivalent to droplet conditions. It was now time to assess
the ability of droplets to retain the reaction product under different conditions.
4.4.2 The Kemp reaction product exchanges between droplets
The system implemented to assess leakage is shown in Figure 4.10. The reaction product
2b was obtained by converting the substrate 2a using NaOH in aqueous solution, which
was neutralised using the equivalent amount of HCl, and diluted into buffer for each test.
Droplets of 70 µm diameter were generated using a chip with two flow-focusing junctions,
which allowed the generation of a 1:1 mixture of droplets either containing product or not.
A food-dye, tartrazine, was used in both solutions at 3mM to set the absorbance of buffer
below that of the fluorous oil (see Appendix C.5). The droplets were collected and re-injected
for analysis in batches of several thousand after different incubation times. Absorbance was
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Fig. 4.9 Reaction progress for positive and negative controls of the Kemp Elimination in well-
plate format (average of three runs, error bars are the standard deviation). Buffer conditions
as indicated. Blank: buffer only control, LB: lysis buffer only, ACP: cell lysate of acidic phos-
phatase 1 (negative control), HG3.17: cell lysate of positive control HG3.17.
Fig. 4.10 Shown are the microfluidic steps involved in the assessment of product leakage for
absorbance-activated droplet sorting. A&B: Droplets are generated in one chip with two
flow-focusing junctions to create a 1:1 droplet mixture of droplets made from two different
solutions without the need for pipetting. C: These droplets are then re-injected batch-wise
into an AADS chip to measure the signal difference over time.
measured at 385 nm in an AADS chip (manufactured according to [61]) under realistic sort-
ing conditions, i.e. at 100Hz.
The signal was measured and analysed using a custom Matlab script as shown in Fig-
ure 4.11. The minima of the droplets were determined (which is what the sorting algorithm
used as sorting criterion) and a histogram of the minima plotted. A kernel-smoothing dis-
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tribution was fitted to the data and the maxima of the two main populations determined.
The difference of the maxima gave the signal ΔS(𝑡) at time 𝑡. Usually, the first data ΔS0 could
be acquired 10min after the end of droplet generation and was used to normalise the signal
according to ΔS(𝑡)/ΔS0.
Unfortunately, it became evident immediately that compound 2b exchanged between
droplets, i.e. it leaked (Figure 4.13). In Tris buffer, half of the initial signal difference was lost
60min after droplet generation. The decay of the signal was non-linear. A single-exponential
fit gave a half-time of 55min. However, the residual plot revealed systematic deviation in-
dicating complex leakage behaviour similar to what was found in the system of Skihiri et al.
which consisted of a droplet incubation chamber from which droplets were re-injected into
a chip to measure leakage [207].
Seven parameters were varied in attempts to reduce leakage Figure 4.12 and Table 4.2.
The conditions were compared to each other based on the time at which half the initial sig-
nal was lost, which was determined by a local linear fit of the three nearest data points. Initial
experiments were performed at pH 6 in NaPi so as to have a low background reaction. At
a surfactant concentration of 2% the two droplet populations immediately equalised even if
the droplet generator was directly coupled to the AADS. Reducing the surfactant concentra-
tion to 1% under the same conditions led to a signal half time of 25min. The cavitand βCD
was hypothesised to form a complex with 2b and thus reduce leakage [70]. Indeed, addition
of five times excess βCD tripled the half time. Next, it was hypothesised that the uncharged
conjugate acid of 2b could leak more readily than the charged equivalent. At pH 6, 1.2%
of the compound would be protonated at any given time, 0.4% at pH 6.5, and 0.1% at pH
7. Indeed, at pH 7 the half time tripled again compared to pH 6.5. This is less than would
be explained by the protonation state of 2b, therefore either both states leak or the effect
is due to another mechanism. The surfactant PicoSurf1 (Dolomite) reduced the half time
seven times compared to fluorosurfactant-008 (FS-008, Ran Biotechnologies) under other-
wise identical conditions. Neat fluorous oils FC40 and FC70, which are more viscous than
HFE7500 thus having a smaller diffusion constant, led to unstable emulsions. A stable 1:1
mixture of HFE7500 and FC70 had a similar half time to neat HFE7500. Finally, the half
time was not affected by exchanging NaPi or Tris buffer.
In summary, the influence of the tested parameters was similar to what others found in
the study fluorophore leakage [71, 72, 207]. Unfortunately, what was beneficial to product
retention, was also promoting the background reaction of the substrate. As Equation 4.3
shows, elevated pH promotes substrate turnover due to catalysis by hydroxide. βCD reduced
leakage of product, but was found to catalyse the Kemp reaction and its catalytic activity in-
creased with pH (Appendix Fig. C.6). Another additive, BSA, showed detectable activity in
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Fig. 4.11 The leakage of Kemp reaction product in droplets. A:Droplets that passed through
the light path reduced signal due to absorbance. The minimum for each droplet was deter-
mined. B:Thehistogram ofminima revealed the two intended populations with and without
product. A kernel-smoothing distribution was fitted to the data and used to determine the
difference in the maxima of the two populations. C: Over time, the two main populations
moved closer together, indicating the leakage of the Kemp reaction product from filled to-
wards empty droplets. D: In this experiment, which was performed in 20mM Tris buffer
with 50mM NaCl, a non-linear decay of the inital signal difference was observed. However,
a fitted single-exponential decay (dotted line) did not fit the data well as shown by systematic
deviation in the residuals (E).
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Fig. 4.12 Timecourses of product leakage in a 1:1 mixture of droplets with and without prod-
uct under different assay conditions. Addition of βCD and increasing the pH reduced leak-
age. There was no difference between NaPi and Tris buffer. In addition to 2b), two more
Kemp reaction products were tested (structures shown in Figure 4.13), which showed re-
duced and no leakage, respectively. Table 4.2 lists additional leakage conditions tested.
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Table 4.2 The conditions under which leakage of 1mM Kemp reaction product was tested.
Product [Surfactant] Surfactant Oil Buffer† pH βCD‡ 𝑡 12 *
(w/w) (min)
2b 2% FS-008 HFE7500 NaPi 6.0 <1
2b 1% FS-008 HFE7500 NaPi 6.0 25
2b 1% FS-008 HFE7500 NaPi 6.0 ✓ 90
2b 1% FS-008 HFE7500 NaPi 6.5 ✓ 180
2b 1% FS-008 HFE7500 NaPi 7.0 ✓ 320
2b 1% FS-008 HFE7500/FC70§ NaPi 7.0 ✓ 290
2b 1% PicoSurf1 HFE7500 NaPi 7.0 ✓ 40
2b 0.75% FS-008 HFE7500 Tris 7.0 60
2b 0.75% FS-008 HFE7500 NaPi 7.0 70
3b 0.75% FS-008 HFE7500 NaPi 7.0 230
4b 0.75% FS-008 HFE7500 NaPi 7.0 >10,000
† 40mM buffer compound and 100mM NaCl.
‡ β-cyclodextrin was added (✓) at 5mM.
* time after which half the original signal was lost.
§ 1:1 mixture of the two oils.
droplets at 50 µM, which is why it was not tested as an additive (Appendix C.6). Therefore,
the assay conditions could not be optimised without a major trade-off between leakage and
background activity. Therefore, two approaches were followed to circumvent these limita-
tions:
• First, two additional 1,2-benzisoxazole derivates were synthesized in an attempt to
abolish leakage by introducing a charged group.
• Second, a microfluidic device was designed to generate and sort droplets in-line. The
advantage of this approach is, that the incubation time of all droplets is very similar
thus controlling the maximal leakage time. The limitation is that incubation times be-
yond 1 to 2 h would be technically difficult to implement, because high back-pressure
would destabilise the device.
4.4.3 Modified 1,2-benzisoxazole substrates
The idea for substrate modificaiton was to introduce a permanently charged group to the
substrate, which would limit the partitioning into the fluorous phase but should not itself be
able to act as a general base. Two suitable modifications previously used to adapt substrates
for droplets are trimethyl ammonium and sulfonate. The syntheses were performed by Dr
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Fig. 4.13 Shown are the Kemp substrates and the respective reaction products, which were
tested for leakage in droplets. 3a-4b courtesy of Dr Josephin Holstein.
Josephin Holstein and yielded 1,2-benzisoxazoles 3a and 4a. The original goal for 3a was to
introduce the larger substitution -N(CH3)C2H4N(CH3)3+ following the strategy ofObexer et
al. [47, 79]. However, all attempts to further react the 6-dimethylamino group failed, which
left a general base in the substrate itself. Nitration, which was intended to increase the re-
activity of substrate and the absorbance of the product, was directed towards the 7 position.
Nitration of 6-sulfonyl-1,2-benzisoxazole also occurred in position 7. Substitution of the sul-
fonate by nitrate was substantial for this substrate and purification by HPLC was necessary
to obtain 4a.
Despite these limitations, 3a and 4a were converted under basic conditions to yield the
respective Kemp products 3b and 4b. The leakage half time of 3b was extended over 3 fold
compared to 2b under the same conditions. Leakage of 4bwasmost strikingly reduced. After
seven days of incubation (close to 105min), 65% of the original signal difference remained.
While 4b had excellent product retention, the synthesis of substrate 4a was not reproducible
and numerous attempts to synthesise more of the compound failed. In conclusion, the tested
compounds had reduced leakage. However, they were not suitable as alternative substrates.
4.4.4 In-line droplet generation and sorting
Given the rate of product leakage observed, the maximal incubation time was limited to
several hours. Because the sorting rate was also in the hours range, this meant that droplets
measured at the beginning and end of sorting were not comparable. The idea of the in-line
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chip was to fix the incubation time for each individual droplet by linking droplet generation,
incubation, and sorting within one microfluidic device2.
It connected the droplet generator and the droplet sorter designed by Gielen et al. via
a delay line with intermittent constrictions [61], see Figure 4.14A. The constrictions were
intended to mix the droplets throughout the delay line to avoid broadening of the incubation
time [208]. In order to assess product leakage, two flow-focusing junctions were included
in the design (Figure 4.14A1). An oil extractor (Figure 4.14A2) removed excess oil needed
for droplet generation before the droplets entered 20 loops of incubation chambers. The
calculated area of the incubation chambers was 635mm2. With a chamber height of 80 µm
and a flow-rate of 1.5 µLmin−1, the expected incubation time was 30min.
It was possible to run the chip stably for several hours. With one droplet generator run-
ning, typical flow-rates for stable operationwere 30 µLh−1 for each aqueous phase, 120 µLh−1
for the oil phase, and −90 µLh−1 for the oil extractor. This resulted in droplet generation at
50Hz and, with 85 µm diameter, slightly larger droplets than in the two step (off-line) pro-
cedure (the difference in volume was less than 2 fold). The incubation time was found to be
longer than expected at 40 and 50min with the total flow-rate of 1.5 µLmin−1 in the incu-
bation chambers. This indicates that under these conditions the flow rate of the droplets in
the chambers was mostly determined by the total injection rate of the aqueous phase, while
the oil passed the droplets rather than pushing them. However, below a ratio of 1:2 of oil to
aqueous flow the dense packing of droplets led to increased merging and at high extraction
rates droplets started breaking off at the extractor. After the incubation line, droplets were
spaced for the absorbance measurement and sorting. Up to a flow-rate of 20 µLmin−1 for
the spacing oil, the rate of droplet generation equalled the rate of droplet sorting. Beyond
20 µLmin−1, the sorting rate decreased and the droplets started to stall inside the chip and
eventually merged.
Two droplet generators were used to test leakage of 2b at 1mM using Tris buffer and
0.75% FS-008 surfactant. The flow-rates were 30 µLh−1 for each aqueous phase (one per
flow-focusing junction), 90 µLh−1 for each oil phase, and −150 µLh−1 for the oil extractor.
The droplet generation rate was 25Hz in each flow-focusing junction. Under these condi-
tions, only one population of droplets could be observed at the end of the incubation line.
This indicated complete equalisation had occurred. It was possible to reduce the surfactant
concentration down to 0.1% without compromising the stability of the emulsion3. This en-
abled discrimination of two droplet populations at the end of the incubation line. Even at
2The concept and initial chips were designed by me. The final design shown here was created with the
support of Dr Tomasz Kaminiski
3The minimal concentration of surfactant in the two-step procedure was 0.75% below which droplet merg-
ing dominated. This may be due to the higher flow-rates and shear forces acting on the droplets.
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Fig. 4.14 Design and results for the In-Line AADS. A: The final design featured two droplet
generators (1). One or both could be used to run the chip. The oil extractor (2) removed
excess oil to slow the droplets down and pack them for incubation. The incubation cham-
bers (3) featured constrictions to mix droplets to minimise difference in incubation time.
Finally, droplets were spaced, measured, and sorted (4). B: Leakage of product was found to
be increased compared to the two-step (off-line) procedure (off-line 0.75% surfactant, in-line
0.1% surfactant). C: Cells having expressed HG3.17 were encapsulated according to a Pois-
son distribution with λ of 0.35 but no activity could be observed at the end of the incubation
line (a second droplet population of several thousand droplets would have been expected).
4.4 The absorbance-based Kemp eliminase assay 109
such low surfactant concentration, the leakage was still about 3-fold stronger in-line (differ-
ence of the population means (385 ± 60)mV) than after a comparable incubation time of
40min in the off-line procedure (difference of population means (600 ± 80)mV), see also
Figure 4.14B.
In both set-ups, the complete leakage of product occurred over a time-frame of sev-
eral hours, whereas completion of the reaction by HG3.17 at single-cell lysate dilutions was
reached after about 1 h (Figure 4.9). It was therefore conceivable, that enzymatic activity
may be detectable in droplets. Cells having expressed HG3.17 were co-encapsulated with
lysis agent at λ of 0.35 and analysed in-line. However, no enzymatic activity was observed as
can be seen in Figure 4.14C. There are only five events below background, where thousands
would have been expected.
In contrast to this finding, enzymatic activity could be detected in droplets using the
off-line system (see the following section and Figure 4.15). There were three possible expla-
nations for this difference: the cells were not encapsulated (e.g. due to sedimentation in the
syringe), the cells were not lysed efficiently, or the increased leakage in-line prevented a sig-
nal from developing. The first was unlikely to be the case, since cell encapsulation at similar
flow-rates and at similar time-scales in the esterase assay was efficient (Chapter 3). The ly-
sis agent used was BugBuster (Merck-Millipore) at 0.1x final dilution. An increase of up to
0.5x BugBuster and another lysis agent, polymyxin B at 4mgmL−1, gave the same results. It
was thus concluded that the most likely limitation of the in-line system is the increased rate
of product leakage. This may be explained by excess oil flowing past the droplets acting as
a leakage sink during incubation. Also, 70% of droplets were empty, potentially acting as
product sinks, rather than 50% as in the leakage test.
In summary, a new microfluidic device for on-chip droplet generation, incubation, and
sorting based on absorbance was designed and tested. Its operation was stable for several
hours. Leakage of the Kemp reaction product 2b was found to be stronger in-line com-
pared to off-line indicating a difference in leakage dynamics. Enzymatic Kemp activity of
HG3.17 could not be detected using this device. However, the chip should be suitable for
the screening of enzyme libraries based on assays that do not suffer from leakage of its read-
out compounds, e.g. those based on formazan dyes [61]. Indeed, a different selection regime
becomes accessible, based on measurement during the early (linear) phase of the reaction
which is dominated by kcat/Km. So far, sorting was started 2 h after droplet generation, i.e.
during the late (plateau) phase of the reaction, which is determined by the amount of enzyme
produced and the total turnover number and therefore dominated by changes in expression
and stability. For the Kemp elimination, this selection regime was not an option at the mo-
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Fig. 4.15 Activity of HG3.17 in droplets. A:The number of droplet in the droplet population
left of the arrow is 13% of the good agreement with the expected 16% containing HG3.17.
B: The seperation of the two populations increased in the first hour of reaction, indicating
enzymatic activity, and decreased thereafter indicating the dominance of leakage.
ment. Therefore, I turned my attention to the two-step procedure again, and tested if the
activity of HG3.17 was detectable.
4.4.5 Activity of HG3.17 is detectable in droplets
To test if activity of HG3.17 was detectable in the two-step procedure, cells having expressed
HG3.17 and ACP (negative control) were mixed 1:1 and co-encapsulated with substrate and
lysis agent at an average droplet occupancy λ of 0.35, i.e about 16% of droplets were expected
to contain at least one cell expressing the positive control. Indeed, a droplet population with
increased absorbance was observed, as shown in Figure 4.15. Figure 4.15A is a histogram of
3100 droplets of which 400, i.e. 13%, are in the population with lower voltage (cut-off indi-
cated by the arrow). This is in good agreement with the expected number of positive droplets
and indicates that the second population is due to HG3.17 activity. Both droplet populations
were observed 10min after stopping the droplet generation. The separation between the av-
erage signal increased up to 40min and decreased again after 65min. The two populations
never separated completely. In the well plate assay (Figure 4.9), it took the enzyme about
60min to reach saturation under similar conditions. Taking this into account, it can be as-
sumed that in the first phase of reaction the rate of product accumulation exceeds the rate
of leakage. After 60min, the situation is reversed and leakage dominates over accumulation.
Interestingly, the time after which half the maximal signal difference is lost again, is about
120min, which is twice that observed in the leakage test under the same conditions. That is
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Table 4.3 Results for the enrichment of HG3.17 over N20 using the tributyrin
culture plate assay for the phenotypic readout. Halos indicate the presence of
N20, no halos indicate the presence of HG3.17.
Ratio Before Sorting After Sorting Enrichment
Halo No Halo ε0† Halo No Halo ε1 ε1/ε0
1:100 358 9 0.025 11 307 0.965 39
1:1000 47 0 0.001 3 194 0.985 985
† ε is the ratio of non-halo forming colonies over halo forming colonies.
ε0 for the 1:1000 dilution is assumed.
the leakage was apparently reduced in the cell lysate assay. However, faster leakage would
have been expected because almost 9 in 10 droplets acted as potential leakage sinks. This in-
dicates that conversion of substrate continues beyond 60min possibly due to the transfer of
substrate from negative towards positive droplets. In summary, these observations strongly
indicated that activity of HG3.17 was transiently detectable in 70 µm droplets from single-
cell lysates. To prove that this was indeed the case, an enrichment of HG3.17 over a negative
control was performed.
4.4.6 Enrichment of HG3.17 using AADS is efficient
To assess the enrichment of HG3.17, a simple culture plate assay was established by using the
esterase N20 (see Chapter 3) instead of ACP as the negative control. Colonies harbouring
the plasmid pHAT_N20 developed a clear zone (halo) around them if growing on 1% tribu-
tyrin plates. The halo appeared without the need for cell lysis, in the absence of expression
induction, and in both the BL21(DE3) and the commercial E. cloni 10G strains of E. coli.
Therefore, either strain could be plated onto tributyrin plates to measure the ratio of cells
harbouring the genes for N20 and HG3.17 respectively. This was convenient, because the
former strain was needed to overexpress HG3.17 for the droplet assay, whereas the latter was
needed to recover plasmids after droplet sorting. For the purpose of this enrichment, the
HG3.17 gene was cloned into the pHAT vector.
Two enrichments were performed (see Figure 4.16 and Table 4.3). In the first enrich-
ment, cells having expressed HG3.17 and N20 were mixed 1:100 and encapsulated at λ of
0.35. Over 60min, 1.5 × 105 droplets were sorted of which 150 were collected. Half of the
recovered DNA was transformed and 318 colonies obtained, i.e. about 4 colonies per col-
lected droplet. The percentage of colonies changed from 2.5% without halos prior to sorting
to 96.5% without halos after sorting indicating 39× enrichment. The maximum possible en-
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Fig. 4.16 Enrichment of Kemp eliminase HG3.17 over esterase N20 at ratios of 1:100 (A) and
1:1000 (B). Shown are the respective droplet histograms and tributyrin-containing culture
plates from before and after the enrichment. The disappearance of the halos indicates en-
richment of HG3.17. The dotted arrow indicates the sorting threshold, red arrows indicate
colonies without a halo before sorting, red circles indicate colonies with halos after sorting.
richment from 2.5% would have been 40×, i.e. the sorting was 97% efficient. Ten colonies
were picked for colony PCR with gene-specific primers to confirm the phenotypic readout.
The result was as expected: all of the colonies without halo were positive for the HG3.17 gene
but not the N20 gene and vice versa (Figure 4.17).
A second enrichment with a starting ratio of 1:1000 was performed and similar results
obtained. This time, 4.5 × 105 droplets were sorted over 120min and 130 droplets were col-
lected. Again, about 4 colonies per sorted droplet were obtained. The starting ratio could
not be confirmed on culture plate, because too few colonies grew (all of which formed ha-
los). Assuming the starting ratio was as intended, the enrichment was close to 99% efficient.
In summary, it was shown that HG3.17 activity was detectable in single-cell lysates using
70 µm droplets. Efficient enrichment based on this activity was possible in a time-frame of
at least 2 h. In principle, enrichment of a well-expressed enzyme with high Kemp eliminase
activity was now possible.
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Fig. 4.17 The phenotypic readout of the culture plate assay was confirmed via colony PCR.
Ten colonies from after the 1:100 enrichment were picked. Two PCR reactions performed on
each using primers specific to the pHAT2_N20 and pHAT5_HG3.17 plasmids respectively.
In each case, the phenotype predicted the genotype correctly (X = negative control).
4.4.7 No activity observed in functional metagenomic screening
Cells were transformed and grown over two days on plates to allow for gene expression
and then encapsulated using the same conditions as in the enrichments. This time, 3 × 105
droplets were analysed. There were events with absorbance above background. However,
all of these were artifacts such as merged droplets or dust (Figure 4.18). No colonies could
be recovered from the collected droplets. Therefore, the assay using substrate 2a appeared
not to be sensitive enough for functional metagenomic screening. In the next section, the
suitability of this assay to screen mutagenic libraries of HG3.17 at unprecedented through-
put was explored instead. The ability to perform a functional metagenomic screen for Kemp
eliminases was further investigated using a novel fluorogenic substrate, first reported here,
in Chapter 5.
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Fig. 4.18 No genuine activity was observed when screening cells transformed with the
metagenomic SCV library. All events with a voltage below background were artifacts (e.g.
large droplets) as indicated in A and B by the red arrow. No colonies could be recovered
from the collected droplets.
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4.5 Directed evolution of HG3.17 using AADS
Theabsorbance-basedKemp elimination assaywas shown to be efficient at enrichingHG3.17
wild-type enzyme over a negative control. Therefore, I explored the utility of this assay in
screening large mutagenic libraries of Kemp eliminases. The screening of Kemp eliminases
has been limited by the throughput of 96-well plate assays. The enzyme HG3.17 itself was
evolved from HG3 using substrate 2a. Each round, ten 96-well plates were screened, a prac-
tical limitation putting the throughput at >103 [16]. The total number of variants screened
by Blomberg et al. was in the range of 104 – a number which using AADS at a λ = 0.35 could
be screened in less than 10min. Therefore, the utility of pre-screening libraries of HG3.17
using the droplet method was tested.
Three different libraries were prepared. The first introduced random amino acid substi-
tutions by pointmutation (changing one base at a time in the sequence); the second consisted
of deletions of a triplet base pair at a random position in the gene (deletion of one amino acid
per sequence); and the third contained insertions of an NNN triplet basepair (N being any
base, adding one amino acid per gene). Figure 4.19 shows how changes in the nucleotide
sequence in these libraries can affect the protein sequence.
Together point substitutions, insertions and deletions (InDels) account for the majority
of changes in the evolution of proteins [209]. Substitutions occur more frequently with the
Fig. 4.19 Three libraries of HG3.17 were prepared. The first introduced point mutations
changing one base-pair at a time. This method can lead to synonymous mutations (conserv-
ing the protein sequence due to the redundancy of the genetic code) and non-synonymous
mutations (change of the protein sequence). Themethod used to generate 3bp InDels allowed
the introduction or removal of 3 base-pairs anywhere along the sequence. Thus, in the ab-
sence of bias, 1/3 are in-frame and 2/3 out-of-frame. Out-of-frame InDels are likely to cause
an amino-acid mutation adjacent to the InDel as shown by the examples. The construction
of the libraries is explained in Figure 4.20.
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ratio to InDels being 1:20 in the genomes of bacteria [210]. This drops to 1:5 in non-coding
regions and increases to 1:40 in coding regions, indicating that InDels occur frequently, but
are under stricter selection compared to substitutions [210]. Point substitutions change the
side chain of one amino acid, often having locally confined effects. In contrast, InDels change
the length of the protein backbone, requiring repositioning of both the backbone and side
chains. Due to this more drastic impact on the structure, InDels may be more deleterious to
protein function, rationalising the increased selection pressure. Accordingly, substitutions
have been studied much more extensively than InDels both in general [210–212]. Yet, In-
Dels occur frequently, [210, 211], and have been shown to be associated with crucial steps in
functional divergence of proteins [180, 211, 213, 214].
InDel libraries of enzymes have a lower proportion of active variants not just because of
the larger impact on the protein’s function, but also because only InDels of 3n base pairs avoid
highly deleterious frame-shifts. Randomised approaches not controlling for the number of
base-pairs inserted or deleted cause >66% frame-shifts (for example [215]). Here, I used an
unpublished method developed by Dr Stephane Emond dubbed Transposition-based Ran-
dom Insertion And Deletion mutagenesis (TRIAD, unpublished). This method produces a
majority of in-frame InDels based on engineered transposons. The cloning strategy is out-
lined in Figure 4.20 and the detailed procedures described in the Methods.
In the following, I first created a substitution library to evaluate the ability to enrich ac-
tive HG3.17 library variants using AADS and then screened deletion and insertion libaries,
respectively.
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Fig. 4.20 Three libraries of HG3.17 were generated. The first library was created using error-
prone PCR (epPCR), which introduced point mutations into the gene based on an error-
prone DNA polymerase. The other two libraries were generated using transposable elements
to delete or introduce three base pairs at random positions in the target gene (unpublished
method developed by Dr Stephane Emond).
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4.5.1 The screening workflow
Every library was screened following the same workflow shown in Figure 4.21. First, the li-
brary was transformed into E. coli BL21-Gold(DE3) (Agilent), which were plated onto LB
agar plates. After overnight incubation at 37 °C to allow the colonies to grow, the plates were
scraped and the resulting cell suspension used to start two liquid cultures. These were in-
duced using isopropyl β-D-1-thiogalactopyranoside (IPTG) for protein expression at 20 °C.
After overnight expression, these cells were used to generate droplets using the same reac-
tion conditions as in the enrichment experiment of wild-type HG3.17 against esterase N20
(Section 4.4.6). Immediately after droplet generation, AADS was used to sort the droplets
at 100Hz for up to three hours. After sorting, the DNA was recovered from droplets using
a highly competent commercial strain of E. coli (E cloni 10G Elite, Lucigen, >1010 cfu/µg).
The DNA was then extracted and transformed into the expression strain (BL21-Gold(DE3),
Agilent, 107 cfu/µg) and individual colonies picked to inoculate 96-well plates. Cell lysate
assays were performed to compare the distribution of enzymatic activity in the library before
and after droplet sorting and to pick individual variants for further characterisation.
Fig. 4.21Workflowused to screen theHG3.17 libraries using substrate 2a andAADS.Droplet
screening was performed using the same reaction conditions as in the HG3.17 enrichment
experiment (Section 4.4.6). Cell lysate assays were performed to compare the distribution of
activity in the libraries before and after droplet screening.
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4.5.2 Directed evolution of HG3.17 using substitutions or InDels
Screening of an epPCR library of HG3.17
Error-prone PCR (epPCR) introduces point mutations into a gene by means of a low-fidelity
polymerase and variation of the reaction conditions [216]. This is a widely used approach in
protein engineering and directed evolution [9, 217] and was previously used in the directed
evolution of HG3.17 [16]. Error-rates can range between 1 and 20 × 10−3 depending on the
reaction conditions [217]. While epPCR provides access to large substitution libraries, it is
important to note the full theoretical sequence diversity is not accessible by thismethod. Due
to the low frequency of the mutations, usually only one base is modified in any one codon.
Therefore, not every amino acid can by mutated to any other For example, a change from va-
line (GUN) to threonine (ACN) requires both of the first two base-pairs to mutate. The dif-
ference between the maximum diversity and the accessible diversity is sequence-dependent
and was calculated for HG3.17 using the program PEDEL-AA [218]. With a length of 307
amino acids (His-tag excluded), the maximum library size for one amino acid mutation per
protein is 307 ∗ 19 = 5833. If allowing only 1 base-pair substitution per codon the acces-
sible number of single amino acid substitutions is 1843. For two amino acid mutations per
protein, the maximum number of protein variants is 1.7 × 107 and the accessible variants by
single base pair mutations 1.7 × 106. The actual number of variants contained in a library
for any number of amino acid mutations is between the two extremes and depends on the
average mutation frequency, bias and library size.
Generation of the epPCR library Here, the GeneMorph II kit (Agilent) was used (detailed
reaction conditions in Section 7.2.4). The mutational frequency, ligation and transformation
efficiency can vary between different library preparations. Therefore, four libraries were con-
structed based on independent epPCR reactions. Two epPCR reactions were performed each
at 25 and 30 PCR cycles and the results are shown in Table 4.4.
Table 4.4 Substitution libraries generated by epPCR.
Sample Cycles Transformants Insert Library Size Mutations/gene
25.1 25 30 × 103 1/10 3 × 103 -
25.2 25 300 × 103 4/10 120 × 103 3.5
30.1 30 40 × 103 5/10 20 × 103 1.8
30.2 30 30 × 103 4/10 12 × 103 1.8
epPCR 9/9 152 × 103 2.7
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Fig. 4.22 The circles indicate the positions of nucleotide mutations found in 9 randomly
picked variants from the naive epPCR library (on average 2.7 mutations/variant). At the
amino acid level there were 2.3 substitutions/variant on average.
Ten variants were sequenced from each library. The library size was estimated by multi-
plying the total number of variants obtained by the proportion of variants containing vector
with insert. Sample 25.1 resulted in a particularly small library andwas discarded. The largest
library was obtained from sample 25.2 with an average of 3.5 mutations per gene. Because all
libraries had a high proportion of empty vector, a portion of libraries 25.2, 30.1 and 30.2 was
digested using restriction enzyme EcoRI (only present in vector without insert), the purified
product mixed at ratios representing the original library size and freshly transformed. All
of the sequenced variants of this final library (epPCR) contained insert and the estimated
diversity was on the order of 105. The mutational bias in the library was estimated using
the program Mutanalyst [219]. The ratio of transitions to transversions was 0.6 (close to the
ideal of 0.5) and the ratio of AT→GC to GC→AT was 0.4 (similar to 0.6 reported by the
manufacturer). Mutanalyst fits a Poisson distribution to the input mutations and estimated
a 𝜆mut = 2.8, meaning the library is expected to contain about 6% wild-type sequence and
about 20% each with one, two and three base pair mutations, respectively. Themutations ob-
served in the randomly picked variants were distributed across the whole gene (Figure 4.22).
In the following, I report on two screening campaigns of this library. In the first cam-
paign it was tested how sorting stringency (top fraction of droplets collected) influences the
enrichment of activity. During the second campaign two subsequent rounds of enrichment
were performed to test whether improved variants can be further enriched.
First Sorting Campaign The epPCR library was transformed into chemically competent
E. coli BL21-Gold(DE3) cells resulting in a library of 2.5 × 104 clones4. While this was only a
4Construction of the final library was performed using highly electro-competent E. coli cells (E cloni 10G
Elite, Lucigen) covering the estimated size of 1.5 × 105 at least 10 fold. Electro-competent BL21-Gold(DE3) cells
were subsequently prepared (Methods 7.2.2) to achieve higher transformation efficiencies for library expression
and droplet sorting.
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subset of the epPCR library, it was 10 times larger than any library screened before in a single
round for the Kemp elimination. This library was used to investigate the influence of sorting
stringency on activity enrichment.
Droplet screening reduces library size by enriching the top-performing variants in the
library. The cut-off point is determined by the sorting threshold of the sort and determines
the ratio of the input library size 𝑁lib to the output library size 𝑁out. This ratio is not only
influenced by the sorting threshold, but also by the coverage 𝐶 of the library:
𝐶 = 𝑁cells𝑁lib
= 𝑁tot ∗ 𝜆𝑁lib
(4.5)
With 𝑁tot being the total number of droplets screened and 𝜆 the average droplet occu-
pancy of the sample. If a library is undersampled (𝐶 ≪ 1), then the output library size will
approximately equal the number of collected droplets (𝑁coll ≈ collected cells), because the
likelihood of collecting the same library member twice is low. If a library is oversampled
(𝐶 ≫ 1), then the output library size will be approximately the number of collected droplets
divided by the coverage, assuming the same library member will give a similar signal every
time it is measured:
𝐶 ≪ 1 ∶ 𝑁out ≈ 𝑁coll (4.6)






By reducing the droplet sorting threshold (higher absorbance) the collection frequency
will be reduced. More droplets will need to be screened, increasing 𝐶 , but fewer droplets can
be collected due to the time limitation of the assay, both effects increasing stringency. Higher
stringency is advantageous because the smaller output library can be fully re-screened in the
96-well plate assay (e.g. an output of 10 can easily be oversampled in a single plate). However,
higher stringency also increase the chance of erroneous sorting events occurring due to the
prolonged sorting time, introducing a stringency trade-off.
To investigate the effect of sorting stringency in this assay, the epPCR library was sorted
using two different thresholds. Both sorts were performed on the same day. The droplet
samples were each produced immediately prior to sorting and using the same cell suspension
(stored on ice between the two sorts).
The results are shown in Figure 4.23 and Table 4.5. Both sorts showed a similar signal
distribution with a main peak just above 6V and trailing off approximately exponentially
towards lower voltages. Almost no droplets had a signal below 4.5V. The first sort was per-
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Fig. 4.23 Histograms of two droplet sorts of the epPCR library of HG3.17 using AADS. The
first sort was performed at a lower stringency (top 0.8% of droplets) and the second at higher
stringency (top 0.06% of droplets). Droplets in the blue range were collected.
formed at a lower stringency with a sorting threshold of 5.5V resulting in the collection of 1
in 100 droplets. Shifting the threshold to 5.1V reduced the collection frequency to 5 × 10−4.
The output library sizes were estimated to differ about 15 fold.
Table 4.5 Number of clones analysed for the two droplet sorts of the epPCR library of Kemp
eliminase HG3.17.
Stringency Threshold† Cells Analysed Coverage Droplets Collected Output Library
(mV) 𝑁tot ∗ 𝜆 𝐶 𝑁coll 𝑁out
Lower 580 9 × 104 3.5 2.0 × 103 ~ 600
Higher 960 16 × 104 6.4 2.6 × 102 ~ 40
† difference to the mode of the signal distribution.
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UponDNA recovery, the lower stringency sample yielded 4 colonies per collected droplet
and the higher stringency sample yielded 3 colonies per droplet. Individual colonies were
picked from before droplet screening and for each sample and grown in deep 96-well plates.
After protein expression in 500 µL medium, the cells were pelleted and lysed in 100 µL lysis
buffer. The lysis solution was diluted step-wise to 2 × 104 times. Assuming an average OD600
of 3 to 3.5 for each well, the dilution of the cytosol was about 10 fold higher compared to
droplets. The results for the cell lysate assay are shown in Figure 4.24.
The reaction rates during the first 5min were calculated for each well and normalised
to the HG3.17 (positive) and N20 (negative) controls. Almost half of the clones tested for
the naive library activity fell below 10% cell lysate activity compared to the HG3.17 control.
This fraction was reduced by more than 2 fold to 18% in the lower stringency sample, but
to only 33% in the higher stringency sample. Thus, this experiment established that sorting
with a lower threshold was more efficient at removing inactive variants from the library. As
explained above, lower enrichment of activity at high stringency can be explained by the
prolonged sorting time, which increases the number of erroneously collected droplets due to
low-frequency events such as small dust particles disturbing the flow in the sorting chip.
No clones with activity more than 2 fold above HG3.17 were observed. There were four
clones with activity 1.5 fold above wild typeHG3.17, which were selected for further analysis.
They were re-grown in 3mL medium and the protein expressed overnight. The OD600 was
adjusted to 0.5 to account for differences in the growth rate and 1.8mL of each sample was
spun down to repeat the cell lysate assay, plasmids were extracted from the remainder of the
sample for sequencing. The result is shown in Figure 4.26: as in the previous assay, all of the
selected variants showed higher activity compared to the control (ranging from 1.2 to 1.6 fold
depending on substrate concentration).
Sequencing revealed that clones 1D6, 3F10 and 4F11 were all equal to the HG3.17 wild-
type sequence. Clone 4A11, which was themost active in both cell lysate assays, had two syn-
onymousmutations (C90T, T693C).While all four clones were therefore identical to HG3.17
at the amino acid level, the small increase in activity was reproduced in the repeat experi-
ment. This may be explained by synonymous mutations affecting protein expression levels
to a small extent. The C90T mutation in 4A11 changed an ACC codon to ACT (threonine).
Boel et al. found the first codon to be associated with reduced expression and the latter with
improved expression in a large-scale protein expression study [220]. The T693C mutation
changed a GGT codon to GGC (glycine), which was found to be near neutral in the same
study. Factors put forward to explain changes in expression include effects on mRNA fold-
ing, stability and translation rates, but remain amatter of debate [220]. The increased activity
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Fig. 4.24 Cell lysate plate assays of the naive epPCR library (top plate) and after sorting at
lower stringency (bottom plate). Reactions were started by adding 1mM 2a to diluted cell
lysate (2 × 104 fold) and monitored at 380 nm (using UV-transparent 96-well plates). Buffer:
20mM TrisHCl pH 7, 50mM NaCl, 10% v/v MeOH.
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Fig. 4.25 The rate during the initial 5min of reaction was obtained by linear regression (red
lines in Figure 4.24) and normalised with respect to the controls. The resulting histograms
show the distribution of cell lysate activity. Shown are the probabilities to account for the
differing number of samples N, bins are in 10% steps. Droplet selection at lower stringency
wasmore successful at removing low activity variants (reduction from46% to 18%) compared
to higher stringency (33% remaining).
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Fig. 4.26 A: Cell lysate assay of four selected variants at different substrate concentrations
(OD600 was equalised prior to cell lysis). The red lines are a linear fit of the first 5min of the
reaction with slope vobs. B: All four selected variants showed increased activity compared to
HG3.17 (substrate concentration during both droplet and plate screening was 1mM).
in the other clones could be explained by a mutation elsewhere on the plasmid (e.g. affecting
the plasmid copy number) or in the host genome.
In summary, droplet screening for Kemp eliminase enriched active library members and
was more effective in doing so at the lower stringency. While the library screened here did
not yield any strongly improved variants, it was shown that the plate assay was sensitive to-
wards small improvements in cell lysate activity. In the next section this approachwas further
explored by screening the epPCR library over two rounds.
Second Sorting Campaign Given that the higher stringency sort was less efficient, the al-
ternative route of sorting the library over two rounds using two steps at the lower stringency
was tested in this second sorting campaign. The epPCR library was transformed again, this
time into electro-competent BL21-Gold(DE3) cells, yielding ~1.2 × 105 transformants.
This library was sorted twice, with the DNA recovered from the first round used as the
input for the second round. The results are shown in Table 4.6 and Figure 4.27. In the first
round, sorting was performed using even lower stringency compared to the above sorts, with
an aim to reduce the library size from ~105 to ~104. The second round was performed using
0.75mM substrate as an alternative way to increase stringency. During the second sort a
defined shoulder to the left of the main peak was observed. The fraction of events below the
intervening minimum (at 5.93V) was 0.35 matching the λ used to encapsulate cells. This
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indicated that after the first round of sorting, all library members had detectable activity in
droplets above a certain minimum.
Table 4.6 Number of clones analysed during each round of enrichment of the epPCR library
of Kemp eliminase HG3.17.
Sample Threshold† Cells Analysed Coverage Droplets Collected Output Library
(mV) 𝑁tot ∗ 𝜆 𝐶 𝑁coll 𝑁out
Round 1 340 3.5 × 105 2.9 3.0 × 104 ~10,000
Round 2 600 1.6 × 104 16.4 2.6 × 102 ~ 160
† difference to the mode of the signal distribution.
As in the previous experiment, the initial rates in cell lysate were measured after each
round of enrichment (Figure 4.28). The data for the naive librarywas taken from the previous
experiment. In the first round of enrichment, the proportion of clones with <10% activity
compared to HG3.17 was reduced to 17%. In the second round this proportion increased
slightly to 23% while the overall distribution did not change.
As before, no variants with activity 1.5 fold higher compared to the HG3.17 control were
observed. Nonetheless, the six most active variants in lysate were selected for sequencing
(Table 4.7). One was identical to the wild-type sequence of HG3.17 and two had synony-
mous mutations. Variant 2E10 had amino acid mutations Q143R, I150V and D179N. The
locations of these mutations in the structure of HG3.17 is indicated in Figure 4.29. Q143 is
a surface exposed residue and mutation to arginine introduces a charge which may improve
the protein’s solubility. D179 is only partially exposed while I150 is a buried residue medi-
ating the interaction between two helices. Variants 3E10 and 3C12 both had the amino acid
mutation A5T, but differed in a second amino acid mutation with Q77R and A181V respec-
tively. Residue A5 is not observed in the crystal structure of HG3.17 and thus is unlikely
to impact on the protein’s structural integrity. Q77 is a surface exposed residue, and as in
the case of Q143, mutation to arginine may have improved soluble expression of the protein.
Finally, A181 is also located near the surface. Taken together, all the observed amino acid
mutations were far from the active site andwould be expected to have a small to neutral effect
on the enzyme’s activity.
The three variants which had amino acid mutations and HG3.17 were expressed, puri-
fied, and their Michaelis Menten parameters determined (Table 4.8). The catalytic efficiency
kcat/Km obtained for HG3.17 was in good agreement with the literature value (2.3 × 105,
[16]), although lower kcat and Km values were obtained respectively. As expected, the cat-
alytic efficiencies obtained for the three mutant enzymes were close to wild type activity but
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Fig. 4.27 Two rounds of AADS of the epPCR library of HG3.17. The first sort was performed
at 1mM substrate, the second at 0.75mM in order to increase selection pressure. Droplets
in the blue range were collected.
Table 4.7 Mutations found in the six most active variants in the cell lysate
re-screening assay.
Variant Mutations
2E10 T123C, A428G (Q143R), A448G (I150V), G535A (D179N)
3C12 G13A and A15T (A5T), C542T (A181V)
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Fig. 4.28 Initial rates of clones from the epPCR library before and after each round of sorting.
The rates are normalised using the average rates of three HG3.17 (𝑣wt) and three N20 (𝑣neg)
samples respectively. As can be seen, the proportion of inactive clones is reduced after just
one round of sorting.
about 2 fold lower. That these catalytic parameters were lower than for HG3.17 indicates that
they were more active in lysate due to compensatory improved expression.
As a crude measure of soluble protein expression the size and intensity of the respective
protein bands on gel were quantified in the insoluble and soluble fractions after overnight
expression under the same conditions as for the droplet screening and cell lysis (see Fig-
ure 4.30). The sample loading of in particular of the pellet varied between samples and was
therefore normalised relative to an endogenous E. coli protein band (indicated in the figure)
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Fig. 4.29 Locations of the mutated residues in the three characterised variants within the
structure of HG3.17 (PDB: 4BS0, complexed with transition state analogue 6-nitrobenzo-
triazole shown in green, [16]). The enzyme has a TIM barrel fold, with the catalytic aspartate
located in the centre of the β-barrelH-bonded to the transition state analogue shown in green.
The annotated residues were mutated in the characterised variants and are located far from
the active site near the protein surface.
Table 4.8Michaelis-Menten kinetic parameters of the
variants selected in the cell lysate assay which had
amino-acid mutations for substrate 2a.
Enzyme kcat (s-1) Km (mM) kcat/Km (Ms)-1
HG3.17 243 ± 21 1.0 ± 0.2 2.4 ± 0.2 × 105
2E10 276 ± 61 2.6 ± 0.8 1.1 ± 0.2 × 105
3C12 163 ± 26 1.2 ± 0.4 1.4 ± 0.2 × 105
3E10 237 ± 66 1.7 ± 0.8 1.4 ± 0.4 × 105
Assay conditions: Enzymes at 5 to 6 nM, sub-
strate 40 µM to 2mM, 20mM TrisHCl pH 7,
50mM NaCl, 10% v/v MeOH.
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to account for the difference. While soluble expression of HG3.17 started high at 88%, the
analysis indicated 1.6 to 1.8 fold overall im proved total soluble protein expression for vari-
ants 2E10, 3E10, and 3C12.
Improvements in soluble protein expression have previously been observed in directed
evolution campaigns. For example, Aharoni et al. found that the initial rounds of evolution of
the mammalian paraoxonase PON1 yielded variants that were 20 fold more active in lysate
compared to the starting point, but had no improvements in its specific activity [221]. A
similar trend was observed by Gielen et al. who evolved phenylalanine dehydrogenase in
the only other directed evolution campaign that used AADS for screening [61]. The best
variant isolated after two rounds of evolution showed 4.6 fold increased activity in lysate,
but showed no change in kcat/Km but about 2 fold improved soluble expression. Similar
to these, the selection criterion in this assay was 1) activity in single-cell lysates in droplets
and 2) in bulk lysates in 96-well plates. Therefore, enrichment was determined by both the
enzyme’s catalytic properties as well as the concentration of functional enzyme, influenced by
its stability under the conditions in both screening steps. Mutations that improve one at the
cost of the other (a form of compensatory epistasis) will pass the selection threshold [222].
It is possible that there are additional stability requirement in droplets different from
plates (e.g. interactions with a fluoruous interface at the droplet boundary and fast turbulent
mixing as droplets move through microfluidic channels). Furthermore, in droplets cell-to-
cell expression variation will play a role (high variation reducing the likelihood of collecting
the variant), whereas in bulk measurements cell-to-cell variation is masked as long as the
population’s mean expression improves.
In conclusion, a 100×larger epPCR library of HG3.17 was screened in a single round of
screening than previously possible, but no catalytically improved variants were discovered.
Given that HG3.17 was the endpoint of a previous directed evolution campaign, mutations
to further improve catalytic activitymay be very rare. At the same time, microfluidic droplets
may place new stability constraints on the enzyme which require initial compensatory muta-
tions, after which a new evolutionary trajectory becomes accessible in droplets. Importantly,
it was shown that the droplet assay was efficient at enriching the proportion of active vari-
ants in the library. It was thus hypothesised that libraries with a bigger impact on the protein
structure (a larger proportion of inactive variants) could be screened using this method to
purge the least active variants. Therefore, the InDel libraries were constructed and screened,
as described in the following.
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Fig. 4.30 Analysis of bulk soluble expression of HG3.17 and the characterised variants. Each
protein band was assigned a value by multiplying the unadjusted average gray-scale intensity
and area of the band (determined in ImageJ). The sample loading for each pellet and soluble
lane was normalised to the respective lanes in the HG3.17 lane to determine the changes in
soluble fraction and total protein expression.
Directed evolution using InDel libraries
As explained in Section 4.5, insertions and deletions have a larger impact on protein struc-
ture than substitutions and InDel libraries have thus a bigger proportion of inactive variants.
Here, I explored if purging inactive variants at high-throughput is useful to identify positions
that can tolerate InDels.
Generation of InDel libraries of HG3.17 using TRIAD In the deletion library, 3 consec-
utive base-pairs were deleted at a time. Therefore, the theoretical library size is equal to the
number of base-pair triplets that can be deleted. Excluding the start-codon and 6xHis-tag
that is 916 (~103) in the case of HG3.17. While a library of 103 could be covered 1-2 times
in 96-well plates, achieving high coverage is only practically possible using droplet microflu-
idics. In the case of the insertion library, an NNN triple base-pair was inserted. The library
size in this case is 916 ⋅ 64 = 58,624 ≈ 6 × 104.
After library construction, ten colonies were picked and sequenced for the deletion and
insertion libraries, respectively (see Figure 4.31). In the deletion library, all ten variants
showed a 3 bp deletion and in two cases this led to mutation of one adjacent amino acid
(due to out-of-frame deletion, see Figure 4.19). In the insertion library, six of ten variants
had a 3 bp insertion, three variants had less than 3 bp inserted causing a frame-shift and one
sequence was wild-type. This is a typical result of the cloning method used (oral commu-
nication Dr Stephane Emond). Assuming that only 60% of the obtained library had 3 bp
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Fig. 4.31 The circles indicate the location of deletions and insertions, respectively. In the
insertion library there was a slight bias towards insertions in the second half of the gene.
Fig. 4.32 AADS histograms for the deletion and insertion libraries. The shape of the his-
tograms is distinctly different from the epPCR libraries, indicating a lower proportion of
variants with detectable activity. Droplets in the blue range were collected (A and C).
insertions, the theoretical library size was still covered 30 fold in the final transformation
step.
134 An absorbance-activated droplet sorting assay for the Kemp elimination
Fig. 4.33 The empirical cumulative probability function of the droplet sort for the epPCR,
insertion and deletion libraries. As expected, the proportion of droplets with a signal below
98% of the signal distribtution mode is reduced in the latter two, indicating that there are
fewer variants with detectable activity.
Screening of InDel libraries Each of the libraries was transformed into electro-competent
BL21-Gold(DE3) for protein expression and screened in droplets. The sorting histograms are
shown in Figure 4.32. Using these histograms, the empirical cumulative probability function
for each sort was calculated and compared to the first round of sorting of the larger (second)
epPCR campaign. Figure 4.33 shows that the number of droplets with a signal below the
mode of the distribution dropped off more quickly in both InDel libraries compared to the
epPCR libary. This suggests the fraction of droplets that contained variants with detectable
activity was markedly reduced, as would be expected due to the more disruptive nature of
InDels compared to point substitutions. At 97% of the distribution’s mode there was a dis-
tinct “kink”, most likely corresponding to a transition between droplets with non-detectable
and detectable activity. The probability to be below this threshold was 16.2% in the epPCR
library but only 5.2% and 5.6% in the deletion and insertion libraries, respectively. Taking
into account the Poisson distribution, this translates into 46%, 15% and 16% of the single-
cells having detectable activity in droplets. Interestingly, at low signal (high activity), the
InDel libraries had slightly increased probabilities, suggesting there may be more active but
rare variants present compared to the epPCR library.
In the case of the deletion library, 3 × 104 droplets were screened allowing over 10 fold
coverage of the theoretical library size in just 10min of sorting (Table 4.9). In the case of the
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insertion library, 8.6 × 105 droplets were sorted over ~2.5 h covering the theoretical library
size 5 fold (3 fold if discounting for the frame-shifted variants).
Table 4.9 Number of variants analysed during each round of enrichment of the epPCR library
of Kemp eliminase HG3.17.
Sample Threshold† Cells Analysed Coverage Droplets Collected Output Library
(mV) 𝑁tot ∗ 𝜆 𝐶 𝑁coll 𝑁out
Deletions 590 1.0 × 104 11.5 4.0 × 102 ~ 40
Insertions 690 3.0 × 105 5.1 1.2 × 104 ~ 400
† difference to the mode of the signal distribution.
Individual variantswere tested in cell lysate assays and the resulting histograms are shown
in Figure 4.34. Prior to enrichment, 90% of the deletion library had less than 10% activity in
cell lysate compared to HG3.17 wild-type activity. This is in good agreement with the pre-
diction from the cumulative probability function of the sorting histogram5. The proportion
of low-activity (and inactive) variants was reduced to 40% after droplet sorting suggesting
effective enrichment. Unfortunately, too few colonies from the naive insertion library prior
to sorting re-grew to perform the cell lysate assays. However, given that the cumulative prob-
ability functions of the insertion and deletion libraries were very similar, it is likely that the
proportion of low-activity variants was similar. However, the enrichment of activity was less
effective for the insertion library with low-activity variants retained at 60%.
As previously, the most active variants in cell lysate were sequenced. In particular the
deletion library had a number of promising candidates, at 2 fold and higher activity com-
pared to wild-type. Yet, all of them were wild-type except for variant 4A09, which was
2.7 fold more active in lysate. This variant had a deletion of A181 (DelA181) with adjacent
mutation S182G. Interestingly, variant 3C12 from the epPCR library carried a mutation in
the same position, A181V. Variant 4A09 was purified and its Michaelis-Menten parameters
determined. Its kcat/Km was 10 fold reduced compared to HG3.17 compensated for by an
estimated 4.5 fold improved soluble expression (Figure 4.35) and possibly other stabilising
factors. This is particularly interesting, as discussed earlier improved expression or at least
adaptation to droplet conditions is likely necessary, while the deletion itself together with
starting at a reduced initial activity may open unprecedented mutational trajectories for im-
proved catalytic activity, further explored below.
5Which was 15%, N = 20 in the cell lysate was small. If one more variant would be tested and found to be
active, the cell lysate proportion would be 14%.
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Fig. 4.34 Initial rates in cell lysates normalised using the average rates of three HG3.17 (𝑣wt)
and threeN20 (𝑣neg) samples, respectively. As can be seen, the proportion of inactive variants
is markedly reduced after sorting the deletion library. Too few variants of the naive insertion
library re-grew to assess the enrichment, but assuming a similar distribution prior to sorting,
it was less efficient than for the deletion library.
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Table 4.10 Michaelis-Menten kinetic parameters of deletion variant
4A09 (DelA181, S182G) for substrate 2a.
Enzyme kcat (s-1) Km (mM) kcat/Km (Ms)-1
HG3.17 243 ± 21 1.0 ± 0.2 2.4 ± 0.2 × 105
4A09 (DelA181, S182G) 63 ± 20 3 ± 1 2 ± 1 × 104
Assay conditions: Enzyme 4A09 at 10 nM, substrate 40 µM to
2mM, 20mM TrisHCl pH 7, 50mM NaCl, 10% v/v MeOH.
Fig. 4.35 Analysis of relative protein expression according to the same method described for
Figure 4.30.
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The identification of neutral InDels may open unprecedented mutational trajectories
The majority of variants sequenced from all library sorts so far were wild-type. Given that
the starting activity of HG3.17 was high andmostmutations detrimental, this was not wholly
unexpected. In fact, it could be seen as a quality marker of the droplet screen to enrich wild-
type sequence present in the libraries. To gain a more comprehensive understanding of the
outcomes of the InDel library screening, two entire 96-well plates were sequenced, one for
the deletion and one for insertion library, both post-sorting.
It became apparent that the majority of variants on the deletion plate were wild-type
HG3.17 (45 of 83), see Figure 4.36. No wild-type had been found in the ten randomly se-
quenced variants from the naive library. The next most frequent variants (13) had deletions
in positions 305-307 (C-terminus) retaining an average activity of 93 ± 22% in lysate relative
to HG3.17. These C-terminal residues do not appear in the crystal structure of HG3.17, i.e.
they are unstructured and unlikely to have a large impact on the protein structure. DelA66
was found 8 times, with an average of 13 ± 3% lysate activity relative to HG3.17. Deletion
of A66 without adjacent mutations is possible through removal of 196-GCG-198 (in-frame)
or 197-CGG-199 (out-of-frame), the resulting sequences being indistinguishable. Assuming
no bias in the library, the expected frequency for two independent triplet base deletion is
2/916; i.e. DelA66 was enriched about 44 fold. Interestingly, DelP233 was found twice (10
and 15% activity) along with a DelP233, Q234E variant (only 2% activity). Proline is rigid
(φ is locked to −65°, because its side chain is attached to the α-amine) and often observed
at the end of secondary structure elements when the back-bone reverses its direction (e.g. in
β-turns). It’s introduction or removal would therefore generally be expected to be disruptive,
but this depends on the structural context. DelS182 was showed 107% activity in cell lysate,
further corroborating that positions 181-182 are tolerant towards both deletions and substi-
tutions. Furthermore, two variants with substitutions were found, which could have arisen
from errors during the cloning procedure.
About 23 wells of the insertion plate did not yield sequences, which may have been due
to a contamination and explain in part why the enrichment appeared to be less efficient com-
pared to the deletion plate. Again, a large proportion of the sequences (20 of 67) were wild-
type. In this library, one of the ten randomly sequenced variants had been wild-type, indicat-
ing an approximate 3 fold enrichment after droplet sorting. Again, an insertion into the C-
terminal region was found (Ins305L, 103%), but more strikingly Ins61F (27%), Ins67L (18%)
and Ins68G (60%) were identified, indicating that the region 61-68 is tolerant towards both
insertions and deletions. Another region of interest emerged at positions 229-233: Ins230G,
A230S (13%) and S229I (38%). Ins106Q (13%) was identified along with 2x Ins106R, L106V
(1%) and another substitution A181V (109%) was found once more.
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Fig. 4.36One 96-well plate of the deletion library post-sortingwas sent for sequencing. Wild-
type HG3.17 (WT) was the most commonly found sequence (54%). Black squares indicate
no growth or a contamination. Normalised activities (relative to HG3.17 and N20 controls)
in cell lysate are shown in the bottom panel.
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Fig. 4.37 One 96-well plate of the insertion library post-sorting was sent for sequencing.
Wild-type HG3.17 (WT) was the most commonly found sequence (30%). Black squares
indicate no growth or a contamination. Normalised activities (relative to HG3.17 and N20
controls) in cell lysate are shown in the bottom panel.
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Fig. 4.38Relative cell lysate activity of InDels versus amino acid position and secondary struc-
ture elements in HG3.17. As can be seen, all InDels that have near neutral to small effect on
activity are located at the start or end of secondary structure elements. Some InDels are tol-
erated in the α-helices but reduce activity 100 fold.
Table 4.11 summarises the variants with mutations in nearby locations which were found
multiple times or in more than one library. The libraries were all constructed independently
and based on different cloning strategies, thus finding mutations in similar locations is a
strong indication that these variants were selected for during the droplet sorting campaigns.
The location of themutations in the secondary and tertiary structure of HG3.17 are indicated
in Figures 4.38 and 4.39, respectively.
Enrichment of the C-terminal mutations was also an indication of positive selection.
Q305 is the first C-terminal residue that does not appear in the crystal structure (no elec-
tron density recorded) and S307 is the last residue at which deletion or insertion can occur
without affecting the restriction site used to clone the gene into the vector used for screen-
ing. Thus, it is unlikely that changes in these three residues affect the proteins structure as is
shown by the near-wild-type activity levels in lysate.
The overall structure of HG3.17 is a TIM-barrel, i.e. there is a core of eight parallel β-
sheets connected by intervening α-helices (Figures 4.38). Regions 61-68, 181-182, 196-199
are located at the beginning or end of an α-helix whereas residues 229-233 comprise the
loop connecting α-helix 6 to β-sheet 7. No InDels with residual activity were identified in
the β-sheet core. This is consistent with other studies of InDels. Kim and Guo found in a
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systematic analysis of 200 protein structures that themajority of InDel residues were exposed
to solvent, i.e. near the protein surface and that a third of InDels were located in disordered
regions [223]. Gonzalez et al. studied single amino acid insertions and deletions in TEM-1
β-lactamase [224]. They found that insertions and deletions were tolerated in loops and at
the ends of α-helices and β-sheets (10 to 100 fold drop in fitness) but not within them (>
100 fold drop in fitness). Similar locations and changes in fitness expressed as activity in cell
lysate were observed for HG3.17. The locations of the mutations can be further rationalised
by looking at the B-factors, which are an indicator of flexibility 6. These indicate that the
surrounding α-helices aremore flexible than the β-sheet core, which is wheremostmutations
were found. The exception is α-helix 2, which appears to be more rigid.
In light of these considerations, regions 61-68 and 106-109 seem of particular interest.
As can be seen in Figure 4.40A, L106 and V109 both mediate interactions with the loop con-
necting α-helix and β-sheet 3 (dark blue) and a short α-helix in the loop connecting α-helix
and β-sheet 2 (purple). At the N-terminus of this short helix, residue Q52 protrudes into the
active site forming a hydrogen bondwith transition state analogue 6-nitrobenzotriazole. This
interaction was suggested to facilitate catalysis by stabilising the negative charge developing
on the oxygen ([16]). In the original computational design of this enzyme (HG2), lysine was
placed at this position intended to bind the nitro-group of the substrate [15]. However, the
crystal structure of HG2 revealed that the transition state analogue was flipped with respect
to the design. During the directed evolution towards HG3.17, the lysine the first mutated to
histidine (K52H) and further to glutamine (H52Q). A Q52A mutant of HG3.17 was 50 fold
less active compared to wild-type HG3.17, establishing the importance of the observed in-
teraction. Deletions and insertions at positions G61, A66, G67, and A68 would also affect
interactions with the Q52 α-helix as well as the loop connecting to β-sheet 2 (cornflower
blue). Together both loops adjacent to the Q52 α-helix also mediate access to the active site
as they partially cover it (4.40B). Changes in the dynamics of these loops will thus affect
substrate entry and product release.
Therefore, a region of interest capable of accepting insertions and deletions has been
identified. One beneficial mutation, T107I was oberved in the 106-109 region previously
by Blomberg et al., but none in the region 61-68. While the introduction of InDels reduced
the activity in cell lysate, they may open up new evolutionary trajectories. A study of InDels
in evolving proteins of Drosophila showed that incorporation of InDels triggers new sub-
stitutions with a high fraction of them occurring in previously conserved positions [227].
It may be interesting to construct combinatorial libraries of the mutations in regions 61-68
and 106-109 and variant 4A09 (Del181A, S182G), which was found to have improved soluble
6The B-factor measures the attenuation of x-ray scattering due to thermal motion of the atoms [225, 226].
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expression. A better expressing InDel variant could then be subjected epPCR to introduce
substitutions and explore if new sequence space has become accessible to improve the cat-
alytic efficiency beyond the levels of HG3.17.
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Fig. 4.39 Topology of HG3.17 (top panel) and location of regions identified to accept InDels
(orange, middle panel). The thickness of the backbone in the middle and bottom panel is
indicative of the average B-factor of the residue at the given position. The bottom panel is
additionally coloured according to the B-factor at the respective position. PDB: 4BS0 ([16]).
146 An absorbance-activated droplet sorting assay for the Kemp elimination
Fig. 4.40 A:The mutations found during the InDel screening campaign (orange residues) are
likely to affect interactions with two loops (dark blue, cornflower blue) which mediate access
to the active site and, crucially, a short α-helix (purple) from which residue Q52 protrudes.
This residue forms a hydrogen bond with the transition state analogue 6-nitrobenzotriazole.
B: Top view of HG3.17 showing how the indicated loops and α-helix restrict access to the
active site. PDB: 4BS0 ([16])
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4.6 Conclusions
In order to screen for Kemp eliminase activity, a droplet-based microfluidic assay was de-
veloped. The assay was based on the substrate 5-nitro-1,2-benzisoxazole (2a). The relative
ease of the detection of its reaction product has made 2a the choice substrate amongst 1,2-
benzisoxazoles. In contrast to other 2-hydroxybenzonitriles, 2-hydroxy-5-nitrobenzonitrile
has a strong absorption band in the near UV range at 380 nm [94]. For this reason, 2a was
chosen as the substrate to test in droplets. The droplets used were 70 µm in diameter (180 pL
in volume). It was found that the reaction product exchanged between droplets on a timescale
of several hours, which limited the ability to distinguish droplets containing active or no en-
zyme after long incubation times.
In spite of this limitation, enzymatic activity of the Kemp eliminaseHG3.17was observed
from single-cell lysates in droplets. Two enrichment experiments of HG3.17 over a negative
control, the esterase N20, were successful with efficiencies of 97% and 99% compared to the
maximal possible enrichment. This is the first report on detecting Kemp eliminase activity
in microfluidic droplets. Screening of the metagenomic library SCV did not yield any events
with absorbance above background. Therefore, given the product leakage, the assay was not
sensitive enough for functional metagenomic screening.
Since HG3.17 was shown to enrich over a negative control, it presented itself as an in-
teresting case to screen mutant libraries using this assay. Blomberg et al. evolved HG3.17
from HG3 over 17 rounds and it remains the best Kemp eliminase reported to date [15, 16].
The 96-well plate assay used to perform this evolution had a throughput of only 103 mutants
per round. The droplet assay established outstrips this by two orders of magnitudes (based
on sorting for 60min at 100Hz). A higher-throughput was previously shown to overcome
limitations in directed evolution as in the case for another de novo enzyme by Obexer et al.
[47, 79]. Therefore, three libraries of HG3.17 were prepared. One using epPCR to obtain
point mutations resulting in amino-acid substitutions and two libraries deleting or inserting
3 base-pairs, respectively. These libraries contained all possible single amino acid insertions
and deletions, as well as all possible substitutions of either the N-terminal or C-terminal
neighbouring amino acid.
The epPCR library (~1.5 × 105) was screened twice using different strategies to fine-tune
the stringency of droplet collection. The fraction of low-activity variants was consistently
reduced post-sorting, indicating positive selection. It is interesting to note that the low ac-
tivity fraction (>10% or no activity) was reduced from about 60% to 17-20% and remained at
about this level even after two rounds of sorting. There are different sources of bias and error
in droplet sorting, which can explain why low-activity variants are carried over. Here, the
carry-over can be fully explained by co-encapsulation of more than one cell in droplets due
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to the Poisson distribution (detailed explanation in Section 6). For example, when collecting
400 droplets from a droplet population with λ = 0.35 one can predict that close to 300 of
these would contain only one (positive) cell, while the remainder would contain additional
“passenger” cells corresponding to about 20% of all cells collected. Therefore, these sorting
outcomes could be improved in future experiments by reducing λ – with the limitation that
a low λ would require longer sorting times, which are limited for this assay. A promising
strategy could be to perform a first round of sorting using λ = 0.35 and reduce it to e.g. 0.1 in
a second round (8% carry-over predicted). Changing λ does not affect the stringency of the
sort. This could be independently changed by an increased collection threshold or reduced
substrate concentration as explored for these epPCR library sorts.
The epPCR sorting campaigns did not yielded variants of HG3.17 which were likely to
have improved soluble expression, but none with improved catalytic parameters were found.
An often invoked metaphor for the directed evolution of an enzyme is an up-hill walk in a
fitness landscape [228]. Using this metaphor, it may be that HG3.17 was atop a local fitness
peak, which could not easily be overcome at the mutational load (2.7 mutations/gene) used.
In a future study, a highermutational load combined with the high throughputmay allow the
“jumping” to a different fitness peak due to e.g. epistatic effects between several mutations.
Here, I chose to follow an alternate route and screen the much less studied insertion and
deletion libraries. The insertion or deletion of an amino acid can be thought of as a leap in
sequence space. In general this may be detrimental initially, but starting from a new point
in sequence space, an adaptive up-hill walk may be able to follow a previously inaccessible
trajectory. The InDel screening campaign yielded one variant with improved soluble expres-
sion and revealed five locations in HG3.17 which were able to accept InDels with a retention
of at least ≥10% activity in cell lysate. Two of these are particularly interesting, 61-68 and
106-109. They are in α-helices that mediate interactions with a short α-helix wedged be-
tween them that positions a glutamine residue in the active site of the enzyme, which forms a
hydrogen-bondwith the substrate. Ins68G in particular also displaces a second-shell alanine,
which is in contact with a first-shell proline.
In future experiments one of the highlighted InDel variants combined with mutations
that improved soluble expression could serve as a starting point for a point-substitution li-
brary. A general strategy emerging from this could be to alternate a few rounds of directed
evolution with substitutions, which may better mimic natural evolution. As mentioned pre-
viously, InDels to substitutions occur at a ratio of 1:5 in the non-coding regions of bacterial
genomes ([210]), which could be used as a guide on how often to alternate between the two
types of mutations in an extended directed evolution campaign.
Chapter 5
A novel fluorogenic Kemp substrate to
screen for Kemp eliminases in the
metagenome using FADS
5.1 Abstract
Thework presented here builds on the search for Kemp elimination substrates that do not ex-
change between droplets in droplet-microfluidic assays. I found that one substrate, 5-azido-
1,2-benzisoxazole (6a), yields a fluorescent reaction product after conversion by Kemp elim-
inase HG3.17 and subsequent exposure to UV-light. The evidence presented here supports
that the first reaction step yields the expected Kemp elimination product. While the origin
of fluorescence requires further clarification, it was possible to enrich the Kemp eliminase
HG3.17 over a negative control from single-cell lysates in 1.8 pL droplets using substrate 6a
and the FADS instrument developed in Chapter 2. As opposed to the absorbance-based as-
say discussed in Chapter 4, the fluorescence-based assay detected substrate turnover in func-
tionalmetagenomic screening and the apparent hit-rate indicated that Kemp eliminase activ-
ity was common in the metagenome. After DNA recovery, a much larger number of colonies
than expected was obtained and re-screening in well-plate format revealed that these were
library variants containing deletions in the vector of up to 1 kbp. These are likely to have been
enriched due to biological biases favouring the amplification of small vectors. Droplet screen-
ing using a subset of the SCV metagenomic library containing fewer vectors with deletions
reduced the number of false positives and re-screening combined with sequencing yielded a
potential hit, an ORF predicted to encode for a class IV adenylyl cyclase. This is promising
and, considering the high apparent hit-rates observed, indicates that future screenings using
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high-quality metagenomic libraries could yield many promiscuous enzymes catalysing the
Kemp elimination.
Contributions: I discovered the red fluorescence of the reaction product of compound 6a, inves-
tigated and characterised the reaction in both droplets andwell-plates under different conditions
using UV-VIS spectroscopy. Compound 6a and its precursors 5a and 6awere synthesised by Dr
Josephin Holstein based on our discussions. She provided support by lyophilising the reaction
products for submission to the analytical services at the Department of Chemistry (described
in Section 7.3.5). The analysis and interpretation of the obtained data is my own. I optimised
the droplet screening conditions, performed the enrichment and metagenomic screening experi-
ments, recovered the DNA, re-screened the recovered variants in plates, analysed the sequencing
data, modelled the structure of variant G06, as well as performed all of the analysis and inter-
pretation of the data.
5.2 Amoment of serendipity: a fluorogenic Kemp substrate
The idea of azide 6a (Figure 5.1) was to have the flexibility to add different functional groups
via strain-promoted azide–alkyne cycloaddition (copper-free “click” chemistry) in dilute
aqueous solution at room temperature, such as in compound 7a. Both 6a and 7a were con-
verted using purified HG3.17 and the resulting solutions used for a leakage test. However,
due to small absorption coefficients the initial signal difference was too small to quantify
leakage (data not shown). Surprisingly, the top layer of the droplets acquired a red colour
two days from their generation (Figure 5.2A). The droplets were investigated by fluorescence
microscopy and it was revealed that a red-emitting fluorophore had formed in both samples.
In particular for substrate 6a, it appeared to the eye that there were two equally sized pop-
ulations of differing brightness, as would have been expected. Manual analysis of each 16
droplets from the brighter and darker population showed an unadjusted average brightness
of 45 ± 5 and 35 ± 5 (of 255), respectively. Within the layer which was colourless to the eye
only some of the droplets were fluorescent at all. Why there were two layers was not clear.
Taken together, these initial serendipitous observations merited further investigation of the
two substrates.
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Fig. 5.1 Synthesis of 6a and 7a. Conditions: a) H2SO4/HNO3 b) SnCl4/SnCl2
c)NaNO3/NaN3 d) 20mM TrisHCl pH 7 and 50mM NaCl. These reactions were performed
by Dr Josephin Holstein.
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Fig. 5.2 Substrates 6a and 7a were converted under basic conditions and tested for leakage.
A:The droplets generated for the leakage test turned red after two days at room temperature.
In each sample two layers, one red and one colourless, were observed. B: Fluorescence mi-
croscopy revealed red fluorescence of the droplets in the red layer. In the colourless layer,
droplets were not fluorescent at all or brightly fluorescent (rather than being of e.g. interme-
diate fluorescence). Excitation: 531/40 nm, emission: 593/40 nm.
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5.2.1 Reproducing the initial observations
The first step in investigating the new fluorophore was to reproduce the initial observation.
Two parallel experiments were set up: one in 384-well plate format and one in droplet format.
In the 384-well plate, substrates 6a and 7awere each incubated with the purified enzymes
HG3.17, N20, and in buffer only. The reactions were monitored using fluorescence excita-
tion and emission scans. A fluorescent signal emerged over the course of several days in
all samples, but most strongly for HG3.17. The fluorophore had an excitation maximum at
500 nm and an emission maximum at 600 nm for both substrates. After 5 days of incubation,
the emission at 600 nm was 100× higher in the HG3.17 sample compared to both N20 and
buffer for substrate 6a. For substrate 7a the ratio was 50×.
Droplets of 70 µm diameter were generated for each substrate with and without HG3.17
using the same conditions as in the plate. The samples were stored separately in the dark to
protect the fluorophore from potential bleaching. Surprisingly, after four days of incubation,
none of the samples had developed red fluorescence. A possible explanation came from the
well plate assay: when three measurements were performed consecutively to check if the re-
action product was prone to photo-bleaching, the fluorescence unexpectedly increased after
each measurement. This suggested that the UV light used in the excitation scan promoted
a photochemical step, which was required or beneficial for the final fluorophore. Therefore,
the droplets were exposed to light of 365 nm for 10min using a hand-held UV-lamp (ca.
100 µWcm−2). Indeed, the droplets containing HG3.17 were now red fluorescent, whereas
those without enzyme were not (Figure 5.4A). This was the first indication, that there may be
a two-step mechanism involved. Presumably, the enzyme first converted the substrate to the
Kemp product, which then reacted further upon irradiation with UV light. A 1:1 mixture of
the droplets after exposure to UV light did not show exchange of the red fluorophore after
overnight incubation (Figure 5.4B).
In summary, the emergence of red fluorescence was observed both in droplets and well
plates. Its appearance was accelerated by HG3.17 and was dependent on exposure to UV-
light. The resulting fluorophore did not exchange between droplets. These observations are
remarkable for four reasons:
• Only one fluorogenic substrate for the Kemp elimination was reported to date [229].
This substrate is based on the fluorophore coumarin, which is a bicyclic aromatic com-
pound, is known to leak from droplets, and has excitation and emission bands in the
UV range (300 to 450 nm) [230, 231].
• Assuming the structures of the respective products of 6a and 7a are the expected
cyanophenols, the fluorescence would be far red-shifted for a small conjugated sys-
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tem. Usually, larger π-systems are needed for excitation and emission bands in the
visible light range [230].
• Another remarkable property is the large Stokes-shift. The Stokes-shift is the difference
in the wavelengths of the excitation and emission maxima. In this case it is 100 nm.
Usually, it is much smaller at about 20 nm [230], such as in the case of fluorescein with
maximum absorption at 492 nm and maximum emission at 512 nm [109].
• Finally, the very low background activity in the absence of catalyst and the high sen-
sitivity offered by a fluorescence readout compared to absorbance render these sub-
strates attractive for studies of the Kemp elimination in general. In particular the
smaller substrate 6a is very similar to 2a and the series of other 5-substituted Kemp
substrates used to study linear free energy relationships.
Taking together these considerations, it was clear that these substrates were promising
candidates to screen for Kemp eliminases. However, the observed fluorescence properties
indicated that it was not the simple Kemp reaction product causing the fluorescence. The
working hypothesis emerged, that there were two reactions involved. First, a dark reaction
product, presumably the Kemp product, was generated. Second, a fluorescent reaction prod-
uct or complex was obtained by exposure to UV light. Proving that the existence of these two
reaction steps was the goal of the next section.
5.2 A moment of serendipity: a fluorogenic Kemp substrate 155
Fig. 5.3 Excitation and emission spectra for the reactions of substrate 6a (top) and 7a) (bot-
tom) with purified enzymes HG3.17, N20, and just buffer (20mM Tris pH 7 and 50mM
NaCl), post UV-illumination. The red fluorescent product appeared spontaneously in buffer
and in presence of N20, but its emergence was clearly promoted by Kemp eliminase HG3.17.
There was an excitation maximum at 500 nm and an emission maximum at 600 nm. Excita-
tion scan: emission measured at 620/20 nm; emission scan: excitation at 505/20 nm.
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Fig. 5.4 A: After four days of incubation in darkness, red fluorescence did not appear for
either substrate with or without enzyme. Exposure to 365 nmUV light for 10min generated
the red fluorophore in droplets that contained the enzyme HG3.17, but not in droplets with
buffer only. Shown are the overlays of the transmission and red fluorescence images. B: A
1:1 mixture of the droplets with and without enzyme after exposure to UV light showed no
exchange of the red fluorophore after overnight incubation.
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5.2.2 Two reaction steps lead to fluorescence
By using absorbance instead of fluorescence scans, the two reaction steps could be distin-
guished. The reaction was performed in triplicate in a quartz plate for transparency in the
UV range. Due to a simpler absorbance spectrum, only substrate 6a was used for this char-
acterisation.
The reaction was incubated for 24 h in the dark and monitored using absorbance scans
from 280 to 600 nm. The absorbance increased at 350 nm while it decreased at 310 nm. Isos-
bestic points were observed at 290 and 330 nm (see Figure 5.6). The presence of isosbestic
points indicates the conversion of one substrate to one product. Furthermore, the reaction
followed pseudo first order kinetics as shown by plotting the change of absorbance against
time at a single wavelength. The half life of the reaction was (4.3 ± 0.1) h as estimated by
single-exponential fits at 310 and 350 nm, i.e. after 24 h of incubation the reaction was 98%
complete.
After 24 h, the reaction was exposed to UV light of 365 nm for intervals of 5 s. There was
an increase in absorbance at 300 and 500 nm. The appearance of the 500 nm absorbance band
explains why fluorescence excitation at this wavelength is only possible after exposure to UV
light. The absorbance at the other wavelengths did not change, appart from a decrease at
365 nm possibly due to photo-bleaching. Above a total exposure time of 30 s, the absorbance
started decreasing at all wavelengths, indicating light-induced degradation of the compound.
No isosbestic points were observed, but the absorbance spectra did not cross each other.
Therefore it is not evident whether the intermediate is fully or only partially converted by the
process.
The absorbance and fluorescence emission of product 6c was dependent on pH. This
could be due to protonation and deprotonation of the phenolic oxygen, which is expected in
the Kemp reaction product. Upon addition of HCl the absorbance bands at 300, 350, and
500 nm diminished (Figure 5.7). A separately-prepared sample was diluted 1:9 with buffers
Fig. 5.5 Substrate 6a was converted using enzyme or base to a non-fluorescent intermediate
6b, which was further converted to fluorescent product 6c.
158 A novel fluorogenic Kemp Substrate
Fig. 5.6 The reaction of 1mM 6a with 1 µM HG3.17 was followed by measuring absorbance
spectra over time. The enzymatic reaction (Step 1) was performed in the dark and reached
completion after 24 h. No increase of absorbance was observed at 500 nm during the enzy-
matic reaction. Only during exposure to light of 365 nm (Step 2), did an absorbance band
at 500 nm appear, which can explain the gain of fluorescence upon excitation at this wave-
length. The sample was irradiated with approximately 100 µWcm−2; buffer: 20mM Tris pH
7, 50mM NaCl.
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of varying pH. Fluorescence excitation spectra showed excitation bands at 300, 350, and
500 nm. The emission of fluorescence decreased below a pH of 6.5. The intensity was about
half at pH 5, indicating the group which was protonated had a pKa in this range. The effect
was visible by eye under 365 nm UV-light (Figure 5.7D). Next, it was tested if the conver-
sion of the intermediate to the fluorophore benefited from alkaline pH. The intermediate
was added to either water or 1mM NaOH and exposed to UV light. Interestingly, no fluo-
rescence developed in the basic solution. When base was added to the neutral sample after
UV exposure, the fluorescence increased. This indicated, that a proton was required for the
conversion of the intermediate, but not for fluorescence in the final product.
Furthermore, the bands observed in the fluorescence excitation spectra matched the
bands observed in the absorbance spectrum, indicating that they are part of the same com-
pound, i.e. that exposure to UV light converts the majority of intermediate to final product.
Taken together these results established that a non-fluorescent intermediate was pro-
duced by the enzymatic reaction, followed by a non-enzymatic, UV-induced, and pH de-
pendent conversion to the fluorophore. Next, the intermediate (6b) and the final product
(6c) were separately prepared and purified for structural investigation.
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Fig. 5.7 The emission of red fluorescence by product 6c was dependent on pH indicating the
presence of at least one protonable group. A&B: Addition of HCl to the final reaction mix-
ture quenched the absorbance bands gained in the previous experiment by exposure to UV
light. C&D: 6c was diluted into buffers of different pH. The fluorescence excitation spec-
tra showed that below a pH of 6.5 emission was reduced. E: Basic conditions (1mM NaOH
in water) prior to illumination prevented the formation of the fluorophore, indicating that
a proton is involved in its formation. F: Addition of base after conversion in unbuffered
solution increased fluorescence emission. Buffers all at 20mM with 50mM NaCl; pH 4-5
sodium-acetate; pH 6.5-8.0 sodium-phosphate; pH 9-10 sodium-carbonate.
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Fig. 5.8 Shown are possible reaction pathways for 6a. 1H-NMR indicated that the product of
the first step is the expected Kemp reaction product 6b. There are several possible reactions
that could lead to the fluorophore (explained and in the main text), but the evidence pointed
towards a small structural change (red box).
5.2.3 NMR andMass spectroscopy of the reaction products
The NMR and mass spectrometric analysis confirmed the conversion of the substrate 6a to
the Kemp product 6b in the first reaction step. The spectra of the main product in the second
step, 6c, were similar to those of 6b as will be outlined.
First, the substrate was converted using enzyme HG3.17 and either kept in the dark or
exposed to UV light. The enzyme was then precipitated using formic acid, the solutions
lyophilised and the powders re-dissolved in dimethylsulfoxide (DMSO) or acetonitrile/water
(1:1) for NMR and mass spectrometric analysis, respectively. The purification procedure did
not degrade the red-fluorescent product, as dilution into aqueous solution and measurement
showed the same fluorescence behaviour as before treatment. The reaction product of step 1
was not stable, i.e. developed fluorescence over time, even when kept in the dark. Thus, the
analyses were performed directly after overnight incubation with the enzyme, which meant
that the reaction had not always come to completion.
If 6b was indeed the Kemp reaction product, the expected difference between the 1H-
NMR spectra was the loss of one of the four protons and an upfield shift (towards lower
ppm) of the remaining three protons due to increased electron density at the oxygen. This
was observed. The 1H-NMR spectrum of the substrate 6a showed the four expected protons
and it was possible to unambiguously assign them using the coupling pattern and constants.
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Referring to Figure 5.9, the proton furthest downfield at 9.20 ppm is the proton at position
3. The protons at positions 4, 6 and 7 are at 7.67, 7.41, and 7.83 ppm, respectively. The spec-
trum of 6b showed that the reaction had been stopped at about 80% conversion of substrate
to product. The intensities of the substrate peaks were reduced concomitantly and three new
product peaks appeared. These were shifted upfield as expected. The proton at position 7
showed the strongest shift with -0.74 ppm consistent with the presence of the phenolic oxy-
gen. The peak at 8.16 ppm is likely to stem from formate, which was used in the preparation
of the sample. These observations are consistent with the expected Kemp reaction product.
With the 1H-NMR spectrum of 6b matching the expectations for the Kemp reaction
product, it is of interest to consider what kind of reactions it could undergo. Four major
possibilities emerged after a review of the literature shown in Figure 5.8.
First, azides undergo cycloaddition with cyanides, i.e. the reaction product could react
with itself (or remaining startingmaterial) [232–234], whichwould create a larger conjugated
system. However, this type of reaction requires elevated temperature and is not known to
be promoted by light. In the 1H-NMR spectrum, the proton shifts between the two benzene
moieties would be expected to differ, whichwas not observed. For these reasons, this reaction
pathway was ruled out.
Second, 1,2-benzisoxazole photochemically rearrange to 2-hydroxynitrile [235, 236]. This
can further rearrange, albeit at long illumination times, to benzoxazole [235]. The azide sub-
stituent may allow this process to proceed faster. However, this product would lack a pro-
tonable functional group and thus be inconsistent with the observed pH dependent emission
of the fluorophore.
Third, aryl-azides are known to be photo-sensitive and are prominently used for biocon-
jugation [237]. Upon irradiation, N2 is eliminated creating a singlet nitrene which rapidly
converts to a triplet nitrene [238, 239]. The singlet nitrene can react to form amines, but
typically self-inserts into the ring and reacts with a nucleophile to form azepines [237, 239].
The triplet nitrene can dimerise to form azo- or azoxy compounds, oxidise to nitroso or nitro
compounds, or polymerise to form insoluble tars [238, 239]. Which reaction path is favoured
depends highly on the ring substituents. Using this chemistry, Lord et al. synthesised a series
of azide-based, photo-activatable fluorophores. The non-fluorescent azide was illuminated at
407 nm, which caused conversion to the amine. The amine exhibited red fluorescence, which
was explained with an electron push-pull mechanism [240]. While this constitutes an inter-
esting precedent, the cleavage of the azido group required 10× stronger irradiation for 10×
as long in the cited example. Cleavage of the azido group would also be inconsistent with
the fluorescence of the products of substrate 7a. In this substrate, the azide was converted
to a tetrazole before irradiation. In addition, none of the predicted masses or NMR shifts of
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Fig. 5.9 1H-NMR spectra for 6a (substrate,grey), the dark reaction product (6b, blue), and the
product after UV exposure (6c, red). Formate (green) was a contaminant peak introduced
during the purification procedure. As expected, one proton is lost during the dark reaction
and the remaining three shift upfield. Interestingly, the 1H-NMR of 6c revealed only tighter
grouping of the three proton peaks compared to 6b, indicating no major structural change
of the majority component.
164 A novel fluorogenic Kemp Substrate
the possible reaction products (e.g. the diazo-compound) were observed1. Therefore, this
pathway was excluded as well.
Finally, a subtler change in molecular structure may occur, e.g. due to phototautmeri-
sation, irreversible excited state H or H+ transfer [241], or the rotation of the azide group
from trans to cis with respect to the cyano group, or vice versa, or out of plane as shown in
Figure 5.8. This could enable a previously inaccesible electron transition and explain the ob-
served disappearance of fluorescence by thermal relaxation. The rotation could also enable
the formation of excimers or exciplexes. These are excited state complexes of a molecule with
itself or another compound, which show red-shifted fluorescence emission compared to the
monomer and therefore a large Stokes-shift [230]. This and a reversible excited state H or H+
could explain fluorescence emission at high wavelengths by a small conjugated system [242].
The 1H-NMR spectrum of 6c did not show any new peaks. The three proton peaks ob-
served for 6b shifted closer together, the distance between proton 4 and 7 diminishing from
0.33 to 0.17 ppm. This small shift hinted at only a subtle change of the structure. Several
samples were prepared and combined to obtain a higher concentration of product to ob-
serve possible side products, which could be responsible for the fluorescence. The integral
of the peak which was previously assigned to formate now matched the integral of the three
protons. This could be consistent with a benzoxazole reaction product (Figure 5.8, product
of rearrangement). However, the 13C, DEPT, HSQC, and HSQC NMR spectra showed that
the proton at 8.22 was indeed part of formate and confirmed that the principal compound
in the sample remained consistent with the Kemp reaction product (Appendix Figure D.1 to
D.4). The carbon atoms adjacent to the hydroxy, cyano and azido substituents had typical
chemical shifts of 158, 100, and 131 ppm, respectively. Three minor peaks in the 1H-NMR
between 6.6 and 6.9 ppm showed the coupling pattern expected for a 1,2,4-trisubstituted
benzene derivative. The integrals suggested that this product could constitute 8% of the final
mixture. The chemical shifts could be consistent with the amine product, whose mass was
however not found in the mass spectrum. If any self-complexation processes played a role in
the gain of fluorescence in the final step, e.g. by π-π stacking, it was possible that this process
would not occur in DMSO. Therefore, it would have been desirable to perform 1H-NMR
using a dilution series of the compound in D2O. However, this was not possible due to the
limited solubility of the final compound in water.
To investigate the presence of any other reaction products not detectable by NMR, ana-
lytical reversed-phase high-performance liquid chromatography (RP-HPLC) of the samples
was performed, see Figure 5.10. Importantly, only one major peak was observed for 6c and
1The molecular mass and 1H-NMR spectrum for all the products of the above pathways were predicted
using the program ChemDraw and compared to the experimental data.
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Fig. 5.10 RP-HPLC analysis of 6a (substrate, black) and the dark (6b, blue) and UV reaction
products (6c). 6b eluted almost 2min earlier than the substrate as expected for a decrease
in hydrophobicity. As in the NMR experiment, only one major product is observed and
there is only a small difference between 6b and 2. The main peak was associated with red
fluorescence, ruling out that any of the minor peaks could be responsible for it.
it was associated with red fluorescence after fraction collection of this peak. A small shift to
earlier elution time was observed for 6c compared to 6b, suggesting a small increase in hy-
drophilicity. This shift is 10× smaller compared to the shift observed between the substrate
and 6b.
Liquid chromatography-mass spectrometry (LC-MS) of 6c provides further evidence
that the final product is similar to the Kemp reaction product. The main peak was consistent
with the [M-H]- ion (m/z for C7H3N4O– : 159.03 [M-H]-; found: 159.2), see Figure 5.11.
All ions detected in this peak were consistent with fragments of the Kemp reaction prod-
uct. A smaller peak eluted earlier and showed an m/z of 163.2 which is consistent with the
[M-H]- ion of 5-nitro-2-hydroxy-benzonitrile (m/z for C7H3N2O3 – : 163.01 [M-H]-; found:
163.2). The minor peaks observed in the 1H-NMR spectrum of 6c were not consistent with
5-nitro-2-hydroxy-benzonitrile, as these were previously determined to be at 8.57, 8.33, and
7.13 ppm respectively. This suggests that 5-nitro-2-hydroxy-benzonitrile is a minor reaction
product. However, it does show that elimination of N2 from the azide and oxidation to the
nitro group was a possible reaction path. The nitro-compound by itself is not known to be
fluorescent and mixtures with either the substrate or 6b did not yield the fluorescence before
or after illumination.
Given the detection of at least one product which lost the azido functionality, its integrity
in the bulk component of the final reaction mixture was tested by reacting it with the same
DBCO-derivative used to synthesise substrate 7a. Indeed, after the reaction only the expected
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mass was found and the compound atm/z of 159.2 was not observed (m/z for C36H39N6O7 – :
667.29 [M-H]-; found: 667.7).
Summarising all of the above, the observations usingNMRandmass spectroscopy showed
that the structure andmass of themain reaction product both pre- and post-illuminationwas
consistent with the Kemp elimination product 6b. The difference pre- and post-illumination
of themain component in themixture is small. Yet, RP-HPLCanalysis of the post-illumination
sample linked the observed fluorescence with the main component in the mixture. Together
these data suggest, that gain in fluorescence is achieved not by amajor structural change such
as a dimerisation, but by a more subtle process such as the rotation around the nitrogen-
carbon bond of the azido compound as suggested in Figure 5.8. This rotation could have
an energy barrier due to partial double-bond character of the nitrogen-carbon bond and be
overcome by the absorption of a photon. Further investigation is required to determine if
this is a likely origin of fluorescence. For example, ab initio calculation of the energies of the
highest occupied and the lowest unoccupied molecular orbital for different geometric orien-
tations of the azido groupwould indicate if there is a decrease in the energy gap, which would
explain the observed fluorescence. The main reaction product after both reaction steps was
consistent with the elimination of a proton from the 3 position in 6a, i.e. the Kemp elimina-
tion. Therefore, this substrate was further investigated for use in droplet screening.
5.2.4 The single-cell lysate assay yields green fluorescence
The reaction in droplets was shown above using purified enzyme. Next, it was tested if the
same results could be obtained using single-cell lysates in droplets. Also, since the readout
was now fluorescence, smaller droplets of 15 µm diameter were used. These droplets have the
advantage that the cell lysate is diluted 100× less compared to 70 µm droplets. Combinedwith
the higher sensitivity of fluorescence measurements compared to absorbance, this should
offer a vastly more sensitive assay than used in the previous section.
Fluorescence was not observed in droplets containing single-cells expressing HG3.17 us-
ing the original buffer conditions and UV exposure after overnight incubation. Bulk mea-
surements showed that the reaction stalled after 30min in Tris buffer, whereas fluorescence
kept increasing in NaPi buffer over the duration of the experiment (12 h). Changing the
buffer in the droplet experiment still did not yield fluorescence after overnight incubation
followed by UV exposure. Taking into account that no leakage was observed for 6c, it was
speculated that 6b leaked out of droplets (this could for example be explained by a reduction
of the pKa).
Therefore, an experiment was performed in which the droplets were generated and im-
mediately exposed to 365 nm light for 30 s every 15min. Droplets were mixed before every
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Fig. 5.11 A: The mass of 6c was confirmed by LC-MS (m/z for C7H3N4O– : 159.03 [M-H]-;
found: 159.2). The other observed ions can be explained by fragmentation: 159.1 [M-H]-,
145.2 [M-H-N]-, 131.2 [M-H-N2]-, 103.2 [M-H-N2-CO]-, and 172.3 as an adduct of [M-H-
N2]- and acetontrile (the solvent). B: The integrity of the azide group in 6c was shown via
a click reaction to yield 7b. The compound was reacted with a DBCO derivative to yield
the indicated structure and its generation was confirmed (m/z for C36H39N6O7 – : 667.29
[M-H]-; found: 667.7).
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exposure by slowly rotating the droplet container using a servo motor. The set-up was run
using an Arduino micro-controller. This procedure finally yielded fluorescent droplets after
overnight incubation. Interestingly, under these conditions fluorescence was only observed
in the green channel, but not in the red channel of the fluorescence microscope (excitation:
470/22 nm and 531/40 nm, emission: 525/50 nm. and 593/40 nm). The experiment was re-
peated three times, with the same result. The intensity and wavelength at which fluorophores
emit light is dependent on many factors such as solvent, temperature, viscosity, or specific
interactions with othermolecules [243]. Therefore, the influence of the reaction components
and different solvents was investigated.
Fig. 5.12 When single cells expressing HG3.17 were encapsulated (λ=0.2) with 6a and lysis
agent in droplets, the reaction yielded green fluorescence after overnight incubation with pe-
riodic UV illumination. Conditions at reaction start: 1mM 6a, 20mM NaPi pH 7.0, 50mM
NaCl, 0.1x BugBuster (lysis agent), 54 to 66U/µL rLysozyme. Excitation 470/22 nm, emis-
sion: 525/50 nm.
5.2.5 The fluorophore emits at 335, 544, and 600 nm
The influence of the reaction components in the single-cell lysate assay and different solvents
was investigated revealed that there are three possible fluorescence emission bands at 335,
544, and 595 to 605 nm respectively.
First, the effect of the lysis agent and the cell lysate was tested. A dilution series of lysis
agent showed there was no change in the maximum emission wavelength, see Figure 5.13.
However, an old sample of 6c was used (about 1 week old, stored at room temperature in
DMSO), which appeared to have lost its fluorescence (from 104 down to 103 fluorescence
units using the same instrument settings). After exposing the dilution series to 365 nm light,
the fluorescence was recovered. This indicated that the formation of the fluorophore was re-
versible andhadpossibly undergone thermal relaxationduring storage. Furthermore, this ex-
periment showed that the lysis agent did not interfere with the formation of the fluorophore.
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In contrast to the lysis agent alone, the cell lysate of E. coli cells altered the emission of the
fluorophore. At 100% cell lysate, which corresponds to a 50 to 100 fold dilution of the cy-
tosol, the emission at 600 nm was 12 fold reduced. At the same time, a new peak at 335 nm
appeared. In the absence of cell lysate, there was a minor peak at 310 nm, which was most
likely the Raman peak due to scattering by water [244]. In 15 µm droplets, the cytosol of a
single cell is diluted about 2,000 fold. Therefore, the emission at 335 nm should not play a
major role.
Because this did not explain emission of green light, the fluorescent dye was dissolved
in a series of different solvents to see if the fluorescence could be shifted to green emission.
Indeed, in all solvents initially tested the emission maximum shifted from 600 nm to 540-
545 nm, see Table 5.1. The amount of fluorescence emitted, as measured by area under the
emission curve, was 10 to 100× less in any solvent compared to water. In trying to under-
stand the shift in emissionmaximum, the properties of the different solvents were compared.
Kamlet et al. developed one empirical set of parameters derived from the solvent effects on
many fluorophores. It takes into account solvent dipolarity (π*) as well as hydrogen-bond
acceptor (α) and donor (β) strength [245]. Comparing the different values, it appeared that
a high π* but low β value favoured emission at a higher wavelength. The first is expected.
When a fluorophore goes to the excited state, its dipole typically increases. In response, the
solvent molecules surrounding it reorganise, which lowers the energy of the excited state
causing a red-shift of the emission. The more polarised the solvent, the stronger the stabil-
ising effect and therefore the red-shift [230, 243]. The second observation is consistent with
the observation that protonation of the fluorescent dye quenches fluorescence.
If the shift to green emissionwas due to solvent relaxation alone, then a smooth shift from
600 to 540 nm would have been expected in mixtures of water and other solvents. Instead,
the existence of two emission bands was observed, Figure 5.14. This is indicative of emission
from two different excited states, e.g. a locally excited state and an internal charge transfer
state which are differentially stabilised by the different solvents [243]. The interaction with
nitrobenzene appeared to be specific rather than based on general solvent properties, because
even a small percentage of solvent locked the emission into a broad band.
In summary, it was found that 6c exhibits complex fluorescence behaviour with at least
three emission bands at 335, 544, and 600 nm depending on solvent conditions. These in-
sights indicate, that the green fluorescence observed for the single-cell lysate assay in droplets
originates from the same compound which was characterised previously.
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Fig. 5.13 The effect of additives on light emission by 6c. A: Dilution series of 6c with ly-
sis agent (BugBuster, Merck-Millipore) starting from the recommended concentration (1.0).
An old sample of 6c was used and upon in situ re-exposure to UV light of 365 nm, strong
fluorescence was recovered. B: Dilution series of cell lysate (1.0 corresponds to 50-100 fold
dilution of the cytosol and contains 1.0x lysis agent). The cell lysate quenched fluorescence
at 595 nm while a new peak at 335 nm appeared. Conditions: 1mM 6c in 20mM NaPi pH
7.0, 50mM NaCl, images of wells illuminated at 365 nm.
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Fig. 5.14 Solvents affect the fluorescence emission of 6c. The top row shows the emission
spectra for the different solvent mixtures; the bottom row shows the fraction of the total
emission if acetonitrile (MeCN) or ethanol (EtOH) were added to water an emission band
at 544 nm emerged while the emission at 600 nm decreased. Total emission of fluorescence
between 505 and 700 nmwas reduced by half in acetonitrile andmethanol compared towater.
Fluorescence emission was broad in nitrobenzene and 20× reduced compared to water. Even
at 90% v/v ethanol emission was strongly reduced, but the band at 544 nm emerged. Ftot:
area under the curve, Fmax: highest Ftot, F544nm and F600nm: area under the curve up to and
above 567 nm (isosbestic point). Excitation at 470 nm.
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Table 5.1 The maximum fluorescence emission wavelength in
different solvents and the solvent properties.
Solvent λmax Solvent Properties
†
(nm) π* α β
Water 590 1.09 1.17 0.18
Nitrobenzene 596 1.01 0.39 0.00
Dimethylsulfoxide 540 1.00 0.00 0.76
N,N-Dimethylformamide 545 0.88 0.00 0.69
Acetonitrile 540 0.75 0.19 0.39
Tetrahydrofuran 543 0.58 0.00 0.55
Ethylacetate 540 0.55 0.00 0.45
Ethanol 540 0.54 0.83 0.77
Toluene insoluble 0.00 0.00 0.00
Cyclohexane insoluble 0.00 0.00 0.00
† values from reference [245].
5.2.6 Enrichment of HG3.17 using substrate 6a
Because the appearance of green fluorescence was reproducible and the number of green
fluorescent droplets matched the expectation for a λ of 0.2, an enrichment experiment with
enzymes HG3.17 andN20 was performed. The same phenotypic assay as for the AADS assay
was used (Section 4.4.6). Droplets were generated with a λ of 0.2 and a starting ratio of
1:500 of positive to negative cells (ε0=0.002). The histogram of fluorescence after overnight
incubation and intermittent UV exposure is shown in Figure 5.15. Negative droplets did not
show a detectable fluorescence signal. The number of sorted droplets was therefore estimated
by regularly determining the droplet frequency via high-speed video analysis and averaging
over time. Thus, an estimated 106 droplets were sorted, out of which all droplets with a signal
2 fold above the detection threshold were collected. This yielded 392 droplets, close to the
expected 400. Re-transformation of a third of the recovered DNA yielded 229 without a halo
(HG3.17) and 26 colonies with a halo (N20, false positives). This translates to a recovery
rate of two colonies per droplet and a post-sorting ratio of ε1=0.9, which is an enrichment
of ε1/ε0 = 450. In summary, this experiment showed that the observed green fluorescence is
functionally linked to the activity of HG3.17. This implied that the assay could be tested with
the metagenomic library SCV for functional screening.
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Fig. 5.15 Histogram of the enrichment of HG3.17 diluted 1:500 with N20 using the 6a sub-
strate. The droplets were incubated overnight and intermittently exposed to UV light of
365 nm. The majority of droplets did not give a signal. Their number was estimated at 106
using video analysis. Droplets with a signal 2 fold above detection threshold were collected
(green bars). No droplets with a signal higher than 1V were observed.
5.3 Functionalmetagenomic screening forKempeliminases
5.3.1 Screening of the metagenomic SCV library
The SCV library was prepared as for previous sorting campaigns and encapsulated at a λ
of 0.2. The λ was reduced from the 0.35 used in the esterase screening campaign to reduce
false positives due to co-encapsulation and erroneous sorting [60]. A total of 8 × 106 droplets
were sorted over three days. The droplets were intermittently exposed to UV light over night,
but not during the sorting periods (ca. 5 h). Histograms were obtained that resembled those
obtained during the successful esterase screening campaigns (compare to Figure 3.11). That
is, there were rare events of high fluorescence above the sorting threshold indicating the de-
tection of Kemp eliminase activity. The average apparent hit rate was 2.1 × 10−4 compared
to 4.3 × 10−5 and 4.7 × 10−5 during the esterase sorts. A direct, quantitative comparison of
the hit rates between the two reactions is limited because of differing chemical and biologi-
cal background rates. However, qualitatively they are both in the expected range of 10−5 to
10−4 for metagenomic screening of common enzymes. This finding is remarkable, because
the data suggests that Kemp eliminases are occurring as frequently as esterases. The Kemp
elimination has in general been seen as a non-natural reaction. To date, the highest promis-
cuous activity of an enzyme towards 2a is in the range of 104 M−1s−1 [201]. In the histogram
of sorting day 1, there are 29 events with a signal higher than 1V, which is above the signal
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any droplet containing well-expressed HG3.17 achieved – the best Kemp eliminase known
to date. Taking into account the low expression levels in metagenomics, this indicates that
the observed events were caused by very active Kemp eliminases.
Table 5.2 Summary of the SCV library sort using 6a.
Day Droplets Hit Rate† /10−4
Sorted /106 Collected
1 3.3 211 3.2
2 3.9 105 1.4
3 0.8 22 1.2
Total 8.0 338 2.1
† expressed as hits per library member, assuming
activity of each collected droplet was due to a sin-
gle library member and λ of 0.2 for the sorted
droplets.
To link the observed activities to a gene, the DNA of the collected droplets needed to
be recovered, re-transformed, and re-screened. A total of 338 droplets was collected from
which 5 × 104 colonies were recovered. This number was clearly above the expectation as-
suming typically observed recovery efficiencies of 2 to 5 colonies per droplet. Following
the calculations of Baret et al. [60], one can estimate the carry-over of negative cells due to
co-encapsulation. Using the apparent hit rate and occupancy λ = 0.2, one would expect 67
co-encapsulated cells. In the absence of biological bias, this would introduce only 17% false
positives. In addition to co-encapsulation, random sorting errors due to flow-fluctuations
dust particles can contribute to false positives, this error-rate is typically 10−4 or less. To ex-
plain all of the observed false positives, an apparent error-rate of 10−2 would be required; a
rate which would have been observed during the droplet sort 2. Therefore, it must be con-
cluded that there was a bias towards false positives. Its origin is analysed in more detail in
the next section.
A similar result had been obtained for the esterase screening campaign, albeit with a lower
apparent error-rate of 10−3. A secondary screen on culture plate was successful at identifying
true positives. With the same goal in mind, 1,000 colonies were picked and grown in 12 96-
well plates, 5 plates each for day 1 and 2 and two plates for the last day of sorting. After lysis,
the lysates were screened at 2 fold dilution in 384-well plates using the substrate 6a. However,
2The error-rate during a sort can be estimated by high-speed video analysis. Typically, a few thousand
droplets are analysed in one recording, thus an error rate above 10−3 would have been noticed during the
experiment. An error rate of 10−4 or lower may have gone unnoticed.
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Fig. 5.16 Shown are the histograms of three droplet sorts of the metagenomic library SCV.
The library was co-encapsulated with substrate 6a, incubated, and sorted over three days
with intermittent UV exposure during the overnight incubation periods. Excitation: 488nm,
emission: 525/28nm.
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out of the tested 1,000 colonies the signal of only 10was just beyond three standard deviations
above the average signal, i.e. there were no stand-out positives above background as shown
in Figure 5.17. An emission spectrum recorded one week after incubation (sealed, in the
dark) showed mixed ratios of emission at 335 nm and 595 nm indicating different degrees
of quenching by the cell lysate. The variation in cell lysate concentration was likely to mask
differences in product concentration. Nonetheless, to assess the sorting outcome, 30 variants
were selected based on having 1) a positive change in fluorescence at each measured time-
point and 2) having the highest overall change in fluorescence.
A repeat experiment at 10 fold dilution of the cell lysate, which should have shifted the
majority of the emission to 595 nm, did not improve the outcome. Neither yielded a plate
screen using the substrate 2a any hits above background.
This showcases the superior performance of the droplet assay in detecting weak activities.
In the above case, it allowed a 1,800 fold dilution of the cytosolic content of a single cell,
while the accumulation of fluorescent product was confined to a volume of 1.8 pL. In this
volume, just 1,000 product molecules would yield a concentration of 1 nM. To reach the
same product concentration in the 384-well plate assay (10 µL), 6 × 109 molecules would be
required. For this reason, it was unsurprising that the well-plate assay did not yield clear hits
in the way the droplet assay did. Furthermore, it was practically more difficult to ensure even
illumination of the entire 384-well plate. For comparison, all of the sorted droplets together
took up a volume of less than 10 µL, i.e. would have fitted into a single well of the plate. In
the abscence of an immediate alternative, it was therefore important to identify the origin of
the false positives in order to minimise their number in a new droplet screen. Ideally to such
an extent that most recovered colonies could be assumed to be genuine hits.
5.3.2 Sequence analysis and origin of the false positives
The reason for the high number of false positives was found by sequence analysis of the se-
lected hits. All but one of the 30 selected variants contained a compromised vector. The insert
of the variant with intact vector was 472 bp in length. One complete ORF with a length of
300 bp was predicted, but a database search of its amino-acid sequence showed no homol-
ogy with any previously sequenced gene (using the same method as in Section 3.4.2). This
confirmed the notion that no genuine hits had been observed in the plate screen.
The 29 other variants were all unique and fell into one of two groups (Figure 5.18). Either
sequencing worked only in the forward (M13fwd primer) or in the reverse (M13rev primer)
direction. This was due to a deletion which included the respective opposite primer sequence
whichmeant that the second sequencing primer lacked its binding site on the vector. With 22
variants, the lack of the M13fwd binding sequence wasmost common. In 20 of these variants,
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Fig. 5.17 A: Fluorescence change over time for one of three 384-well plates. The white line is
the average change, the black lines represent 1, 2, and 3 standard deviations above the average.
Timepoints 1: 1h, 2: 2h, 3: 16h, 4: 23h, 5: 40h. B: Fluorescence emission spectrum of the
same well plate after 1 week of incubation (sealed, in the dark) showed fluorescence emission
both at 335 nm and 595 nm.
the deletion started just after the EcoRV restriction site, had a length of 800 to 970 bp, and
ended between the f1 origin of replication and the kanR gene. Of the 7 variants which lacked
an M13rev binding site, 6 started within a 20 bp stretch 3’ of the EcoRV site, had a length of
210 to 500 bp, and ended just before the end of the pUC origin of replication.
Because all of the compromised vectors had deletions starting near the EcoRV restric-
tion site, it is likely that these were created when the metagenomic libraries constituting the
SCV library were constructed using the cloning vector pZero2. The vector pZero2 contains
a C-terminal fusion of the toxic ccdB gene to lacZα. Insertion of a DNA fragment within the
multiple cloning site (MCS) disrupts the expression of the toxin. Therefore, positive recom-
binants can grow but not those transformed with self-ligated vector. However, it is likely that
partial fragmentation of the vector occurred during the library construction. Self-ligation of
fragmented vector caused the observed deletions which disrupted the function of the ccdB
gene. The larger deletions created minimal vectors of 2.3 kbp, which retained only the es-
sential vector elements, i.e. the pUC origin of replication and the resistance gene kanR. This
compares to about 5 kbp for the average library member with insert [53, 246].
Thepresence of small compromised vectors in the library is highly problematic. It is likely
that there is a strong positive bias amplifying them relative to larger plasmids at each trans-
formation step. There are two factors contributing to this: 1) Colin showed that the plasmid
copy number was higher for smaller inserts in vector pZero2 [84], and 2) the transforma-
tion efficiency is generally higher for smaller vectors [247]. Furthermore, small plasmids
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Fig. 5.18 Location of deletiosns observed in 29 of 30 sequenced variants. Two thirds of the
variants had a deletion between the EcoRV site, used to create the metagenomic library, and
the resistance gene kanR. About 20% of the variants had a deletion between the EcoRV site
and the pUC origin of replication.
are more resistant to shear forces than larger ones [248]. Such forces can occur in ice dur-
ing long-term storage of DNA [249]. Indeed, gel electrophoresis of the SCV library plasmids,
whichwere stored at −20 °C in water, showed a smear typical of DNAdegradation (Appendix
Figure D.6).
To assess the state of the naive, i.e. unsorted library, five variants were picked randomly
and sequenced. All five had a deletion, showing that the quality of the library was low from
the outset. As mentioned above, the SCV library is a mixture of several constituent libraries.
Each of these was re-transformed and three variants sequenced to test whether or not they
all had undergone degradation, see Table 5.3. All variants in library ENR-M had a deletion.
One out of three variants had a deletion for libraries ENR-S, TSA, and DIR-MC/RC. With
only three variants sequenced, finding any with a compromised vector was a strong indica-
tion of library degradation. Of the remaining libraries, none of the variants had a deletion.
Based on these results, two new library mixtures were prepared using the original DNA sam-
ples. One was prepared as previously using all libraries (new SCV) and one excluding all li-
braries which had compromised variants. Thus, a new library (small SCV) with an estimated
3.5 × 105 members was created. Both mixtures were transformed again and five variants
were sequenced per sample. In the new SCV library, three out of five variants contained a
deletion. In the small SCV library, four out of five variants contained an insert and did not
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show a deletion. Therefore, both preparing a fresh library mixture and excluding the more
compromised sub-libraries improved the quality of the starting library.
Table 5.3 Listed is the number of variants with a vector deletion and no insert in the differ-
ent metagenomic libraries prior to sorting. The SCV libraries are mixtures of all the other
libraries. Old SCV was used in all the previous experiments, the new SCV and small SCV are
fresh mixtures.
Library Library Size Variants with Used for/104 Deletion small SCV
old SCV 125.3 5/5
ENR-M 2.3 3/3
ENR-S 3.5 1/3
ENR-G 2.5 0/3 ✓
ENR-L 3.0 0/3 ✓
DIR-L 8.0 0/3 ✓
SEM 8.0 0/3 ✓
TSA 4.5 1/3
DIR-MC/RC 80.0 1/3
CR2 13.5 0/3 ✓
new SCV 125.3 3/5
small SCV 35.0 1/5
5.3.3 Droplet screening using the small SCV library reduced false posi-
tive rate
The functional screening was repeated using the small SCV library because of its better qual-
ity. The average droplet occupancy λ was lowered to 0.1 to further reduce carry-over of non-
selected cells. A total of 4.2 × 106 droplets were sorted and 158 collected yielding an apparent
hit rate of 3.8 × 10−4, slightly higher than on day 1 of the previous sorting campaign. This
time, 19 of the collected events showed a fluorescence above 3V, where previously no events
had been observed. This may indicate an increased proportion of active library members in
the smaller SCV library. Upon re-transformation about 5,000 colonies were obtained. Tak-
ing into account the smaller total number of droplets screened, this is 5× reduced compared
to the previous sorting campaign. Therefore, an apparent reduction in false positives was
achieved. Using the same calculations as previously, the apparent sorting error-rate was re-
duced from 10−2 to 10−3. However, overall the number of colonies was still about 10× above
the expectation. Sequencing of five randomly selected variants showed that four out of five
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Fig. 5.19 The sorting histogram of the small SCV library (3.5 × 105 members) showed fluo-
rescent events over the entire range of detection. Therewere 19 eventswith a signal above 3V,
higher than any previously observed signal, indicating that this library a higher proportion
of highly active library members.
had a deletion. Thus, it was likely thatmost of the obtained colonies were again false positives
and that re-screening was required.
5.3.4 Re-Screening using absorbance as primary assay readout
In the previous re-screening campaign the fluorescence change over time was followed. As
discussed earlier, fluorescence emission is sensitive to small variations in the local environ-
ment of the fluorophore and thus affected by differences in cell growth and lysis efficiency.
Therefore, the change in absorbancewasmonitored this time, as absorbance is not affected by
such small variations and should thus be a more robust readout of the turnover of substrate.
Differences in cell growth and lysis would be expected to affect only the absorbance offset.
The assay was performed in 384-well plate format, which allowed for a longer pathlength
(9.2mm) compared to 96-well plates (2.3mm), thus rendering the assay more sensitive by
enhancing the absorbance signal by 4 fold.
As a control, HG3.17 and N20 were expressed in E. coli BL21-Gold and the OD600nm
of the suspensions equalised prior to cell lysis. Each reaction was started by adding 40 µL
buffer (20mM NaPi pH 7, 50mM NaCl), 10 µL cell lysate and 50 µL of 2mM substrate 6a
in buffer. The reaction was monitored at 350 nm, see Figure 5.20. Over a period of three
hours the signal difference between the positive and negative control reached 0.9 a.u. and
doubled to 1.8 a.u. after overnight incubation in dark conditions. As expected, exposure to
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UV-light at 365 nm caused appearance of the absorbance peak at 500 nm and, if excited at this
wavelength, fluoresence emission at 600 nm. The absorbance at 500 nm was strong enough
to see an orange hue in the positive control under daylight conditions.
These conditions were used to re-screen colonies recovered from the droplet screening
of the small SCV library. Figure 5.21 shows the results for one 96-well plate3. Most reac-
tions plateaued within 0.5 h; the last ones plateaued after 2.5 h. Assuming that most variants
were false positives and that the signal had a normal distribution, the average and standard
deviation derived from all wells can be used to identify outliers (2% expected at two standard
deviations above themean, and 0.1% at three standard deviations above themean). After 3 h,
the average absorbance A350nm was 0.50 ± 0.08 a.u. and the average change in absorbance
ΔA350nm was 0.11 ± 0.09 a.u.. The variants in wells A02, B06, C06 and D06 reached a signal
more than two standard deviations above average. These four also had the largest relative
signal change. One variant stood out as having an initial rate vi three standard deviations
above average (F12, Figure 5.22). Unfortunately, when these five variants were sequenced
four had a “type I” deletion (lacking the lacZ, ccdB and f1ori genes) and one had a “type II”
deletion (lacking the M13rev primer), grey cells were controls.
5.3.5 Combining absorbance and sequencing data yields a potential hit
Considering that large vectors are likely to be counter-selected during DNA recovery due to
biological bias, any large-insert vector identified may indicate it was actively enriched during
the droplet screening step. Therefore, to complement the functional assay above, the whole
plate was sequenced using the standard M13Rev primer. Figure 5.23 shows a histogram of
the results. It was found that 74% of the variants had a deletion, 11% inserts had inserts with
fewer than 1 kbp and 15% had inserts with more than 1 kbp.
Every insert was analysed using Blastx to identify open reading frames (ORFs) with ho-
mologous sequences in the NCBI non-redundant protein database. The Blastx hits were used
for putative annotation of the identified ORFs. Only six variants contained complete ORFs
(Table 5.4). Assuming each of these had been selected in the droplet screening, this would
correspond to a hit rate of 7%, which matches with the expected range based on the number
of droplets collected and colonies recovered. Each predicted protein sequence was submitted
to the Pfam database to identify the protein domains and the family they belonged to.
One ORF was predicted to encode for a transriptional regulator, two for transporter-
related proteins, one for a helicase and one for an enzyme related to kanamycin resistance.
These kind of hits are typical examples of “you get what you screen for”. They can give the
3Cells were grown and lysed in deep 96-well plates and the lysates transferred to 384-well plate for the
absorbance assay.
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Fig. 5.20 Cell lysate controls for re-screening in 384-well plates. Triplicates of 100 µL re-
actions with 1mM 6a in 10× diluted lysates of cells expressing HG3.17 or N20. The re-
actions were followed at 350 nm and after 3 h moved to the dark and incubated overnight
(ca. 20 h total incubation time), after which they were exposed to light of 365 nm for 1min
(~100 µWcm−2). Buffer: 20mMNaPi pH7, 50mMNaCl, 0.1× BugBuster (MerckMillipore).
BF: bright-field, UV: 365 nm.
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Fig. 5.21 Re-screening of the small SCV library post droplet sorting following absorbance at
350 nm using 10 fold diluted cell lysates. Conditions: 1mM substrate 6a, 20mM NaPi pH 7,
50mM NaCl, 0.1× BugBuster (MerckMillipore).
Table 5.4 Sequenced variants with inserts containing complete ORFs.
Well Length ORF Protein Pfam (Family size)
A07 2,323 1 DEAD/DEAH box helicase DEAD (133k)
Helicase_C (191k)
A08 2,418 1 PTS ascorbate transporter, IIC EIIC-GAT (2k)
2 PTS ascorbate transporter, IIB PTS_IIB (10k)
A10 1,222 1 Kanamycin-modifying enzyme Acetyltransf_1 (120k)
D12 1,136 1 Transcriptional Regulator HTH_1 (140k)
LysR_substrate (139k)
G06 1,452 1 Class IV adenylyl cyclase CYTH (6k)
H03 1,718 1 Methyltransferase Methyltransf_25 (50k)
variant a growth advantage (kanamycin-resistance is the selection marker for vector pZero2)
or increase the background activity in the cytosol by affecting gene expression. While they
thus often represent genuinely enriched sequences, it is usually based on a property different
from the desired one (catalysis). Discounting these variants, two interesting hits remain: a
class IV adenylyl cyclase and a methyltransferase.
In Figure 5.24 the absorbance assay data was combined with this information. It became
evident that the variation in both reaction rate and total absorbance change was larger for
plasmids without inserts than those containing inserts, further underlining that these are
problematic during library screening. Importantly, variant G06 was found to be the most
active of all variants containing a DNA insert. Taking the average (0.10 a.u.) and standard
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Fig. 5.22 Absorbance after 3 h and initial reaction rates observed during the re-screening
of the small SCV library post droplet sorting following absorbance at 350 nm using 10 fold
diluted cell lysates. Conditions: 1mM substrate 6a, 20mM NaPi pH 7, 50mM NaCl, 0.1×
BugBuster (MerckMillipore).
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Fig. 5.23 Insert size distribution obtained by sequencing two 96-well plates of variants se-
lected post-droplet sorting. The majority of the variants (74%) had a deletion and 1 in 10
had an insert larger than 1 kbp. Blank wells were missing the sequencing primer (“type II”
deletion)
Fig. 5.24Combining the absorbance assay data fromFigure 5.21with sequencing information
reveals that well G06 harboured the most active variant with an ORF-containing insert.
deviation of only the variants containing inserts (0.05 a.u.), G06 is close to three standard
deviations above the mean (0.23 a.u.).
This variant encodes for a predicted class IV adenylyl cyclass (AC). ACs catalyse the syn-
thesis of cyclic adenosine 3’,5’-monophosphate (cAMP) from adenosine triphosphate (ATP).
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These enzymes are members of a small protein family (CYTH) and their fold is an antiparal-
lel β-barrel with a central cavity [250]. Gallagher et al. resolved the structure ofYersinia pestis
AC bound to substrate analogue α,β-methylene ATP (PDB: 3N0Y) and the product cAMP
(PDB: 3N10) [251], see Figure 5.25. The catalytic mechanism is likely to involve two divalent
metal ions (Mn2+ or Mg2+) bound by conserved glutamate and aspartate residues. The metal
ions coordinate the phosphate groups of the substrate and facilitate nucleophilic attack on
the α-phosphate by the 3’OH. The crystal structures reveal a central substrate tunnel pene-
trating the centre of the β-barrel. Notably, one half of the barrel is lined with acidic residues,
coordinating themetal cations, while the other side is lined with arginine and lysine residues.
The structure of variant G06 was modelled using the Phyre II web portal, which predicts
protein structures based on homology with experimentally solved structures [252]. The G06
model was based on the PDB entry 2EEN of a protein of unknown function from Pyrococcus
horikoshii, a hyperthermophilic archaeon (34% sequence identity, 48% sequence similarity).
Alignment of the model with the cyrstal structure of the Yersinia pestis AC indicated conser-
vation of the acidic amino acids that coordinate the metal cations. The top entrance to the
substrate tunnel in G06 had four additional acidic residues with each two in close proximity
to each other. This proximity could perturb their pKa upwardsmaking them efficient general
bases, potentially providing catalysis on the protein surface. In the centre of the tunnel is a
small hydrophobic patch formedbyTyr38, Ala52, Val110, Ser174 andTyr175with two lysines
(Lys8, Lys 76) in close proximity – in this case possibly perturbing their pKa downwardsmak-
ing them better general bases. This latter location may be a more likely environment capable
of catalysing the Kemp elimination. It is reminiscent of a binding pocket in bovine serum
album, within which a catalytic lysine promotes the Kemp elimination [193, 203].
Taking these considerations together, the evidence supports that variant G06 is a poten-
tial hit. The next steps would be to re-clone the gene for protein over-expression and purifi-
cation to confirm Kemp eliminase activity of this enzyme in the absence of cell lysate. As
mentioned in Chapter 4, the only comparable screening campaign was performed by Kher-
sonksy et al. [205], who screened the E. coli ASKA library (~4000 variants) and found two
Kemp eliminases (a hit rate of 5 × 10−4). This indicates that G06 would have been unlikely
to be found in a naive pool of fewer than 100 variants without prior enrichment by droplet
screening.
5.3 Functional metagenomic screening for Kemp eliminases 187
Fig. 5.25 Structure ofYersinia pestis class IV adenylyl cyclase bound to substrate analogue α,β-
methylene ATP (ACP, PDB: 3N0Y) and to product (cAMP, PDB: 3N10), respectively [251].
A model of the structure of G06, a predicted adenylyl cyclase, was generated using Phyre
II [252], which revealed conservation of critical catalytic residues. Catalysis of the Kemp
elimination could occur in the centre of the tunnel where two lysine residues are in close
proximity near a hydrophobic patch.
188 A novel fluorogenic Kemp Substrate
5.4 Conclusions
In order to find a suitable Kemp substrate for functional metagneomic screening in droplets,
several new substrates were synthesised. One of these substrates, 6a, was found to become
fluorescent after conversion to the Kemp product and brief irradiation at 365 nm. Fluores-
cence measurements are generally far more sensitive than absorbance mesaurements [253].
Only one other fluorogenic Kemp substrate has been reported to date [229]. However, this
coumarin-based substrate was not used in the study of enzymology, but rather to quantify
serum albumin in blood for diagnostic purposes. Yet, the potential to detect lower quantities
of Kemp reaction product offers new possibilities in enzyme engineering. For example, most
Kemp eliminases have a Michaelis constant Km in the milli-molar range, whereas the typi-
cal Km of natural enzymes is in the micro-molar range [158]. This can be attributed to the
fact, that absorbance-based screening campaigns are limited to substrate concentrations in
the milli-molar range because of limited sensitivity. A fluorogenic substrate could overcome
this limitation in future evolutionary campaigns. The substrate 6a seems particulary suited
for this, because of its structural similarity to 2a it would be more comparable to existing
literature as compared to the coumarin-based substrate by Sakamoto et al..
It was possible to show that 6a is converted to the expected Kemp reaction product in
the first step. The structure of the fluorophore generated upon irradiation with UV light has
eluded full characterisation due to low solubility in H2O. The available data indicates only
a small change in structure, e.g. the rotation around the azide-carbon bond, which possibly
allows the formation of an exciplex upon excitation. Crystallography of the final compound
would yield strong evidence for its molecular structure. However, dynamic in-solution be-
haviour may play an important role in the mechanism of fluorescence. Future studies should
therefore include 1H-NMR of a dilution series of the final compound in D2O to study the
complexation behaviour, but will require very long integration times.
For the purpose of this study, the focus remained on establishing a functional metage-
nomic screening platform. Therefore, a second droplet assay was developed. In this assay,
the droplet diameter could be reduced to 15 µm diameter (a volume of 1.8 pL). This diluted
the cytosol of a single cell 100× less than in the absorbance assay thus likely lowering the limit
of detection. Again, the selectivity of the assay was shown by enriching the positive control
HG3.17 over the negative control.
Using this substrate for two metagenomic screening campaigns, it was possible to detect
fluorescent events above background. The apparent hit-rate (2.7 × 10−4) was comparable
to what was observed in the esterase screening campaigns (4.5 × 10−5). The fluorescence
signal of about 10% of these apparent hits exceeded the highest signal obtained for HG3.17.
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Together these observations based on screening a large number of library variants indicated
that efficient Kemp eliminases are more common than assumed until now.
However, a high proportion of false positives was obtained after recovery of the DNA
from the collected droplets. Re-screening in plates based on the readout of fluorescence or
absorbance alone was not sensitive enough to recover the hits. Sequencing of a whole plate
revealed that vectors with deletions had a higher variation in signal compared to vectors
containing inserts, thus obscuring the functional readout. Using the sequencing data it was
possible to identify a promising lead, variant G06, which may be the first Kemp eliminase
identified in a metagenomic screening campaign.
This work highlighted the limitations placed on functional metagenomic screening by
poor library quality. Construction of a new high-quality metagenomic library would a)
greatly reduce the number of false positives and b) simplify the re-screening procedure due
to reduced variation of the background activity. This may then yield a much greater number
of potential Kemp eliminase hits. The screening method, for indeed any enzymatic activity,
could be further complemented by a deep-sequenced metagenomic library in which the fre-
quency of each ORF is known - this would allow to compute the likelihood of finding each
ORF by chance and give more confidence in it having been genuinely enriched post-sorting,




In this thesis, I set out tomeet three goals: building a FADS, establishing a functionalmetage-
nomic screen for esterases using the FADS, and establishing a functional metagenmic screen
for Kemp eliminases using AADS.
Chapter 2 described how I implemented a state-of-the-art FADS, which contributed to
the success of several droplet sorting campaigns, including a collaboration on directed evo-
lution of a sulfatase using E. coli autodisplay and directed evolution of a protease using IVTT.
Traditionally, when screening enzyme libraries, single variants need to be separated physi-
cally on amacroscopic level, e.g. into different wells, to be able tomeasure their relative activ-
ities. The screening of enzyme libraries in microfluidic droplets differs, because the library
variants remain pooled in a water-in-oil suspension. Conceptually, it therefore resembles
the screening for binding proteins, e.g. antibodies, in which successive rounds of screening
enrich for improved binders [254, 255]. While the utility of a new system can be verified by
the enrichment of a positive control diluted with a negative control [254], the ultimate test
for the system is the screening of a library of variants [255]. The FADS reported here passed
this test for different enzyme assays and libraries.
In Chapter 3, I used the FADS to set up an esterase assay and reported the first func-
tional metagenomic screen for esterases using droplet microfluidics. Twelve plasmids were
isolated from a million-membered metagenomic library encoding for thirteen novel esterase
genes, which were confirmed to be efficient esterases. The absolute hit rate was 10−5. In
general, hit rates vary strongly between different library formats due to different insert sizes
and environmental sources, for esterases they have been reported from as low as 10−7 to as
high as 10−4 [31]. One previous study, which used plasmids with similar insert sizes as here,
had the same hit rate as the droplet microfluidic assay reported here. However, in this study
over 4× as many esterases were isolated, because 4× as many clones were screened. Of the
thirteen new genes, ten were from the large α/β-hydrolase super-family of proteins (close to
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500,000 sequences on the Pfam database). Two of the hits, N20 and RR11ORF2 were from
the DUF3089 family, which contains only 500 sequences. A sequence belonging to a domain
of unknown function family would not have been isolated by a sequence-basedmetagenomic
screening, especially not from such a small one. Notably, these two enzymes were the most
active esterases reported here. Several other hits were from very small protein families, such
as N13 (Lipase_Bact_N, which with 200 sequences is too small and too distantly related to
even assign it to a super-family). The high proportion of hits from small protein families
indicates that the number of sequences present in a protein family is not a good predictor
of the abundance of these sequences in the environment nor the level of enzymatic activity
of their gene products. Again, a sequence-based methods would have been biased towards
larger families suspecting to find better catalysts in extended sequence clusters. In contrast,
functional metagenomic screening provided access to thinly populated sequence-space con-
taining efficient esterases without the need for a priori knowledge.
As mentioned, hit rates can vary strongly between libraries. Here, the cow rumen sub-
library had a hit rate 6× higher than the other 9 sub-libraries combined (40% of the hits from
10% of the screened clones). In another large-scale screening study for esterases, 40% of the
hits were found in 4 of the 17 sub-libraries (5% of the screened clones) [127]. These find-
ings can be used to guide future research. For example, instead of pooling many libraries
to obtain one large library, the libraries could be pre-screened separately. Using droplet mi-
crofluidics, even very low apparent hit rates can be measured quickly. If the FADS is used
in an “analytical” mode without sorting, the droplet rate can be increased, because the lim-
iting factor in FADS are the dynamics of sorting, not determining the fluorescence signal of
each droplet. Thus, it should be feasible to determine apparent hit rates of ten libraries in a
day’s work at low reagent cost. Then, the libraries with the highest apparent hit rates could be
pooled and screened at very high coverage to ensure recovery of every clone (a library with
105 members would have been oversampled 100× under the conditions used in Chapter 3).
This method could also be used with with cosmid- or fosmid-based libraries. Cosmids and
fosmids tend to have higher hit rates, but low copy numbers (>50 per cell). Isolation of the
low-copy cosmids or fosmids from single droplet has not been published to date. However,
under a pre-screening regime the isolation of the DNA would not be necessary. Several li-
braries could be pre-screened and the one with the highest hit rates than re-screened using
traditional plate methods. This method may also reduce bias and the contribution of false
positives from low-quality metagenomic libraries.
In Chapters 4 and 5, I established droplet microfluidic assays for the Kemp elimination
based on absorbance using substrate 5-nitro-1,2-benzisoxazole (2a) and the newly discov-
ered fluorogenic substrate 5-azido-1,2-benzisoxazole (6b), respectively. Substrate 6b is struc-
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turally very similar to the substrate 2b, which has been most widely used to date because it
can be detected most sensitively in a colorimetric assay.
Both Kemp eliminase assays were able to enrich a positive control for the Kemp elimina-
tion over a negative control. The absorbance-based assay was not sensitive enough for func-
tional metagenomics, but its utility was shown in the screening of several mutant libraries of
the Kemp eliminase HG3.17. The fluorescence-based assay was able to detect Kemp elimi-
nase activity in droplets. The apparent hit rate suggested that promiscuous enzymes capable
of catalysing this reaction are commonplace, but the recovery of hits was impeded by the low
quality of the metagenomic library SCV (discussed in more detail further below). A com-
bination of functional and sequence-based re-screening lead to identification of a possible
lead - library member 4G06, which is predicted to encode for a class IV adenylyl cyclase.
This initial lead indicates that screening of good quality metagenomic libraries in the future
should enable the isolation of promiscuous Kemp eliminases based on the assay developed
here.
In general, substrate 6b should enable more sensitive product detection at lower sub-
strate concentration, therefore also be suited for the evolution of Kemp eliminases towards
lower Michaelis constants and thus higher activities than previously possible. In the case of
HG3.17, which fdid was evolved from HG3, kcat improved from 3 s−1 to 700 s−1, whereas
there was no change in Km with 2.4 and 3.0mM respectively [16]. This indicates, that the
screening was performed in saturating conditions, i.e. the observed reaction rate was close to
vmax, and therefore a change in Km of the enzyme did not significantly influence the observed
initial rate. However, if the substrate concentration [S] ≪ Km, then the Michaelis-Menten
equation (Equation 3.1) simplifies to: vi = (kcat/Km)[S][E0]. If screened in such conditions,
both changes in kcat and Km would influence the inital rate and therefore the selection pres-
sure on Km would be increased. A fluorogenic substrate should enable screening using sub-
strate concentrations in the 10 to 50 µM range (as in the esterase screening), which is 10×
below the concentrations used in the directed evolution of HG3.17 [16]. A directed evolu-
tion campaign using this substrate in microfluidic droplets, should additionally benefit from
ultrahigh-throughput, enabling the screening of different kinds of libraries, e.g. insertion and
deletion libraries, which are currently not routinely used in enzyme engineering because of
the large fraction of inactive variants usually observed [211].
Instead ofHG3.17, the hit N7 (Chapter 3) found to be a promiscuous catalyst of the Kemp
elimination could be used to start from a lower Kemp eliminase activity. It has been observed
that the improvement during the initial rounds of directed evolution for a promiscuous ac-
tivity are large and start to diminish [256, 257]. This was also observed for HG3.17 [16]. It
194 Conclusions
may therefore be easier to use N7 as a starting point to verify 6b as a useful substrate for
directed evolution, and compare its evolutionary trajectory to HG3.17 in a second step.
Analysis of sources of error and bias in droplet sorting A high number of false posi-
tives was observed in both the esterase and the Kemp eliminase screening campaigns. To
improve future screening outcomes, it is useful to analyse the possible causes of this observa-
tion. There are two separate aspects to this. The first one is the ratio of positives to negatives.
It is possible that false positives were actively collected because the sorting thresholds were
close to background levels. However, the second aspect is the total number of colonies recov-
ered per droplet. In control experiments this was in general between two and four, therefore
in any of the metagenomic screens about 103 colonies would have been expected, but 10×
more were obtained. The main question is therefore, where these excess colonies came from.
Figure 6.1 summarises possible sources of these colonies. In a system free of background,
error, and bias, the isolation of a library variant would purely depend on the sensitivity of the
droplet assay and the ability to amplify the collected DNA by recovery and transformation of
fresh cells. However, in a real droplet system there are three possible sources of error:
• co-encapsulation of positive clones with negative ones in droplets due to the Poisson
distribution;
• erroneous droplet collection due to random fluctuations of the droplet flow during
FADS; and
• active droplet collection of negative clones due to phenotypic variation between cells
of identical genotype.
These three types of error allow negative variants to circumvent the screening barriers, creat-
ing false positives. The first two points are purely technological issues and their contribution
to false positives can be calculated.
Co-encapsulation is only a minor contributor to the fraction of false positives. If positive
and negative variants are considered two independent cell populations, the chance of co-
encapsulation can be calculated as the product of the respective Poisson probabilities [60].
Using the average droplet occupancy λ of 0.35, the number of droplets sorted, and the num-
ber of hits collected in esterase sorting campaing I, the number of “passenger” cells can be
calculated to have been 83. If every collected plasmid had equal recovery and transformation
efficiencies, only 26% of recovered colonies would have been false positives1.
1These calculations apply to random co-encapsulation due to Poisson statistics. Non-random co-
encapsulation happens if cells stick together. E. coli forms biofilms if grown at high densities under non-ideal
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Fig. 6.1 Sources of error and bias in functional metagenomic screening that influence the
fraction of false positives. The contribution of each of these factors is discussed in the main
text.
The second technological source of error is due to random collection of droplets, for
example due to a piece of dust passing through the chip or two droplets being sorted together.
During the sorting campaigns, the occurrence of such events was monitored by high-speed
video analysis. They were not observed frequently, but some such events may have been
missed. The only published account of the error rate in FADS found it to be less than 10−4
[60]. An error rate of 10−4 would therefore be a worst case assumption2; and it would have
allowed an additional 549 cells to enter the collection channel, setting the fraction of false
positives to 73%, i.e. 1 in 4 colonies should have been a genuine positive.
This is still two orders above the hit rate actually observed during re-screening on tribu-
tyrin plates. Therefore, the contribution of biological errors and biases to the reduction in hit
frequency exceeds the contribution of pure technology by at least two orders of magnitude.
Phenotypic variation is one source of biological error and affects both the false positive
and false negative rate. It is the general phenomenon that organisms of the same genotype
display different phenotypes, in the way that even monozygotic twins differ from each other.
conditions [258]. If this happens, cells can be observed to form a biofilm even within a microfluidic device dur-
ing droplet generation (Appendix Figure D.7). This effect can be avoided by growing the cells at a controlled
temperature and humidity; thorough washing steps; and filtering through a 5 µm filter.
2At sorting rates up to 103 an error-rate above 10−4 would have been easily observed by video analysis.
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On a cellular level, this can be observed in the stochastic expression of genes which is rooted
in the statistical mechanics of chemical systems at very low concentrations [259, 260]. That
is, the amount of protein expressed can vary strongly between genetically identical cells. The
standard deviation from the mean expression level has been found to be anywhere between
10 and 100% [260]. As mentioned, this may cause some false positive clones to be actively
collected, for example due to the random up-regulation of an esterase encoded in the E. coli
genome. But even if themajority of the collected dropletswould have been false positives, this
effect does not explain the high number of colonies recovered from the droplet experiments.
Therefore, the only remaining explanation is recovery bias in favour of false positives,
which can be due to:
• a variation of growth rate between library members;
• a negative correlation between plasmid copy number and plasmid size (affecting the
recovery efficiency from droplets); and
• a negative correlation between transformation efficiency and plasmid size.
The growth rate can vary between librarymembers, if e.g. an expressed gene is toxic to the
host or gives it a fitness advantage. These effects are unpredictable in metagenomic libraries
and were mitigated by growing the library on culture plates rather than in solution. The
other two factors were discussed in Section 5.3.2, and are likely to have influenced the sorting
outcome themost. They play a role only if there is a strong variation in the size of the plasmids
making up the library which is screened, as was found to be the case for the SCV library due
to the presence of vectors without inserts. These insights lead to three recommendations for
future screening campaigns.
Recommendations to improve functional metagenomic droplet sorting Based on the
analysis above, the best chance to improve the outcome of functional metagenomic screen-
ing in droplets is to obtain or construct a better quality metagenomic library and possible
modification of the workflow.
• If constructing a new metagenomic library, great care should be taken to avoid frag-
mentation or over-digestion of the vector. Furthermore, a cryoprotectant such as glyc-
erol should be added to samples used for long-term storage to avoid freezing and thus
shearing of the DNA [249].
• A second way to reduce bias, could be to avoid cell-lysis and re-transformation. The
cells could be encapsulated in minimal medium without lysis agent to allow limited
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growth of the cells in droplets. Spontaneous lysis of one or more cells in a droplet
would be sufficient to detect enzymatic activity. The sister cells could then be re-grown
directly without the need for re-transformation. The success of this strategy would
depend on the relative influence of transformation and growth bias.
• Finally, the bias could be reduced by using libraries with larger inserts, such as fosmids
with around 40 kbp. Good quality fosmid libaries are freely available from the reposi-
tories of specialised research groups [37]. Assuming, for example, a standard deviation
of 1 kbp of the insert size, it is evident that the physico-chemical differences between
a 39 kbp and a 40 kbp construct (a 2% difference) are smaller than between a 3 and a
4 kbp plasmid (a 25% difference). It is also easier to separate vectors with and insert
from vectors without inserts during library construction. The limitation of fosmids is
their low copy number which poses a challenge to DNA recovery from single cells, but
in combination with the previous point, this may be a viable option.
Together, these recommendations will reduce the frequency of false positives. This will
help to exploit the full power of functional metagenomics at ultrahigh-throughputs for the





7.1.1 Fabrication of microfluidic devices
The microfluidic devices were fabricated following classical soft-lithography procedures us-
ing high-resolution acetate masks (custom prints by Microlithography Services Ltd) and SU-
8 photoresist patterning [55]. After creating access holes using a biopsy punch (1mm, Kai
Medical), the poly(dimethyl siloxane) (PDMS, Dow Corning) micro-channels were plasma
bonded to a microscope glass slide in a low-pressure oxygen plasma generator (Femto, Di-
ener Electronics, Femto), flushed with 1% v/v trichloro(1H,1H,2H,2H-perfluorooctyl)silane
(Sigma-Aldrich) in HFE-7500 (3M), and left at 65 °C for 30min.
In the case of the absorbance device, the obtained PDMS microchannels were plasma
bonded to a thin cured PDMS layer (5 g PDMS in a Petri dish, ø 9 cm), flushed with 1%
v/v trichloro(1H,1H,2H,2H-perfluorooctyl)silane (Sigma-Aldrich) in HFE-7500 (3M), left
at 65 °C for 30min, and the PDMS-PDMS devices then bonded to a microscope glass slide.
The optical fibres (SMA Fiber Patch Cable, ø 50 µm, 0.22 NA, Thorlabs) were tripped so that
only the core and the cladding weremanually inserted into the chip under amicroscope. The
alignment was tested by connecting one fibre to a 385 nm LED light-source (M385FP1,Thor-
labs) and the other to a photo-detector (PDA100A-EC, Thorlabs). The obtained signal was
maximised by adjusting the position of the fibres. They were then fixed with epoxy glue and
freshly mixed and degassed PDMS was inserted into the fibre channels and cured overnight
at room temperature.
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7.1.2 Generation and incubation of droplets
Droplets were produced using microfluidic double flow-focusing junctions. Two aqueous
streams were mixed at the first junction and dispersed into the fluorous oil HFE-7500 (3M)
containing 1% w/w fluorosurfactant-008 (RAN Biotechnologies) at the second junction. The
dimensions at both junctions in width by height were 15 by 16 µm and 50 by 80 µm for
fluorescence and absorbance assays respectively resulting in droplet volumes of about 2 and
200 pL. Theprocesswasmonitored on an invertedmicroscope (SP981, BrunellMicroscopes)
equippedwith a high-speed camera (Miro eX4, PhantomResearch). Themicrofluidic devices
were operated using syringe pumps (Nemesys or Cetoni) and gas-tight syringes (SGE) which
were connected to the chip via fine bore PTFE tubing (ID 0.38mm, OD 1.09mm, Smith
Medical). The standard flowrates were 50 µLh−1 for each aqueous and 500 µLh−1 for the oil
phase for the small droplets. For the large droplets they were 6 µLmin−1 for each aqueous
and 37.5 µLmin−1 for the oil phase.
Thegenerated dropletswere collected into an inverted 500 µLmicrocentrifuge tubewhich
was pre-filled with fluorous oil containing the surfactant. The tube wasmodified by inserting
tubing through access holes at the top and bottom of the microcentrifuge tube. This incuba-
tion chamber was sealed with adhesive glue (Scotch-Weld PR1500, 3M). The droplets were
collected via the top tubing while the bottom tubing served as a drain. After droplet gener-
ation, a gas-tight syringe was connected to the bottom tubing in order to eject the droplets
back out for downstream applications. The droplets were incubated under quiescent condi-
tions at room temperature (ca. 22 °C) and in the dark if a fluorogenic substrate was used.
7.1.3 Droplet leakage assays
Two populations of droplets were generated at a 1:1 ratio on a singlemicrofluidic device com-
prising two separate flow-focusing devices (width 50 µm, height 80 µm at the flow-focusing
junction). One population contained buffer as indicated and the other contained the buffer
and the product at 1mM. The flow rates during droplet generation were: 37.5 µLmin−1
and 12 µLmin−1 for the oil and aqueous phases respectively. For short incubation times,
the droplets were collected into PTFE tubing which had been pre-filled with fluorous oil and
was directly connected to the absorbance chip. For longer incubation times the droplets were
collected into an inverted reaction tube as described above. Fractions of the droplets were
analysed after different time intervals as described in Section 7.1.5.
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7.1.4 Fluorescence-activated droplet sorting (FADS)
The FADS and different stages of its development are described in detail in Chapter 2. In
general, droplets were injected from the modified reaction tube (Section 7.1.2) into the sort-
ing chip at 5 µLh−1 and spaced with plain fluoruous oil HFE7500 at 100 µLh−1 resulting in
a sorting frequency of about 300Hz. Depending on the quality of the droplet sample, the
droplet injection rate was increased up to 15 µLh−1 (to a rate of 2,000Hz) and the oil flow
adjusted to create enough separation to sort single droplets.
The chip was monitored using the microscope (IX73, Olympus) light source with a long-
pass filter (593nm, BrightLine Semrock) and a high speed camera (Miro eX4, Phantom Re-
search). To measure droplet fluorescence, a laser beam (488nm, 30mW, 85 BCD 30 Melles-
Griot, attenuated with ND 1.0) was expanded 10× and focused onto themicrofluidic channel
upstream of the sorting junction via a dichroicmirror (495 nm, Olympus). The induced fluo-
rescence was collected by an air objective (LUCPlanFLN 40x/0.6, Olympus), passed through
a longpass filter (488nm, RazorEdge Semrock), a dichroic mirror (555nm, Thorlabs), and
finally a bandpass filter (525/28nm, BrightLine Semrock) before reaching the detector. Dur-
ing the first metagenomic sorting campaign an avalanche photodiode (SPCM-AQRH-13,
Excelitas Technologies) was used to record the signal. For all other reported experiments a
photomultiplier tube (PM002, Thorlabs) was used due to greater flexibility.
In the first version of the FADS, the signal from the photodetector was split in two. On
one line, it was recorded (6341, NI) and visualised using a custom LabView program. On the
other, the sorting decision was taken by an ATmega328 microcontroller (Arduino Uno). The
signal was either digital (APD) or analog (PMT) and analysed accordingly. In either case, if
the signal exceeded a set threshold, a trigger pulse was sent to the pulse generator (TGP110,
Thurlby Thandar Instruments). In the latest version of the FADS, the signal was fed to an
anaolog-in pin of a Virtex-5 LX30 FPGA (PCIe-7841R, NI). The FPGA quantified the width
at threshold, width at half-maxium, area, and amplitude of each droplet signal. The droplet
data was streamed to a custom LabView program for visualisation and the setting of sorting
thresholds. If a dropletmet the sorting criteria, a trigger pulse was sent to the pulse generator.
If triggered, the pulse generator created a 5V pulse with 500 µs width. This pulse con-
trolled a function generator (20 MHz DDS Function Generator TG 2000, TTi) working in
external gated mode, generating a 10 kHz square signal at an adjustable amplitude (typically
7 to 9V), which was then amplified 100 times with a voltage amplifier (TREK 601c) to ac-
tuate the sorter. The electrodes were made by filling channels with salt solution (5M NaCl)
and connected to the amplifier via syringes [102].
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7.1.5 Absorbance-activated droplet sorting (AADS)
Droplets were injected from the modified reaction tube (Section 7.1.2) into the sorting chip
at 2 µLmin−1 and spaced with plain fluoruous oil HFE7500 at 20 µLmin−1 resulting in a
sorting frequency of about 100Hz. The absorbance signal was generated using a 385 nm
LED light-source (M385FP1,Thorlabs)monitored by a photomultiplier tube (PDA100A-EC,
Thorlabs). The principle sorting set-up was described by Gielen et al. [61]. The chip design,
signal acquisition and sorting actuation was identical. The signal processing was extended to
quantify the time each droplet spent within the detection area as a measure of its size. Paul
Zurek extended the software on the Arduino Due to measure peak width and minimum. I
extended the LabView software to analyse the signal in the equivalent way.
7.1.6 Droplet conditions for the metagenomic esterase screen
Droplets were generated, incubated, and sorted as described above. The two aqueous phases
used to generate the droplets were a suspension of cells expressing the library and a solution
containing substrate and lysis agents. The latter solution was composed o 20 µM fluores-
cein dihexanoate (gift by Ana Torrado Agrasar), 0.4x BugBuster (BugBuster 10X Protein Ex-
traction Reagent, Merck-Millipore), and 27 to 33U/µL rLysozyme (Merck-Millipore) in the
buffer (50mM TrisHCl pH 8.0, 100mM NaCl, 50 µgmL−1 kanamycin, and one tablet/50ml
complete EDTAfree protease inhibitor by Roche). The cell suspension was prepared as fol-
lows. Transformation of 10 ng of the metagenomic library into E. coli (E. cloni 10G Elite,
Lucigen) yielded 5 × 107 variants on Luria Bertani (LB) agar plate (containing 50 µgmL−1
kanamycin) covering the library size about 50times. The bacteria were grown overnight at
37 °C, then incubated at room temperature (ca. 22 °C) for two days. Colonies were subse-
quently scraped from the plates using 3×3mL liquid LB, cooled on ice, and washed three
times by centrifugation at 5,000 g for 3min and resupension in buffer. The OD600nm of the
washed cell suspension was measured and diluted to OD 0.8 in buffer with Percoll (Sigma-
Aldrich) at 25% v/v final. This suspension was expected to result in a droplet occupancy of
λ = 0.35 when diluted 1:1 on chip and generation of 2 pL droplets.
7.1.7 Droplet conditions for the Kemp eliminase assays
Conditions for AADS
Thetwo aqueous solutions for droplet generationwere composed as follows. The substrate/lysis
solution contained 1mM 5-nitrobenzisoxazole, 0.2x BugBuster (BugBuster 10X Protein Ex-
traction Reagent, Merck-Millipore), 27 to 33U/µL rLysozyme (Merck-Millipore), and 10%
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v/v methanol in the buffer (20mM TrisHCl pH 7.0, 50mM NaCl, and 3mM tartrazine). The
cell suspension with cell expressing the metagenomic library was prepared as described in
the preceding section. If the cells were E. coli BL21 with a pHAT based library, they were
scraped on the day before droplet generation, 1mL of undiluted cell suspension was added
to 100mL of liquid LB (with 100 µgmL−1 ampicillin), and the cells allowed to rest for 1 h at
20 °C with shaking at 220 rpm. Overnight expression was then induced with 400 µM IPTG.
The next day, the cell supension was washed three times by centrifugation at 5,000 g for
3min and resupension in buffer. It was diluted to OD600nm of 0.008 in buffer with Percoll
(Sigma-Aldrich) at 25% v/v final. This suspension was expected to result in a droplet occu-
pancy of λ = 0.35 when diluted 1:1 on chip and generation of 200 pL droplets.
Conditions for FADS
The two aqueous solutions were droplet genereation were composed as follows. The sub-
strate/lysis solution contained 2mM 5-azido-1,2benzisoxazole, 0.4x BugBuster (BugBuster
10X Protein Extraction Reagent, Merck-Millipore), and 27 to 33U/µL rLysozyme (Merck-
Millipore) in the buffer (20mM sodium-phosphate pH 7.0, 50mM NaCl). The cell suspen-
sion was prepared as described in Section 7.1.6 using the buffer specified here.
The incubation of the droplets was modified as follows. They were collected into an in-
verted 200 µL PCR tube modified with tubing at the top and bottom. After droplet genera-
tion, the tubing was sealed and the PCR tube was mounted to a custom made UV-exposure
device controlled by an Arduino Uno. Every 15min the droplets were mixed by a servo-
motor (SM-S2309S, SpringRC) rotating 90° left, waiting for 2min, rotating 180° right, wait-
ing for 2min, and returning to the original orientation by rotating 90° left. The tube was
then exposed for 15 s to an expanded beam of light from a 365 nm LED (M365F1, Thorlabs)
which was run at 400mA.
7.1.8 DNA Recovery frommicrofluidic droplets
Sorted droplets were collected into a 1.5mL lowDNA retention reaction tube (DNALoBind,
Eppendorff) prefilled with 20 µL fluorous oil HFE7500. The same tubes and low DNA reten-
tion pipette tips (Low Retention, Axygen) were used for all subsequent steps to minimise
DNA loss. Of a solution of 2 ng µL−1 salmon sperm DNA (Invitrogen), 100 µL was added to
the collected droplets. To the oil layer, 10 µL of 1H,1H,2H,2H-perfluorooctanol (97%, Alfa
Aesar) was added once. The tube was vortexed briefly (ca. 1 sec), inverted several times, and
centrifuged for 1min at 1,000 g. If there was foaming, an additional 10 µL of 1H,1H,2H,2H-
perfluorooctanol was added. The aqueous layer was transferred to a fresh reaction tube and
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the oil extracted twice more with 100 µL of the salmon sperm solution. The resulting 300 µL
of recovered DNA solution was purified using Zymo Clean and Concentrate-5 kit (Zymo
Research) according to the manufacturer’s protocol. The DNA was eluted using 10 µL ultra-
pure water after an extended incubation time of 10min.
7.2 Biochemical procedures
7.2.1 General cloning procedures
Whenever commercial enzymes or kits were used, the manufacturer’s instructions were fol-
lowed unless otherwise indicated. Restriction enzymes were from the FastDigest series by
Thermo Scientific unless otherwise indicated. Ligation reactions were performed using T4
DNA Ligase (Thermo Scientific). Plasmids were extracted from E. coli cells using the Gene-
Jet Plasmid Miniprep Kit. Standard PCR was performed using Phusion High-Fidelity Poly-
merase (New England Biolabs) following the manufacturer’s protocol. Colony PCR was per-
formed using 2x DreamTaq Green MasterMix (ThermoScientific). Gel-electrophoresis was
performed using 1% agarose gels containing 1x TAE buffer (40mM Tris-base, 20mM acetic
acid, 1mM EDTA, pH 8.5 at room temperature) and 1x SYBR Safe DNA gel stain (Invit-
rogen). Gels wer typically run at 90V for 30min to 45min. The DNA was visualised on
a low-power UV-transilluminator (Vilber Lourmat), the required DNA band manually ex-
cised and the DNA extracted using the Zymoclean Gel DNA recovery kit (Zymo Research).
If gel-electrophoresis was not required, DNA was purified using spin-columns (Zymo Clean
and Concentrate-5 kit, Zymo Research). Electrocompetent cells were transformed using
chilled 1mm gap cuvettes and 1,800V (Electroporator 2510, Eppendorf ), followed by im-
mediate addition of 1mL of pre-warmed SOC medium (Lucigen) and recovery at 37 °C and
500 rpm for 60min. The cells were plated onto LB agar plates containing the appropriate
antibiotic(s). The concentrations of antiobitoics were 100 µg µL−1 for ampicillin (Amp),
30 µg µL−1 kanamycin (Kan), 20 µg µL−1 chloramphenicol (Cam) and 10 µgmL−1 tetracy-
cline (Tet), respectively.
7.2.2 Preparation of electro-competent cells
To each of two 2LErlenmeyer flasks containing 350mLof pre-warmed SOBmedium (20 g L−1
tryptone, 7 g L−1 yeast extract, 13mMMgCl2, 13mMMgSO4, 5mMNaCl, 1mMKCl) 3.5mL
of a densely grown pre-culture of E. coli strain BL21-Gold(DE3) (Agilent) in liquid LB+Tet.
The cultures were incubated at 37 °C and 220 rpm until an OD600 of 0.6 was reached. Sub-
sequent steps were conducted in a cold room (4 °C) using pre-chilled material. The cultures
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were cooled in an ice-water bath for 15min and centrifuged at 3,000 g and 4 °C for 10min.
The supernatant was discarded and the cell pellets resuspended in 350mL of 1mM HEPES
(pH 7.0 at RT). This step was repeated twice with 15min of centrifugation. Finally, the cell
pellets were resuspended in 25mL of 10% (w/v) glycerol each, combined and brought to
350 mL with 10% (w/v) glycerol. After a last centrifugation step the supernatant was dis-
carded and the cell pellet slowly resuspended in 500 μL of 10% (w/v) glycerol. This cell
suspension was divided into 50 μL aliquots, shock frozen in liquid nitrogen and stored at
−80 °C. A test transformation with either ultra-pure resulted in a lawn on an LB+Tet agar
plate and no colonies on an LB+Amp agar plate as expected. A test transformationwith 10 ng
pHAT5_HG3.17 showed an efficiency of 1 × 107 cfu/µg.
7.2.3 Construction of the metagenomic SCV library
Themetagenomic libraries from soils, composts and vanilla pods were constructed by Dr Es-
ther Gabor and Dr Annett Kirschner in Groningen. The cow rumen library was constructed
by Dr Balint Kintses and Dr Charlotte Miton in Cambridge. The SCV library combining all
these libraries was prepared by Dr Pierre-Yves Colin in Cambridge. All libraries were stored
at −20 °C.
The libraries constituting the SCV library were constructed from different soil samples
[246], vanilla pods [261] and cow rumen [67], according to the method described by Ga-
bor et al. [262]. Briefly, environmental DNA was sheared using a nebuliser, blunted using
Klenow fragment and 3 to 5 kbp fragments were cloned into the EcoRV restriction site in
plasmid pZero2 (Invitrogen). The DNA from cow rumen was partially digested with the
restriction enzyme MluCI. DNA fragments in the size range of 3 kbp were isolated by gel
electrophoresis and cloned into the EcoRI site of plasmid pZero2 (Invitrogen). Dr Pierre-
Yves Colin received original library samples from the collaborators named above, pooled the
ten libraries directly at ratios respecting the reported library sizes (Table B.1) creating the
SCV library (oral communication Dr Pierre-Yves Colin). This pooled sample was directly
used to transform cells for droplet screening in the work reported here, i.e. between the first
construction to the screening in droplets there was one replication step in cells.
7.2.4 Construction of the epPCR Library of HG3.17
Random mutagenesis of HG3.17 was performed using the GeneMorph II kit (Agilent). Four
reactions of 50 µL were prepared on ice, each containing 230ng of plasmid pHAT5_HG3.17
(50ng of target DNA), 1 µM of each T7 and T7t primers, 800 µM dNTPs and 1 µL of Mu-
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tazyme II in 1x Mutazyme II reaction buffer. The PCR programme is detailed in Table 7.1.
Two reactions were each subjected to 25 and 30 amplification cycles, respectively.
Table 7.1 PCR program for epPCR.
Segment Cycles Temperature (°C) Duration (min)
1 1 95 2
95 0.5
2 25 or 30 52 0.5
72 1
3 1 72 10
After completion of the PCR programme, 0.5 µL of DpnI (FastDigest, Thermo Scientific)
was added to each reaction to digest the template DNA, incubated for 60min at 37 °C and
inactivated for 5min at 80 °C. The reactionmixtures were purified by gel-electropheresis and
the expected bands at 1 kbp extracted. The purified DNA was digested overnight (ca. 16 h) at
37 °C in 20 µL reactions using enzymes NcoI and XhoI (New England Biolabs), inactivated
for 20min at 80 °C and purified using spin-columns. The purified inserts were ligated at 3:1
molar excess into 25ng vector pHAT5 (previously digested with NcoI and XhoI) overnight
(ca. 16 h) using T4 DNA ligase (Thermo Scientific) at 16 °C in 1x T4 DNA ligase buffer.
After inactivation at 65 °C for 10min, 2 µL of the mixture were transformed into 25 µL E.
coli (E. cloni 10G Elite, Lucigen) and plated onto LB+Amp plates, number of transforming
cells reported in Table 4.4.
To remove vector with no insert from the libraries, 1 µg of each was digested using EcoRI
(FastDigest, Thermo Scientific) at 37 °C for 15min, immediately inactivated at 80 °C for
5min and purified using spin-columns. A mixture of the three libraries was prepared at
ratios representing the original diversity resulting in a library with an estimated diversity of
1.5 × 105. This epPCR library was used in the microfluidic droplet screening.
7.2.5 Construction of the deletion library of HG3.17
TheHG3.17 genewas amplified fromplasmidpET32-HG3.17 using theHG3.7-F andHG.317-
B primers. The amplified gene was purified using gel-electrophoresis and digested using
enzymes NdeI and XhoI (FastDigest, Thermo Scientific). The resulting insert was cloned
into vector pID-tet (previously digested with NdeI and XhoI) to create plasmid pID-HG3.17.
Vector pUC57-TransDel was digested using enzyme BglII using gel-electrophoresis and the
expected band at 1.1 kbp extracted (TransDel transposon).
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The transposon reaction was performed in 20 µL using 300ng of pID-HG3.17 and 50ng
of the TransDel transposon using MuA transposase (ThermoScientific). The mixture was
incubated for 1 h at 30 °C, inactivated immediately at 75 °C for 10min, cooled on ice and pu-
rified using a spin-column. The purified DNA (1 µL) was transformed into E. coli (E. cloni
10G Elite, Lucigen) and plated onto one LB+Amp+Cam plate (5 × 104 transformants). The
cells were scraped off using liquid LB and plasmids extracted. Of the resulting plasmids,
1 µg was digested using enzymes XhoI and NdeI and purified using gel-electrophoresis. The
band corresponding to the target gene containing transposon (2 kbp) was extracted and lig-
ated back into pID-tet vector overnight. The inactivated ligation was purified using a spin-
column and 20 ng transformed into E. coli (E. cloni 10G Elite, Lucigen) and plated onto one
LB+Amp+Cam agar plate (1.3 × 105 transformants). The cells were scraped from the plate
and the plasmids extracted. Of the resulting pID-HG3.17xTransDel library, 1 µg was di-
gested using MlyI and the expected DNA band purified from gel (2.7 kbp). The purified
DNA was self-circularised using T4 DNA ligase overnight, purified using spin-columns and
20 ng, transformed into E. coli (E. cloni 10G Elite, Lucigen) and plated onto one LB+Amp
agar plate (6.5 × 105 transformants). The cells were scraped off using liquid LB and the plas-
mids extracted resulting in the pID-HG3.17-Del library. Finally, the library was cloned into
vector pHAT5 using the Eco72I and XhoI restriction sites giving the pHAT5-HG3.17-Del
library used for droplet screening.
7.2.6 Construction of the insertion library of HG3.17
Up to restriction digestion by MlyI the insertion library was constructed following the pro-
tocol above but using the TransIns transposon from the pUC57-TransIns vector instead of
TransDel. The transposon reaction with MuA yielded ca. 8.6 × 104 transformants. The sec-
ond transformation step yielded ca. 1.3 × 105 transformants. Each 1 µg of the resulting plas-
mid library pID-H3.17xTransIns and the vector pUC57-Ins1 were digested using MlyI, pu-
rified by spin-column and eluted using 17 µL ultra-pure water. The eluate was used for a
second restriction digestion using enzyme NotI. The DNA fragment excised from pUC57-
Ins1 was ligated at 3:1 molar excess into 50 ng digested pID-H3.17xTransIns. The purified
ligation product was transformed into E. coli (E. cloni 10G Elite, Lucigen) and plated onto
one LB+Amp+Kan agar plate (>1 × 106 transformants). The cells were scraped off the plates
using liquid LB and the plasmids extracted.
Of the resulting library pID-HG3.17xIns1, 1 µg was digested using AcuI for 40min at
37 °C, immediately inactivated for 5min at 65 °C and purified using a spin-column. Of the
purified DNA, 1 µg was blunt-ended using 1U of the Large Klenow Fragment of DNA Poly-
merase 1 (New England Biolabs), by incubating for 15min at 25 °C followed by immediate
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inactivation by addition of 10mMEDTA (final conc.) and incubation at 75 °C for 5min. The
product was gel purified and 50 ng self-cirularised using 5U T4 DNA Ligase for 1 h at 22 °C
and inactivated for 10min at 75 °C. The DNA was purified using a spin-column, eluted us-
ing 7 µL of ultra-pure water and 3 µL transformed into E. coli (E. cloni 10G Elite, Lucigen).
The cells were plate onto one LB+Amp agar plate agar plate (3 × 106 transformants). The
plasmids extracted resulting in the pID-HG3.17-Ins library. Finally, the library was cloned
into vector pHAT5using the Eco72I andXhoI restriction sites giving the pHAT5-HG3.17-Ins
library used for droplet screening.
7.2.7 Expression of HG3.17 libraries for droplet screening
E. coli strain BL21-Gold(DE3) (Agilent) was transformed with 20 ng of the libary and plated
onto LB+Amp agar plates. The cells were grown overnight at 37 °C and scraped using 3x3mL
of liquid LB+Amp. The cell suspension from all plates were combined in the same reac-
tion tube and gently mixed by inverting several times. Two liquid cultures were prepared by
adding each 1mL of cell suspension to 100mL liquid LB+Amp. The cultures were incubated
for 30min at 20 °C and 220 rpm, followed by addition of IPTG to 400 µM (final conc.) and
overnight incubation under these conditions. After protein expression, the cell suspensions
were washed by pelleting the cells at 3,000 g and 4 °C, discarding the supernatant and resus-
pension in 50mL reaction buffer (20mM TrisHCl pH 7, 50mM NaCl). This was done three
times, on the last iteration the cells from the two separate liquid cultures were resuspended
in 25mL reaction buffer, combined and mixed by inverting the reaction tube several times.
This cell suspension was used for droplet screening as descirbed in Section 7.1.7.
7.2.8 Re-screening of HG3.17 variants in 96-well plates
Of the DNA recovered from the droplet sorting, 10 ng were transformed into electrocom-
petent E. coli (BL21-Gold(DE3), Agilent). Cells were plated onto LB+Amp agar aiming for
1,000 cfu / plate. The plates were incubated overnight at 37 °C and colonies picked using ster-
ile pipettes to inoculate deep 96-well plates containing 500 µL liquid LB+Amp. The 96-well
plates were incubated overnight at 37 °C and 750 rpm. From these plates, glycerol stocks
were prepared by mixing 75 µL of cell culture and 25 µL of 50% w/v glycerol and followed by
storage at −80 °C. Fresh plates were inoculated by adding 10 µL of the cell culture to 390 µL
of liquid LB+Amp. The plates were incubated at 37 °C for 3 h, after which the temperature
was reduced to 20 °C for 20min followed by addition of 100 µL of 1.2mM IPTG in LB+Amp
to induce protein expression. Plates were incubated at 20 °C overnight. They were then cen-
trifuged at 3,000 g for 1 h at 4 °C. The supernatant was discarded and the cell pellets frozen
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at −20 °C for 30min. After thawing, 100 µL of freshly prepared lysis buffer was added (1x
BugBuster (Merck), 15 µL of lysonase/50mL (Merck) and 1 tablet Roche EDTA free protease
inhibitor/50mL). The cells were lysed at room temperature and 1,400 rpm for at least 20min
and stored at 4 °C until used. The lysates were sequentially diluted by 10, 100 and 1,000 fold
using an epMotion robot: 20 µL lysate was added to 180 µL reaction buffer (20mM TrisHCl
pH 7, 50mM NaCl, filtered over 0.2 µm); the solution was mixed by pipetting up and down
10 times and 20 µL used for the next dilution step. Finally, 10 µL of the 1,000 fold dilu-
tion were added to 170 µL reaction buffer in a UV-transparent 96-well plate (Corning). The
reaction was started by adding 20 µL of 20mM 5-nitro-1,2-benzisoxazole in methanol and
followed for 30min at 380 nmwith 15 sec resolution using a spectrophotometer (SpectraMax
190, Molecular Devices).
7.2.9 Protein expression and purification
The cells were grown in LB medium containing 100 µgmL−1 ampicillin at 37 °C until an
OD600nm of 0.5 to 0.7 was reached. Protein expression was induced by addition of 400 µM
IPTG and the cells were grown at 20 °C for 20 h. The cells were then centrifuged at 4,000 g
for 10min at 4 °C. The cells were resuspended in 30mL of 50mM TrisHCl pH 8.0 and lysed
using an Emulsiflex (Avestin). The extract was brought to 100mM NaCl, 10mM imidazole,
and 10% v/v glycerol and centrifuged at 12,000 g for 40min at 4 °C to remove cell debris. The
supernatant was loaded onto Ni-NTA resin (Qiagen) which was pre-equilibrated with purifi-
cation buffer (50mM TrisHCl pH 8.0, 100mM NaCl, 10mM imidazole). The proteins were
eluted using a stepwise imidazole gradient (10, 50, 100, 200, 500mM imidazole). Fractions
containing the target protein were concentrated by centrifugation in an Amicon Ultra-15
concentrator with 30,000 MWCO (Merck-Millipore) at 3,000 g at 4 °C. The samples were
desalted over a Sephadex G-25 PD10 column (Amersham Biosciences) according to manu-
facturer’s protocol and eluted using buffer with 50mM TrisHCl pH 8.0 and 100mM NaCl,
10% v/v glycerol. For the promiscuity test, the concentrated fractions were further purified
by gel filtration on a HiLoad 16/60 Supderdex 75 or 200 column (GE Healthcare) and frac-
tions containing pure protein concentrated as above. Protein concentration was determined
by measuring absorbance at 280 nm using a NanoDrop ND-1000 spectrophotometer (Nan-
oDrop Technologies). The same protocol was followed to purify HG3.17 and other variants,
with 20mMTrisHCl pH7.0 and 50mMNaCl instead of 50mMTrisHCl pH8.0 and 100mM.
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7.2.10 p-Nitrophenyl ester kinetics
A dilution series of the respective p-nitrophenyl carboxylate (all purchased from Sigma-
Aldrich, except for p-nitrphenyl hexanoate, which was from TCI) in 180 µL 50mM TrisHCl
pH8.0 and 100mMNaClwas prepared in the range of tens ofmicromolar to severalmillimo-
lar. The reactions were performed in triplicate and started by addition of 20 µL 10× purified
enzyme in storage buffer or storage buffer only (blank) with the final concentration ranging
from nanomolar to low micromolar. The reactions were followed at 405 nm for 15min us-
ing a spectrophotometer (SpectraMax 190, Molecular Devices). Initial reaction rates were
determined in the linear range and the blank subtracted.
7.2.11 Differential scanning fluorimetry
Enzymes were at 10 µM in 50mMTris-HCl pH, 100mMNaCl, and 2.5% glycerol with 2× or
5× SYPRO Orange Protein Gel Stain (from 5,000× concentrate in DMSO, Thermo Fisher).
Samples of 20 µL were measured in triplicates in reaction tubes which had been heated pre-
viously to reduce sticking of the dye to the plastic surface. Melting curves were recorded on
a Rotor-Gene 6000 Real Time PCR Machine (Corbett). Fluorescence was excited at 470 nm
and measured at 610 nm between 25 and 95 °C in steps of 0.5 °C.
7.2.12 Catalytic promiscuity test
All reactions were performed in 96 well plates, had a volume of 200 µL, and were followed
at 405 nm using a SpectraMax190 spectrophotometer (Molecular Devices). All enzymes
were used at the highest concentration possible (N1ORF4: 1.6 µM, N1ORF5: 13.7 µM, N4:
13.8 µM,N7: 28.8 µM,N11: 0.3 µM,N13: 0.3 µM,N16: 14.7 µM,N26: 35.7 µM, RR11ORF1:
1.0 µM, RR11ORF2: 55.1 µM, ). Each substrates was at 1mM. The substrates were purchased
from Sigma-Aldrich unless otherwise stated: 1: pNP-hexanoate, 2: pNP-dodecanoate, 3:
oNP-decanoate, 4: β-lactamase substrate (CENTA™, Calbiochem), 5: pNitroacetanilide, 6:
pNP-phosphate, 7: pNP-phenylphosphonate, 8: pNP-sulfate, 9: pNP-β-D-glucopyranoside,
10: pNP-α-D-glucopyranoside, 11: pNP-β-D-galactopyranoside, 12: pNP-α-D-galactopyr-
anoside, 13: pNP-β-D-xylopyranoside, 14: pNP-β-D-fucopyranoside, 15: 2-Chloro-4-phenyl-
β-cellobioside (Megazyme), 16: pNP-β-xylobiose (Megazyme), 17: 5-nitrobenzisoxazole, 18:
S-phenylthioacetate, 19: 2,3-Mercapto-1-propanol, 20: S-Methyl-thiobutanoate. In reac-
tions 1-16 the buffer was 50mM TrisHCl pH 8.0 and 100mM NaCl. Reactions 18-20 were
performed in the same buffer with 10mM 5,5’-Dithiobis(2-nitrobenzoic acid) for the de-
tection thiols [263]. Reaction 17 was performed in 20mM TrisHCl pH 8.0 and 50mM in
TrisHCl pH 7.0.
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7.2.13 Kemp elimination kinetics
The formation of 4-nitro-2-cyanophenol (Kemp reaction product of 2a, see below) wasmon-
itored by UV–VIS spectroscopy (SpectraMax 190, Molecular Devices) at 380 nm at 25 °C for
30min using UV-transparent 96-well plates (Corning). The reactions were set up by adding
20 µL of a 10x stock solution of purified enzyme in 20mM TrisHCl pH 7, 50mM to 160 µL
of the same buffer and started by adding 20 µL of a 10x stock solution of the desired substrate
concentration in MeOH (10% v/v final). The enzyme concentrations ranged between 5 and
10 nM and the substrate concentrations between 40 µM and 2mM.
Buffer tests were performed using 40mM buffer and 100mM NaCl with 200 µM 2a. The
buffers were: sodium acetate (pH < 6), sodium phosphate (6 < pH < 8), sodium borate (pH
9) and sodium carbonate (pH 10). The substrate 2a was dissolved at 10mM in MeOH and
diluted to 1mM in 10mM HCl. The reactions were started by the addition of 40 µL of the
1mM substrate solution to each well. The total reaction volume was 200 µL.
7.3 Chemical procedures
7.3.1 Synthesis of 5-nitro-1,2-benzisoxazole 2a
Concentrated sulphuric acid (5.4mL, 89mmol) was cooled in an ice/water bath to 0 °C and
concentrated nitric acid (2.8mL, 44mmol) was added drop-wise.To this mixture, 1,2-benz-
isoxazole (3.0mL, 30mmol) was added drop-wise never allowing the reaction temperature
to rise above 15 °C. The solutionwas stirred for 30min and poured onto an ice/watermixture
(1:1, 70mL). The crude product was collected as a precipitate and recrystallised from anhy-
drous ethanol to yield 5-nitro-1,2-benzisoxazole (930mg, 6mmol, 20% yield) as colourless
needles, δ𝐻 (500MHz; (CD3)2SO): 9.45 (s, 1 H), 8.88 (d, J = 2.3 Hz, 1 H), 8.50 (dd, J = 9.3
Hz, J = 2.3 Hz, 1 H), 8.02 (d, J = 9.3 Hz, 1H); δ𝐶(500MHz; (CD3)2SO): 163.7 (arom. C-O),
148.7 (arom. CH=N), 144.4 (arom C-NO2), 125.9, 122.1, 120.4, 110.7 (arom.).
7.3.2 Synthesis of 4-nitro-2-cyanophenol 2b
5-Nitro-1,2-benzisoxazole was incubated under basic conditions (6.7mM in 0.33M NaOH)
for three hours, followed by neutralisation with HCl yielding 5mM 4-nitro-2-cyanophenol
in 0.5M NaCl. The apparent extinction coefficient was determined from four concentra-
tions (50, 100, 150 and 200 µM) at each pH in the respective buffer with NaCl adjusted to
100mM. A maximum was observed at 380 nm and the apparent extinction coefficient at pH
7 determined to be ε380𝑛𝑚 = 15,900M−1 cm−1, in close agreement with literature [94].
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7.3.3 Synthesis of 5-amino-1,2-benzisoxazole 5a
This compound was synthesised by Dr Josephin Holstein according to previously published
procedures [191].
Yield 70%. δ𝐻 (400MHz; CDCl3): 8.55 (s, 1H), 7.43 (d, J = 8.8 Hz, 1H), 6.98 (dd, J = 2.3 Hz,
J = 8.8 Hz, 1H), 6.93 (dd, J1 = 0.5 Hz, J2 = 1.8 Hz, 1H). m/z for C7H7N2O+: 135.06 [M-H]+;
found: 135.2
7.3.4 Synthesis of 5-azido-1,2-benzisoxazole 6a
This compound was synthesised by Dr Josephin Holstein.
5-amino-1,2-benzisoxazole (100mg, 0.75mmol) was dissolved in 10mL of 2MHCl. The so-
lutionwas cooled to 0 °Cwith an ice bath. An aqueous solution ofNaNO2 (65mg, 0.78mmol,
in 1mL water) was added slowly to the solution. The mixture was stirred for 30min. Then,
NaN3 (95mg, 1.5mmol) in water (4.25mL) was added to the mixture. The mixture was
stirred for 3 h at room temperature. The resulting brownish solution was extracted with
ethyl acetate (3×30mL). The combined organic layers were washed with brine (50mL). The
solvent was evaporated and the resulting brown product dried under high vacuum yielding
60mg (0.37mmol, 50%) product. δ𝐻 (400MHz,CD3(SO)): 8.69 (s, 1H), 7.63 (d, J = 8.8 Hz,
1H), 7.39 (d, J = 2.2 Hz, 1H), 7.26 (dd, J = 2.2 Hz, J = 8.8 Hz, 1H).
7.3.5 Small molecule characterisation
Dr Josephin Holstein lyophilised the reaction products and submitted them to the below services
at the Department of Chemistry.
To characterise the reaction products of 6a, it was converted using 1 µM purified HG3.17
in 20mM TrisHCl pH 7, 50mM NaCl overnight in the dark. It was then either kept in the
dark until measured or exposed to light of 365 nm for 10min using a hand-held UV-lamp
(ca. 100 µWcm−2). The enzyme was precipitated by addition formic acid (conc.) and the
supernatant lyophilised (E-C MicroModulyo, ThermoFisher).
UPLC-MS Samples were dissolved in 50% aqueous acetonitrile and characterised using a
Waters system consisting of an H-Class UPLC, a photodiode array for UV detection (190 to
800 nm) and a SQD2 single quadrupole mass spectrometer (100 to 500 m/z) using electro-
spray ionisation. Samples were run on a C18 UPLC column using a 5 to 95% acetonitrile
gradient, 2mM ammonium acetate, over 1min under neutral, acidic (+ 0.1% formic acid) or
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basic (+2mM ammonium hydroxide) conditions with detection switching between positive
and negative mode.
NMR The compound was dissolved in 600 µL DMSO-d6 (MagniSolve, Merck) and sub-
mitted to the NMR service at the Department of Chemistry where it was measured on a
Bruker 400MHz UltraShield Plus magnet equipped with a Quattro Nucleus Probe (QNP)
cryoprobe.
7.4 Sequence Similarity Networks
Thefull-length fasta sequenceswere downloaded fromPfam (PFAM32.0, https://pfam.xfam.org/,
April 2019) for the largest families of each clan. To reduce the number of sequences (nodes) in
the network, the individual families were clustered stepwise to 90%, 60% and 30% sequence
identity using cd-hit and psi-cd-hit [264]. The most representative sequence for each cluster
was used combined with the esterase hit sequences into a single database, which was used
for an all-versus-all alignment (Protein-Protein BLAST 2.6.0+, [265]). Each line in the out-
put file defined an edge (alignment) connecting two nodes (representative sequence) of the
network. Duplicate edges, self-loops and edges above a certain e-value were removed using
a custom python script. The simplified network was then imported into CytoScape 3.7.1 to
visualise the network [266].
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Fig. A.1 Transmission spectra of the filters used in the FADS.
240 Supplementary Data Chapter 2
Fig. A.2 Shown is the raw data from which the linearity of fluorescence measurements in
Figure 2.8 was derived. The peaks were detected using peak detection inMatlab and assigned
concentrations from the highest to the lowest peak, the width of peaks was measured at half
peak promincence.
241
Fig. A.3 Shown is a simulation of different fluorescence signals based on normal distribu-
tions with various amplitudes and standard deviations (relating to droplet size). The width,
FWHM, and are were then calculated according to the algorithm in Figure 2.4.

Appendix B
Supplementary Data Chapter 3
Table B.1 The SCV library is a combination of several metagenomic libraries in plasmid
pZero2 [67]. The average library member is 3 to 5 kbp in size.
Library Library Size /103 Source
ENR-M 23 Marine Sludge
ENR-S 35 Goose Pond
ENR-G 25 Sandy Soil
ENR-L 30 Loamy Soil
DIR-L 80 Loamy Soil
SEM 80 Vanilla Pods
TSA 45 Vanilla Pods
DIR-MC 500 Medium Compost
DIR-RC 300 Thermophilic Compost
CR2 135 Cow Rumen
SCV 1,253
B.1 DNA Inserts








244 Supplementary Data Chapter 3
Fig. B.1 The Vector Map of pZero2.





2 R F E P Y E C L N S E I T G D Y D K A H A V K C V N G T F V
901 CGTTTTGAACCGTACGAATGCTTGAACAGCGAAATCACCGGAGATTACGACAAGGCCCATGCCGTGAAGTGCGTGAACGGCACCTTTGTG
32 G T E E H G V A S W L G I P F A K P P V G G R R F K A P E Y
991 GGAACCGAGGAGCACGGGGTCGCGTCGTGGCTGGGCATCCCCTTCGCGAAGCCGCCCGTGGGCGGGCGCCGCTTTAAGGCGCCGGAGTAC
62 V D A S D R V F K A R Y Y G K C A F G A Q A Y P D C V Q K L
1081 GTGGACGCCAGCGACCGGGTCTTCAAGGCCAGGTACTACGGAAAGTGCGCTTTCGGCGCACAAGCCTATCCGGATTGTGTGCAGAAGCTG
92 S S E D C L Y L N I W A N T D D K T E K K P V M V W I H G G
1171 AGCTCCGAGGACTGCCTTTACCTGAACATCTGGGCCAACACCGACGATAAGACCGAGAAGAAGCCGGTTATGGTCTGGATCCACGGCGGG
122 A Y V T G S G S Q I S Y S G A N L V Q K H S D I I M V N I N
1261 GCTTACGTCACCGGCTCGGGCTCGCAGATCTCCTATAGCGGAGCCAACCTGGTCCAGAAGCATAGCGATATCATCATGGTGAACATCAAC
152 Y R L N M Y G F M D F S S V P G G E N F K T A P C N G L L D
1351 TACCGCCTGAACATGTACGGCTTCATGGACTTCTCGTCGGTACCCGGCGGCGAAAACTTTAAGACGGCGCCCTGCAACGGCTTGCTCGAC
182 Q A M A L R W V H E N I A A F G G D P D N V T I F G Q S A G
1441 CAGGCTATGGCGCTCCGGTGGGTGCACGAGAACATCGCCGCTTTCGGCGGCGACCCCGACAACGTGACCATCTTCGGGCAAAGCGCCGGC
212 G G S V S I L P V M K E A N R Y F Q K V I A Q S G S A T L A
1531 GGCGGCTCGGTCTCCATCCTGCCGGTCATGAAGGAAGCGAACCGGTATTTCCAGAAGGTCATCGCCCAGAGCGGCTCGGCCACCCTGGCA
242 F P V D C E A A Q G K T K A L L E F T G C K T M D D I M A L
1621 TTCCCGGTGGACTGCGAAGCAGCCCAGGGCAAAACTAAGGCACTGCTGGAGTTCACCGGCTGCAAGACCATGGACGACATCATGGCGCTG
272 S E E A L Q E A Y V E A V G K F T S C P Y Y G T E V L P E A
1711 AGCGAAGAGGCGCTTCAGGAGGCGTATGTGGAAGCAGTCGGCAAGTTCACCTCCTGCCCCTACTACGGAACGGAGGTTCTCCCCGAGGCG
302 P I E L Y R K G Y A K H I S I M A G T T A D E M R L F M G E
1801 CCCATCGAGCTGTACCGTAAAGGTTACGCAAAGCACATATCCATCATGGCAGGCACCACGGCCGACGAGATGAGGCTGTTCATGGGCGAG
332 G P C L S L E E Q K L Y A R R A A G D A V P Y L K E E D K K
1891 GGCCCGTGTCTGAGCCTGGAAGAACAAAAACTATACGCCCGGCGCGCTGCGGGCGACGCAGTTCCCTACCTGAAGGAAGAGGACAAAAAG
362 Y Y E E F R R V C R D Q E P G L V E T E F I N E L M F R V P
1981 TATTACGAAGAATTCCGGCGGGTATGCAGGGATCAGGAGCCGGGACTTGTGGAGACGGAGTTCATAAATGAGCTCATGTTCAGGGTCCCC
392 M L Q Q L D A Q S A F N K T F C Y Y W S Y P G S N P D M G A
2071 ATGCTCCAACAGCTCGACGCCCAAAGCGCGTTCAACAAGACGTTCTGCTACTACTGGTCGTACCCGGGCAGCAACCCGGATATGGGGGCA
422 A H S V E L L F V F D F R G V G T D S T F N G T N I P E E I
2161 GCGCATTCCGTGGAGCTCCTGTTCGTGTTCGACTTTCGCGGCGTGGGGACGGACAGCACCTTCAATGGCACCAACATCCCCGAAGAGATC
452 F T A V Q Q M W T N F A R C G N P S T D K V E W K A Y S V D
2251 TTCACGGCTGTTCAGCAGATGTGGACCAATTTCGCACGCTGCGGCAACCCGTCCACAGACAAGGTCGAATGGAAGGCGTACTCGGTGGAC
482 D Q N V L V I A G P D D I H I E Q G L L A D Q Y K A V L P L
2341 GACCAGAACGTCCTGGTCATCGCCGGGCCGGATGACATTCATATCGAACAGGGCCTTCTGGCCGATCAGTACAAGGCCGTGCTCCCCTTG
512 L G Y Y Q F M D K F F T P G Y L L D I V A A R Q Q N A *
2431 CTGGGCTACTACCAGTTCATGGACAAGTTCTTTACGCCCGGCTACCTTTTGGATATCGTCGCCGCGCGCCAGCAGAATGCCTAAgctctg
540 M N T K I K C N N G T F I G
2521 tagggaatataagacaaactttggtaaaaagagaaagaagcaaatcacATGAACACTAAGATCAAATGCAACAACGGCACTTTCATCGGC
554 K E T D G L I I W K G I P Y A T Q P V G K L R W K K A L P A
2611 AAGGAGACAGACGGACTGATAATCTGGAAGGGCATCCCCTACGCAACCCAGCCTGTGGGAAAGCTTCGCTGGAAGAAGGCACTTCCTGCC
584 A D D D G V Y D A T K P G H I P I G P V N D S M E T A E F G
2701 GCGGACGATGACGGCGTGTACGACGCCACAAAGCCCGGCCACATTCCGATCGGGCCCGTGAACGACTCCATGGAAACAGCGGAGTTCGGC
614 E D C L V L N I Y C N T G C T D S R K P V M V W I H G G G F
2791 GAGGACTGCCTCGTGCTGAACATTTATTGCAATACCGGATGCACTGACAGCAGGAAGCCGGTCATGGTATGGATCCACGGCGGCGGGTTC
644 C A E S Q A S P L Y D L T G I S R Q Y P D I L F V S I D Y R
2881 TGCGCTGAATCCCAGGCGTCGCCCCTTTACGACCTTACCGGCATCTCCAGACAGTACCCCGACATCCTGTTCGTGTCCATCGACTACCGG
674 L G F L G F I N F E R V P G G K N F R E A G N L G L L D Q L
2971 CTCGGATTCCTGGGGTTTATAAACTTCGAGCGGGTTCCGGGGGGAAAAAACTTCAGGGAGGCAGGCAACCTCGGCCTGCTCGACCAGCTT
704 E A L R W V Q K N I A G F G G D P D N V T I F G E S A G S A
3061 GAGGCCCTCAGGTGGGTACAGAAAAACATCGCCGGGTTCGGCGGCGATCCGGACAACGTGACAATATTTGGTGAGTCCGCAGGCTCGGCA
734 S V T F L P L I N G S E G L F R K C I A Q S A N I A Y C D T
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3151 AGCGTCACGTTCCTCCCCCTCATCAACGGAAGCGAGGGGCTCTTCAGGAAATGCATCGCACAAAGCGCCAACATCGCCTACTGCGACACC
764 M E H G I H V T Q N F L T A A G C Q T M D E L M E L T T G E
3241 ATGGAGCACGGCATCCACGTGACGCAGAACTTCCTGACCGCAGCGGGCTGCCAGACCATGGACGAACTGATGGAGCTCACCACCGGGGAG
794 L V D A Y Q K A S I I D K N C V L G T A N F P L L D G V T L
3331 CTTGTTGATGCCTATCAGAAAGCAAGTATCATTGACAAGAACTGCGTTCTGGGAACTGCCAACTTCCCGCTTCTCGACGGCGTCACGCTG
824 P E D R A D M Y G M W G D E K R A K I D L M I G S N Q D E I
3421 CCCGAGGACCGGGCGGACATGTACGGGATGTGGGGAGACGAAAAGAGAGCCAAGATCGATTTGATGATTGGGTCTAACCAAGATGAAATC
854 R Y F V P F E G G E E G F A N T L R W I A K R D R A L L N E
3511 AGGTACTTTGTTCCCTTCGAGGGCGGCGAAGAAGGCTTCGCGAATACGCTGAGGTGGATCGCGAAGAGAGATCGCGCGCTGCTCAACGAG
884 Q E K A M Y D E F M A T L A N E S E G S R L E Q Y C N D I N
3601 CAGGAGAAGGCCATGTATGACGAGTTCATGGCCACGCTGGCAAACGAGAGCGAGGGGAGCAGGTTGGAGCAATACTGCAACGACATCAAC
914 F R A G N T N M A I R H S A A G G N T Y M Y F M K K P V I T
3691 TTCCGCGCCGGTAACACCAATATGGCCATCAGGCATTCTGCCGCCGGCGGAAACACCTACATGTACTTCATGAAGAAGCCGGTGATAACC
944 P Q L G A I H A A E I P Y L F D T C L E D P M G S G E I V G
3781 CCCCAGCTTGGCGCGATACACGCAGCCGAAATTCCGTACCTGTTCGACACTTGCCTGGAGGATCCGATGGGAAGCGGAGAGATCGTTGGG
974 T D E C E F R H V V K E M W V N F A R T G N P S T D K Y E W
3871 ACCGACGAGTGCGAGTTCCGCCACGTCGTAAAGGAGATGTGGGTCAACTTTGCCCGGACGGGCAATCCTTCCACCGACAAATACGAGTGG
1004 K K F S G D D R Q T M V F D D A I G M Q K D L F G R R E D L
3961 AAAAAGTTCTCGGGGGACGACCGCCAGACGATGGTCTTCGATGATGCCATCGGCATGCAGAAGGATCTGTTCGGAAGGCGCGAGGATCTG
1034 M M S W A E R L G N G S S K R V C *
4051 ATGATGTCCTGGGCAGAACGCCTCGGGAACGGATCGTCCAAGAGGGTCTGCTAAcgtgggcgtaagcgcaagtaacgattagaaattaat
4141 cttcaaaatccaaagattttttgcggctaatatgttataataaataagcaatgtttaaccattgcaatggtagtttcttt
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2701 gaccaccacgctttaagtgctgagtccaagagaaaggcgcctctgcaacgggcgcctcttctgaacccgtgagaagcaagggatgctggc
2791 caatagccaatattcctaatgatcttgtcctgtttgtgacgtaacgcttcactgttgatacatgacatggcgatatgcgtcgtaactgct
1 M L N T A L R R P F A A C L L S L
2881 accttctcgttcagtaatacaaaacaagaagggatttctcgATGCTCAACACTGCTCTGCGCCGCCCTTTCGCGGCCTGTCTCCTCTCGC
18 A C S S A M A A S S P Y S T M I V F G D S L A D A G Q F P D
2971 TCGCCTGCTCCTCGGCCATGGCGGCTTCCTCTCCCTACTCGACGATGATCGTCTTCGGTGACAGCCTTGCCGACGCGGGCCAGTTCCCCG
48 A G G P A G S T L R F T N R V G P T Y L N G S G E A F G L N
3061 ATGCGGGCGGCCCTGCCGGATCGACCCTGCGTTTCACCAACCGTGTCGGCCCAACCTACCTGAACGGCAGTGGCGAAGCGTTCGGGTTGA
78 S S T L L G G M L G V A P N D L Q A S T S P V R A A Q G L A
3151 ACTCATCGACGCTCCTGGGCGGCATGCTGGGCGTCGCCCCCAACGACCTGCAGGCCTCGACGTCTCCCGTGCGCGCCGCTCAGGGCCTGG
108 D G N N W A V G G D R T D Q I L A A I T T Q S Q V A N T T S
3241 CGGACGGCAACAATTGGGCGGTGGGCGGGGATCGAACGGACCAGATCCTGGCGGCCATCACGACCCAGTCCCAGGTCGCCAACACCACCT
138 G V T T V F R T R P G Y L V E N N F R A D P N A L Y Y L T G
3331 CGGGGGTGACGACCGTGTTCCGCACCCGACCGGGCTATCTGGTTGAGAACAATTTTCGCGCCGACCCCAATGCCCTGTACTACCTGACGG
168 G G N D F L Q G R V I S P G Q A I S A A N N L A D G A Q V L
3421 GGGGCGGCAATGACTTCCTGCAAGGGCGCGTAATCAGCCCCGGCCAAGCCATCAGCGCGGCCAATAATCTCGCCGACGGCGCGCAAGTGC
198 S Q A G A R Y I M V W L L P D I G Q T P A V S G T F L Q G P
3511 TGTCCCAGGCCGGCGCGCGCTACATCATGGTCTGGCTGCTGCCTGATATCGGTCAGACACCCGCCGTCTCTGGCACCTTTCTGCAAGGGC
228 S T L L S G V F N Q Q L V N R L G Q I N A E V I P L N V P G
3601 CATCGACGCTGCTCAGCGGCGTGTTCAATCAGCAGTTGGTCAATCGCCTTGGCCAGATCAACGCAGAAGTGATCCCGCTGAACGTGCCGG
258 L V R E V L D D P A R F G L A A D Q N L V G T C F S G N S C
3691 GACTTGTTCGGGAAGTTCTGGACGACCCTGCCCGCTTTGGCCTCGCGGCGGATCAAAATCTGGTGGGCACCTGCTTCAGCGGCAACAGTT
288 T A N S V Y G I G G T S P D P S K L L F N D G V H P T V A G
3781 GCACCGCCAACAGCGTTTACGGCATCGGCGGCACCAGCCCCGATCCGAGCAAACTGCTGTTCAACGATGGCGTGCACCCGACGGTCGCCG
318 Q R L I A D Y G Y S I L S A P W E I T L L P E M A N G T L R
3871 GTCAGCGGCTGATCGCCGACTACGGTTACTCGATTCTCTCGGCGCCGTGGGAAATCACCCTGCTCCCGGAAATGGCCAACGGCACCTTGC
348 A Q Q D E L R S Q W L A D W G N W Q N V G E W R A I V A G G
3961 GTGCGCAGCAGGACGAACTGCGCAGCCAGTGGCTGGCCGATTGGGGCAACTGGCAGAACGTTGGAGAATGGCGCGCCATCGTCGCAGGCG
378 G Q K L D F D A Q G N S A S G D G H G Y N L T V G G S Y R F
4051 GCGGTCAGAAACTGGACTTCGATGCGCAAGGCAATTCCGCGAGCGGCGACGGCCATGGCTACAACCTGACCGTGGGCGGCAGCTACCGCT
408 A E D W R S G L V A G A Y R Q T L E A G P R D S D Y T L N S
4141 TTGCTGAAGACTGGCGCTCAGGGCTGGTGGCCGGGGCCTATCGGCAGACGCTGGAAGCCGGGCCAAGGGATTCGGACTACACACTCAACA
438 Y I A T A F V Q F H T N H W W A D L A A S G G K L D Y D N L
4231 GCTACATCGCCACGGCTTTCGTGCAGTTTCATACGAATCACTGGTGGGCCGACCTGGCGGCATCAGGCGGCAAGCTGGACTACGACAACC
468 K R K F A L G V S E G A E K G D T D G N L W A L S G R L G Y
4321 TCAAGCGCAAGTTCGCGCTCGGGGTCAGCGAGGGCGCAGAGAAAGGCGACACCGACGGCAACCTCTGGGCGCTGAGCGGACGGCTTGGCT
498 D L A E Q S S R W H V S P F I S A D Y S R V E V D G Y S E N
4411 ATGACCTGGCCGAGCAGAGCAGTCGCTGGCATGTCTCGCCCTTCATCAGTGCCGACTACTCCCGCGTCGAGGTCGATGGCTATTCGGAGA
528 S T R A T A L N Y D D Q T R R S K R L G A G L Q G K F D V T
4501 ACAGCACTCGCGCCACTGCGCTCAATTATGACGACCAGACCCGCCGGTCGAAGCGTCTGGGTGCAGGCCTGCAAGGCAAGTTCGATGTCA
558 P Q T Q V F G E V A H E R E F D T D Q Q D V T I A L N S V P
4591 CGCCGCAGACGCAGGTGTTTGGCGAAGTGGCCCACGAACGCGAATTCGACACCGATCAGCAGGACGTGACCATTGCCCTGAACAGCGTGC
588 G V D F N L Q G Y E P Q R S L N R A S V G L S Q K L T Q D L
4681 CGGGTGTGGATTTCAATCTGCAGGGGTATGAGCCGCAACGCAGTTTGAATCGGGCGAGTGTGGGATTGAGCCAGAAGCTGACGCAGGACC






B.1.3 N7 DNA Insert
1 agaacaggaaaaacggcaccagggcggcaacaagtggatcggcacgggcggcacttcgccattcggacattcgggctacaacccggaagg
91 tgtccgtatcggcggcgagggaaagcatgggcgggccatcaaagtctgggaaaagcgcgagtttgccaatctcgacaacacacgtgaact








1 M G D A I E V T G L Q V P A R T I P T P
811 acgtaagaaacattaatctgcggaggaatgaATGGGGGACGCGATTGAAGTGACAGGGCTGCAAGTGCCGGCCCGGACCATCCCGACGCC
21 N T I S S E A Q A F L S R G L P I M P P E I P H T D K D R W
901 CAACACGATAAGTTCCGAAGCGCAGGCTTTCCTGTCTCGTGGCCTCCCCATAATGCCGCCGGAGATCCCGCACACAGACAAGGATCGTTG
51 R G Y V A Q V E A Q I V R V A E M R A R A F P A A I S E H R
991 GCGTGGCTATGTCGCGCAGGTCGAAGCGCAGATCGTCCGGGTGGCAGAAATGCGTGCTCGCGCCTTTCCTGCGGCCATATCGGAACATCG
81 L G S T T L Y E V T P D T L D P A D E D K A I L H I H G G A
1081 CCTGGGCAGCACGACACTCTACGAGGTGACCCCCGACACGCTCGATCCAGCCGATGAGGATAAGGCGATCCTCCATATTCATGGCGGCGC
111 F I V G G G K S A A Y T A Q T I S S L A G I R A F S P D Y R
1171 GTTCATCGTCGGGGGCGGAAAATCCGCCGCATACACGGCCCAGACCATTTCCAGCCTTGCCGGGATACGCGCCTTCTCTCCAGACTACCG
141 M P P D H P Y P A G L D D C V E A Y R F L L E R Y D P S R I
1261 GATGCCGCCCGATCATCCTTATCCGGCCGGACTGGACGATTGCGTGGAAGCCTATCGCTTTCTTCTGGAACGGTATGATCCGTCCAGAAT
171 A L E G S S A G A N L V A A T I L R A R D E G L P L P G A C
1351 CGCGCTGGAAGGATCATCGGCCGGGGCCAACCTTGTCGCTGCCACGATTCTGCGCGCGAGGGACGAAGGATTGCCACTTCCCGGTGCATG
201 S L H T A G V D L T H S G D T F A T N E V I D I V L R G P Q
1441 TTCGCTCCATACCGCGGGTGTGGACTTGACCCACTCTGGCGACACCTTCGCAACCAACGAGGTGATCGACATCGTCCTTCGCGGGCCGCA
231 P E T M L L Y A G G H D M R D P Y L S P V F G D V T K G F P
1531 GCCGGAAACCATGCTCCTGTATGCAGGTGGCCATGACATGCGAGATCCCTATCTTTCGCCAGTTTTCGGGGATGTGACCAAGGGTTTTCC
261 P T I L V S G T R D L L L S P T V L M H R A L R R A G I E A
1621 TCCCACGATTCTCGTATCAGGCACGCGCGACCTGCTTCTCTCGCCCACGGTGCTGATGCATCGCGCCCTGCGCCGCGCAGGGATCGAGGC
291 D L H V F E A M P H G G L G G A S P E D R E L Q L E I A S F
1711 TGACCTGCATGTCTTTGAAGCGATGCCGCACGGCGGCCTTGGCGGCGCTTCGCCTGAAGATCGTGAACTGCAGCTGGAGATCGCAAGCTT


























B.1 DNA Inserts 249
4051 tctcctcaatgacggcagacagggcaatgcagcgctcacccggcgacagcggtatcgtggct


















1 M A N I S V R F Y S N C L R R
1531 aataattaagaaagtattccaaccacccacagaaaggaagaatgacATGGCAAATATTTCTGTTCGCTTTTATTCAAACTGTTTGAGAAG
16 F T T F N M Y L P N D I R E E E P N E S E Y A N R P I K T L
1621 ATTTACGACATTTAATATGTATCTGCCCAATGATATAAGGGAAGAGGAGCCCAACGAGTCGGAGTACGCGAATCGTCCGATTAAGACGCT
46 F L L H G Y T G D A D N W V P W Y L A D K Y N F A V V I P N
1711 GTTCCTGCTTCACGGATATACGGGCGACGCAGATAACTGGGTGCCGTGGTATCTGGCGGATAAGTATAATTTTGCGGTTGTGATTCCAAA
76 G E N A F W L D G I S T G H A F C K F V G E E L M D Y V R R
1801 CGGAGAGAACGCATTCTGGCTTGACGGCATTTCGACGGGTCATGCATTCTGCAAATTCGTGGGCGAGGAACTCATGGATTATGTCAGGAG
106 V F G L A K T K E D T Y I M G L S M G G F G A L H T A L Y Y
1891 AGTTTTCGGCCTCGCAAAAACAAAGGAAGACACCTACATCATGGGATTGTCCATGGGCGGATTCGGCGCACTGCACACCGCTTTGTACTA
136 P D K F G T A T A L S P A L I V H E V A S L K E G E G N G I
1981 TCCCGATAAATTTGGCACCGCGACAGCACTTTCTCCCGCGTTAATCGTACATGAAGTAGCGTCCCTAAAAGAGGGCGAAGGAAACGGGAT
166 A N Y E Y F R E C F G D L T K V L E S R N N P E T L I K E I
2071 AGCAAATTATGAGTACTTCAGAGAATGCTTCGGAGATCTCACGAAAGTGCTTGAAAGCAGGAACAATCCCGAAACGCTCATAAAAGAAAT
196 K A E G K D C P K I F M A C G T D D F L I E N N R D F H K F
2161 AAAAGCCGAAGGCAAAGACTGCCCTAAAATATTCATGGCTTGTGGGACAGATGATTTCCTGATCGAGAATAACCGAGACTTCCACAAATT
226 L E S E G I E H V Y A E E K G D H N M E F W D K Y L R I F I
2251 CCTTGAATCCGAGGGAATTGAACATGTTTATGCGGAAGAGAAGGGCGATCATAACATGGAATTTTGGGATAAATATTTGAGGATATTTAT
256 P K M F E *
2341 ACCTAAGATGTTCGAATAActcgagggtgctttggctaccgggtgacactgggggacggggttttaatgtaatagaaaaatcca




2 K K K L I Y A A V V S A L L S G C G G S D E N K G D T S S Y
181 GAAAAAGAAGCTAATTTACGCGGCAGTCGTGAGTGCGCTGCTGAGCGGTTGTGGTGGCAGTGACGAAAACAAAGGCGATACCTCAAGCTA
32 L D Y L L S G T N A A R P S A L A A R A S D G T L K F S T E
271 TCTCGATTATCTGCTGAGCGGCACCAATGCGGCGCGCCCCAGCGCCCTGGCCGCCCGTGCCAGTGACGGCACCCTGAAGTTCTCCACCGA
62 T A D L S N P V S A L S T L D G W S T T Q A I Q I V P V T A
361 AACGGCCGATCTCTCCAATCCAGTCTCAGCCCTCTCCACCCTGGATGGCTGGTCCACTACCCAGGCGATCCAGATAGTGCCAGTGACTGC
92 S G I T V K A P S A A E F G A S V A P L Y L L E L E F D S A
451 CTCGGGCATCACAGTCAAGGCGCCGTCCGCCGCCGAATTCGGTGCCTCAGTGGCTCCGCTCTACCTGCTGGAGCTGGAATTCGACAGCGC
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122 A L R P S G V K K V L A Y G V D F V V A E S A G K L N L V P
541 CGCCCTGCGCCCGAGTGGTGTGAAGAAGGTGCTGGCCTACGGGGTGGACTTCGTGGTCGCCGAGTCGGCGGGCAAGCTGAACCTGGTGCC
152 L K P L N P S S Y Y M I V A T D S L K D S S G N P L R A G S
631 GCTCAAGCCGCTCAATCCCTCTTCCTACTACATGATAGTGGCGACCGATTCGCTCAAGGACAGCAGCGGCAACCCCCTGCGGGCGGGCAG
182 D Y S N Y K S T T G S N A Q E Q T I S G L I A L Q E G L F K
721 CGACTATAGCAACTACAAGAGCACCACCGGCAGCAATGCCCAGGAGCAGACCATCAGCGGCCTGATAGCGCTGCAGGAAGGGTTGTTCAA
212 A A T G I T S D H V I F S D W F G T Q S G A D V L V A V K G
811 GGCGGCCACCGGCATCACCAGCGACCATGTGATCTTCTCCGACTGGTTCGGTACCCAGTCCGGCGCCGATGTGCTGGTGGCGGTGAAGGG
242 A A A S V L K S P T L D A A A L W K Q D A L G N T S L P G T
901 CGCGGCCGCTTCCGTGCTCAAGAGCCCGACCCTGGACGCAGCCGCCCTGTGGAAGCAGGATGCCCTGGGCAACACCAGCCTGCCCGGCAC
272 Y T L A V T G S N T F L T Q L D A E Q F L P Q E Q K D A I A
991 CTACACCCTGGCCGTGACCGGTAGCAATACCTTCCTGACCCAGCTGGATGCGGAGCAGTTCCTGCCGCAAGAGCAGAAAGATGCCATTGC
302 A A V E V N P Q L K G L A G M T Q V F T G T V K L P Y F L S
1081 CGCCGCCGTTGAAGTTAACCCGCAATTGAAAGGTCTTGCCGGTATGACCCAGGTCTTTACCGGTACGGTCAAGCTGCCCTACTTCCTCTC
332 S P A T A G S W D K A R T Q S W H G A I P S L Y A I A N A L
1171 CTCTCCGGCCACTGCCGGCTCCTGGGACAAGGCCAGGACCCAGTCCTGGCATGGTGCCATCCCCAGTCTCTATGCCATCGCCAATGCGCT
362 K A Q D A E V I G G L V G A G V D P A L L G E L I A D P S R
1261 GAAGGCACAGGATGCCGAGGTGATCGGCGGTCTGGTGGGCGCCGGTGTGGATCCGGCCCTGCTGGGCGAGCTCATCGCCGATCCGAGCCG
392 Q A E L L A E A S K L I G V T L T S G G K A L D P E Q N I G
1351 TCAGGCCGAGCTGCTGGCGGAGGCGAGCAAGCTGATCGGGGTGACCCTCACCTCCGGCGGCAAGGCGCTGGATCCCGAGCAGAACATAGG
422 R F N P L P K L E E V Q S V P M R I F A A T N D L K T I T D
1441 CCGCTTCAACCCGCTGCCCAAGCTGGAAGAGGTGCAGTCCGTGCCTATGCGGATCTTCGCCGCAACCAATGACCTGAAGACCATCACAGA
452 V I I Y Q H G V T S V K E N A Y A L A L G Q I G A G A Q A S
1531 TGTGATCATCTATCAGCACGGCGTCACCTCGGTGAAGGAGAACGCCTACGCCCTGGCACTGGGTCAGATCGGTGCCGGTGCCCAGGCGAG
482 K N V A V V V I D H P L H G E R G F A L T G S P D S V T T D
1621 CAAGAACGTGGCCGTGGTGGTGATCGATCATCCGTTGCACGGGGAGCGTGGCTTCGCCCTGACCGGCAGTCCTGACTCGGTCACCACGGA
512 K N P T P Y L N V S Y L T V A R D N L K Q S V A D L L G L R
1711 TAAGAACCCGACCCCCTACCTGAACGTGAGCTACCTGACGGTGGCGCGGGACAACCTGAAACAGAGCGTGGCGGATCTGCTGGGCCTGCG
542 L A V G L A N A K G A I G Q K G L K V H F L G H S L G A I A
1801 TCTGGCGGTGGGTCTGGCCAATGCCAAGGGTGCTATCGGTCAGAAGGGCCTCAAGGTGCACTTCCTGGGTCACTCCCTGGGTGCCATCGC
572 G A N L L A V A N Q P I G N A Q A D A L F K F T T G G L A M
1891 CGGGGCCAACCTGCTGGCGGTGGCCAACCAGCCCATCGGCAACGCCCAGGCGGATGCCCTGTTCAAGTTCACCACCGGCGGCCTGGCCAT
602 P G G G I A P L L L N S P T F G P T I Q M S V L T G G S A A
1981 GCCGGGTGGCGGCATAGCCCCGCTGCTGCTGAACTCGCCGACCTTCGGCCCGACCATCCAGATGAGCGTGCTGACCGGTGGCAGTGCTGC
632 L K T A F T A Y A P N C K T A A P T C F V N E F L P S L D A
2071 CCTGAAGACGGCTTTCACCGCCTATGCGCCGAACTGCAAGACGGCGGCGCCGACCTGCTTCGTCAACGAGTTCCTGCCGAGCCTGGACGC
662 A T Q A S A A G T L Q S Y S F A A Q S V L D S A D P I N L G
2161 CGCCACCCAGGCGAGCGCGGCCGGTACCCTGCAGAGCTACAGCTTCGCGGCCCAGTCGGTGCTGGATTCGGCGGATCCGATCAACCTGGG
692 R G I A A D F P L F A T E V V G D G A L S L S D R V I P N S
2251 TCGCGGCATAGCGGCGGACTTCCCGCTGTTTGCCACCGAAGTCGTCGGCGACGGCGCCCTGAGCCTGTCGGATCGGGTTATCCCGAACAG
722 I A T A P L G G T E P L F K V L A L Q P L S A T G A A N H H
2341 CATTGCCACCGCCCCCCTGGGTGGCACCGAGCCGCTGTTCAAGGTGCTGGCCCTGCAACCCCTGAGCGCGACCGGTGCGGCCAACCACCA
752 A T R F V A G G H S S L L A P D E N F D P T G A V T T E M Q
2431 CGCCACCCGCTTCGTGGCCGGTGGTCACAGCTCGCTGCTGGCACCGGACGAGAACTTCGATCCGACCGGTGCCGTCACCACAGAGATGCA








B.1 DNA Inserts 251











1 M Q F R A N S K I T D G N Y D R S L A V K C I N G T F
901 aggaacgaagaATGCAGTTCAGAGCAAACAGCAAGATTACCGATGGCAATTATGACAGGTCTCTGGCTGTCAAATGCATCAACGGCACTT
28 V G R K E D G V I V Y R G I P F V G K Q P V G E N R W K A P
991 TTGTCGGCAGGAAAGAAGACGGGGTCATCGTTTACAGGGGGATTCCCTTCGTGGGAAAGCAGCCTGTGGGGGAGAACCGTTGGAAGGCAC
58 V D V V P D D G V Y E A Y Y K G K S P C Q H K D F S D V E D
1081 CGGTGGATGTTGTTCCGGATGACGGCGTATACGAGGCGTATTACAAAGGGAAGAGCCCCTGCCAGCATAAGGATTTCAGCGATGTGGAAG
88 T L I N Q G E D C L Y L N V W K A D D D S T A K K P V M V W
1171 ATACCCTTATCAACCAGGGAGAAGATTGTCTTTATCTGAACGTCTGGAAAGCGGACGATGACAGCACAGCGAAGAAGCCGGTCATGGTGT
118 I H G G A F E F G A A A F S L F E C D N F L R E N P D I I I
1261 GGATCCACGGCGGCGCCTTTGAGTTCGGCGCGGCAGCCTTTTCACTGTTTGAGTGCGATAATTTCCTGAGAGAGAATCCGGATATCATTA
148 V T V A Y R L G I F G Y F H L S H L P D G G D F P D A Q N L
1351 TCGTTACTGTCGCGTACCGGCTGGGTATCTTTGGTTACTTCCACCTGTCCCACCTGCCGGACGGAGGGGATTTCCCGGATGCGCAGAACC
178 G P L D Q L M G L K W V H E N I A G F G G D P D N V T I Y G
1441 TGGGCCCTCTGGATCAGCTTATGGGCTTAAAGTGGGTCCATGAAAACATTGCAGGCTTTGGCGGCGATCCGGACAATGTGACGATCTATG
208 E S A G A G S V S L L P L L K G S H A Y F K R V I A Q S G S
1531 GAGAATCTGCCGGCGCCGGAAGCGTATCCCTGCTTCCGCTTCTCAAGGGTTCCCACGCCTACTTTAAACGGGTTATTGCCCAGAGCGGTT
238 P T L T R S P E E A I D C T K V M M E V L G C K T A A D L M
1621 CCCCTACCCTGACAAGATCCCCGGAAGAGGCTATCGATTGCACGAAGGTAATGATGGAGGTCCTCGGCTGCAAAACTGCTGCCGACCTGA
268 K V D A R T L A D E S E A V R L R I C P E R D G R W L P T D
1711 TGAAGGTAGATGCCCGGACTCTCGCGGACGAATCCGAAGCGGTAAGGCTTCGCATATGTCCGGAACGGGACGGAAGATGGCTGCCGACGG
298 P Y E A Y A G G A A K D I D L M F G C N K N E F D W F A A A
1801 ATCCTTATGAGGCTTATGCCGGGGGAGCGGCGAAGGATATCGACCTTATGTTCGGCTGCAACAAGAATGAATTCGACTGGTTCGCGGCTG
328 M G E E G I K M L A A D R K E R K L D K L P E K E K A L L E
1891 CGATGGGCGAGGAAGGCATCAAAATGCTGGCTGCCGACCGGAAGGAGAGGAAGCTCGACAAGCTGCCGGAGAAGGAGAAGGCCCTGCTCG
358 S F C K D V K G E G C E G E C R L F D Q L W F N A P V I R I
1981 AGAGCTTCTGCAAAGATGTGAAGGGTGAAGGCTGCGAGGGCGAGTGCCGCCTGTTCGACCAGCTCTGGTTTAATGCGCCGGTCATCCGGA
388 S E S Q A A A G G N I H T Y F F T A E P G H G V E L E I I F
2071 TCTCGGAGAGCCAGGCGGCAGCCGGCGGCAATATCCACACCTATTTCTTCACGGCGGAACCCGGACACGGTGTGGAGCTGGAGATCATTT
418 D H Q N T D R E L G R V F D E T F G K T V R K M W V Q F A K
2161 TTGATCATCAGAATACGGATCGTGAACTTGGAAGAGTTTTTGATGAGACCTTCGGAAAGACTGTGCGGAAGATGTGGGTCCAGTTTGCTA
448 T G D P S L S A D I S P D G K A K K W P A Y D P E T R Q V M
2251 AGACCGGCGATCCCTCCCTCAGCGCGGACATTTCTCCGGACGGAAAGGCAAAGAAGTGGCCGGCCTATGACCCGGAGACCCGGCAGGTGA
478 V L D E F D I H S E K E S A V K I V D W D R T Y D L T K Y Y
2341 TGGTCCTGGATGAGTTCGATATCCATAGTGAGAAAGAATCGGCGGTAAAGATTGTAGATTGGGACAGGACCTATGACCTGACCAAATATT
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B.1.7 N18 DNA Insert
1 gcctgccgtcccggtcgccttgcaacccctctggcccaggcctctcagcgctgcaacgaacgtctcgtacttttttgttcacaaccagat
1 M T F S L
91 acaacgtcataaaaaccgtctagcttcagacgacgcgcccaacgcgtgctccgataacaacaatcaaggtgcaggcATGACATTTTCTCT
6 R Q R L P L A I A L A T A L A A T V Q A A P N P Y S G F T V
181 CAGGCAACGCCTGCCGCTGGCCATCGCCCTGGCGACGGCGCTCGCGGCAACCGTGCAGGCGGCTCCCAATCCCTACAGTGGCTTCACCGT
36 F G D S L L D A G Q F P D T G V T G A S L R F T N R V G P G
271 GTTCGGCGACAGCCTGCTTGATGCCGGGCAATTTCCCGATACCGGGGTGACCGGCGCCAGCCTCAGATTCACCAACCGGGTCGGCCCCGG
66 Y S A A G G A V T G P V S S I L L G Q Q L G F D A R T L D A
361 CTACAGCGCCGCCGGCGGCGCGGTGACCGGACCGGTGTCGTCGATCCTGCTCGGCCAGCAACTGGGTTTCGACGCCCGGACCCTGGACGC
96 S T S V I N R L L G L A A G D N W A T G G Y T T A Q I R D S
451 CTCGACCTCGGTGATCAATCGGCTGCTGGGCCTCGCCGCCGGCGACAACTGGGCCACCGGTGGCTACACCACGGCGCAGATTCGCGATTC
126 I T A A N G S V V A A N G L T L R S R D G Y L P G L A S Q G
541 CATCACCGCCGCCAACGGCTCGGTGGTGGCGGCCAATGGCCTGACCCTGCGCAGCCGCGACGGCTACCTGCCCGGACTCGCCAGCCAGGG
156 L R L D P N T L F Y I S G G G N D F L Q G L V T S P A S A A
631 GCTGCGCCTGGATCCCAACACCCTGTTCTATATCAGCGGGGGCGGTAACGACTTTCTCCAGGGCCTGGTCACCTCGCCGGCCAGCGCCGC
186 A A A N R L G D G V A A L Q Q A G A R Y L V V W L L P D I G
721 GGCGGCGGCCAATCGCCTGGGCGATGGCGTCGCCGCCCTGCAGCAGGCCGGTGCGCGCTACCTGGTGGTCTGGCTGCTGCCCGACATCGG
216 R T P A L A G S P Q Q A A S S A L S Q V Y N Q A L V A R L A
811 CCGGACGCCGGCGCTGGCCGGCTCGCCGCAACAGGCGGCCAGCTCGGCCCTGAGCCAGGTCTACAACCAGGCGTTGGTGGCCCGCCTGGC
246 G I D A E I I G L N V P Q L L A E V V A D P A R Y G L A T G
901 CGGCATCGATGCCGAGATCATCGGCCTGAACGTGCCGCAGTTGCTCGCCGAGGTGGTGGCCGATCCGGCGCGCTACGGCCTGGCGACCGG
276 Q D L T G T C F S G D N C T R N T T Y G L G A A A A D P S Q
991 GCAGGATCTCACCGGGACCTGCTTCAGCGGTGACAACTGCACCCGCAACACCACCTACGGCCTGGGCGCCGCGGCAGCGGACCCGAGCCA
306 L L F N D R V H P T I S G Q R L I A D Y A Y S L L A A P W E
1081 GCTGCTGTTCAACGACCGCGTCCACCCGACCATCAGCGGCCAGCGGCTGATCGCCGACTACGCCTATTCGCTGCTGGCCGCGCCCTGGGA
336 V T L L P E M A Q S T L R A H Q D G L H Q R W L G D W Y A W
1171 GGTCACCCTGCTGCCGGAGATGGCGCAGTCCACCCTGAGGGCGCACCAGGATGGCCTGCACCAGCGCTGGCTGGGCGACTGGTATGCCTG
366 Q P V G R W Q G Y V D T S G R R L D V D D Q R S T A G G D G
1261 GCAGCCGGTGGGGCGCTGGCAGGGCTACGTGGATACCAGCGGGCGCCGGCTGGACGTCGACGACCAGCGCAGTACCGCCGGGGGCGATGG
396 N G Y G L D L G G S Y R L S D T W R L G V A A G V S R Q H L
1351 CAACGGCTATGGCCTGGACCTGGGCGGCAGCTACCGGCTCAGCGACACCTGGCGCCTCGGCGTGGCCGCCGGGGTTTCGCGCCAGCACCT
426 E V G A A D S D Y R L N S Y L L S A F A Q Y Q G E R L W G D
1441 GGAGGTGGGTGCGGCCGATTCCGACTATCGCCTGAACAGCTACCTGCTCAGCGCCTTCGCCCAATACCAGGGCGAGCGGCTCTGGGGCGA
456 L T A T G G R L D Y D D L S R R F V L G P T T R S E R G D T
1531 TCTCACCGCCACCGGTGGCCGGCTGGACTACGACGACCTGAGCCGTCGTTTCGTCCTGGGCCCGACCACCCGCAGCGAGCGCGGCGATAC
486 D G D L R A L S A R L G Y D L A A A S S P W H L S P Y L S A
1621 CGACGGCGACCTGCGCGCCCTCTCGGCGCGCCTGGGGTATGACCTGGCGGCCGCCAGCAGTCCCTGGCACCTGAGTCCCTACCTGAGCGC
516 D Y A R V Q V D G Y R E R S S D A A A L A F A D Q S S T S R
1711 CGACTATGCCCGCGTCCAGGTGGACGGCTATCGCGAGCGCAGCAGCGATGCCGCCGCGCTGGCCTTTGCTGACCAGTCGAGTACCTCGCG
546 R L G L G L Q G R W Q F T P A T A L F A D V G R E R E F A D
1801 GCGGCTGGGCCTGGGGCTGCAGGGCCGCTGGCAATTCACCCCGGCCACGGCGCTGTTCGCCGATGTGGGCCGCGAGCGGGAATTCGCCGA
576 G T H D L T M S L N S V P G L D Y T L D G Y Q P D S D R T R
1891 CGGTACCCATGACCTGACCATGAGCCTGAACAGCGTGCCGGGGCTGGACTACACCCTGGACGGCTACCAGCCCGACAGCGACCGCACCCG
606 L S L G V V Q R L T P E L T L R G G Y S Y A G A G D S H Q Q
1981 CCTGAGTCTGGGCGTGGTGCAGCGGCTGACCCCGGAGTTGACCCTGCGCGGTGGCTACAGCTATGCCGGCGCGGGCGATAGCCATCAGCA



























1 M K T T T D Y S Q K A N W C K F P
811 tatttactagattatttatcaataaattaaaataaaaacgATGAAAACAACTACCGATTACTCCCAGAAGGCTAACTGGTGTAAATTCCC
18 Q I T K D V D T F Y I F A T E Y I M G S F E E G A P D Y G T
901 CCAAATTACCAAGGACGTAGATACGTTCTACATATTTGCTACTGAGTATATCATGGGAAGCTTTGAAGAAGGTGCCCCAGATTATGGTAC
48 L D N Q E M I E G M N V E Y L V H A T T Y A D S T N V F A P
991 ACTCGACAATCAAGAGATGATAGAGGGTATGAATGTTGAGTATTTAGTACATGCAACAACATATGCCGACTCAACCAATGTGTTCGCTCC
78 Y Y R Q T G L R F A G D I Y K R D G N F E A A L I G T P I D
1081 ATACTACCGCCAGACTGGTCTAAGGTTTGCTGGTGACATATATAAGAGAGATGGCAATTTCGAGGCTGCGCTTATCGGTACGCCCATTGA
108 D I M A A L D Y Y F E H Y N E G R P F I I A G H S Q G S A L
1171 TGACATCATGGCAGCCCTCGACTACTATTTCGAGCACTACAACGAGGGCCGTCCGTTCATCATCGCAGGTCACAGCCAAGGCTCCGCATT
138 V K V V L M K Y F K E H P D Y Y R R M V A A Y V I G Y S V T
1261 GGTCAAGGTGGTATTGATGAAATACTTCAAGGAACACCCAGACTATTACCGGCGCATGGTGGCTGCCTATGTTATAGGTTACTCCGTCAC
168 K E D L E N Y P Y L K F A T G E S D A G V I V S W N T E G P
1351 AAAAGAAGACCTTGAGAACTATCCGTATCTGAAATTCGCTACTGGCGAGAGTGATGCAGGGGTCATTGTCAGTTGGAACACCGAAGGTCC
198 K N V E E N T K T V V L L P N A I S I N P L N W K R D E T Y
1441 AAAGAATGTTGAGGAGAATACTAAGACCGTTGTGCTGCTACCAAACGCTATCAGCATCAACCCGCTGAACTGGAAGCGCGACGAGACTTA
228 A P A S E N L G S L V V N E E T G E P E I G D L G A D A Q V
1531 TGCGCCCGCCAGCGAGAATCTGGGGTCGCTTGTGGTGAACGAAGAAACCGGAGAGCCTGAGATTGGTGATCTTGGTGCGGACGCACAGGT
258 N L A R G T I V T H A K V V P M P E D A A K V A A E F F G P
1621 GAATCTTGCCCGAGGCACAATCGTGACGCACGCTAAAGTAGTCCCGATGCCCGAGGATGCCGCCAAGGTAGCCGCAGAGTTCTTCGGACC
288 D G R H G E D Y T Y F Y N N I K D N V A K R I A T F K T N M
1711 CGATGGCCGTCATGGTGAAGACTATACATACTTCTACAACAATATCAAGGACAACGTTGCCAAGCGCATCGCCACCTTCAAGACGAATAT










B.1.9 N26 DNA Insert
1 ttgacaatcgtgctgtaggctgcattgtgtgcgccgacggtgcgcaagccatgggttcaacattgtcaacactgcgctcaattgtgcatg
254 Supplementary Data Chapter 3
91 cgttgcggggttggcccacgccttatgctgccgtgattaattccagcctgaagccttttgaggctgatggcagtatcaagaatcccgacg
1 L S S L P A A R A L P P A S R R P L I
181 tggccgctcagctgaatattatggccggtcaggTTGTCGAGTTTGCCCGCCGCGCGCGCCTTGCCGCCAGCGTCGAGGCGTCCGTTAATT
20 K T G V S N M A F E E S F I T V D G C R T R I R R G G K G P
271 AAAACAGGAGTCAGCAATATGGCGTTTGAAGAGTCTTTTATTACCGTTGATGGTTGCCGAACCCGTATCCGGCGGGGTGGCAAAGGGCCA
50 T V L Y L H G A N G A P M I Q P F M E V L A Q D Y D L I V P
361 ACGGTGTTGTATTTGCATGGTGCAAATGGTGCGCCAATGATTCAGCCTTTCATGGAAGTGCTGGCGCAAGATTATGATTTGATCGTGCCC
80 E H P G F G M S D E P E W L D S M Q D L A Y F Y L D L L D H
451 GAGCACCCTGGTTTTGGTATGTCGGATGAGCCCGAATGGCTCGACAGCATGCAAGACCTGGCATATTTTTATCTCGATTTGCTCGACCAT
110 M K L D S V H V V G S S M G G W L G M E M G I R E P R R I K
541 ATGAAGCTAGACAGCGTGCATGTGGTGGGTAGTTCGATGGGTGGCTGGCTCGGTATGGAAATGGGTATTCGTGAGCCCCGTCGTATTAAA
140 S L T L V G T A G V R V P G I L P G D I F L W D A E T A A R
631 TCGCTTACTTTGGTGGGTACGGCCGGTGTGCGTGTTCCGGGTATTTTGCCAGGGGATATTTTTCTCTGGGACGCAGAAACGGCAGCCCGC
170 N T F F N Q D I A Q K V L S M A P K T E E A Q D I M L K N R
721 AATACGTTCTTCAACCAAGACATTGCGCAGAAAGTGCTGTCGATGGCACCCAAAACCGAGGAAGCGCAGGACATCATGCTCAAGAATCGG
200 E T V A R L A W Q P R L F D L N L P K W L H R I Q A P V K L
811 GAAACGGTTGCAAGGCTGGCTTGGCAACCGCGCTTGTTCGATCTTAACTTGCCCAAGTGGCTGCATCGTATTCAGGCGCCGGTCAAGCTG
230 I W G E Q D K I M P L A V G E A L Q P K L P N A T L Q V F K
901 ATATGGGGTGAGCAAGACAAGATTATGCCTTTAGCGGTCGGCGAGGCGTTGCAGCCCAAACTGCCGAATGCGACGTTGCAGGTGTTCAAA

















1 M T F S L R Q R L P
1081 ccgtctagcttcagacgacgcgcccaacgcgtgctccgataacaacaatcaaggtgcaggcATGACATTTTCTCTCAGGCAACGCCTGCC
11 L A I A L A T A L A A T V Q A A P N P Y S G F T V F G D S L
1171 GCTGGCCATCGCCCTGGCGACGGCGCTCGCGGCAACCGTGCAGGCGGCTCCCAATCCCTACAGTGGCTTCACCGTGTTCGGCGACAGCCT
41 L D A G Q F P D T G V T G A S L R F T N R V G P G Y S A A G
1261 GCTTGATGCCGGGCAATTTCCCGATACCGGGGTGACCGGCGCCAGCCTCAGATTCACCAACCGGGTCGGCCCCGGCTACAGCGCCGCCGG
71 G A V T G P V S S I L L G Q Q L G F D A R T L D A S T S V I
1351 CGGCGCGGTGACCGGACCGGTGTCGTCGATCCTGCTCGGCCAGCAACTGGGTTTCGACGCCCGGACCCTGGACGCCTCGACCTCGGTGAT
101 N R L L G L A A G D N W A T G G Y T T A Q I R D S I T A A N
1441 CAATCGGCTGCTGGGCCTCGCCGCCGGCGACAACTGGGCCACCGGTGGCTACACCACGGCGCAGATTCGCGATTCCATCACCGCCGCCAA
131 G S V V A A N G L T L R S R D G Y L P G L A S Q G L R L D P
1531 CGGCTCGGTGGTGGCGGCCAATGGCCTGACCCTGCGCAGCCGCGACGGCTACCTGCCCGGACTCGCCAGCCAGGGGCTGCGCCTGGATCC
161 N T L F Y I S G G G N D F L Q G L V T S P A S A A A A A N R
1621 CAACACCCTGTTCTATATCAGCGGGGGCGGTAACGACTTTCTCCAGGGCCTGGTCACCTCGCCGGCCAGCGCCGCGGCGGCGGCCAATCG
191 L G D G V A A L Q Q A G A R Y L V V W L L P D I G R T P A L
1711 CCTGGGCGATGGCGTCGCCGCCCTGCAGCAGGCCGGTGCGCGCTACCTGGTGGTCTGGCTGCTGCCCGACATCGGCCGGACGCCGGCGCT
221 A G S P Q Q A A S S A L S Q V Y N Q A L V A R L A G I D A E
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1801 GGCCGGCTCGCCGCAACAGGCGGCCAGCTCGGCCCTGAGCCAGGTCTACAACCAGGCGTTGGTGGCCCGCCTGGCCGGCATCGATGCCGA
251 I I G L N V P Q L L A E V V A D P A R Y G L A T G Q D L T G
1891 GATCATCGGCCTGAACGTGCCGCAGTTGCTCGCCGAGGTGGTGGCCGATCCGGCGCGCTACGGCCTGGCGACCGGGCAGGATCTCACCGG
281 T C F S G D N C T R N T T Y G L G A A A A D P S Q L L F N D
1981 GACCTGCTTCAGCGGTGACAACTGCACCCGCAACACCACCTACGGCCTGGGCGCCGCGGCAGCGGACCCGAGCCAGCTGCTGTTCAACGA
311 R V H P T I S G Q R L I A D Y A Y S L L A A P W E V T L L P
2071 CCGCGTCCACCCGACCATCAGCGGCCAGCGGCTGATCGCCGACTACGCCTATTCGCTGCTGGCCGCGCCCTGGGAGGTCACCCTGCTGCC
341 E M A Q S T L R A H Q D G L H Q R W L G D W Y A W Q P V G R
2161 GGAGATGGCGCAGTCCACCCTGAGGGCGCACCAGGATGGCCTGCACCAGCGCTGGCTGGGCGACTGGTATGCCTGGCAGCCGGTGGGGCG
371 W Q G Y V D T S G R R L D V D D Q R S T A G G D G N G Y G L
2251 CTGGCAGGGCTACGTGGATACCAGCGGGCGCCGGCTGGACGTCGACGACCAGCGCAGTACCGCCGGGGGCGATGGCAACGGCTATGGCCT
401 D L G G S Y R L S D T W R L G V A A G V S R Q H L E V G A A
2341 GGACCTGGGCGGCAGCTACCGGCTCAGCGACACCTGGCGCCTCGGCGTGGCCGCCGGGGTTTCGCGCCAGCACCTGGAGGTGGGTGCGGC
431 D S D Y R L N S Y L L S A F A Q Y Q G E R L W G D L T A T G
2431 CGATTCCGACTATCGCCTGAACAGCTACCTGCTCAGCGCCTTCGCCCAATACCAGGGCGAGCGGCTCTGGGGCGATCTCACCGCCACCGG
461 G R L D Y D D L S R R F V L G P T T R S E R G D T D G D L R
2521 TGGCCGGCTGGACTACGACGACCTGAGCCGTCGTTTCGTCCTGGGCCCGACCACCCGCAGCGAGCGCGGCGATACCGACGGCGACCTGCG
491 A L S A R L G Y D L A A A S S P W H L S P Y L S A D Y A R V
2611 CGCCCTCTCGGCGCGCCTGGGGTATGACCTGGCGGCCGCCAGCAGTCCCTGGCACCTGAGTCCCTACCTGAGCGCCGACTATGCCCGCGT
521 Q V D G Y R E R S S D A A A L A F A D Q S S T S R R L G L G
2701 CCAGGTGGACGGCTATCGCGAGCGCAGCAGCGATGCCGCCGCGCTGGCCTTTGCTGACCAGTCGAGTACCTCGCGGCGGCTGGGCCTGGG
551 L Q G R W Q F T P A T A L F A D V G R E R E F A D G T H D L
2791 GCTGCAGGGCCGCTGGCAATTCACCCCGGCCACGGCGCTGTTCGCCGATGTGGGCCGCGAGCGGGAATTCGCCGACGGTACCCATGACCT
581 T M S L N S V P G L D Y T L D G Y Q P D S D R T R L S L G V
2881 GACCATGAGCCTGAACAGCGTGCCGGGGCTGGACTACACCCTGGACGGCTACCAGCCCGACAGCGACCGCACCCGCCTGAGTCTGGGCGT
611 V Q R L T P E L T L R G G Y S Y A G A G D S H Q Q G V G L G
2971 GGTGCAGCGGCTGACCCCGGAGTTGACCCTGCGCGGTGGCTACAGCTATGCCGGCGCGGGCGATAGCCATCAGCAGGGGGTAGGCCTGGG




B.1.11 RR11 DNA Insert
1 M D E A K I Q
1 acaaagagggtgaaaaaacgccgcttgtctactttattcacggcggtggttatcattttggcaatgtgagtATGGATGAAGCGAAGATAC
8 G V A D G C G T T V I A P D Y T L S L D P S Y K Y P M E L E
91 AGGGTGTGGCAGATGGGTGCGGCACCACGGTGATAGCTCCTGACTATACGCTTTCGCTGGATCCTTCATACAAATATCCCATGGAGCTTG
38 Q V Y A G L L Y A Y E H A D E L N I D A D N I V I E G E S A
181 AACAGGTATATGCCGGACTCCTTTATGCTTATGAGCATGCTGACGAATTAAATATCGATGCGGATAACATTGTCATTGAGGGAGAAAGCG
68 G G G L T A R L A L Y N K D K G K V P L K G Q V L I Y P M L
271 CCGGTGGTGGACTGACTGCACGCCTGGCTCTTTACAACAAGGACAAGGGAAAGGTTCCCCTGAAGGGTCAGGTGCTGATATACCCCATGC
98 D Y R T G G E K D I Y K N E Y A G D C I W T K E N N I F G W
361 TTGACTACCGTACCGGCGGCGAAAAAGACATTTACAAGAATGAATATGCCGGGGATTGTATCTGGACCAAGGAGAATAACATCTTCGGAT
128 G K L V E G Q E K K L T D E E M I Y F S P A V A T A E Q L K
451 GGGGGAAACTGGTTGAAGGTCAGGAAAAGAAACTTACCGACGAGGAAATGATCTATTTTTCACCCGCAGTGGCAACTGCTGAGCAACTGA
158 G L P E T F V I V G S L D L F C D E D I S Y A Q K L M E A G
541 AGGGATTGCCAGAGACTTTCGTGATTGTCGGCAGCCTTGATCTTTTCTGCGATGAAGACATTTCCTATGCCCAGAAGCTTATGGAGGCTG
188 V F T E L H V E P G V P H A Y E Y L E W T P Q A H R F I E M
631 GTGTTTTCACAGAACTCCATGTAGAACCCGGAGTTCCTCACGCTTATGAGTACTTAGAGTGGACACCTCAGGCGCATAGGTTTATTGAAA
218 R N H A T A R M L G A E K D V K E S A E A K A F R E L L S K
721 TGAGAAACCATGCGACAGCACGGATGCTTGGAGCTGAAAAAGACGTAAAAGAGTCTGCTGAAGCAAAGGCTTTCAGAGAACTTTTGTCAA
248 Y N I E Q * M S E N M N R P L D Y S Q K
811 AGTATAACATTGAGCAGTAAtacagcctaattaaaaccttataatacaATGAGTGAAAATATGAATCGGCCATTAGATTATTCTCAGAAG
268 A N W Y Q I P E V T K E F D T F Y V Y A T E Y I L S S M E E
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901 GCCAATTGGTATCAGATTCCAGAAGTTACAAAGGAATTCGACACATTTTATGTATATGCAACCGAGTACATCCTGAGTAGCATGGAGGAG
298 G A P D Y A D M E N A E M L E G A A A E Y M L H A T A Y A D
991 GGTGCTCCGGATTATGCTGATATGGAAAATGCCGAAATGCTGGAGGGTGCTGCTGCAGAATATATGTTGCACGCCACCGCATACGCAGAT
328 S T N V F M P Y Y R Q V G L R Y A G V V W K R D G I F D A S
1081 TCCACCAACGTGTTCATGCCTTACTACCGTCAAGTAGGCTTGCGTTATGCCGGGGTCGTCTGGAAGAGGGACGGAATCTTCGATGCCTCC
358 V A G M P Y G D I V A A L D Y Y F E H Y N N G R P F I I A G
1171 GTTGCTGGTATGCCTTATGGCGACATTGTTGCCGCATTAGACTATTACTTCGAGCACTACAACAACGGCCGCCCATTCATCATCGCTGGC
388 H S Q G S A I I K M V L K K Y F V E H P D Y Y K R M I A A Y
1261 CATAGTCAGGGATCGGCTATTATTAAGATGGTGCTAAAAAAATATTTTGTGGAGCACCCCGATTACTACAAGCGTATGATTGCCGCTTAC
418 P I G Y A F T K D E F K T Y P H M K F A T G E C D T G V I I
1351 CCGATTGGCTACGCTTTCACGAAGGACGAGTTCAAGACATACCCACATATGAAGTTTGCCACTGGTGAGTGCGATACGGGTGTTATCATC
448 T W N T E G P K N R E V N A D T C V L Q P G S M S I N P L N
1441 ACCTGGAATACCGAAGGACCTAAGAACAGGGAAGTAAACGCTGATACGTGTGTGCTGCAGCCGGGTTCTATGAGTATAAACCCGCTTAAC
478 W K L D D T Y A P A S M N L G S L F P N K D T G K L E I Q D
1531 TGGAAACTGGACGACACTTATGCTCCGGCCAGCATGAATCTGGGGTCTCTTTTTCCGAACAAAGATACCGGCAAACTGGAGATTCAGGAC
508 L G A D A Q V F P D R G V V V T H A M G E E M T E E T A K V
1621 CTGGGTGCGGACGCACAGGTGTTCCCTGACCGCGGAGTGGTAGTTACCCATGCCATGGGTGAGGAAATGACCGAGGAGACCGCCAAAGTG
538 A A E F F G P D G R H G E D Y V L F Y C N I K D N V A K R I
1711 GCAGCCGAATTCTTCGGCCCTGATGGCCGTCACGGCGAAGATTACGTACTTTTCTATTGCAACATTAAGGATAATGTGGCTAAACGTATC
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Fig. B.2 The Vector Map of pHAT2.
B.1 DNA Inserts 259
Fig. B.3 Sequence similarity network of the SGNH superfamily (Pfam CL0264) containing
hits N2 and N18. They are members of the Lipase GDSL 2 family, where they are located
centrally near other functionally characterised GDSL Lipases (darker blue). The network
built using the four largest families in CL0264 (62,000 sequences clustered into 4,000 nodes
representing 90% of the clan’s sequences), connecting lines represent e-values <10−9, node
size is proportional to the number of sequences represented (range 1 to 1165).
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Fig. B.4 Sequence similarity network for N13, which is a member of the Lipase_bact_N
family. N13 (red) sits between to clusters which each contain one characterised enzyme,
a lipase from A. hydrophila (LIPE_AERHY, yellow) and a lysophospholipase of V. cholerae
(VOLA_VIBCH, blue). Built using Pfam family PF12262 (230 sequences), connecting lines
correspond to e-values <10−100, nodes represent one sequence each.
Fig. B.5 The vectors pHAT, pHAT2, and pHAT5 differ only in their multiple cloning site.
pHAT and pHAT2 can be used to add an N-terminal His-6-tag, pHAT5 can be used to add
a C-terminal His-tag.
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Table B.3 Cloning sites for each hit in vector pHAT as well as expression straindand temper-
ature.
Name N-ter C-ter Gene MW Strain Temperature
(kbp) (kDa) °C
N1ORF4 SpeI HindIII 1.6 61.4 BL21(DE3) 37
N1ORF5 SpeI NotI 1.5 58.3 BL21(DE3) 20
N2Lip SpeI HindIII 1.0 36.2 BL21(DE3) 15
N4ΔSP SpeI NotI 1.2 44.0 SHuffle T7 Express 15
N7 SpeI NotI 1.0 37.1 BL21(DE3) 20
N11 SpeI HindIII 0.8 31.5 SHuffle T7 Express 20
N13 SpeI HindIII 2.4 84.2 BL21(DE3) 20
N16 SpeI HindIII 1.5 58.4 BL21(DE3) 20
N18 SpeI HindIII 1.9 68.1
N20 NcoI NotI 0.9 37.8 Bl21(DE3) 20
N26 SpeI HindIII 0.9 33.4 BL21(DE3) 20
RR11ORF1 SpeI Eco47III 0.9 32.9 BL21(DE3) 20
RR11ORF2 SpeI HindIII 1.0 36.4 BL21(DE3) 37
Fig. B.6 SDS-PAGE of protein purification.
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Table B.4 Michaelis-Menten parameters of the metagenomic hits with
pNP–O–C(––O)– (CH2)n-CH3..
Enzyme n Km / M vmax /(mU/min) kcat / s-1 kcat/Km /(Ms)-1
N1ORF4
0 7.45E-04 ± 8.27E-05 3.38E+02 ± 1.34E+01 1.10E+01 1.47E+04
1 1.29E-03 ± 8.64E-04 9.58E+02 ± 4.34E+02 3.10E+01 2.41E+04
2 9.65E-04 ± 3.96E-04 4.77E+02 ± 1.26E+02 1.55E+01 1.60E+04
3 9.71E-04 ± 1.00E-04 4.50E+02 ± 1.78E+01 1.46E+01 1.50E+04
4 9.48E-04 ± 1.96E-04 8.00E+02 ± 6.33E+01 1.64E+00 1.73E+03
5 1.41E-03 ± 8.52E-04 2.43E+02 ± 9.97E+01 2.49E-01 1.77E+02
6 6.62E-04 ± 4.02E-05 1.31E+02 ± 4.53E+00 3.32E-02 5.01E+01
7 3.86E-03 ± 1.04E+03 8.69E+01 ± 1.68E+01 6.32E-03 1.64E+00
N1ORF5
0 7.74E-04 ± 3.16E-05 1.54E+02 ± 2.27E+00 6.06E-01 7.83E+02
1 1.20E-03 ± 4.29E-04 7.09E+02 ± 1.65E+02 2.79E+00 2.33E+03
2 8.06E-04 ± 2.48E-04 4.56E+02 ± 8.44E+01 1.80E+00 2.23E+02
3 1.69E-03 ± 5.89E-04 1.03E+03 ± 2.73E+02 1.63E+01 9.65E+03
4 1.78E-03 ± 1.12E-03 6.13E+02 ± 2.96E+02 1.03E-01 5.81E+01
5 3.46E-04 ± 1.16E-04 3.77E+01 ± 3.71E+00 7.00E-04 2.17E+00
N2
0 8.45E-03 ± 4.06E-01 7.38E+02 ± 2.61E+01 4.54E+00 5.37E+02
1 1.46E-03 ± 2.52E-01 3.28E+02 ± 2.46E+01 1.01E+00 6.89E+02
2 2.44E-04 ± 3.15E-02 4.72E+01 ± 1.75E+00 1.45E-01 5.97E+02
N4
0 6.23E-03 ± 1.22E+00 2.03E+03 ± 2.72E+02 6.08E+00 9.77E+02
1 1.54E-03 ± 3.22E-01 1.36E+03 ±1.26E+02 4.08E+00 2.65E+03
2 4.28E-04 ± 6.08E-02 9.54E+02 ± 4.18E+01 2.87E+00 6.70E+03
3 3.53E-04 ± 3.95E-02 6.74E+02 ± 2.22E+01 2.86E+00 8.11E+03
4 2.11E-03 ± 8.21E-02 1.28E+03 ± 2.45E+01 5.43E+00 2.58E+03
5 1.01E-03 ± 1.59E-01 2.88E+02 ± 1.77E+01 1.36E+00 1.35E+03
6 1.32E-03 ± 4.62E-01 6.64E+01 ± 9.81E+00 3.95E-01 2.99E+02
N7
0 1.37E-03 ± 1.63E-04 3.38E+02 ± 1.72E+01 3.33E+00 2.43E+03
1 3.14E-03 ± 3.27E-04 6.16E+02 ± 3.58E+01 6.06E+00 1.93E+03
2 2.81E-03 ± 2.47E-03 1.05E+03 ± 7.41E+02 1.04E+01 3.69E+03
3 5.11E-04 ± 3.23E-05 2.69E+02 ± 5.48E+00 6.62E-01 1.29E+03
4 4.98E-04 ± 5.38E-05 6.48E+02 ± 2.24E+01 1.60E-01 3.20E+02
5 8.79E-04 ± 1.88E-04 1.07E+02 ± 8.58E+00 2.63E-02 3.00E+01
6 7.74E-04 ± 5.70E-05 1.08E+02 ± 2.87E+00 9.30E-03 1.20E+01
7 3.64E-04 ± 2.97E-05 3.51E+01 ± 8.50E-01 3.00E-03 8.33E+00
N11
0 5.29E-03 ± 5.31E-03 2.02E+03 ± 1.57E+03 9.96E-01 1.88E+02
1 2.67E-03 ± 5.08E-05 7.11E+02 ± 7.16E+00 3.50E-01 1.31E+02
2 1.26E-03 ± 1.24E-04 5.08E+02 ± 2.08E+01 2.50E-01 1.98E+02
3 1.26E-03 ± 5.96E-05 2.92E+02 ± 5.75E+00 1.44E-01 1.14E+02
4 7.44E-04 ± 5.18E-05 9.45E+01 ± 2.34E+00 3.10E-02 4.17E+01
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Table B.5 Michaelis-Menten parameters of the metagenomic hits with
pNP–O–C(––O)– (CH2)n-CH3.
Enzyme n Km / M vmax /(mU/min) kcat / s-1 kcat/Km /(Ms)-1
N13
0 3.65E-03 ± 2.92E-01 2.76E+02 ± 1.29E+01 7.31E+00 2.00E+03
1 1.81E-03 ± 2.72E-01 6.18E+02 ± 4.33E+01 6.18E+00 3.41E+03
2 7.51E-04 ± 1.32E-01 6.23E+02 ± 3.90E+01 6.24E+00 8.30E+03
3 7.15E-04 ± 8.85E-02 4.17E+02 ± 1.82E+01 4.17E+00 5.84E+03
4 1.27E-03 ± 8.77E-02 5.56E+02 ± 1.61E+01 5.56E+00 4.39E+03
N16
0 3.56E-02 ± 1.85E-02 1.18E+04 ± 5.63E+03 3.64E+00 1.02E+02
1 1.12E-02 ± 2.92E-03 3.49E+03 ± 7.11E+02 1.72E+01 1.53E+03
2 4.61E-03 ± 1.09E-03 6.99E+02 ± 5.48E+02 3.44E+00 7.47E+02
3 1.71E-03 ± 6.20E-04 3.67E+02 ± 9.72E+01 4.52E-01 2.64E+02
4 7.67E-04 ± 1.27E-04 1.52E+02 ± 1.51E+01 4.69E-02 6.11E+01
N20
0 1.33E-03 ± 8.08E-05 1.57E+02 ± 3.40E+00 6.19E+01 1.63E+04
1 2.26E-03 ± 2.51E-04 2.60E+02 ± 2.12E+01 6.39E+02 2.83E+05
2 1.43E-03 ± 6.54E-04 6.57E+02 ± 2.10E+02 2.59E+02 1.81E+05
3 1.17E-03 ± 2.52E-04 1.89E+03 ± 2.60E+02 3.71E+02 3.17E+05
4 1.55E-03 ± 2.01E-04 3.21E+02 ± 2.74E+01 3.16E+01 2.03E+04
5 2.07E-03 ± 1.10E-03 1.03E+03 ± 3.52E+02 5.01E-01 2.45E+02
6 4.43E-03 ± 5.06E-04 4.36E+02 ± 2.49E+01 4.29E-02 9.70E+00
7 4.85E-03 ± 1.18E-03 1.63E+02 ± 2.04E+01 1.60E-02 3.31E+00
N26
0 6.90E-04 ± 1.57E-04 5.11E+02 ± 5.87E+01 5.03E+00 7.29E+03
1 7.50E-04 ± 4.68E-04 3.44E+02 ±1.55E+02 3.39E+00 4.52E+03
2 8.70E-04 ± 1.13E-04 5.07E+02 ± 2.46E+01 1.25E+00 1.43E+03
3 7.46E-04 ± 1.41E-04 4.13E+02 ± 2.79E+01 1.02E+00 1.36E+03
4 8.27E-04 ± 1.28E-04 2.84E+02 ± 1.62E+01 7.00E-01 8.26E+02
5 1.87E-03 ± 1.26E-03 2.80E+02 ± 1.48E+02 6.88E-01 3.68E+02
6 7.97E-04 ± 5.95E-05 1.80E+02 ± 4.89E+00 1.11E-01 1.39E+02
7 1.26E-03 ± 3.81E-04 8.35E+01 ± 1.05E+01 5.14E-02 4.09E+01
RR11ORF1
0 2.18E-03 ± 1.55E-01 1.11E+03 ± 3.92E+01 1.09E+00 5.01E+02
1 2.86E-03 ± 3.31E-01 1.36E+03 ± 8.50E+01 6.67E-01 2.33E+02
2 4.62E-04 ± 1.71E-01 4.39E+02 ± 5.09E+01 2.16E-01 4.68E+02
3 4.84E-04 ± 1.20E-01 3.50E+02 ± 2.75E+01 1.72E-01 3.56E+02
4 7.14E-04 ± 5.93E-02 1.58E+02 ± 4.61E+00 4.13E-02 5.78E+01
RR11ORF2
0 3.02E-02 ± 4.41E+00 5.02E+03 ± 6.60E+02 3.96E+02 1.31E+04
1 2.23E-03 ± 5.99E-01 5.83E+02 ± 7.83E+01 4.63E+01 2.08E+04
2 7.29E-04 ± 2.39E-01 4.54E+02 ± 5.28E+01 3.58E+01 4.91E+04
3 3.79E-04 ± 4.16E-02 1.48E+02 ± 4.86E+00 1.17E+01 3.08E+04
4 2.00E-03 ± 1.99E-01 2.79E+02 ± 1.34E+01 5.49E+00 2.74E+03
5 2.84E-03 ± 4.16E-01 1.26E+02 ± 9.98E+00 7.83E-01 2.76E+02
6 1.54E-03 ± 2.04E-01 3.73E+02 ± 2.20E+01 3.96E-02 2.57E+01
7 7.42E-03 ± 2.17E+00 3.21E+02 ± 6.70E+01 1.70E-02 2.30E+00
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Fig. C.1 Vector Map of pET32 with human ACP (negative control in Kemp assay)
Fig. C.2 Vector Map of pET32 with HG3.17 (positive control in Kemp assay)
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Fig. C.3 Enzymes N20 and HG3.17 were expresed in E. coli BL21(Gold) DE3 overnight at
20 °C with 400 µM IPTG. Enzymes were purified by immobilised metal ion affinity chro-
matography (IMAC). Shown is the elution profile. Fractions eluted at 50 and 100mM imi-
dazole were combined and concentrated.
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Fig. C.4 A: Absorbance versus time for the reaction of 200 µM 5NBI alone or with the in-
dicated reagents in 40mM sodium phosphate at pH 6 and 100mM sodium chloride. B:
Conditions as in A only at pH 8. C: The observed reaction rate constant for BSA is about
10-fold higher than for βCD up to pH 8. The rate constants were determined by linear fits
of the initial velocity of the reaction (up to the first 5min). D: The effect of BugBuster (BB)
and CellLytic (CL) on the reaction. BugBuster did not affect the reaction, where CellLytic led
to an acceleration. Addition of cell lysate (average of three measurements) did not further
affect the reaction in either case. Error bars were omitted for clarity. All reaction rates kobs
were obtained from linear initial velocity fits (slope of first 1 to 5min of reaction).
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Fig. C.5 Shown is the use of tartrazine to offset the absorbance signal. A: If buffer without
a dye to offset the absorbance signal is used, a strong edge effect is visible when a droplet
enters and leaves the detection area. Furthermore, the signal at the centre of the droplet
(corresponding to the transmission of the droplet contents) is very similar to the baseline,
which requires the lowering of the incoming light intensity to avoid saturation effects. Thes
effects lower the observed difference between droplets with and without product. B: Addi-
tion of 3mM tartrazine icnreases the absorbance of all droplets, masking the edge effect and
lowering the signal below the baseline. Thus, the incoming light intensity can be increased
for more sensitive detection.
Fig. C.6 The Kemp elimination catalysed by BSA and buffer in microdroplets. Left: Average
signal versus time for droplets containing 50 µM BSA or buffer only with each 500 µM 5NBI
(conditions as in Table 4.2, No. 5). The buffer catalysed reaction starts at a lower signal
than the BSA catalysed reaction. Right: Data normalised according to normalised according
to 𝑆𝑛(𝑡) = 1 − 𝑆(𝑡)𝑆0 revealed BSA catalysis over background. Error bars are the standard
deviation of the distribution of the mean droplet values. The dotted lines guide the eye.
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Fig. C.7 Sequences of nine randomly picked clones from the epPCR library of HG3.17.
Amino acid mutations are highlighted in blue, dots indicate no change.
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Fig. C.8 Sequences of ten randomly picked clones from the deletion library of HG3.17.
Amino acid deletions are highlighted in blue, dots indicate no change.
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Fig. C.9 Sequences of ten randomly picked clones from the insertion library of HG3.17.
Amino acid insertions are highlighted in blue, dots indicate no change.
Fig. D.1 13C-NMR of 6c.
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Fig. D.2 DEPT-NMR of 6c (negative signals are from carbon atoms connected to a hydrogen
atom via one σ-bond).
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Fig. D.3 HSQC-NMR of 6c (HSQC shows the coupling between carbon and hydrogen atoms
connected via one σ-bond).
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Fig. D.4 HMBC-NMR of 6c (HMBC shows the coupling between carbon and hydrogen
atoms two or three σ-bonds away from each other).
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Fig. D.5 The fluorescence of 6c increased up to 40 µM above which the fluorescence de-
creased again. This self-quenching was indicative of resonance energy transfer between in-
dividual molecules, a behaviour observed for many fluorophores including fluorescein . The
bottom panel shows the two competing effect on relative fluorescence intensity: increasing
absorbance and decreasing efficiency according to [267].
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Fig. D.6 Gel-electrophoresis of the old SCV library (undigested plasmids) shows a smear
indicating degradation of the library.
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Fig. D.7 If E. coli cell are grown at high density for prolonged time on agar plates, they se-
crete polysaccharides to protect themselves. Even after thorough washing, individual cells
are sticky enough to start forming a biofilm (dark grey strings) during droplet generation.
Strings of cells can break off, which causes the co-encapsulation of multiple cells.
